<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/216029-a-zirconium-complex by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 10:12:02 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 216029:A ZIRCONIUM COMPLEX</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">A ZIRCONIUM COMPLEX</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>A compund of Formula I, an N-oxide thereof or suitable salt thereof whereim A and B are idependently O or S; each J is independently a phenyl ring, a naphthyl ring system,a 5-or 6-membered heteroaromatic ring or an aromatic 8-,9-or 10-membered fused heterobicyclic ring system wherein each or ring system is optionally substitued with 1 to 4 R5</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>FORM 2<br>
THE PATENTS ACT, 1970<br>
COMPLETE SPECIFICATION<br>
Section 10<br>
E.I. DU PONT DE NEMOURS AND COMPANY, a corporation organized and existing under the laws of the State of Delaware, USA of 1007 Market Street, Wilmington, Delaware 19898, USA.<br>
The following specification particularly describes invention and the manner In which it is to be performed:<br>
1<br>
\\Vulcah\patent data\geeta\13386(p-10).doc<br>
8 FEB 2008<br><br><br>
BACKGROUND OF THE INVENTION This invention relates to certain heterocyclic diamides, their N-oxides, suitable salts and compositions, and a method of their use for controlling invertebrate pests in both agronomic and nonagronomic environments.<br>
" The control of invertebrate pests is extremely important in achieving high crop efficiency. Damage by invertebrate pests to growing and stored agronomic crops can cause significant reduction in productivity and thereby result in increased costs to the consumer. The control of invertebrate pests in forestry, greenhouse crops, ornamentals, nursery crops, stored food and fiber products, livestock, household, and public and animal health is also important. Many products are commercially available for these purposes, but the need continues for new compounds that are more effective, less costly, less toxic, environmentally safer or have different modes of action.<br>
NL 9202078 discloses N-acyl anthranilic acid derivatives of Formula i as insecticides<br><br>
R1       Z<br>
wherein, inter alia, X is a direct bond; Y is H or CrC6 alkyl; Z is NH2, NH(CrC3 alkyl) or N(C1C3 alkyl)2; and R1 through R9 are independently H, halogen, C1C6 alkyl, phenyl, hydroxy. C1-C6 alkoxy or C1-C7 acyloxy.<br>
WOO 1/070671 discloses 7V-acyl anthranilic acid derivatives of Formula i as arthropodicides<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br><br><br><br><br>
R^NvR3<br>
wherein, inter alia, A and B are independently 0 or S; J is an optionally substituted phenyl ring, 5- or 6-membered heteroaromatic ring, naphthyl ring system or an aromatic 8-s 9- or 10-membered fused heterobicyclic ring system; R1 and R3 are independently H or optionally substituted CrC6 alkyl; R2 is H or CrC6 alkyl; each R4 is independently H, CrC6 alkyl, CrC6 haloalkyl, halogen or CN; and n is I to 4.<br>
SUMMARY OF THE INVENTION This invention pertains to compounds of Formula I, and jV-oxides or suitable salts thereof<br><br><br><br>
10<br><br>
15<br>
20<br><br>
wherein<br>
A and B are independently O or S;<br>
each J is independently a phenyl ring, a naphthyl ring system, a 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system wherein each ring or ring system is optionally substituted with 1 to 4<br>
R5;<br>
K is, together with the two contiguous linking carbon atoms, a 5- or 6-membered heteroaromatic ring optionally substituted with 1 to 3 R4:<br>
n is 1 to 3:<br>
R1 is H; or CrC6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl or C3-C6 cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, N02, hydroxy, C1-C4 alkoxyC1-C4 alkylthio, C1-C4 <br><br>
WO 02/070483<br><br>
PCT7US02/06582<br><br>
3<br>
aikylsulfinyl, C1-C4  alkylsulfonyl, C2-C4 alkoxycarbonyl,C1-C4 alkylamino, C2-C8 dialkyiamino and C3-C6 cycioalkylamino; or R1 is 0,-C6 alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C-3-C8<br>
dialkylaminocarbonyl or C(=A)J; R2 is H, CrC6 alkyl C2-C6 alkenyl, C2-C6 alkynyL C3-C6 cycloalkyl, CrC4 alkoxy, CrC4 alkylamino, C2-C8 dialkyiamino, C3-C6 cycioalkylamino, C2-C6 alkoxycarbonyl or C2-C6 alkylcarbonyl; R3 is H; G; or CrC6 alkyl, C2-C6 alkenyl C2-C6 alkynyl, C3-C6 cycloalkyl, each optionally substituted with one or more substituents selected from the group consisting of G, halogen, CN, N02, hydroxy, C1-C4  alkoxy, C1-C4  haloalkoxy, C1-C4 alkylthio, C1-C4  aikylsulfinyl, CrC4 alkylsulfonyl, C2-C6 alkoxycarbonyl, C2-C6 alkylcarbonyl, C3-C6 trialkylsilyl, or a phenyl, phenoxy or 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6; or R2 and R3 can be taken together with the nitrogen to which they are attached to form a ring containing 2 to 6 atoms of carbon and optionally one additional atom of nitrogen, sulfur or oxygen, and said ring may be optionally substituted with one to four substituents selected from R12; and G is a 5- or 6-membered nonaromatic carbocyclic or heterocyclic ring, optionally including one or two ring members selected from the group consisting of C(=0), SO or S(0)2 and optionally substituted with one to four substituents selected from R12; each R4 is independently H, CrC,5 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, CrC6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, N02, hydroxy, C1-C4  alkoxy, C1-C4  haloalkoxy, C1-C4  alkylthio, C3-C4 aikylsulfinyl,C1-C4  alkylsulfonyl, C1-C4  haloalkylthio., C1-C4  haloalkylsulfmyl, CrC4 haloalkylsulfonylC1-C4  alkylamino, C2~C&amp; dialkyiamino, C3-C6 cycioalkylamino, C1-C4  alkoxyalkyl, C1-C4  hydroxyalkyl, C(0)R10, C02R10, CCONR^Rl^NR^Ri^NCRl^^R10; or each R4 is independently a phenyl, benzyl, phenoxy or 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6; each R5 is independently H, CrC6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, CrC6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C2-C6 halocycloalkyl, halogen, CN, C02H, CONH2, N02, hydroxy, CrC4 alkoxy,     â–  C1-C4  haloalkoxy C1-C4  alkylthio, C1-C4 aikylsulfinyl, CrC4 alkylsulfonyl, C1-C4  haloalkylthioC1-C4 haloalkylsulfmyl, C1-C4  haloalkylsulfonyl,C1-C4 alkylamino, C2-C^ dialkylammo, C3-C6 cycioalkylamino, C2-C6 alkylcarbonyl.<br><br>
WO 02/070483<br><br>
PCT/TJS02/06582<br><br>
C2-C6 alkoxycarbonyl, C2-C6 alkylaminocarbonyL C3-Cg dialkylaminocarbonyl,<br>
C3-C6 trialkylsiiyl; or<br>
each R5 is independently a phenyl, benzyl, benzoyl, phenoxy, 5- or 6-membered<br>
heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic<br>
5	ring system, each ring or ring system optionally substituted with one to three<br>
substituents independently selected from R6; or (R5)2 when attached to adjacent carbon atoms can be taken together as -OCF2O-,<br>
-CF2CF20-&gt; or -OCF2CF20-; and<br>
each R6 is independently C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C3-C6<br>
10	cycloalkyl, C1-C4 haloalkyl, C2-C4 haloalkenyl,C1-C4  haloalkynyl, C3-C6<br>
halocycloalkyl, halogen, CN, N02, C1-C4  alkoxy, C1-C4  haloalkoxy, C1-C4 <br>
alkylthio, C1-C4 alkylsulfmyl,C1-C4  alkylsulfonyl, C1-C4  alkylamino, C2-C.g<br>
dialkylamino, C3-C6 cycloalkyl amino, C4-C6 (alkyl)cycloalkylamino,C1-C4 <br>
alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3-C%<br>
15	dialkylaminocarbonyl or C3-C6 trialkylsiiyl;<br>
each R10 is independently H, C1-C4  alkyl or C1-C4  haloalkyl; each R1 T is independently H or C1-C4 alkyl; and<br>
each R12 is independently C]-C2 alkyl, halogen, CN, N02 or Ci~C2 alkoxy. This invention also pertains to a method for controlling an invertebrate pest comprising 20      contacting the invertebrate pest or its environment with a biologically effective amount of a compound of Formula I, an TV-oxide thereof or a suitable salt of the compound (e.g., as a composition described herein). This invention also relates to such a method wherein the invertebrate pest or its environment is contacted with a biologically effective amount of a compound of Formula I or a composition comprising a compound of Formula I, an TV-oxide 25      thereof or a suitable salt of the compound and a biologically effective amount of at least one additional compound or agent for controlling invertebrate pests.<br>
This invention also pertains to a composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Formula I, an TV-oxide thereof or a suitable salt of the compound and at least one additional component selected from the 30      group consisting of surfactants, solid diluents and liquid diluents. This invention also pertains to a composition comprising a biologically effective amount of a compound of Formula I, an TV-oxide thereof or a suitable salt of the compound and an effective amount of at least one additional biologically active compound or agent.<br>
DETAILS OF THE INVENTION<br>
35	In the above recitations, the term "alky!", used either alone or in compound words such<br>
as "alkylthio" or "haloalkyl" includes straight-chain or branched alkyl, such as, methyl, ethyl, . propyl, z-propyl, or the different butyl, pentyl or hexyl isomers. "Alkenyl" includes straight-chain or branched alkenes such as ethenyl, 1-propenyl, 2-propenyl, and the different<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
5<br>
butenyl. pentenyl and hexenyl isomers. "Alkenyl" also includes polyenes such as 1,2-propadienyl and 2,4-hexadienyl. "Alkynyl" includes straight-chain or branched alkynes such asethynyl, 1-propynyl, 2-propynyl and the different butynyl, pentynyl and hexynyl isomers. "Alkynyl" can also include moieties comprised of multiple triple bonds such as 2.5-hexadiynyl. "Alkoxy" includes, for example, methoxy, ethoxy, Â«-propyloxy, isopropyloxy and the different butoxy, pentoxy and hexyldxy isomers. "Alkoxyalkyl" denotes alkoxy substitution on alkyl. Examples of "alkoxyalkyl" include CH3OCH2, CH3OCH2CH2, CH3CH2OCH2, CH3CH2CH2CH2CH2 and CR3CH2CH22CH2 "Alkylthio" includes branched or straight-chain alkylthio moieties such as methylthio, ethylthio, and the different propylthio and butylthio isomers. "Alkylsulfmyl" includes both enantiomers of an alkylsulfmyl group. Examples of "alkylsulfmyl" include CH3S(0), CH3CH2S(0)5 CH3CH2CH2S(0), (CH3)2CHS(0) and the different butylsulfmyl isomers. Examples.of "alkylsulfonyl" include CH3S(0)2, CH3CH2S(0)2, CH3CH2CH2S(0)2, (CH3)2CHS(0)2 and the different butylsulfonyl isomers. "Alkylamino", "dialkylamino", "alkenylthio", "alkenylsulfmyl", "alkenylsulfonyl", "alkynylthio", "alkynylsulfinyl", "alkynylsulfonyl"., and the like, are defined analogously to the above examples. "Cycloalkyl" includes, for example, cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl. "Aromatic" indicates that each of the ring atoms is essentially in the same plane and has a^-orbital perpendicular to the ring plane, and in which (4n + 2) 71 electrons, when n is 0 or a positive integer, are associated with the ring to comply with Hiickel"s rule. The term "aromatic ring system" denotes fully unsaturated carbocycles and heterocycles in which at least one ring of a polycyclic ring system is aromatic. The term "aromatic carbocyclic ring or ring system" includes fully aromatic carbocycles and carbocycles in which at least one ring of a polycyclic ring system is aromatic (e.g. phenyl and naphthyl). The term "nonaromatic carbocyclic ring or ring system" denotes fully saturated carbocycles as well as partially or fully unsaturated carbocycles where the Hiickel rule is not satisfied by any of the rings in the ring system. The term "hetero" in connection with rings or ring systems refers to a ring or ring system in which at least one ring atom is not carbon and which can contain I to 4 heteroatoms independently selected from the group consisting of nitrogen, oxygen and sulfur, provided that each ring contains no more than 4 nitrogens, no more than 2 oxygens and no more than 2 sulfurs. The terms "heteroaromatic ring or ring system" and "aromatic fused heterobicyclic ring system" includes fully aromatic heterocycles and heterocycles in which at least one ring of a polycyclic ring system is aromatic (where aromatic indicates that the Kuckel rule is satisfied). The term "nonaromatic heterocyclic ring or ring system" denotes fully saturated heterocycles as well as partially or fully unsaturated heterocycles where the Hiickel rule is not satisfied by any of the rings in the ring system. The heterocyclic ring or ring system can be attached through any available carbon or nitrogen by replacement of a hydrogen on said carbon or nitrogen.<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
6<br>
The term "halogen", either alone or in compound words such as "haloalkyl", includes fluorine, chlorine, bromine or iodine. Further, when used in compound words such as "haloalkyl", said alkyl may be partially or fully substituted with halogen atoms"which mayÂ¬be the same or different. Examples of "haloalkyl" include F3C, C1CH2, CF3CH2 and 5      CF3CC12. The terms "haloalkenyl", "haloalkynyl", "haloalkoxy", "haloalkylthio", and the like, are defined analogously to the term "haloalkyl". Examples of "haloalkenyl" include (C1)2C-CHCH2 and CF3CH2CH=CHCH2. Examples of "haloalkynyl" include HOCCHCL CF3CsC, CC13C=C and FCH2C=CCE2- Examples of "haloalkoxy" include CF30, CC13CH20, HCF2CH2CH20 and CF3CH20. Examples of "haloalkylthio" include CCl3S, 10     CF3S, CC13CH2S and C1CH2CH2CH2S. Examples of "haloalkylsulfinyl" include CF3S(0), CC13S(0), CF3CH2S(0) and CF3CF2S(0). Examples of "haloalkylsulfonyl" include CF3S(0)2, CC13S(0)2, CF3CH2S(0)2 and CF3CF2S(0)2.<br>
Examples of "alkylcarbonyl" include C(0)CH3, C(0)CH2CH2CH3 and C(0)CH(CH3)2. Examples of "alkoxycarbonyl" include CH30C(=O),"CH3CH20C(=0), 15      CH3CH2CH2OC(=0), (CH3)2CHOC(=0) and the different butoxy- or pentoxycarbonyl isomers. Examples of "alkylaminocarbonyl" include CH3NHC(=0), CH3CH2NHC(=0), CH3CH2CH2NHC(=0), (CH3)2CHNHC(=0) and the different butylamino- or pentylaminocarbonyl isomers. Examples of "dialkylaminocarbonyl" include (CH3)2NC(=0), (CH3CH2)2NC(=0), CH3CH2(CH3)NC(=0), CH3CH2CH2(CH3)NC(=0) 20     and (CH3)2CHN(CH3)C(=0).<br>
The total number of carbon atoms in a substituent group is indicated by the "CiCj" prefix where i and j are numbers from 1 to 6. For example, C1-C3 alkylsulfonyl designates methylsulfonyl through propylsulfonyl; C2 alkoxyalkyl designates CH3OCH2; C3 alkoxyalkyl designates, for example, CH3CH(O.CH3), CH3OCH2CH2 or CH3CH2OCH2; 25      and C4 alkoxyalkyl designates the various isomers of an alkyl group substituted with an alkoxy group containing a total of four carbon atoms, examples including CH3CH2CH2OCH2 and CH3CH2OCH2CH2.<br>
In the above recitations, when a compound of Formula I is comprised of one or more heterocyclic rings, all substituents are attached to these rings through any available carbon or 30     nitrogen by replacement of a hydrogen on said carbon or nitrogen.<br>
When a compound is. substituted with a substituent bearing a subscript that indicates the number of said substituents can exceed 1, said substituents (when they exceed 1) are independently selected from the group of defined substituents. Further, when the subscript indicates a range, e.g. (R)i_j, then the number of substituents may be selected from the 55      integers between i and j inclusive.<br>
The term "optionally substituted with one to three substituents" and the like indicates that one to three of the available positions on the group may be substituted. When a group contains a substituent which can be"hydrogen, for example R1 or ~R5, then, when this<br><br>
WO 02/070483<br><br>
PCT7US02/06582<br><br>
7<br>
suhstituent is taken as hydrogen, it is recognized that this is equivalent to said group being unsubstituted.<br>
Compounds of this invention can exist as one or more stereoisomers. The various stereoisomers include enantiomers, diastereomers, atropisomers and geometric isomers. One skilled in the art will appreciate that one stereoisomer may be more active and/or may exhibit beneficial effects when enriched relative to the other stereoisomer(s) or when separated from the other stereoisomer(s). Additionally, the skilled artisan knows how to separate, enrich, and/or to selectively prepare said stereoisomers. Accordingly, the present invention comprises compounds selected from Formula I, TV-oxides and agriculturally suitable salts thereof. The compounds of the invention may be present as a mixture of stereoisomers, individual stereoisomers, or as an optically active form.<br>
One skilled in the art will appreciate that not all nitrogen containing heterocycles can form TV-oxides since the nitrogen requires an available lone pair for oxidation to the oxide; one skilled in the art will recognize those nitrogen containing heterocycles which can form //-oxides. One skilled in the art will also recognize that tertiary amines can form TV-oxides. Synthetic methods for the preparation of TV-oxides of heterocycles and tertiary amines are very well known by one skilled in the art including the oxidation of heterocycles and tertiary amines with peroxy acids such as peracetic and w-chloroperbenzoic acid (MCPBA), hydrogen peroxide, alky! hydroperoxides such as /-butyl hydroperoxide, sodium perborate, and^dioxiranes such as dimethydioxirane. These methods for the preparation of TV-oxides have been extensively described and reviewed in the literature, see for example: T. L. Gilchrist in Comprehensive Organic Synthesis, vol. 7, pp 748-750, S. V. Ley, Ed., Pergamon Press; M. Tisler and B. Stanovnik in Comprehensive Heterocyclic Chemistry, vol. 3, pp 18-20, A. J. Boulton and A. McKillop, Eds., Pergamon Press; M. R. Grimrnett and B. R. T. Keene in Advances in Heterocyclic Chemistry, vol. 43, pp 149-161, A. R. Katritzky, Ed., Academic Press; M. Tisler and B. Stanovnik in Advances in Heterocyclic Chemistry, vol. 9, pp 285-291, A. R. Katritzky and A. J. Boulton, Eds., Academic Press; and G. W. H. Cheeseman and E. S. G. Werstiuk in Advances in Heterocyclic Chemistry, vol. 22, pp 390-392, A. R. Katritzky and A. J. Boulton, Eds., Academic Press.<br>
The salts of the compounds of the invention include acid-addition salts with inorganic or organic acids such as hydrobromic, hydrochloric, nitric, phosphoric, sulfuric, acetic, butyric, furnaric, lactic, maleic, malonic, oxalic, propionic, salicylic, tartaric, 4-toluenesulfonic or valeric acids. The salts of the compounds of the invention also include those formed with organic bases (e.g., pyridine, ammonia, or triethylamine) or inorganic bases (e.g., hydrides, hydroxides, or carbonates of sodium, potassium, lithium, calcium, magnesium or barium) when the compound contains an acidic group such as a carboxylic acid or phenol.<br><br>
â–  WO 02/070483<br><br>
PCT/US02/06582<br><br>
8<br>
As noted above, J is a phenyl ring, a naphthyl ring system, a 5- or 6-membered<br>
heteroaromatic ring or an aromatic 8-. 9- or 10-membered fused heterobicyclic ring system<br>
wherein each ring or ring systsm is optionally substituted with 1 to 4 R5. The term<br>
"optionally substituted" in connection with these J groups refers to groups which are<br>
unsubstituted or have at least one non-hydrogen substituent that does not extinguish the<br>
biological activity possessed by the unsubstituted analog. An example of phenyl optionally<br>
substituted with 1 to 4 R5 is the ring illustrated as U-l in Exhibit 1, wherein Rv is R5 and r is<br>
an integer from 1 to 4. An example of a naphthyl group optionally substituted with 1 to 4 R5<br>
is illustrated as U-85 in Exhibit 1, wherein Rv is R5 and r is an integer from 1 to 4.<br>
Examples of 5- or 6-membered heteroaromatic rings optionally substituted with 1 to 4 R5<br>
include the rings U-2 through U-53 illustrated in Exhibit 1 wherein Rv is R5 and r is an<br>
integer from 1 to 4. Note that J-l through J-13 below also denote 5- or 6-membered<br>
heteroaromatic rings. Note that U-2 through U-20 are examples of J-l, U-21 through U-35<br>
and U-40 are examples of J-2, U-36 through U-39 are examples of J-3, U-41 through U-48<br>
are examples of J-4 and U-49 through U-53 are examples of J-5. Note that J-6 is a subset of<br>
U-l 1, J-7 or J-10 are a subset of U-26, J-8 is a subset of U-42, J-9 is a subset of U-45, J-l 1 is<br>
a subset ofXJ-4 and J-12 or J-13 are a subset of U-24. Also note that in J-6 through J-13 that<br>
R7 and R9 are subsets of R5. Examples of aromatic 8-, 9- or 10-membered fused<br>
heterobicyclic ring systems optionally substituted with 1 to 4 R5 include U-54 through U-84<br>
illustrated in Exhibit 1 wherein Rv is R5 and r is an integer from 1 to 4.<br>
Although Rv groups are shown in the structures U-l through U-85, it is noted that they<br>
do not need to be present since they are optional substituents. Note that when Rv is H when<br>
attached to an atom, this is the same as if said atom is unsubstituted. The nitrogen atoms that<br>
require substitution to fill their valence are substituted with H or Rv. Note that some U<br>
groups can only be substituted with less than 4 Rv groups (e.g. U-14, U-15, U-l 8 through<br>
U-21 and U-32 through U-34 can only be substituted with one Rv). Note that when the<br>
attachment point between (Rv)r and the U group is illustrated as floating, (Rv)r can be   .<br>
attached to any available carbon atom of the U group. Note that when the attachment point<br>
on the U group is illustrated as floating, the U group can be attached to the remainder of<br>
Formula I through any available carbon of the U group by replacement of a hydrogen atom.<br>
Exhibit 1<br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
4      3<br><br><br>
-WO 02/070483<br><br>
PCT7US02/06582<br><br>
10<br><br><br>
11<br><br><br><br>
As noted above, K is, together with the two contiguous linking carbon atoms, a 5-or 6-5     membered heteroaromatic ring optionally substituted with 1 to 3 R4. Examples of said K rings wherein said rings are optionally substituted with 1 to 3 R4include the ringsystems illustrated as K-l to K-37 in Exhibit 2, wherein n is an integer from 1 to 3 and R4 is as defined above. The term "optionally substituted" in connection with these K groups refers to K groups which are unsubstituted or have at least one non-hydrogen substituent that does not 10     extinguish the biological activity possessed by the unsubstituted analog. As with the carbon<br>
atoms in the ring, the nitrogen atoms that require substitution to fill their valence are substituted with hydrogen or with R4. Although (R4)n groups are shown in the structures K-l to K-37, it is noted that R4 does not need to be present since it is an optional substituent. Note that some K groups can only be substituted with less than 3 R4 groups (e.g. K-7 15     through K-10, K-15, K-16, K-20, K-21, K-23, K-24, K-26 and K-27 can only be substituted with one R4). In the exemplified K groups, the upper right bond is attached through the available linking carbon atom to the nitrogen atom of the NR1(=A)J portion of Formula I and the lower right bond is attached through the available linking carbon atom to the carbon<br><br>
WO 02/070483<br><br>
PCT/US02/O6582<br><br>
12 atom of the C(=B)NR2R3 portion of Formula I. The wavy line indicates that the K ring is attached to the remainder of Formula I as illustrated below.<br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br><br>
13<br>
Preferred K rings include optionally substituted thiophene, isoxazole, isothiazole, pyrazole, pyridine and pyrimidine rings. More preferred K rings include K-l, K-14, K-15, K-18, K-23, K-28, K-29, K-30, K-31 and K-33. Most preferred are K-28, K-31 and K-33.<br>
As noted above, R3 can be (among others C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, each optionally substituted with one or more substituents selected from the group consisting of a phenyl ring, or 5- or 6-memberedheteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6. Examples of such rings incorporated into said R3 groups include the rings illustrated as U-l through U-53 and U-86 illustrated in Exhibit 1, except that such rings are optionally substituted with 1 to 3 substituents independently selected from R6 rather than (Rv)r and are attached.to an R3 group selected from the list immediately above.<br>
As noted above, R3 can"be (among others) G, or C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, each optionally substituted with G; wherein G is a 5- or 6-membered nonaromatic carbocyclic or heterocyclic ring, optionally including one or two ring members selected from the group consisting of C(=0). SO or S(0)2 and optionally substituted with 1 to 4 substituents selected, from R12. The term "optionally substituted" in connection with these G groups refers to groups which are unsubstituted or have at least one non-hydrogen substituent that does not extinguish the biological activity possessed by the<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
14<br><br>
10<br><br>
unsubstituted analog. Note that when the attachment point on the G group is illustrated as floating, the G group can be attached to the remainder of Formula I through any available carbon of the G group by replacement of a hydrogen atom. The optional substituents can be attached to any available carbon by replacing a hydrogen atom. Examples of 5- or 6-membered nonaromatic carbocyclic rings as G include the rings illustrated as G-1 through G-8 of Exhibit 3. Examples of 5- or 6-membered nonaromatic heterocyclic rings as G include the rings illustrated as G-9 through G-48 of Exhibit 3. Note that when G comprises a ring selected from G-31 through G-34, G-37 and G-38, Q} is selected from O, S or N. Note that when G is G-11, G13, G-14, G16, G-23, G-24, G-30 through G-34, G-37 and G-38 and Q1 is N5 the nitrogen atom can complete its valence by substitution with either H or C1-C2 â– alkyl.<br>
Exhibit 3<br><br><br><br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br><br>
As noted above, each R4 can be independently (among others) a phenyl, benzyl, phenoxy or 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6. Examples of such R4 groups include the rings or ring systems illustrated as U-1 through U-53, U-86 and U-87 illustrated in 5     Exhibit 1, except that such rings are optionally substituted with 1 to 3 substituents independently selected from R6 rather than (Rv)r.<br>
As noted above, each R5 can be independently (among others) a phenyl, benzyl, benzoyl, phenoxy, 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system, each ring optionally substituted with one to 10     three substituents independently selected from R6. Examples of such R3 groups include the rings or ring systems illustrated as U-1 through U-88 illustrated in Exhibit 1, except that such rings are optionally substituted with 1 to 3 substituents independently selected from R6 rather than (Rv)r<br>
Preferred compounds for reasons of better activity and/or ease of synthesis are:<br>
15	Preferred 1. Compounds of Formula I above, and TV-oxides and suitable salts thereof,<br>
wherein A and B are both O and J is a phenyl ring optionally substituted with 1 to 4 R5. Preferred 2. Compounds of Preferred 1 wherein<br>
each R4 is independently C1-C4 alkyl C]-C4 haloalkyl, halogen, CN, N02 or<br>
20	C1-C4 alkoxy, and one R4 group is attached to the K ring at the atom<br>
adjacent to either the NR! C(=A) J moiety or the C(=B)NR2R3 moiety;<br>
and<br>
each R5 is independently H, halogen,C1-C4 allcyl, Cy-O^ alkoxy, C1-C4<br>
haloalkyl, CN, N02, C1-C4haloalkoxyC1-C4 alkylthio, C3-C4<br>
25	alkylsulfinyl, C1-C4 alkylsulfonyl, CrC4 haloalkylthio, CrC4<br>
haloalkylsulfinyl,C1-C4 haloalkylsulfonyl or C2-C4 alkoxycarbonyl; or<br><br>
each R5 is independently a phenyl or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6; or<br>
(R5)2 when attached to adjacent carbon atoms can be taken together as -0CF2O-, -CF2GF20- or -OCF2CF20-. Preferred 3. Compounds of Preferred 2 wherein<br>
Rl"isHj/;- ;"<br>
R2isHorC%<br>
R3 is 0^04 alkyl optionaUy substituted with one or more substituents<br>
independently selected from halogen, CN, QCH3or S(0)pGH3;	â€¢<br>
each R4 is independently CH3, C^.CN or halogen, and one R4 group is attached to the Kring at the atom adjacentto me NRk^A^ moiety;<br>
each R5 is independently H, halogen, methyl, CF3, OCF3, OCHF2, S(0)peF3, S(0)pCHF2, OCH2CF3, QCF2CHF2, S(0)pCI^CI^orS(0)p(^CHF2r^ or aphenyl, pyrazole, imidazole; triazole, pyridine or pyrimidine ring, each ring optionally substituted with; one to three substituents independently selected from C1-C4 alkyl, C1-C4haloalkyl, halogen or CN;and<br>
pisO, 1 or 2. Preferred 4. Compounds of Preferred 3 wherein R3 is C2-C4 alkyl. Preferred 5. Compounds of Formula I wherein<br>
A and B are both O;<br>
J is a 5- or 6-membered heteroaromatic ring selected from the group consisting of J-l, J-2, J-3, J-4 and J-5, each J optionally<br>
J-l	J-2	J-3	J-4	J-5	.<br>
Q is O, S or NR5; and<br>
W, X, Y and Z are independently N or CR5, provided that in J-4 and J-5 at<br>
least one of W, X, Y or Z is N. Preferred 6. Compounds of Preferred 5 wherein<br>
each R4 is independently CrC4 alkyl, CrC4 haloalkyl, halogen, CN, N02 or<br>
C1-C4 alkoxy, and one R4 group is attached to the K ring at the atom<br><br>
17<br><br>
10<br><br>
adjacent to either die NR1C(=A)J moiety or the C(=B)NR2R3 moiety;   :  and each R5 is independently H,C1-C4 alkyl* C1-C4 haloalkyl, halogen, CN, NQ2, C1-C4 haloalkoxy, C1-C4 all^lthio, C2-C4 alkylsulfinyl, C1-C4 alkylsulfonyl,C1-C4 haloalkylthio, C1-C4 halpalkylsulfiriyl,C1-C4 haloalkylsulfonyl or C2-C4 alkoxycarbonyl; or a phenyl or a 5- or 6~membered heteroaromatic ring, each ring optionally substituted with<br>
: R6.   .,."	<br>
Preferred 7. Compounds of Preferred 6 wherein r<br>
J is selected from the group consisting of J-6,K7.-J-8, J-9, J-10, J-ll, J-12 and^<br>
1-13     "â– ";â– .	<br><br><br>
N-^.<br><br>
R9<br><br><br><br><br>
and<br><br>
R5 is H, CrC4 alkyl, CrC4 haloalkyl, or<br><br><br><br><br>
15<br><br>
V is N, CH, CF, CC1, CBr or CI;<br>
each R6 and R7 is independently H, C1-C6 alkyl, C3-C6 cycloalkyl, Cj-Cg.<br>
haloalkyl, halogen, CN, C1-C4 alkoxy, C1-C4 haloalkoxy orC1-C4<br>
haloalkylthio; and<br><br>
18 ...:""":<br>
R9 is H, CrC6 alkyl, CrC6 haloalkyl, C3-C6 alkenyl, C3-C6 haloaJkenylJ â–  C3~C6alkynylor C3-C6 haloalkynyl; provided R7 and R9 are not both<br>
H. .".â– â– ".	.;,:.;â– ;"":"â– ".	:?:i<br>
Preferred 8. Compounds of Preferred 7 wherein VisN.<br>
5	Preferred9. Compounds of Preferred 7 whferem Vis CH.CF, CClor CBr.<br>
Preferred 10. Compounds of Preferred 8 or Preferred 9 wherein â€¢  Rfis"H; R2isHorCH3;<br>
R3 is C1-C4 alkyl optionally substituted with one or more substituents<br>
10	independently selected from halogen, CN, OCH3 or S(0)pCH3;<br>
each R4 is mdependenfly CH3, CF3, CN or halogen, and one R4 group is<br>
attached to the Kring at the atom adjacent to the NR1C(=A)J moiety;<br>
R6 is CJ-C4 alkyl, C!-C4 haloalkyl, halogen or CN;<br>
R7 is H, CH3, CF3, OCH2CF3, OCHF2 or halogen; and<br>
15	pis0,lor2.<br>
Preferred 11. Compounds of Preferred 10 wherein R? is C1-C4 alkyl; one R4 group is<br>
independently CH3, CI, Br or I and is attached to the K ring at the atom adjacent<br>
to the NRiC^A)! moiety; and a second optional R4 is H, F, CI, Br, f or CF3.     i<br>
Preferred 12. Compounds of Preferred 11 wherein J is J-6; R6 is CI or Br; and R7 is<br>
20	halogen, 6CH2CF3 or CF3.<br>
Preferredl3. Compound^ of Preferred 12 wherem VisN; R3 is methyl, ethyl,<br>
isopropyl, tertiary butyl or; and R7 is Br, CI, OCH2CF3 or CF3.<br>
Preferred 14. Compounds of Preferred 11 wherein J is J-7; R6 is CI or Br; and R9 is<br>
CF3, CHF2, CH2CF3 or CF2CHF2.<br>
25	Preferred 15. Compounds of Preferred 11 wherein J is J-8; R6 is. CI or Br; and R7 is<br>
halogen, OCH2CF3 or CF3. Preferred 16. Compounds of Preferred 11 wherein J is J-9; R6 is Cl or Br; and R7 is<br>
OCH2CF3orCF3.<br>
Preferred 17. Compounds of Preferred 11 wherein J is J-10; R6 is Cl or Br; and R9 is<br>
30	CF3,CHF2,CH2CF3orCF2CHF2.<br>
Preferred 18. Compounds of Preferred 11 wherein J is J-l 1; R6 is Cl or Br; and R7 is<br>
halogen, GCH2CF3, or CF3.<br>
Preferred^19. Compounds of Preferred 11 wherein J is J-12; R6 is Cl or Br; R7 is H,<br>
halogen or CF3, and R9 is H, CF3, CHF2, CH2CF3, or CF2CHF2.<br>
35	Preferred 20. Compounds of Preferred 11 wherein J is J-13; R6 is Cl or Br; and R9 is H,<br>
CF3, CHF2, CH2CF3 or CF2CHF2.<br><br>
r WO 02/070483<br><br>
PCT/US02/065S2<br><br>
19 Most preferred is the compound of Formula I selected from the group consisting of:<br>
4-[[[l-(2-Chlorophenyl)-3-(1xifluoromemyI)4i7-pyra2ol-5-yiJcarbonyl]amirio]-5-methyl-jV-1 -methylethyl)-3-pyridincarboxamide.<br>
4-Methyl-A^-(l-methylethyl)-3-[[2--methyl-4-(triiluoromethyI)ben2oyl]amino]-2" thiophencarboxamide,<br>
l-Methyl-iV-(l-memylethyl&gt;5-[[4^trifluoromemyl)benzoyl]ammo]4ii/"-pyrazole-4-carboxamide;<br>
4-[[[3-Bromo-1 -(3-chloro-2-pyridinyl)- l#-pyrazol~5-yI]carbonyl]amino]-5-chloro-7V-methyl-3-pyridinecarboxamide;<br>
3-[[[3-Bromo-l-(3-chloro-2-pyridinyl)-lif-pyrazol-5-yl]carbonyl]ammo]-2,6-dichloro-Ar-methyl-4-pyridinecarboxarmde;<br>
2.6-dichloro-3 -[[[ 1 -(3-chloro-2-pyri dinyl)-3 -(trifluoromethyl)- lff-pyrazol- 5 -yl]carbonyI]amino]-7V-(l -methylethyl)- 4-pyridinecarboxamide; 3-[[[3-Brorno-1 -(3-chloro-2-pyridinyI)- li7-pyrazol-5-yl]carbonyIjamino]-6-chioro-A/,4-dimethyl-2-pyridinecarboxamide;<br>
3-[[[3-Bromo4-(3-chloro-2-pyridinyl)-lF-pyrazol-5-yl]carbonyl]amino]-4,6-dichloro-N-methyl-2-pyridinecarboxamide;<br>
5-[[[3-Chloro-1-(3-chloro-2-pyridinyl)-li7-pyrazol-5-yl]carbonyI]amino]-A^,6-dimethyl-4-pyrimidinecarboxamide; and , .5-[[[3-BromoT-(3-chloro-2-pyridinyl)T/^-pyrazol-5-3^1}carbonyl]amino]-A?;Ar:,2,6-<br>
tetramethyl-4-pyridinecarboxamide. This invention also pertains to a composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Formula I, an vY-oxide thereof or a suitable salt thereof and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents. This invention also pertains to a composition comprising a biologically effective amount of a compound of Formula I, an Tv-oxide thereof or a suitable salt thereof and an effective amount of at least one additional biologically active compound or agent. The preferred compositions of the present invention are those which comprise the above preferred compounds.<br>
This invention also pertains to a method for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of Formula I, an .iV-oxide thereof or a suitable salt thereof (e.g., as a composition described herein). This invention also relates to such a method wherein the invertebrate pest or its environment is contacted with a biologically effective amount of a compound of Formula! or a composition comprising a compound of Formula I. anjV-oxide thereof or a suitable salt thereof and a biologically effective amount of at least one additional compound or agent for controlling invertebrate pests. The preferred methods of use are those involving the above preferred compounds.<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
20<br>
Of note are compounds of Formula 1 (a subset of Formula I) and A^-oxides or suitable salts thereof<br><br>
J<br>
R2^   ^R3<br>
1<br>
wherein<br>
5	A and B are independently 0 or S;<br>
each J is independently a phenyl ring, a naphthyl ring system, a 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system wherein each ring or ring system is optionally substituted with 1 to 4<br>
R5;<br>
10	K is, together with the two contiguous linking carbon atoms, a 5- or 6-membered<br>
heteroaromatic ring optionally substituted with 1 to 3 R4; n is 1 to 3;<br>
R1 is H; or  C2-C6alkyl, C2-C6 alkenyl, C2-C6 alkynyl or C3-C6 cycloalkyl each<br>
optionally substituted with one or more substituents selected from the group<br>
15	consisting of halogen, CN, N02, hydroxy, C 1-C4 alkoxyC 1-C4 alkylthio,C 1-C4<br>
alkylsulfinyl,C 1-C4 alkylsulfonyl, C2-C4 alkoxycarbonylC 1-C4alkylamino,<br>
C2-C8 dialkylamino and C3-C6 cycloalkylamino; or<br>
R1 is  C2-C6 alkylcarbonyl,  C2-C6 alkoxycarbonyl,  C2-C6alkylarninocarbonyl, C3-Cg<br>
dialkylaminocarbonyl or C(=A)J;<br>
20	R2 is H, CrC6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl,  C2-C6 cycloalkyl,C 1-C4alkoxy,<br>
25<br>
C 1-C4alkylamino,  C2-C6 dialkylamino, C3-C5 cycloalkylamino, C2-C6<br>
alkoxycarbonyl or  C2-C6 alkylcarbonyl;<br>
R3 is H; G; CrC6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, each<br>
optionally substituted with one or more substituents selected from the group<br>
consisting of halogen, G, CN, N02, hydroxyC 1-C4alkoxy, C 1-C4haloalkoxy,<br>
C 1-C4 alkylthioC 1-C4 alkylsulfmyl, C 1-C4 alkylsulfonyl, C2-C6<br>
alkoxycarbonyl, C2-C6 alkylcarbonyl, C3-C6 trialkylsilyl, or a phenyl; phenoxy<br>
or 5- or 6-membered heteroaromatic ring, each ring optionally substituted with<br>
one to three substituents independently selected from the group consisting of<br>
30	C 1-C4 alkyl, C2-C4alkenyl, C2-C4 alkynyl, C3-C6 cycloalkyC2-C4haloalkyl,<br><br>
21<br>
C2-C4 haloalkenyl, C2-C4 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN,<br>
NO2, C1-C4alkoxy,C1-C4 haloalkoxyC1-C4 alkylthio, C1-C4 alkylsulfinyl,<br>
C1-C4alkylsulfonyl, C1-C4 alkylamino, C2-C8dialkylarrmrc&gt;, C3-C6<br>
cycloalkylamino, C4-C6 (alkyl)cycloalkylamino, C2-C4 alkylcarbonyl, C2-C6<br>
5	alkoxycarbonylvC2-C6alkylaminocarbQnyl,G3-CgdiallÂ£ylaminocOT<br>
C3-C6trialkylsiiyl; C1-C4 alkoxy;C1-C4alkylamino;C2-C8 dialkylamino;<br>
C3-C6cycloallcylamino;C2-C6 alkoxycarbonyl or/C2-C6 alkylcarbonyl; or<br>
R2 and R3 can be taken together with-the nitrogeti to which they are attached to form a<br>
ring containing 2 to 6 atoms of carbon and optionally one additional atom of<br>
10	nitrogen, sulfur or oxygen, said ring may be optionally substituted with 1 to4<br>
substituents selected from the group consisting of C1-C2 alkyl, halogen, CN,<br>
N02 and C1-C2  alkoxy;<br>
G is a 5- or 6-membered nonaromatic carbocyclic or heterocyclic ring, optionally<br>
,   .	including one or two ring members selected from the group consisting of C(=0),<br>
15	SO or S(0&gt;2 and optionally substituted with 1 to 4 substituents selected from the<br>
group consisting of CrC2 alkyl, halogen, CN, NO2 and C2-C4 alkoxy;<br>
each R4 is independently H,C2-C4 alkyl, C2-C4alkenyl, C^-Cg alkynyl, C3-C6<br>
cycloalkyl, C!^ haloalkyl, C2-C6 haloalkenyl, C^-Cg haloalkynyl, C3-C6<br>
halocycloalkyl, halogen, CN, NO2, hydroxy, C1-C4 alkoxy, C1-C4 haloalkoxy,<br>
20	C!-C4 alkylthio, CrC4 alkylsulfinyl, C1-C4 alkylsulfonyl, CrC4 halodkylthio,<br>
Cj^haloalkylsulfinyl,C2-C4 haloalkylsulfqnyl, C1-C4alkylaminoC2-C4<br>
dialkylammo, C3-C6 cycloalkylammo, or C3-C6 Malkylsilyl; or<br>
each R4 is independently phenyl, benzyl or phenoxy, each optionally substituted With<br>
CrC4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C3-C6 cycloalkyl,/C1-C4 haloalkyl,<br>
25	C2-C4 haloalkenyl, C2-C4 haloalkynyl, C3-C5 halocycloalkyl, halogen, CN,<br>
N02, C1-C4 alkoxy, CrC4 haloalkoxy, CrC4 alkylthio, CrC4 alkylsulfinylj<br>
CrC4 alkylsulfonyl, C1-C4alkylamino, C^-Cg dialkylamino, C3-C6<br>
cycloallcylammo, C3-Cg (alkyl)cycloalkylamino, C2-C4 alkylcarbonyl, C2-Cg<br>
alkoxycarbonylC2-C6 alkylaminocarbonyl, Cs-Cg dialkylaminocarbonyl or<br>
30	C3-C6 trialkylsiiyl;<br>
each R5 is independently H, CrC6 alkyl,C2-C6 alkenyl, C2-C6alkynyl, C3-C6<br>
cycloalkyl, C2-C6haloalkyl, C2-C6 haloalkenyl, C2-C6haloalkynyl, C3-C6<br>
halocycloalkyl, halogen, CN, C02H, CONH2, NOz, hydroxy, CrC4 alkoxy,<br>
C1-C4 haloalkoxy,C1-C4alkylthio, CrC4 alkylsulfinyl, C1-C4 alkylsulfonyl,<br>
35	C1-C4haloalkylthio, C1-C4haloalkylsulfinyl, CrC4 haloalkylsulfonyl, C1-C4<br>
alkylamino, C2~C8 dialkylamino,C3-C6 cycloalkylamino, C2-C6 alkylcarbonyl, C2-C6alkoxycarbonyl,C2-C6alkylaminocarbonyl, C3-C6 $aIkylaminocarbonyl, C3-C6 trialkylsiiyl; or<br><br>
22<br>
eachR5 is independently a phenyl, benzyl, benzoyl, phenoxy, 5- or 6-membered<br>
heteroarornatic ring or an aromatic 8-9- or 10-membered fused heterobicyclic<br>
ring system, each ring optionally substituted with one to three substiuients   â– <br>
independently selected from the group consisting of C1-C4 alkyl, C2-C4 alkenyl,<br>
	C2-C4alkynyl,C3-C6Cycl6alkyl,C1-C4haloa^l,C2-C4hdoalkenyl,C2-C4.<br>
haloalkynyl, C3-C6 halbeycloalkyl, halogen, CN, N02,  C1-C4 alkoxy,  C1-C4<br>
haloalkoxy,  C1-C4alkyithio,  C1-C4 alkylsulfinyl, C1-C4alkylsulfonyl,  C1-C4<br>
alkylarnino,  C1-C4dialkylamino, C3-C6 cycloalkylamino, C3-Cg<br>
(alkyl)cycloalkylamino,C2-C4 alkylcarbonyl, (C2-C6 alkoxycarbonyl, C2-C6<br>
10	alkylaminbcarboriyl, C3-Cg dialkylaminocarbonyl orC3-C6 trialkylsilyl; or<br>
(R5&gt;2 when attached to adjacent carbon atoms can be taken together as-OCF2O-,<br>
-CF2CF20-, or -OCF2CF2O-.<br>
  .      Also of note are. selected compounds for reasons of cost, ease of synthesis and/or<br>
biological efficacy:	<br>
15	Selection A. Compounds of Formula 1 wherein K is, together with the two linking<br>
atoms, a thiophene, pyrazole, isoxazole, pyridine or pyrimidme optionally<br>
substituted with 1 to 3 R4.<br>
Selection B. Compounds of Selection A wherein J is independently a phenyl ring or a 5-<br>
or 6-membered heteroaromatic ring wherein each ring is optionally substituted<br>
20    	with l to2R5.<br>
Selection C. Compounds of Selection A wherein<br>
J is a phenyl ring or a 5- or 6-membered heteroaromatic ring selected from the group consisting of J-1, J-2, J-3,J-4and J-5; each ring optionally<br><br>
25<br><br><br><br>
Y<br>
J-4	J.5<br>
.<br><br>
23<br>
Selection D. Compounds of Selection B or Selection C wherein<br>
A and Bare both O;<br>
	riislto2;	<br>
R1 is H, C1-C4 alkyl, C2-C4 alkenyl, C2-C4  alkynyl, C3-Cg cycloalkyl, C2-C6::;<br>
5	alkylcarbonyl or C2-C6 alkoxycarbonyl;<br>
R2 is H, C1-C4 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, c<br>
alkylcarbonyl orC2-C4  alkoxycarbonyl;<br>
R3 is C1-C4 alkyl, C2-C6 alkenyl, C2-C6 alkynyl or C3-C6 cycloalkyl each<br>
optionally substituted with one or more substituents selected from the<br>
10	group consisting of halogen, CN, C1-C2 alkoxy, C1-C2 alkylthio, C1-C2<br>
alkylsurfmyl and C2-C6alkylsulfonyl;<br>
one of the R4 groups is attached to the heteroaromatic ring at one of the two ,<br>
positions ortho to the two linking; atoms, and said R4 is C1-C4  alkyl;;        : *<br>
C1-C4  haloalkyl; halogen, CN, NO2,C2-C6alkoxy, C1-C4  haloalkoxy,<br>
15	C1-C4 alkylthio, C1-C4alkylsulfinyl,C1-C4  alkylsulfonyl, CrC4<br>
haloalkylthio, C1-C4  haloalkylsulfinylorC1-C4 haloalkylsulfonyl;<br>
each R5 is independently H,C1-C4 alkylC1-C4 haloalkyl, halogen, GN,NQ2,<br>
C1-C4haloalkoxy, C1-C4 alkylmioC1-C4 alkylsulfinylC1-C4<br>
alkylsulfonyl,C1-C4 haloalkylthio,C1-C4haloalkylsulfinylC1-C4<br>
20	haloalkylsulfonyl or C2-C4 alkoxycarbonyl; or a phenyl or a 5-or<br>
6-membered heteroaromatic ring, each ring optionally substituted with<br>
C1-C4 alkyl, C2-C4 alkenyl, C2-C4  alkynyl, C3-C6 cycloalkylC1-C4<br>
haloalkyl, C2-C4  haloalkenyl, C2-C4  haloalkynyl, C3-C6 halocycloalkyl,<br>
halogen, CN.N02, , C1-C4alkoxy, , C1-C4haloalkoxyl C1C4 alkylthio,<br>
25	C1-C4 alkylsiJfmyl, C1-C4 alkylsulfonyl, C1-C4 alkylamino,C1-C4<br>
dialkylamino, C3-C6 cycloalkylaminb, C4-C6 (alkyl)cycloalkyiamino,<br>
C2-C4 alkylcarbonyl,C2-C6 alkoxycarbonyl, C2-C6<br>
alkylaminocarbonyl, C3-C8 dialkylaminocarbonyl or C3-C6 trialkylsilyU<br>
or	.	â– â–  "<br>
30	(R5)2 when attached to adjacent carbon atoms can be taken together as-<br>
OCF20-, -CF2CF20 or -OCF2CF20-. Selection E. Compounds of Selection D wherein<br>
J is selected from the group consisting of phenyl, pyridine, pyrimidine,<br>
pyrazole, imidazole, triazole, thiophene,thiazole arid oxazole, furan,<br>
35	isotbiazole and isoxazole, each optionally substituted with 1 to 2 R5.<br>
Selection F. Compounds of Selection E wherein<br><br>
WO 02/070483	PCT/OS02/06582<br>
24<br>
J is selected from the group consisting of phenyl, pyridine, pyrimidine,<br>
pyrazole, thiophene and thiazole, each optionally substituted with 1 to 2<br>
R5;<br>
R1 and R2 are both H;<br>
5	H3 is CrC4 aJkyl optionally substituted with halogen, CN, OCH3, S(0)pCH3;<br>
each R4 is independently CH3, CF3, OCF3J OCHF2, S(0)pCF3, S(0)pCHF2,<br>
CN or halogen; each R5 is independently H, halogen, CH3, CF3, OCHF2, S(0)pCF3,<br>
S(0)pCHF2, OCH2CF3, OCF2CHF2, S(0)pCH2CF3, S(0)pCF2CFÂ£F2;<br>
3 0	or phenyl, pyrazole, imidazole, triazole, pyridine or pyrimidine, each<br>
ring optionally substituted with CrC4 alkyl, C] -C4 haloalkyl, C] -C4<br>
alkoxy, CrC4 haloalkoxy, CrC4 alkylthio, CrCA alkylsulfinyl, CrC4<br>
alkylsulfonyl, halogen or CN; and<br>
p is 0, 1 or 2.<br>
15	Selection G. Compounds of Selection F wherein R3 is CpC4 alkyl.<br>
Selection H. Compounds of Selection G wherein J is a phenyl optionally substituted<br>
with 1 to 2 R5.<br>
Selection I. Compounds of Selection H wherein one R5 is a phenyl optionally<br>
substituted with CrC4 alkyl, CrC4 haloalkyl, halogen or CN.<br>
20	Selection J. Compounds of Selection H wherein one R5 is a pyrazole, imidazole.<br>
triazole, pyridine or pyrimidine, each ring optionally substituted with CrC4<br>
alkyl, C]-C4 haloalkyl, halogen or CN.<br>
Selection K, Compounds of Selection I wherein J is a pyridine optionally substituted<br>
with 1 to 2 R5.<br>
25	Selection L. Compounds of Selection K wherein one R5 is a phenyl optionally<br>
substituted with C]-C4 alkyl, C]-C4 haloalkyl, halogen or CN.<br>
Selection M. Compounds of Selection K wherein one R5 is a pyrazole, imidazole,<br>
triazole, pyridine or pyrimidine, each ring optionally substituted with C]~C4<br>
alkyl, C1-C4 haloalkyl, halogen or CN.<br>
30	Selection N. Compounds of Selection I wherein J is a pyrimidine optionally substituted<br>
with 1 to 2 R5. Selection O. Compounds of Selection N wherein one R5 is a phenyl optionally<br>
substituted with CrC4 alkyl, CrC4 haloalkyl halogen or CN.<br>
Selection P. Compounds of Selection N wherein one R5 is a pyrazole. imidazole,<br>
35	triazole, pyridine or pyrimidine, each ring optionally substituted with C1-C4<br>
alkyl, CrC4 haloalkyl, halogen or CN. Selection Q. Compounds of Selection I wherein J is a. pyrazole optionally substituted with 1 to 2 R5.<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
25	â€¢<br>
Selection R. Compounds of Selection Q wherein one R5 is a phenyl optionally  â€¢<br>
substituted with C1 -C4 alkyl, C1 -C4 haloalkyl, halogen or CN. Selection S. Compounds of Selection Q wherein one R5 is a pyrazole, imidazole,<br>
triazole, pyridine or pyrimidine, each ring optionally substituted with C|-C4<br>
alkyl, CrC4 haloalkyl, halogen or CN. Selection T. Compounds of Selection S wherein one R5 is a pyridine optionally<br>
substituted with CrC4 alkyl, CrC4 haloalkyl, halogen or CN.<br>
Most select is the compound of Formula 1 selected from the group consisting of:<br>
â–     4-[[[l -(2-Chlorophenyl)-3-(trifluoromethyI)- l#-pyrazol-5-yI]carbonyI]amino]-5-methyl-?vr-l-methylethyl)-3-pyridincarboxamide,<br>
4-Memyl-7^-(l-memylemyl)-3-[[2-methyI-4-(trifiuoromemyI)benzoyI]ammo]-2-thiophencarboxamide, and<br>
l-Memyl-AL(l-methylemyl)-5-[[4-(rrifluoromethyl)benzoyljamino]-l^/-pyrazole-4-carboxamide. The compounds of Formula I can be prepared by one or more of the following methods and variations as described in Schemes 1-19. The definitions of A, B, J, K, R], R2, R3, R4, R5 and n in the compounds of Formulae I and 2-41 below are as defined above in the Summary of the Invention. Compounds of Formulae Ia-c, 2a-b and 4a-g are various subsets of the compounds of Formula I, 2 and 4, respectively. Of note are compounds of Formulae I, 2, 5, 6, 6a, 13, 14, 15. 40 and 41 wherein K is selected from the group consisting of optionally substituted thiophene, isoxazole, isothiazole, pyrazole, pyridine and pyrimidine rings. Also of note are compounds of Formulae I, 2, 5, 6, 6a, 13, 14, 15, 40 and 41 wherein K is K-1, K-14, K-15, K-18, K-23, K-28, K-29, K-30, K-31 and K-33. Of particular note are compounds of Formulae I, 2, 5, 6, 6a, 13, 14, 15, 40 and 41 wherein K is K-28, K-31 and K-33.<br>
Compounds of Formula I can be prepared by procedures outlined in Schemes 1-19. A typical procedure is detailed in Scheme 1 and involves coupling of an ortho amino carboxylic acid amide of Formula 2 with an acid chloride of Formula 3 in the presence of an acid scavenger to provide the compound of Formula la. Typical acid scavengers include amine bases such as triethylamine, diisopropyl ethyl amine and pyridine; other scavengers include hydroxides such as sodium and potassium hydroxide and carbonates such as sodium carbonate and potassium carbonate. In certain instances it is useful to use-polymer-supported acid scavengers such as polymer-bound diisopropylefhylamine and polymer-bound dimethylaminopyridine. In a subsequent step, amides of Formula la can be converted to thioamides of Formula lb using a variety of standard thio transfer reagents including phosphorus pentasulfide and Lawesson"s reagent.<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
26 "-Scheme 1<br><br><br><br>
An alternate procedure for the preparation of compounds of Formula la involves â€¢ coupling of an amide of Formula 2 with an acid of Formula 4 in the presence of a dehydrating agent such as dicyclohex-ylcarbodiimide (DCC). Polymer supported reagents are useful here, such as polymer-bound cyclohexj^carbodiimide. Synthetic procedures of Schemes 1 and 2 are only representative examples of useful methods for the preparation of Formula I compounds as the synthetic literature is extensive for this type of reaction.<br>
Scheme 2<br><br>
+<br><br><br>
O<br><br>
OH<br><br>
dehydrative coupling reagent<br><br>
la<br><br>
10<br><br>
15<br><br>
One skilled in the art will also realize that acid chlorides of Formula 3 may be prepared from acids of Formula 4 by numerous well-known methods.<br>
An alternate procedure for the preparation of compounds of Formula la involves coupling of an ortho amino carboxylic acid ester of Formula 5 with an acid chloride of Formula 3 by a method similar to that described in Scheme 1, followed by transformation of the ester group into an amide functionality. This transformation can be achieved by an animation with an amine of Formula 7. A Lewis acid such-as trimethyl aluminum as shown in Scheme 3 may catalyze this reaction.<br><br><br>
20<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
27<br>
Alternatively the ester 6 can be transformed to an amide (6a) as shown, in Scheme 4 by saponification with a base such as aqueous sodium hydroxide followed by dehydrative coupling with an amine of Formula 7 by a procedure similar to that described in Scheme 2.<br>
Scheme 4<br><br>
base<br><br>
6a<br><br>
C02H<br><br>
R2R3NH<br>
dehydrative coupling agent<br><br>
la<br><br>
Benzoic acids of Formula 4 (J is optionally substituted phenyl) are generally well known in the art as are procedures for their preparation. One particularly useful subset of benzoic acids of this invention are 2-methyl-4-perfluoroalkyl benzoic acids of Formula 4a (R5(a) equals e.g. CF3, C2Â¥^ C3F7). The synthesis for these compounds is outlined in<br>
10     Schemes 5-9. Benzoic acids of Formula 4a may be prepared from the benzonitriles of Formula 8 by hydrolysis. The conditions used may involve the use of a base such as an alkaline metal hydroxide or alkoxide (e.g. potassium or sodium hydroxide) in a solvent such as water, ethanol or ethylene glycol (e.g. J. Chem. Soc. 1948, 1025). Alternatively, the hydrolysis may be carried out using an acid such as sulfuric acid or phosphoric acid in a<br>
15     suitable solvent such as water (e.g. Org. Synth. 1955, Coll. vol. 3, 557). The choice of the conditions is contingent on the stability of R5 to the reaction conditions and elevated temperatures are usually employed to achieve this transformation.<br>
Scheme 5<br><br><br>
R5(a)<br>
Hydrolysis<br><br><br>
R (b) is Me<br>
Nitciles of Formula 8 may be prepared from anilines of Formula 9 by the classical 20     sequence involving diazotization and treatment of the intermediate diazonrurn salt with a copper cyanide salt (e.g. J. Amer. Chem. Soc. 1902, 24, 1035).<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br><br>
28 Scheme 6 R5(a)<br><br>
9	R5(b) is Me<br>
Anilines of Formula 9 may be prepared from compounds of Formula 10. This transformation may be achieved by a well-known procedure that employs Raney Nickel (Org. Synth. Coll. Vol. VI, 581). Alternatively, the same transformation may be effected by the use of a suitable catalyst such as palladium in the presence of hydrogen. The reaction is usually conducted at pressures of 104 to 107 kPa in a suitable organic solvent such as, but not limited to, toluene. Elevated temperatures of 80-110 Â°C are usually required to achieve the transformation. As one skilled in the art will realize, numerous chemical modifications of the thioether moiety are possible, and may be employed when necessary to facilitate this transformation..<br>
Scheme 7<br><br>
-SMe 10<br>
Compounds of Formula 10 may be prepared from iminosulfuranes of Formula 11. The transformation may be achieved in a protic solvent such as methanol or water, in a non-protic solvent such as dichloromethane or toluene in the presence of a suitable base such as triethylamine (e.g. Org. Synth. Coll. Vol. VI, 581) or sodium methoxide, or in a combination of a protic solvent, a protic solvent and a base. The temperature at which the reaction is conducted is usually in the range 40-110 Â°C. As one skilled in the art will realize, suitable salts of compounds of Formula 11 such as, but not limited to a hydrochloride, a sulfate or a bisulfate may also be employed, provided that the appropriate amount of base is first used to generate the free base 11. This may be done as a separate step or as an integral part of the step involving the transformation of compounds of Formula 11 to compounds of Formula 10.<br><br>
WO 02/070483 "<br><br>
PCTAJS02/06582<br><br>
29<br>
Scheme 8<br><br><br>
Rearrangement<br><br>
10<br><br><br><br>
10<br><br>
Compounds of Formula 11 may be prepared from anilines of Formula 12 by reaction with dimethyl sulfide and a suitable chlorinating agent such as, but not limited to N-chlorosuccinimide (e.g. Org. Synth. Coll. Vol. VI, 581), chlorine or N-chlorobenzotriazole. Alternatively, anilines of Formula 12 may be treated with dimethyl sulfoxide which has been "activated" by treatment with an agent such as acetic anhydride, trifluoroacetic, .anhydride, trifluoromethanesulfonic anhydride, cyclohexylcarbodiirnide, sulfur trioxide, or phosphorus pentoxide. The reaction is conducted in a suitable organic solvent such as dichloromethane or dimethyl sulfoxide. The reaction is conducted at a temperature of-70Â°C to 25 Â°C and is dependent on the solvent and reagent used.<br>
Scheme 9<br><br><br><br><br>
HoN"<br><br>
11<br><br>
12<br><br>
15<br>
20<br><br>
Intermediate ortho amino carboxylic acid amides of Formula 2a and 2b may also be prepared from isatoic anhydrides of Formula 13 and 14 (Scheme 10). Typical procedures involve combination of equimolar amounts of the amine 7 with the isatoic anhydride in polar aprotic solvents such as pyridine and dimethylformamide at temperatures ranging from room temperature to 100 Â°C. R1 substituents such as alkyl and substituted alkyl may be introduced by the base catalyzed alkylation of isatoic anhydride 13 with known alkylating reagents R1_Lg (wherein Lg is a leaving group such as halogen, alkyl or aryl suphonates or alkyl sulfates) to provide the alkyl substituted intermediates 14. Isatoic anhydrides of Formula 13 may be made by methods described in Coppola, Synthesis 1980, 505 and Fabis et al Tetrahedron, 1998, 10789.<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
30 Scheme 10<br><br><br><br><br>
10<br><br>
An alternate procedure for the preparation of specific compounds of Formula I (wherein A is O, B is O and R1 is H) involves reaction of an amine 7 with a heterocyclic fused oxazinone of Formula 15. Typical procedures involve combination of the amine with the oxazinone in solvents such as tetrahydrofuran or pyridine at temperatures ranging from room temperature to the reflux temperature of the solvent. Oxazinones are well documented in the chemical literature and are available via known methods that involve the coupling of either an ortho amino carboxylic acid with an acid chloride. For references to the synthesis and chemistry of heterocyclic fused oxazinones see Jakobsen et al, Biorganic and Medicinal Chemistry, 2000, 8, 2803-2812 and references cited therein.<br>
Scheme 11<br><br><br>
Ic (A is O, B is O, R1 is H)<br>
Heterocyclic acids of Formula 4, wherein J is an optionally substituted heterocycle, can be prepared by procedures outlined in Schemes 12-17. Both general and specific<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br><br><br>
10<br>
15<br><br>
31<br>
references to a wide variety of heterocyclic acids including thiophenes, furans. pyridines, pyrrolidines, triazoles, imidazoles, pyrazoles, thiazoles, oxazoles, isothiazoles, thiadiazoles. oxadiazoles, triazines, pyrazines, pyridazines, and isoxazoles can be found in the following compendia: Rodd"s Chemistry of Chemistry of Carbon Compounds, Vol. Wato IVL, S. Coffey editor, Elsevier Scientific Publishing, New York, 1973; Comprehensive Heterocyclic Chemistry, Vol. 1-7. A. R. Katritzky and C. W. Rees editors, Pergamon Press, New York, 1984; Comprehensive Heterocyclic Chemistry II, Vol. 1-9, A. R. Katritzky, C. W. Rees, and E. F. Scriven editors, Pergamon Press, New York, 1996; and the series, The Chemistry of Heterocyclic Compounds, E. C, Taylor, editor, Wiley, New York. Particularly useful heterocyclic acids of .this invention include pyridine acids, pyrimidine acids and pyrazole acids. Procedures for the synthesis of representative examples of each are detailed in Schemes 12-17. A variety of heterocyclic acids and general methods for their synthesis may be found in World Patent Application WO 98/57397.<br>
The synthesis of representative pyridine acids (4b) is depicted in Scheme 12. This procedure involves the known synthesis of pyridines from P-ketoesters and 4-aminobutenones (19). Substituent groups R5(a) and R5(b) include e.g. alkyl and haloalkyl.<br>
Scheme 12<br><br><br>
The synthesis of representative pyrimidine acids, (4c) is depicted in Scheme 13. This 20     procedure involves the known synthesis of pyrimidines from vinylidene-(3-ketoesters (22) and amidines. Substituent groups R5(a) and R5(b) include e.g. alkyl and haloalkyl.<br><br>
WO 02/070483<br><br>
PCT/TJS02/06582<br><br>
32 Scheme 13<br><br><br><br><br>
10<br>
15<br><br>
The synthesis of representative pyrazole acids (4d-4g) is depicted in Schemes 14-17. Pyrazoles 4d are described in Scheme 14. The synthesis of Scheme 14 involves as the key step introduction of the R5(b) substituent via alkylation of the pyrazole. The alkylating agent R5(b)-Lg (wherein Lg is a leaving group such as CI, Br, I, sulfonates such as p-toluenesulfonate or methanesulfonate or sulfates such as -S02OR7(b)) includes R7(b) groups such as CrC6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, CrC6 haloalkyl C2-C6 haloalkenyl, C2-Cg haloalkynyl, C3-C6 halocycloalkyl, C2-C6 alkylcarbonyl, C2~C6 alkoxycarbonyl, C3-Cg dialkylaminocarbonyl, C3-C5 trialkylsilyl; or phenyl, benzyl, benzoyl, 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system, each ring or ring system optionally substituted. Oxidation of the methyl group affords the pyrazole carboxylic acid. Some of the more preferred R5(a) groups include haloalkyl.<br>
Scheme 14<br><br><br>
Pyrazoles 4e are described in Scheme 15. These pyrazole acids may be prepared via metallation and carboxylation of pyrazoles of formula 28 as the key step. The R5(b) group is<br><br>
WO 02/070483<br><br>
PCT7US02/06582<br><br>
33<br>
introduced in a manner similar to that of Scheme 14, i.e. via alkylation with a R5(b) alkylating agent. Representative R5(a) groups include e.g. cyano, and haloalkyl.<br>
Scheme 15<br><br><br><br><br>
10<br><br>
Pyrazoles 4f are described in Scheme 16. These can be prepared via reaction of an optionally substituted phenyl hydrazine 29 with a pyruvate 30 to yield pyrazole esters 31. Hydrolysis of the ester affords the pyrazole acids 4f. This procedure is particularly useful for the preparation of compounds where R5(b) is optionally substituted phenyl and R5(a) is haloalkyl.<br>
Scheme 16<br><br><br>
Pyrazoles acids of Formula 4g are described in Scheme 17. These can be prepared via 3+2 cycloaddition of an appropriately substituted nitrilimine (32) with either substituted propiolates (33) or acrylates (36). Cycloaddition with acrylates requires additional oxidation<br>
15      of the intermediate pyrazoline to the pyrazole. Hydrolysis of the ester affords the pyrazole acids 4g. Preferred iminohalides for this reaction include the trifluorornethyl iminochloride (38) and the irninodibromide (39). Compounds such as 38 are known (J. Heterocyd. Chem. 1985, 22(2), 565-8). Compounds such as 39 are available by known methods (Tetrahedron Letters 1999, 40, 2605). These procedures are particularly useful for the preparation of<br>
20     compounds where R5(b) is optionally substituted phenyl and R5(a) is haloalkyl or bromo.<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
34 Scheme 17<br><br><br><br>
Ort/zo-amino carboxylic acid esters of Formula 5 wherein R1 is H can be prepared from monoesters of ortho dicarboxylic acids of Formula 40 via rearrangement of the corresponding acyl azide and hydrolysis of the resulting isocyanate (or alternatively by trapping of the isocyanate with an alcohol and cleaving of the resulting carbamate) as shown in Scheme 18.<br>
Scheme 18<br><br><br><br>
1)	(COCQ2<br>
2)	NaN3<br>
3)	heat<br>
4)	hydrolysis<br><br>
or<br><br>
40<br><br><br>
1)	(PhO^PCO)^, ROH<br>
2)	hydrolysis<br><br>
5 (R1 is H)<br><br>
Alternatively ortfio-amino carboxylic acid esters of Formula 5 can be prepared from ortho carboxamide carboxylic esters of Formula 41 by Hoffman rearrangement with reagents such as sodium hydroxide and bromine as shown in Scheme 19.<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
35<br>
Scheme 19<br><br><br><br><br>
Compounds of Formulae 40 and 41 are known in the art or can be readily prepared from compounds known in the art. (For example, see Tetrahedron, 1997, 53,14497; J. Chem. Soc, Perkin Trans. 1, 1996,10, 1035; WO92/08724 and EP 418667).<br>
It is recognized that some reagents and reaction conditions described above for preparing compounds of Formula I may not be compatible with certain functionalities present in the intermediates. In these instances, the incorporation of protection/deprotection sequences or functional group interconversions into the synthesis will aid in obtaining the desired products. The use and choice of the protecting groups will be apparent to one skilled in chemical synthesis (see, for example, Greene, T. W.; Wuts, P. G. M. Protective Groups in Organic Synthesis, 2nd ed.; Wiley: New York, 1991). One skilled in the art will recognize that, in some cases, after the introduction of a given reagent as it is depicted b any individual scheme, it may be necessary to perform additional routine synthetic steps not described in detail to complete the synthesis of compounds of Formula I. One skilled in the art will also recognize that it may be necessary to perform a combination of the steps illustrated in the above schemes in an order other than that implied by the particular sequence presented to prepare the compounds of Formula I.<br>
One skilled in the art will also recognize that compounds of Formula I and the intermediates described herein can be subjected to various electrophilic, nucleophilic, radical, organometallic, oxidation, and reduction reactions to add substituents or modify existing substituents.<br>
Without further elaboration, it is believed that one skilled in the art using the preceding description can utilize the present invention to its fullest extent. The following Examples are, therefore, to be construed as merely illustrative, and not limiting of the disclosure in any way whatsoever. Percentages are by weight except for chromatographic solvent mixtures or where otherwise indicated. Parts and percentages for chromatographic solvent mixtures are by volume .unless otherwise indicated. HNMR spectra are reported in ppm downfield from tetramethylsilane; s is singlet, d is doublet, t is triplet, q is quartet, m is multiplet, id is doublet of doublets, dt is doublet of triplets, brs is broad singlet.<br><br>
36<br>
EXAMPLE 1<br>
Preparation of 5-methyl-N-f(l-memylemyi)-4-4-tfifluoromemoxy)benzoyl1amino1-3-<br>
pyridmecarboxarnide<br>
Step A:	Preparation of ethyl 4-azido-5 methyl-3rpyridinecarboxylate<br>
5	A slurry of 14.1 g (78 rnmol) of ethyl 1,4-dihydro-S&gt;-methyl-4-oxo-3-<br>
pyridinecarboxylate (prepared according to Horvath, G.; Dvortsak, P. J. Heterocycl. Chem, 1980, 359) in 30ml of phosphorous pxychloride was refiuxed for 1 hour. After cooling, the volatiles were removed with a rotary evaporator. The residue was poured into cold saturated aqueous sodium bicarbonate. Dichloromethane was added and the mixture was filtered 10     through celite. The layers were separated. The organic layer was dried (sodium sulfate) and the solvent was removed with a rotary evaporator. The residue was dissolved in 150 inL of ^ diinethylformamide. 15.2g (234 rnmol) of sodium azide was added. The mixture was heated at 95Â°C for lhour. After cooling, the solvent was removed with a rotary evaporator. The residue was partitioned between ethyl acetate and water. The organic layer was dried 15     (sodium sulfate) and the solvent was removed with a rotary evaporator. The residue was passed through a plug of silica gel with 25% ethyl acetate in hexanes as eluant to afford 11.9g of the title compound as a cream colored solid.<br>
!HNMR (CDCI3) S 1.41 (t,3H), 2.12 (s,3H), 4.36 (q,2H), 8.12 (s,lH), 8.83 (s,lH).<br>
Step B:	Preparation of ethyl 4-amino-5-methyl-3-pvridinecarboxvlate<br>
20	0.50 g of materialprepared in Step A was dissolved in 15 mL of ethanol. 0.15gof<br>
10% palladium on carbon was added. The reaction mixture was placed under one<br>
atmosphere of hydrogen for 2 hours. The catalyst was removed by filtration. The solvent<br>
was removed with a rotary evaporator to afford 0.43 g of the title compound as a white solid.<br>
1H NMR (CDCI3) 5 1.42 (OH), 2.30 (s,3H)&gt; 4.45 (q,2H), 8.47 (s,IK), 8.87 (s, 1H).<br>
25     StepG;	Preparation of ethyl 5-memvl-4-rr4-trifluoromethoxv)berizoyllammo1-3-<br>
pvridinecarboxvlate l.Og (5.6 rnmol)""of material prepared in Step B was dissolved in 30 mL of dichloromethane. 0.77 mL (5.6 rnmol) of triethylamine, a catalytic amount of 4-dimethylaminopyridine and 0.88 mL (5.6 mmol) of 4-(trifluoromethoxy)benzoyl chloride 30     were added. The mixture was stirred overnight. The reaction mixture was washed with water. The organic layer was dried (sodium sulfate) and the solvent was removed with a rotary evaporator. The residue was purified by medium-pressure liquid chromatography (MPLC) with a gradient of 15-100% ethyl acetate in hexanes as eluant. The bisacylation product eluted first, then 0.42 g of the title compound as white solid. Starting material 35     (0.52 g) was also recovered.<br>
!H NMR (CDCI3) 5 1.41 (t,3H), 2.32 (s,3H), 4.39 (q,2H), 7.37 (d,2H), 8.08 (d,2H), 8.63 (brs,lH), 9.04 (brs,lH), 10.78 (brs,lH).<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
Step D:	Preparation of 5-methvl-N-( 1-methyl ethvl)4-[T4-<br>
trifluoromethoxv)benzovi1aminol-3-pvridinecarboxamide To a solution of 0.049 mL (0.57 mmol) of isopropylamine in 20 mL of dichloroethane at 0 Â°C was added 0.64 mL (1.3 mmol) of a 2M solution of trimethylaluminum in toluene 5     dropwise. A solution of 0.21 g (0.57 mmol) of the material prepared in Step C in 5 mL of dichloroethane was added dropwise. Four days later an additional 0.049 mL of isopropylamine and 0.64 mL of trimethylaluminum were added. The reaction was refluxed for 6h, After cooling 20 mL of IN HC1 was added. The layers were separated. The aqueous layer was made basic with a saturated sodium bicarbonate solution. Dichloromethane was<br>
10     added and the mixture was filtered through celite. The dichloromethane was separated,<br>
combined with the dichloroethane layer from above and dried (sodium sulfate). The solvent was removed with a rotary evaporator. The residue was purified by MPLC with a gradient of 25-50% ethyl acetate in hexanes as eluant to afford 0.047 g of the title compound, a compound of the invention, as a white solid; m.p. 202-204 Â°C.<br>
15	]HNMR (CDC13) 6 1.27 (d,6H), 2.33 (s,3H), 4.23 (m,lH), 6.46 (br.lH), 7.35 (d,2H),<br>
8.07 (d,2H), 8.56(brs,lH), 8.69 (brs,lH), 11.15 (brs,lH).<br>
EXAMPLE 2<br>
Preparation of 1 -methyl-N-0-methvlethvl)-5-rf4-trifluoromethoxv)benzovl]amino]-lH-<br>
pyrazole-4-carboxamide<br>
20      Step A:	Preparation of_5-amino-1 -methyl-N-Q -methylethyl)-lH-pyrazole-4-<br>
carboxamide l.Og (8.0 mmol) of 2-cyano-A/-(l-methylethyl)acetamide (prepared according to the procedure of Cheikh et a] J. Org. Chem., 1991, 56, 970) was combined with 3.1 mL of triethylorthoformate, 5 mL of acetic anhydride and 0.01 g of anhydrous zinc chloride. The 25      mixture was refluxed for 1 hour. A distillation head was placed on the flask and the reaction was heated at 120 Â°C for 8 hours. After standing for two days the mixture was heated again for 12 hours at 120 Â°C for 12 hours. The volatiles were removed with a rotary evaporator. Ethanol was added and the volatiles were again removed with a â€¢rotary evaporator. This material was dissolved in 15 mL of ethanol. 0.34 mL (6.4 mmol) of methyl hydrazine was 30     added. The reaction mixture was refluxed for 5 hours and then allowed to stand at room<br>
temperature overnight. The solvent was removed with a rotary evaporator. The residue was purified by MPLC (ethyl acetate as eluant) to afford 0.14g of the title compound as a solid.<br>
lHNMR (CDC\3) 5 1.23 (d,6H), 3.61 (s,3H), 4.21 (m..lH), 5.17 (brr2H), 5.34 (br/fH), 7.38 (s, 1H).<br><br>
WO 02/070483<br><br>
PCT/TJS02/06582<br><br>
38<br>
StepB:	Preparation of l-methvl-K(fl-methvlethvIV5-[[4-<br>
trifluoromethoxvlbenzoyllaminol-1 H-pvrazole-4-carboxamide 0.14 g (0.77 mmol) of the material from Step A was dissolved in 20 mL of tetrahydrofuran and 0.12 mL (0.85 mmol) of triethylamine and 0.12 mL (0.77 mmol) of 5     4-(rrifluoromethoxy)benzoyl chloride were added. Three days later 0.12 mL (0.S5 mmol) of triethylamine and 0.12 mL (0.77 mmol) of 4-(trifluoromethoxy)benzoyl chloride were added. The reaction mixture was refluxed for two days. After cooling the reaction mixture was partitioned between ethyl acetate and water. The organic layer was dried (sodium sulfate) and the solvent was removed with a rotary evaporator. The residue was purified by 10      MPLC with 50% ethyl acetate in hexanes as eluant to afford 0.18 g of the title compound, a compound of the invention, as a white solid; m.p. 68-75 Â°C.<br>
"H NMR (CDC13) 8 1.22 (d,6H), 3.91 (s,3H), 4.14 (m,lH), 5.92 (brd,lH), 7.32 (d,2H), 7.62 (s,lH), 8.08 (d,2H), 10.78 (brs,lH).<br>
EXAMPLE 3<br>
15	Preparation of 4-methvI-JV-d -methyiethyl)-3-rr4-trifluoromethvl")ben20vI]aminoj-2-<br>
thiophenecarboxamide<br>
Step A:	Preparation of 7-methvi-2H-thienor3.2-d] IT ,3"|oxazine-2.4(l FD-dione<br>
Phosgene in toluene (4.4 g, 20%, 8.88 mmol) was added to the sodium salt of 3-amino-<br>
4-methyl-thiophene-2-carbocyclic acid (1 g, 5.58 mmol) in water (17 mL) at 0 C. The<br>
20      mixture was allowed to warm to room temperature and was stirred for 1 hour. The mixture<br>
was filtered. After drying in vacuum the product was obtained as a solid 0.49 g (47%).<br>
IR (NujolÂ®) 1785, 1696,1580, 1513, 1236, 988, 918, 848, 826 cm-1.<br>
m NMR (DMSO-d6) 8 2.20 (s,3H), 7.88 (s,lH).<br>
StepB:	Preparation of 7-methvl-244-(trifluoromethyl)phenyI]-4H-thieno|"3.2-<br>
25	<firi31oxazin-4-one></firi31oxazin-4-one>
4-(Dimethylamino)pyridine (0.66 g, 5.41 mmol) was added to the product from Step A in dioxane (10 mL). 4-(Trifluoromethyl)benzoyl chloride (1.13 g, 5.42 mmol) was added to the mixture and the mixture was boiled for approximately 3 hours. The mixture was allowed to cool to room temperature and was poured into hydrochloric acid (100 mL, 1 N). The 30      mixture was extracted with ethyl acetate (3 x 50 mL) and the combined extracts were dried and evaporated. Chromatography on silicon gel (eluted with ethyl acetate/hexanes) gave the product as a white solid 1.56 g, (91.7%).<br>
IR (NujolÂ®) 2923, 1763, 1600, 1572, 1410,1312, 1234, 1170, 1125, 1068, 1013,978,<br>
934,851,813 cm-1.   "<br>
35	]HNMR (CDCI3) 5.2.47 (s,3H), 7.60 (s,lH)5 7.77 (d,2H),8.45(d,2H).<br><br>
I WO 02/070483	PCT/US02/06582<br>
39<br>
Step C:	Preparation of 4-methvl^-ri-methvlethvn-3-rr4-<br>
trifluoromethvnben2ovIlaminol-2-thiophenecarboxarnide A mixture of the product from Step B (0.2 g. 0.043 mmol) and isopropylamine (0.2 g, 3.39 mmol) in THF (5 mL) was stirred for 6 hours. The solvent was removed under reduced â–    5     pressure to give the product, a compound of the invention, as a solid 0.21 g, (91%).<br>
IR(NujolÂ®) 3294, 1664, 1625, 1573, 1524, 1409,1327, 1207, 1167 1126, 1068, 1018, 954, 885, 857 cm-1.<br>
JHNMR(CDC13) 5 1.22 (d,6H), 2.30 (s,3H)5 4.22-4.11 (m,lH), 5.58 (d,lH), 7.03 (sslH), 7.75 (d, 2H), 8.13 (d52H), 10.63 (5,1H).<br>
10	EXAMPLE 4<br>
Preparation of 5-nT3-Chloro-l-(3-chIoro-2-pvridinvI)-liJr-pyrazol-5-vncarbonvllamino]-<br>
,Af6-dimethyl-4-pyrimidinecarboxamide<br>
Step A:	Preparation of HLl-dimethylethyP) 4-ethvl-2-acetvl-3-amino-2-butenedioate<br>
To a mixture of 17.15g (108 mmol) of ^-butyl acetoacetate and 12.8 mL (130 mmol) of 15      ethyl cyanoformate in 25 mL of dichloromethane was added 1.64g of zinc acetylacetonate hydrate. After stirring overnight the volatiles were removed with a rotary evaporator. The residue was dissolved in ethyl acetate and filtered through celite. The solvent was removed with a rotary evaporator to afford 29.9g of the title compound as a white solid as an E/Z isomer mixture. 20       .    â–    *H NMR (CDC13) 6 1.33 (t,3H), 1.52 (s,9H), 2.35 (s,3H) [minor.isomer 2.40 (s,3H)], 4.33 (m,2H).<br>
Step B:	Preparation of 5-f 1.1 -dimethylethyl) hydrogen 6-methvl-4,5-<br>
pyrimidinedicarboxylate To a solution of 11.6g (45 mmol) of the material from Step A in 55 mL of ethanol was 25     added 10.9g (135 mmol) of formamidine hydrochloride; The reaction mixture was cooled in an ice bath and 17 mL (135 mmol) of 1, 1,3,3-tetramemylguanidme was added dropwise. After the mixture was stirred overnight the solvent was removed with a rotary evaporator. The residue was partitioned between ethyl acetate and water. The aqueous layer was cooled in an ice bath, acidified with concentrated HC1 and extracted three times with ethyl acetate. 30      The organic layer was dried (sodium sulfate) and the solvent was removed with a rotary evaporator to afford 9.12g of the title compound"as a yellow solid.<br>
"HNMR (CDC13) 5 1. 65 (s,9H), 2.68 (s,3H), 9.19 (s,lH).<br>
Step C:	Preparation of 5-f LI-dimethyl ethyl) 4-methvl 6-methyl-4.5-<br>
pyrimi dinedi carboxylate<br>
&gt;5	To a solution of 9.12g (38 mmol) of the material from Step B in 100 mL of<br>
N,N-dimethyl formamide (DMF) was added 3.1 mL (50 mmol) of iodomethane .and 3.7g (50 mmol) of lithium carbonate. The reaction mixture was heated at 60 Â°C for 3 hours.<br><br>
WO 02/070483	PCT/US02/06582<br>
40<br>
After cooling the reaction mixture was partitioned between dichloromethane and water. The organic layer was dried (sodium sulfate) and the solvent was removed with a rotary-evaporator and then a vacuum pump. The residue was purified by MPLC with a gradient of 20-30% ethyl acetate in hexanes as eluant to afford 7.58g of the title compound as an off-5      white solid.<br>
!H NMR (CDC13)S 1.63 (s,9H), 2.67 (s,3H), 4.01 (s,3H),9.19(s,lH).<br>
Step D:	Preparation of methyl 5-ITd.l -dimemylethoxy)carbonyllammo]-6-methyl-4-<br>
pvrimidinecarboxylate 7.55g of the material from Step C was dissolved in 40 mL of dichloromethane. 20 ml 10      of trifluoroacetic acid was added. After two days the reaction mixture was refluxed for 6<br>
hours. After an additional day the volatiles were removed with a rotary evaporator. Toluene<br>
was added and the solvent was removed with a rotary evaporator. This material (9.2g) was<br>
dissolved in 100 mL of/-butanol. 9.2 mL (66 rnmol) of triethylamine and 14 mL (66 mmoi)<br>
of diphenylphosphoryl azide were added. The reaction was refluxed 3 hours. After cooling,<br>
15      the solvent was removed with a rotary evaporator. The residue was partitioned between<br>
ethyl acetate and water. The organic layer was dried (sodium sulfate) and the solvent was<br>
removed with a rotary evaporator. The residue was purified by MPLC with a gradient of<br>
40-100% ethyl acetate in hexanes as eluant to afford 5.8 lg of the title compound as a yellow<br>
solid.<br>
20	*H NMR (CDC13) 5 1.52 (s,9H), 2.60 (s,3H), 4.03 (s,3H), 8.07 (br,lH),8.98 (s,lH).<br>
Step E:	Preparation of methyl 5-amino-6-methyl-4-pyrimidinecarboxvlate<br>
5.8g of the material from Step D was dissolved in 25 mL of trifluoroacetic acid. After stirring for 90 minutes the solvent was removed with a rotary evaporator. Saturated aqueous sodium bicarbonate was added. The aqueous layer was extracted five times with 25      dichloromethane. The organic layer was dried (sodium sulfate) and the solvent was removed with a rotary evaporator to afford 3.78g of the title compound with a small amount of an impurity.<br>
JH NMR (CDCI3) 5 2.50 (s,3H), 4.00 (s,3H), 5.76 (br,2H),8.56 (s,lH).<br>
Step F:	Preparation of 5-amino-6-methvl-4-pvrimidinecarboxylic acid monosodium<br>
30	salt<br>
2.0g (12"mmol) of the material from Step E was dissolved in 24 mL of methanol.<br>
12 mL of a IN solution of sodium hydroxide was added. After 1 hour the solvent was<br>
removed with a rotary evaporator. The residue was dried in a vacuum oven overnight to<br>
afford 2.39 g of the title compound as a tan solid.<br>
35	3HNMR(D20)S 2.45 (s^H), 8.37 (s,lH).<br>
Step G:	Preparation of 3-chloro-N,N-dimethvI-lH-pyrazole-l-sulfonamide<br>
To a solution of jV-dimethylsulfemoylpyrazole (188.0 g, 1.07 mol) in dry tetrahydrofuran (1500 mL) at -78 Â°C was added dropwise a solution of 2.5 M"Â«-butyl-<br><br>
 WO 02/070483	PCT/US02/06582<br>
41<br>
lithium (472 mLs 1.18 mol) in hexane while maintaining the temperature below<br>
-65 Â°C. Upon completion of the addition the reaction mixture was maintained at -78 Â°C for<br>
an additional 45 minutes, after which time a solution of hexachloroethane (279 g, 1.18 mol)<br>
in tetrahydrofuran (120 mL) was added drop wise.   The reaction mixture was maintained for<br>
an hour at -78 Â°C, warmed to -20 Â°C and then quenched with water (1 L). The reaction<br>
mixture was extracted with methylene chloride (4x500 mL); the organic extracts were dried<br>
over magnesium sulfate and concentrated. The crude product was further purified by<br>
chromatography on silica gel using methylene chloride as eluent to afford the title product<br>
compound as a yellow oil (160 g).<br>
}H NMR (CDC13) 5 3.07 (d, 6H), 6.33 (s, 1H), 7.61 (s, 1H).<br>
Step H:	Preparation of 3-chloropyrazole<br>
To trifluoroacetic acid (290 mL) was added dropwise the chloropyrazole product<br>
(160 g) from Step G, and the reaction mixture was stirred at room temperature for 1.5 hours<br>
and then concentrated at reduced pressure. The residue was taken up in hexane, insoluble<br>
solids were filtered off, and the hexane was concentrated to afford the crude product as an<br>
oil. The crude product was further purified by chromatography on silica gel using<br>
ether/hexane (40:60) as eluent to afford the title product as a yellow oil (64.44 g).<br>
)HNMR (CDCI3) S 6.39 (s, 1H), 7,66 (s, 1H), 9.6 (br s, 1H).<br>
Step I:	Preparation of.3-chloro-2-(3-chloro-lff-pyrazol-l -yl)pyridine<br>
To 2 mixture of 2,3-dichloropyridine (92.60 g, 0.629 mol) and 3-chloropyrazole (64.44 g, 0.629 mol) in TV.TV-dimethylformamide (400 mL) was added potassium carbonate (147.78 g, 1.06 mol), and the reaction mixture was then heated to 100 Â°C for 36 hours. The reaction mixture was cooled to room temperature and slowly poured into ice water. The precipitated solids were filtered and washed with water. The solid filter cake was taken up in ethyl acetate, dried over magnesium sulfate and concentrated. The crude solid was chromatographed on silica gel using 20% ethyl acetate/hexane as eluent to afford the title product as a white solid (39.75 g).<br>
3H NMR (CDCI3) 8 6.43 (s, 1H), 7.26 (m, 1H), 7.90 (d, 1H), 8.09 (s, IE), 8.41 (d, 1H).<br>
Step J:	Preparation of 3-chloro-l-(3-chloro-2-pvridinyl)-lff-pyrazole-5-carboxylic<br>
acid To a solution of the pyrazole product from Step I (39.75 g. 186 mmol) in dry tetrahydrofuran (400 mL) at-78 Â°C was added dropwise a solution of 2.0 M lithium diisopropylamide (93 mL, 186 mmol) in tetrahydrofuran. Carbon dioxide was bubbled through the amber solution for 14 minutes, after which time the solution became pale brownish-yellow. The reaction was made basic with IN aqueous sodium hydroxide solution and extracted with ether (2x500 mL). The aqueous extracts were acidified with 6N hydrochloric acid and extracted with ethyl acetate (3x500 mL). The ethyl acetate extracts were dried over magnesium sulfate and concentrated to afford the title product as an off-<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
42<br>
white solid (42.96 g). (Product from another run following similar procedure melted at 198â€” 199 Â°C.)<br>
1H NMR (DMSO-d6) 6 6.99 (s, 1H), 7.45 (m, 1H); 7.93 (d, 1H), 8.51 (d, 1H).<br>
Step K:	Preparation of 2-r3-chloro-l"("3-chloro-2-pvridinvl)-lijr-pvrazol~5-vll-8-<br>
5	methvl-4iy-pvrimidor5.4-^f][1.3]oxa2in-4-one<br>
To a solution of 0.26 mL (3.3 mmol) of methanesulfonyl chloride in 18 mL of acetonitrile at 0Â°C was added 0.77g (3.0 mmol) of 3-cMoro-l-(3-chloro-2-pyridinyI)-l#-pyrazol-5-carboxylic acid from Step J. 0.42 mL (3.0 mmol) of triethylamine in 9 mL of acetonitrile was added dropwise. After 20 minutes at 0 Â°C, 0.525g (3.0 mmol) of material 10     from Step F was added. After 15 minutes 0.42 mL (3.0 mmol) of triethylamine was added dropwise. After 2 hours 0.26 mL (3.3 mmol) of methanesulfonyl chloride was added. After stirring overnight. The reaction mixture was poured into" water. Filtration afforded 0.27g of the title compound.<br>
]H NMR (GDC13) Â§ 2.20 (s,3H),-7.23 (s,lH), 7.54(dd,lH), 8.01 (dd,lH)s 8.57(dd,lH)," 15      9.20 (s,lH).      .<br>
Step L:	Preparation of 5-f[["3-Chloro-l "r3-chloro-2-pvridinvl)-lff-pvra2ol-5-<br>
y]]carbonvllamino)-A/.6-dimethv]-4"Pvrimidinecarboxamide 2 mL of a 2M solution of methylamine in tetrahydrofuran was added to 0.090g of material from Step K. After stirring overnight the solvent was removed with a rotary 20      evaporator to afford.0.071g"of the title compound, a compound of the invention, as a tan solid; m.p. 205-207 Â°C.<br>
!H NMR (CDCI3) 5 2.48 (s,3H), 3.04 (d,3H), 7.06 (s,lH), 7.41(dd,lH), 7.89 (dd,lH), 8.30 (br,lH), 8.48 (dd,lH); 8.85 (s,lH), 11:57 (br,lH).<br>
EXAMPLE 5<br>
25       Preparation of 2.6-dichloro-3-f|"ri-(3-chloro-2-pvridinvI)-3-(trifluoromethvl)-liJ"-pyrazol-5-<br>
vl]carbonyl1ammoTA/"-fl-methvlethvl)-4-pvridinecarboxamide<br>
Step A;	Preparation of ethyl 3-amino-4-pyridinecarboxylate<br>
To a solution of 1 g (7.25 mmol) of 3-amino-4~pyridmecarboxylic acid in 5 mL of ethyl alcohol was added 2 mL of sulfuric acid. The mixture was warmed under reflux for 2 30     h. It was cooled and basified with cone. NH4OH solution to pH = 8. The resulting solution was extracted with ethyl acetate and the organic layer was washed with brine and water, dried (MgSCU) and concentrated in vacuo to give 1.04 g of the title compound as a white solid (87%).<br>
]H NMR (CDCI3) 6 8.19 (s 1H), 7.93 (d 1H, J is 5.1Hz), 7.60 (d, 1H, J is 5.1Hz), 35     5.67 (brs,2H), 4.36 (q,2H), 1.40 (t, 3H).<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
43<br>
StepB:	Preparation of ethvl 3-arnino-2,6-dichloro-4-pvridinecafboxylate<br>
To a solution of 1.04 g (6.27 mmol) of ethyl 3-amino-4-pyridfnecarboxylate in 5 mL of DMF was added 1.67 g of JV-chlorosuccinimide (12.5 mmol) in a single portion at room temperature. The mixture was then stirred at the same temperature for 24 hours. The 5     resulting mixture was concentrated in vacuo and purified by silica gel column to give 1.40 g of the title compound as a white solid (95%).<br>
!HNMR (CDC13) 5 7.67 (s IK), 6.18 (br s, 2H), 4.39 (q, 2H), 1.42 (t, 3H).<br>
Step C:	Preparation of 3-amino-2n6-dichloro-4-pvridinecarboxvlic monopotassium<br>
salt<br>
10	To a solution of 1.30 g (5.54 mmol) of ethyl 3-amino-236-dichloro-4-<br>
pyridinecarboxylate in a mixture of 5 mL of water and 20 mL of ethyl alcohol was added<br>
622 mg (11 .-1 mmol) of potassium hydroxide at room temperature and the reaction mixture<br>
was warmed at 90 Â°C for.lhour. The mixture was then concentrated in vacuo and evaporated<br>
with benzene three times to give 1.63 g of the title compound as a white solid. The crude<br>
15     product was used in the next reaction without any further purification (98%).<br>
!H NMR (DMSOd-6) 5 7.31 (s, 1H), 7.14 (br s, 2H).<br>
Step D:	Preparation of 6,8-dich]oro-2ff-pyridoF3,4-Â£fin,3]oxa2ine-2.4flifl-dione<br>
To a solution of 1.64 g (5.54 mmol) of the material from Step C in 20 mL of dioxane was added 2.2 g (11.1 mmol) of diphosgene at 0 Â°C. The mixture was allowed to warm to 20     room temperature and stirred for 24 hours. The mixture was then concentrated in vacuo to give 1.70 g of the title compound as a white solid (quantitative).<br>
!H NMR (DMSOd-6) 5 7.99 (s, 1H).<br>
Step E:	Preparation of 3-chloro-2-[3Â»ftrifluorom ethyl)-1 .ff-pyrazol-1 -vl]pyridine<br>
To a mixture of 2,3-dichloropyridine (99.0 g, 0.67 mol) and 3-trifluoromethyl pyrazole 25     (83 g, 0.61 mol) in dry ACA"-dimethylformamide (300 mL) was added potassium carbonate (166.0 g, 1.2 mol) and the reaction was then heated to 110-125 Â°C over 48 hours. The reaction was cooled to 100 Â°C and filtered through CeliteÂ® diatomaceous filter aid to remove , solids. jVLV-Dimexhylformamide and excess dichloropyridine were removed by distillation at atmospheric pressure. Distillation of the product at reduced pressure (b.p. 139-141 Â°C, 30      7 mm) afforded the desired intermediate as a clear yellow oil (113.4 g).<br>
H NMR (CDCI3) 5 6.78 (s, IK), 7.36 (t, IK), 7.93 (d, IK), 8.15 (s, IK), 8.45 (d, IK).<br>
Step F:	Preparation of 1 -f3-chloro-2-pvridinvl)-3-(trifluoromethyn-lg-pvra2ole-5-<br>
carboxvlic acid To a solution of the pyrazole product from Step E (105.0 g5 425 mmol) in dry 35     tetrahydrofuran (700 mL) at -75 Â°C was added via cannula a -30 Â°C solution of lithium diisopropylamide (425 mmol)-in dry tetrahydrofuran (300 mL). The deep red solution was stirred for 15 minutes, after which time carbon dioxide was bubbled through at -63 Â°C until the solution became pale yellow and the exothermicity ceased. The reaction was stirred for<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
44<br>
an additional 20 minutes and then quenched with water (20 mL). The solvent was removed under reduced pressure, and the reaction mixture partitioned between ether and 0.5 N aqueous sodium hydroxide solution. The aqueous extracts were washed with ether (3x), filtered through CeliteÂ® diatomaceous filter aid to remove residual solids,- and then acidified to apH of approximately 4, at which point an orange oil formed. The aqueous mixture was stirred vigorously and additional acid was added to lower the pH to 2.5-3. The orange oil congealed into a granular solid, which was filtered, washed successively with water and IN hydrochloric acid, and dried under vacuum at 50 Â°C to afford the title product as an off-white solid (130 g). (Product from another run following similar procedure melted at 175-176 Â°C.)<br>
!HNMR (DMSO-^y) 5 7.61 (s, 1H), 7.76 (dd, 1H), 8.31 (d, IK), 8.60 (d, 1H).<br>
Step G:	Preparation of 2.6-dichloro-3-[[[[ -(S-chloro^-pyridinvD-S-rtrifluoromethvl)-<br>
lff-pvrazol-5-yl]carbonvIlamino1-jV-n~methylethvl")- 4-pyridinecarboxamide To a solution of 268 mg (0.92 mmol) of l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-l.ff-pyrazole-5-carboxylic acid (from Step F) in 5 mL of dichlorom ethane was added 160 uL (1.84 mmol) of oxalyl chloride and two drops of DMF in sequence at room temperature. The mixture was then stirred at the same temperature for 1 hour. The crude mixture was then"concentrated in vacuo. The resulting mixture was dissolved with 5 mL of acetonitrile followed by additions of 280 mg (0.92 mmol) of the compound prepared in Step D and 298 u.L (3.68 mmol) of pyridine in sequence. The reaction mixture was warmed to 70 Â°C for 2 hours and allowed to cool to room temperature. A solution of 157 pL (1.84 mmol) of isopropylamine in 1 mL of acetonitrile was added to the mixture and it was wanned to 60 Â°C for J hour. The reaction was allowed to cool to room temperature and quenched with water. The aqueous layer was extracted with ethyl acetate and the organic layer was dried with MgSO"4 and concentrated in vacuo. The resulting mixture was purified with a silica gel column to give 250 mg of the title compound, a compound of the invention, as a white solid (52%). m.p. 240-242 Â°C.<br>
"HNMR (CDCI3) S 9.85 (s, IK), 8.53 (dd, IK), 7.90 (dd, IK), 7.56 (s, IK), 7.42 (dd,    1H), 7.22 (s, IK), 6.08 (br d, IK), 4.13 (m, IK), 1.14 (d, 6H).<br>
By the procedures described herein together with methods known in the art, the following compounds of Tables 1 to 32 can be prepared. The following abbreviations are used in the Tables: t is tertiary, s is secondary, n is normal, i is iso, c is cyclo, Me is methyl, Et is ethyl, Pr is propyl, i-Pi is isopropyl, t-Bu is tertiary butyl, Ph. is phenyl, OMe is methoxy, OEt is ethoxy, SMe is methyltm"o, SEt is ethylthio, CN is cyano, N02 is nitro, TMS is trimethylsilyl, S(0)Me is methylsulfmyl, and S(0)2Me is methyisulfonyl. Structures of K for Tables 15,16 and 17 can be found in Exhibit 2.<br><br>
PCT/US02/06582<br>
WO 02/070483<br><br><br><br><br>
(f)m<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
46<br><br>
R4	(R5)m<br>
	R4	(R5)m<br>
	"     R4	(R5)m<br><br>
F	2-SCF3	F	3-SCF3	F	4-SCF3<br>
F	2-SOCF3	F	3-SOCF3	F	4-SOCF3<br>
F	2-S02CF3	F	3-SO7CF3	F	4-S02CF3<br>
F	2-SCF2H	F	3-SCF2H	F-	4-SCF2H<br>
F	2-SOCF2H	F	3-SOCF2H	F	4-SOCF2H<br>
F	2-S02CF2H	F	3-S02CF2H	F	4-S02CF2H<br>
Br	2-CF3	Br	3-CF3	Br	4-CF3<br>
Br	2-OCF3	Br	3-OCF3	Br	4-OCF3<br>
Br	2-OCF2H	Br	3-OCF2H	Br	4-OCF2H<br>
Br	2-OCF2CF2H	Br	3-OCF2CF2H	Br	4-OCF2CF2H<br>
Br	2-OCH2CF3	Br	3-OCH2CF3	Br	4-OCH2CF3<br>
Br	2-SCF3	Br	3^SCF3	Br	4-SCF3<br>
Br	2-SOCF3	Br"	3-SOCF3	Br	4-SOCF3<br>
Br	2-S02CF3	Br	3-S02CF3	Br	4-S02CF3<br>
Br	.    2-SCF2H	Br	3~SCF2H	Br	4-SCF2H<br>
Br	2-SOCF2H	Br	3~SOCF2R	Br	4-SOCF2H<br>
Br	2-S02CF2H	Br	3-S02CF2H	Br	4-S02CF2H<br>
	2-CF3		3-CF3		4-CF3<br>
	2-OCF3		3-OCF3    ,		4-OCF3<br>
	2-OCF2H		3-0CF2H		4-OCF2H<br>
	2-OCF2CF2H		3-OCF2CF2H		4-OCF2CF2H<br>
	2-OCH2CF3		3-OCH7CF3		4-OCH2CF3<br>
	2-SCF3		3-SCF3		4-SCF3<br>
	2-SOCF3		3-SOCF3		4-SOCF3<br>
	2-SO7CF3		3-S02CF3		4-S02CF3<br>
	2-SCF2H		3-SCF2H		4-SCF2H<br>
	2-SOCF7H		3-SOCF2H		4-SOCF2H<br>
	2-S02CF2H		3-S02CF2H		4-S02CF2H<br>
OMe	2-CF3	OMe	3-CF3	OMe	4-CF3<br>
OMe.	2-OCF3	OMe	3-OCF3	OMe	4-OCF3<br>
OMe	2-OCF2H	OMe	3-OCF2H	OMe	4-OCF7H<br>
OMe	2-OCF2CF2H	OMe	3-OCF2CF2H	OMe	4-OCF2CF2H<br>
OMe	2-OCH2CF3	OMe	3-OCH2CF3	OMe	4-OCH7CF3<br>
OMe	2-SCF3	OMe	3-SCF3	OMe	4-SCF3<br>
OMe	2-SOCF3	OMe â– 	3-SOCF3	OMe	- -    4-SOCF3<br>
OMe	2-S02CF3	"OMe	3-S02CF3	OMe	4-S02CF3<br>
OMe	2-SCF2H	OMe	3-SCF2H	OMe	4-SCF2H<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
47<br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br><br><br><br><br>
WO 02/070483	PCTAJS02/06582<br>
49<br><br><br>
WO 02/070483<br><br>
PCT/US02/O6582<br><br>
50<br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
51<br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br><br><br><br><br><br>
WO 02/070483<br><br>
53<br><br>
PCT/US02/06582<br><br><br><br>
^WO 02/070483<br><br>
PCT/US02/06582<br><br><br>
R4	(R5)m<br>
	R4	(R5)m<br>
	R4	(R5)m<br><br>
Br	2-Me-4-OCH2CF3		2-Me-4-OCH2CF3	OMe	2-Me-4-OCH2CF3<br>
Br	2-Me-4-SCF3		2-Me-4-SCF3 â– 	OMe	2-Me-4-SCF3<br>
Br	2-Me-4-SOCF3		2-Me-4-SOCF3	OMe	2-Me-4-SOCF3<br>
Br	2-Me-4-S02CF3 _		2-Me-4-S02CF3	OMe	2-Me-4-S02CF3<br>
Br	2-Me-4-SCF2H		2-Me-4-SCF2H	OMe	2-Me-4-SCF2H<br>
Br	2-Me-4-SOCF2H		2-Me-4-SOCF2H	OMe	2-Me-4-SOCF2H<br>
Br	2-Me-4-S02CF2H		2-Me-4-S02CF2H	OMe	2-Me-4-S02CF2H<br>
CF3	2-Me-4-CF3	N02	2-Me-4-CF3	SMe	2-Me-4-CF3<br>
CF3 CFo	2-Me-4-0CF3	N02	2-Me4-0CF3	SMe	2-Me-4-0CF3<br><br>
	2-Me-4-OCF2H	N02	2-Me4-0CF2H	SMe	2-Me-4-OCF2H<br>
3 CFn	2-Me-4-OCH2CF3	N02	2-Me-4-0CH2CF3	SMe	2-Me-4-OCH2CF3<br>
CF3	2-Me-4-SCF3	N02	2-Me-4-SCF3	SMe	2-Me-4-SCF3<br>
CF3	2-Me-4-SOCF3	NO7	2-Me4-S0CF3	SMe	2-Me-4-SOCF3<br>
J<br>
CF3	2-Me-4-S02CF3	N02	2-Me~4-S02CF3	SMe	2-Me4-S02CF3<br>
CF3 CF3	2-Me-4-SCF2H	N02	2-Me-4-SCF2H	SMe	2-Me-4-SCF2H<br><br>
	2-Me-4-SOCF2H	N02	2-Me-4-SOCF2H	SMe	2-Me-4-SOCF2H<br>
CF3	2-Me-4~S02CF2H	N02	2-Me-4-S02CF2H Table 4	SMe	2-Me-4-S03CF2H<br><br><br>
R4	(R5)m<br>
	R4	(R5)m<br>
	R4	(R5)m<br><br>
Me	2-CF3	Me	3-CF3	Me	4-CF3<br>
Me	2-OCF3	Me	3-OCF3	Me	4-0CF3<br>
Me	2-OCF2H	Me	3-0CF2H	Me	4-OCF7H<br>
Me	2-OCF2CF2H	Me	3-OCF2CF2H	Me	4-OCF2CF2H<br>
Me	2-OCH2CF3	Me	3-OCH2CF3	Me	4-OCH2CF3<br>
Me	2-SCF3	Me	3-SCF3	Me	4-SCF3<br>
Me	2-SOCF3	Me	3-SOCF3	Me	4-SOCF3<br>
Me	2-S02CF3	Me	3-S02CF3	Me	4-S02CF3<br><br>
WO 02/070483<br>
56<br><br>
PCTAJS02/06582<br><br><br><br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
57<br><br>
R4	(R5)m<br>
	R4	(R5)m<br>
	R4	(R5)m<br><br>
	2-OCF3		3-OCF3		4-OCF3-<br>
	2-OCF2H		3-OCF2H		4-OCF2H<br>
	2-OCF2CF2H		3-OCF2CF2H		4-OCF2CF2H<br>
	2-OCH2CF3		3-OCH2CF3		4-OCH2CF3<br>
	2-SCF3		3-SCF3		4-SCF3<br>
	2-SOCF3		3-SOCF3		4-SOCF3<br>
	2-S02CF3		3-SO7CF3		4-S02CF3<br>
	2-SCF2H		3-SCF2H		4-SCF2H<br>
	2-SOCF2H		3-SOCF2H		4-SOCF2H<br>
	2-S02CF2H		3-S02CF2H		4-S02CF2H<br>
OMe	2-CF3	OMe	3-CF3   â– 	OMe	4-CF3<br>
OMe	2-OCF3	OMe	3-OCF3	OMe	4-OCF3<br>
OMe	2-OCF2H	OMe	3-OCF2H	OMe	4-OCF2H<br>
OMe	2-OCF2CF2H	OMe	3-OCF2CF2H	OMe	4-OCF2CF2H<br>
OMe	. 2-OCH2CF3	OMe	3-OCH2CF3	OMe	4-OCH2CF3<br>
OMe	2-SCF3	OMe	3-SCF3	OMe	4-SCF3<br>
OMe	2.SOCF3	OMe	3-SOCF3	OMe	4-SOCF3<br>
OMe	2-SO7CF3	OMe	3-S02CF3	OMe	4-SO7CF3<br>
OMe	2-SCF2H	OMe	3-SCF2H	OMe	4-SCF2H<br>
OMe	2-SOCF2H	OMe	3-SOCF2H	OMe	4-SOCF2H<br>
OMe	2-S02CF2H	OMe	3-S02CF2H	OMe	4~S02CF2H<br>
CF3	2-CF3	CF3	3-CF3	CF3	4-CF3<br>
CF3	2-OCF3	CF3	3-OCF3	CF3	4-OCF3<br>
CF3	2-OCF2H	CF3	3-OCF2H	CF3	4-0CF2H<br>
CF3	2-OCF2CF2H	CF3	3-OCF2CF2H	CF3	4-0CF2CF2H<br>
CF3	2-0"CH2CF3	CF3	3-OCH2CF3	CF3	4-OCH2CF3<br>
CF3   .	2-SCF3	CF3	3-SCF3	CF3	4-SCF3<br>
CF3	2-SOCF3	CF3	3-SOCF3	CF3	4-SOCF3<br>
CF3	2-S02CF3	CT3	3-S02CF3	CF3	4-S02CF3<br>
CF3	2-SCF2H	CF3	3-SCF2H	CF3	4-SCF2H<br>
CF3	2-SOCF2H	CF3	3-S0CF2H	CF3	4-SOCF2H<br>
CF3	2-S02CF2H	CF3	3-S02CF2H	.CF3	4-S02CF2H<br>
OCF2H	2-CF3	OCF2H	3-CF3	OCF2H	4-CF3<br>
OCF2H	. , 2-OCF3	:OCF2H	3-OCF3	OCF2H	4-OCF3<br>
OCF2H	2-OCF2H	"   OCF2H	" 3-OCF2H	OCF2H	"      4-OCF2H<br>
OCF2H	2-OCF2CF2H	OCF2H	3-OCF2CF2H	OCF2H	4-OCF2CF2H<br>
OCF2H	2-OCH7CF3	OCF2H	3-OCH2CF3	OCF2H	4-OCH2CF3<br><br>
WO 02/070483	PCT/US02/065S2<br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
59 Table 5"<br><br><br>
R4	(R5)m<br>
	R4	(R5)m<br>
	R4	(R5)m<br><br>
Me	â– 2-CF3	Me	3-CF3	Me	4-CF3<br>
Me	2-OCF3	Me	3-OCF3	Me	4-OCF3<br>
Me	2-OCF2H	Me	3-OCF2H	Me	4-OCF2H<br>
Me	2-OCF2CF2H	Me	3-OCF2CF2H	Me	4-OCF2CF2H<br>
Me	2-OCH2CF3	Me	3-OCH2CF3	Me	4-OCH2CF3<br>
Me	2-SCF3	Me	3-SCF3	Me	4-SCF3<br>
Me	2-SOCF3	Me	3-SOCF3	Me	4-SOCF3<br>
Me	2S02CF3	Me	3-S02CF3	Me	4-S02CF3<br>
Me	2-SCF2H	Me	3-SCF2H	Me	4-SCF2H<br>
Me	2-SOCF2H	Me	3-SOCF2H	Me	4-SOCF2H<br>
Me	2-S02CF2H	Me	3-S02CF2H	Me	4-S02CF2H<br>
CF3	2-Me-4-CF3	CF2H	2-Me^-CF3	CH2CF3	2-Me^-CF3<br>
CF3	2-Me-4-OCF3	CF2H	2-Me^-OCF3	CH2CF3	2-Me-4-OCF3<br>
CF3	2-Me-4-OCF2H	CF2H	2-Me-4-OCF2H	GH2CF3	2-Me-4-OCF2H<br>
CF3 â€¢	2-Me4-OCH2CF3	CF2H	2-Me-4-OCH2CF3	CH2CF3 â– 	2-Me-4-OCH2CF3<br>
CF3	2-Me-4-SCF3	CF2H	2-Me^-SCF3	CH2CF3	2-Me-4-SCF3<br>
CF3	2-Me-4-SOCF3	CF2H	2-Me~4-SOCF3	CH2CF3	2-Me^-SOCF3<br>
CF3	2-Me-4-S02CF3	CF2H	2-Me^-S02CF3	CH2CF3	2-Me-4-S02CF3<br>
J<br>
CF3	2-Me-4-SCF2H	GF2H	2-Me-4-SCF2H	CH2CF3	2-Me-4-SCF2H<br>
CF3 â€¢	2-Me-4-SOCF2H	CF2H	2-Me-4-SOCF2H	CH2CF3	2-Me-4-SOCF2H<br>
CF3	2-Me-4-S02CF2H	CF2H	2-Me-4-S02CF2H	CH2CF3	2-Me-4-S02CF2H<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
60 Table 6<br><br><br><br><br>
"WO 02/070483<br><br>
PCT/US02/06582<br><br><br><br><br>
WO 02/070483<br><br>
63<br><br>
WO 02/070483<br><br>
PCT/US02/O6582<br><br><br><br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
65<br><br><br>
R4	(R5)m<br><br>
Me	2-SCF2H<br>
Me	2-SOCF2H<br>
Me	2-S02CF2H<br>
CI	2-CF3<br>
CI	2-OCF3<br>
CI	2-OCF2H<br>
CI	2-OCF2CF2H<br>
CI	2-OCH.2CF3<br>
CI	2-SCF3<br>
CI	2-SOCF3<br>
CI	2-S02CF3<br>
CI	2-SCF2H<br>
CI	2-SOCF2H<br>
CI	2-S02CF2H<br>
F	2-CF3<br>
F	2-OCF3<br>
F	2-OCF2H<br>
F	2-OCF2CF2H<br>
F	2-OCH2CF3<br>
F	2-SCF3<br>
F	2-SOCF3<br>
F	2-S02CF3<br>
F	2-SCF2H<br>
F	2-SOCF2H<br>
F	2-S02CF2H<br>
.Br	2-CF3<br>
Br	2-OCF3<br>
Br	2-OCF2H<br>
Br.	2-OCF2CF2H<br>
Br	2-OCB2CF3<br>
Br	2-SCF3<br>
Br	2-SOCF3<br>
Br	,2-S02CF3<br>
Br	2-SCF2H<br>
Br	2-SOCF2H<br>
Br	2-S02CF2H<br>
I	2-CF3<br><br><br>
R4	(R5)m<br><br>
Me	3-SCF2H<br>
Me	3-SOCF2H  .<br>
Me	3-S02CF2H<br>
CI	3-CF3<br>
CI	3-OCF3<br>
CI	3-OCF2H<br>
CI	3-OCF2CF2H<br>
CI	3-OCH2CF3<br>
CI	3-SCF3<br>
CI	3-SOCF3<br>
CI	3-S02CF3<br>
CI	3-SCF2H<br>
CI	3-SOCF2H<br>
CI	3-S02CF2H<br>
F	3-CF3<br>
F	3-OCF3<br>
F	3-OCF2H<br>
F	3-OCF2CF2H<br>
F	3-OCH2CF3<br>
F	3-SCF3<br>
F	3-SOCF3<br>
F	3-S02CF3<br>
F	3-SCF2H<br>
F	3-SOCF2H<br>
F	3-S02CF2H<br>
Br	3-CF3<br>
Br	3-OCF3<br>
, Br	3-OCF2H<br>
Br	3-OCF2CF2H<br>
Br	3-OCH2CF3<br>
Br	3-SCF3<br>
Br	3-SOCF3<br>
Br	3-S02CF3<br>
Br	3-SCF2H<br>
" Br	"    "3-SOCF2H"<br>
Br	3-SO2CF2H<br>
I	3-CF3<br><br><br>
R4	(R5)m<br><br>
Me	4-SCF2H<br>
Me	4-SOCF2H<br>
-Me	4-S02CF2H<br>
CI	4-CF3<br>
CI	4-OCF3<br>
CI	4-OCF7H<br>
CI	4-OCF2CF2H<br>
CI	4-OCH2CF3<br>
CI	4-SCF3<br>
CI	4-SOCF3<br>
CI	4-S02CF3<br>
. CI	4-SCF2H<br>
CI	4-SOCF2H<br>
CI	4-S02CF2H<br>
F	"4-CF3<br>
F	4-OCF3<br>
F	4-OCF9H<br>
F	4"0CF2CF2H<br>
F	4-OCH2CF3<br>
F	4-SCF3<br>
F	4-SOCF3<br>
F	4-S02CF3<br>
F	4-SCF2H<br>
F	4-SOCF2H<br>
F	4-S02CF2H<br>
Br	4-CF3<br>
Br	4-OCF3<br>
Br	4-OCF2H<br>
Br	4-OCF2CF2H<br>
Br	4-OCH2CF3<br>
Br	4-SCF3<br>
Br	4-SOCF3<br>
Br	4-S02CF3<br>
Br	4-SCF2H<br>
Br	4-SOCF2H<br>
Br	4-S02CF2H<br>
â–  I	4-CF3<br><br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br><br><br><br>
El OCF2H OCF2H OCF2H OCF2H OCF2H OCF2H Me Me Me Me Me Me Me Me Me Me Br Br Br Br Br Br Br Br Br Br CF3 CF3 CF3 CF3<br>
CF3 CF3 CF3 CF3 "CF3<br>
CF3<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br><br><br><br><br><br><br><br><br><br><br><br><br>
R
f      I	6i	I	<br><br><br><br><br><br>
El	(EX	El	m^im	El	(Btm<br>
Me	2-CF3	Me	3-CF3	Me	" 4-CF3<br>
Me	2-OCF3	Me	3-OCF3	Me	4-OCF3<br>
Me	2-OCF2H	Me	3-OCF2H	Me	4-OCF2H<br>
Me	2-OCF2CF2H	Me	3-OCF2CF2H	Me	4-OCF2CF2H<br>
Me	2-OCH2CF3	Me	3-OCH2CF3	Me	4-OCH2CF3<br>
Me	2-SCF3	Me	3-SCF3	Me	4-SCF3<br>
Me	2-SOCF3	Me	3-SOCF3	Me	4-SOCF3<br>
Me	2-S02CF3	Me	3-S02CF3	Me	4-S02CF3<br>
Me	2-SCF2H	Me	3-SCF2H	Me	4-SCF2H<br>
Me	2-SOCF2H	Me	3-SOCF2H	Me	4-SOCF2H<br>
.Me	2-S02CF2H	Me	3-S02CF2H	Me	4-S02CF2H<br>
CI	2-CF3	CI	3-CF3	CI	4-CF3<br>
CI	2-OCF3	CI	3-OCF3	CI	4-OCF3<br>
CI	.2-OCF2B	CI	3-OCF7H	CI	4-OC?2H<br>
CI	2-OCF2CF2H	CI	3-OCF2CF2H	CI	4-OCF2CF2H<br>
CI	2-OCH2CF3	CI	3-OCH2CF3	CI	4-OCH2CF3<br>
CI	2-SCF3	CI	3-SCF3	ci	4-SCF3<br>
CI	2-SOCF3	CI	3-SOCF3	CI	4-SOCF3<br>
CI	2-S02CF3	CI	3-S02CF3	CI	4-S02CF3<br>
CI	2-SCF2H	CI	3-SCF2H   "	CI	4-SCF2H<br>
CI	2-SOCF2H	CI	3-SOCF2H	CI	4-SOCF2H<br>
CI	2-S02CF2H	CI	3-S02CF2H	CI	4-S02CF2H<br>
F	2-CF3	F	3-CF3	F	4-CF3<br>
F	2-OCF3	F	3-OCF3	F	4-OCF3<br>
F	2-OCF2H	F	3-OCF2H	F	4-OCF2H<br>
F	2-OCF2CF2H	F	3-OCF2CF2H	F	4-OCF2CF2H<br>
F	2-OCH2CF3	F	3-	DCH2CF3	F	4-OCH2CF3<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
69<br><br>
R4<br>
	(R5)m<br>
	R4	(R5)m<br>
	R4<br>
	(R5)m<br><br>
F	2-SCF3	F	3-SCF3	F	4-SCF3<br>
F	2-SOCF3	F	3-SOCF3	F	4-SOCF3<br>
F	2-S02CF3	F	3-S02CF3	F	4-SO7CF3<br>
F	2-SCF2H	F	3-SCF2H	F	4-SCF2H<br>
F	2-SOCF2H	F	3-SOCF2H	F	4-SOCF2H<br>
F	2-S02CF2H	F	3-S02CF2H	F	â–     4-S02CF2H<br>
Br	2-CF3	Br	3-CF3	Br	4-CF3<br>
Br	2-OCF3	Br	3-OCF3	Br	4-OCF3<br>
Br	2-OCFoH	Br	3-OCF2H	Br	4-OCF2H<br>
Br	2-OCF2CF2H	Br	3~OCF2CF2H	Br	4-OCF2CF2H<br>
Br	2-OCH2CF3	Br	3-OCH2CF3	Br	4-OCH2CF3<br>
Br	2-SCF3	Br	3-SCF3	Br	4-SCF3<br>
Br	2-SOCF3	Br	3-SOCF3	Br	4-SOCF3<br>
Br	2-S02CF3	Br	3-S02CF3	Br	4-S02CF3<br>
Br	.     2-SCF2H	Br	3-SCF2H	Br	4-SCF2H<br>
Br	2-SOCF2H	Br	3-S0CF2H	Br	4-S0CF2H<br>
Br	2-S02CF2H	Br	3-S02CF2H	Br	4-S02CF2H<br>
	2-CF3		3-CF3		4-CF3<br>
	2-OCF3		3-OCF3		4-OCF3<br>
	2-OCF2H		3-OCF2H		4-OCF2H<br>
	2-OCF2CF2H		3-OCF2CF2H		4-OCF2CF2H<br>
	2-OCH2CF3		3-OCH7CF3		4-OCH2CF3<br>
	2-SCF3		3-SCF3		4-SCF3<br>
	2-SOCF3		3-SOCF3		4-SOCF3<br>
	2-S02CF3		3-S02CF3		4-S02CF3<br>
	2-SCF2H		3-SCF2H		4-SCF2H<br>
	2-SOCF2H		3-SOCF2H		4-SOCF2H<br>
	2-S02CF2H		3-S02CF2H		4-S02CF2H<br>
OMe	2-CF3	OMe	3-CF3	OMe	4-CF3<br>
OMe	2-OCF3	OMe	3-OCF3	OMe	4-OCF3<br>
OMe	2-OCF2H	OMe	3-OCF2H	OMe	4-OCF2H<br>
OMe	2-OCF2CF2H	OMe	3-OCF2CF2E	OMe	4-OCF2CF2H<br>
OMe	2-OCH2CF3	OMe	3-OCH9CF3	OMe	4-OCH2CF3<br>
OMe	2-SCF3     â– __	OMe.	3-SCF3	OMe	4-SCF3<br>
OMe	2-SOCF3	OMe	3-SOCF3	OMe	4-SOCF3<br>
OMe	2-S02CF3	OMe	3-S02CF3	OMe	4-SO?CF3<br>
OMe	2-SCF9H	OMe	3-SCF2H	OMe	4-SCF2H<br><br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
71<br><br>
R4	(R5)m<br>
	R4		(R5)m<br>
		R4	(R5)m<br>
Br	2-Me-4-OCH2CF3		2-Me-4-OCH2CF3	OMe	2-Me-4-OCH2CF3<br>
Br	2-Me-4-SCF3		2-Me-4-SCF3	OMe	2-Me-4-SCF3<br>
Br	2-Me-4-SOCF3		2-Me-4-SOCF3	OMe	2-Me-4-SOCF3<br>
Br	2"Me-4-S02CF3		2-Me-4-S02CF3	OMe	2-Me-4-S02CF3<br>
Br	2-Me-4-SCF2H		2-Me-4-SCF2H	OMe	2-Me-4-SCF2H<br>
Br	2-Me-4-SOCF2H		2-Me-4-SOCF2H	OMe	2-Me-4-SOCF2H<br>
Br	2-Me^-S02CF2H		2-Me-4-S02CF2H	OMe	2-Me-4-S02CF2H<br>
CF3	2-Me-4-CF3	N02	2-Me^-CF3	SMe	2-Me-4-CF3<br>
CF3	2-Me-4-OCF3	N02	2-Me-4-OCF3	SMe	2-Me-4-OCF3<br>
CF3	2-Me-4-OCF2H	N02	2-Me-4-OCF2H	SMe	2-Me-4-OCF2H<br>
CF3	2-Me^-OCH2CF3	N02	2-Me-4-OCH2CF3	SMe	2-Me-4-OCH2CF3<br>
CF3	2-Me-4-SCF3	.   N02	2-Me^-SCF3	SMe	2-Me-4-SCF3<br>
CF3	2-Me^-SOCF3	N02	2-Me4-SOCF3	SMe	2-Me-4-SOCF3<br>
CF3	2-Me-4-S02CF3	N02	2-Me-4-S02CF3	SMe	2-Me-4-S02CF3<br>
CF3	2-Me-4-SCF2H	N02	2-Me-4-SCF2H	SMe	2-Me-4-SCF2H<br>
CF3	2-Me-4-SOCF2H	N02	2-Me-4-SOCF2H	SMe	2-Me-4-SOCF2H<br>
CF3	2-Me-4-S02CF2H	N02	2-Me-4-S02CF2H Table 10	SMe	2-Me-4-S02CF2H<br>
				1      H	-(R5),	Tl	<br>
		R4Â°^^		<br>
		I	1           H ^   ^(/-Bu)		<br>
R4	(R5)m<br>
	R4	(R5)m<br>
	R4	(R5)m<br><br>
Me	2-CF3	Me	3-CF3	Me	4-CF3<br>
Me	2-OCF3	Me	3-OCF3	Me	4-OCF3<br>
Me	2-OCF2H	Me	3-OCF2H	Me	4-OCF2H<br>
Me	2-OCF2CF2H	Me	3-OCF2CF2H	Me	4-OCF2CF2H<br>
Me	2-OCH2CF3	Me	3-OCH2CF3	Me	4-OCH2CF3<br>
Me	"     2-SCF3     7	Me	3-SCF3	Me	4^SCF3<br>
Me	2-SOCF3	Me	3-SOCF3	Me	4-SOCF3<br>
Me	2-S02CF3	Me		3-S02C	F3	Me	4-S02CF3<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
72<br><br>
R4	(R5)m<br>
	R4	(R5)m<br>
	R4	(R5)m<br><br>
Me	2-SCF2H	Me	3-SCF2H	Me	4-SCF2H<br>
Me	2-SOCF2H	Me	3-SOCF2H	Me	4-SOCF2H<br>
Me	.     2-SOjCF2H	Me	3-S02CF2H	Me	4-S02CF2H<br>
CI	2-CF3	CI	3-CF3	CI	4-CF3<br>
CI	2-OCF3	CI	3-OCF3	CI	4-OCF3<br>
C!	2-OCF2H	C)	3~OCF2H	CI	4-OCF2H<br>
CI	2-OCF2CF2H	CI	3-OCF2CF2H	C!	4-OCF2CF2H<br>
CI â€¢	2-OCH7CF3	CI	3-OCH2CF3	CI	4-OCH2CF3<br>
CI	2-SCF3	CI	3-SCF3	C]	4-SCF3<br>
CI	2-SOCF3	CI	3-SOCF3	CI	4-SOCF3<br>
CI	2-SG2CF3	CI	3-S02CF3	CI	4-S02CF3<br>
CI	2-SCF2H	CI	3-SCF2H	CI	4-SCF2H<br>
CI	2-SOCF2H	CI	3-SOCF2H	C[	4-SOCF2H<br>
CI	2-S02CF2H	CI	3-S02CF2H	CI	4-S02CF2H<br>
F	2-CF3	F	3-CF3	F	4-CF3<br>
F	2-OCF3	F	3-OCF3	F	4-OCF3<br>
F	2-OCF2H	F	3-OCF2H	F	4-OCF2H<br>
F	2-OCF2CF2H	F	3-OCF2CF2H	F	4-OCF2CF2H<br>
F	2-OCH2CF3	F	3-OCH2CF3	F	4-OCH2CF3<br>
F	2-SCF3	F	3-SCF3	F	4-SCF3<br>
F	2-SOCF3	F	3-SOCF3	F	4-SOCF3<br>
F	2-S02CF3	F	3-SG2CF3	F	4-SO9CF3<br>
F	2-SCF2H	F	3-SCF2H	F	4-SCF2H<br>
F    "	2-SOCF2H	â–    F	3-SOCF2H	F	4-SOCF2H "<br>
F	2-S02CF2H	F	3-S02CF2H	F	4-S02CF2H<br>
Br	2-CF3   "	Br	3-CF3	Br	4-CF3<br>
Br	2-OCF3	Br	3-OCF3	Br	4-OCF3<br>
Br	2-OCF2H	Br	3-OCF2H	Br	4-OCF2H<br>
Br	2-OCF2CF2H	Br	3-OCF2CF2H	Br	4-OCF2CF2H<br>
Br	2-OCH2CF3	Br	3-OCH2CF3	Br	4-OCH2CF3<br>
Br	2-SCF3	Br	3-SCF3	Br	4-SCF3.<br>
Br	2-SOCF3	Br	3-SOCF3	Br	4-SOCF3<br>
Br	2-S02CF3	Br	3-S02CF3	Br	4-S02CF3<br>
Br	2-SCF2H	â–    Br	3-SCF2H	Br	4-SCF2H<br>
Br	2-SOCF2H    â€¢	Br	3-SOCF2H	Br	4-SOCF2H<br>
Br	2-SO,CF2H	:    Br	3-S02CF2H	Br	4-S02CF2H<br>
I	2-CF3	I	3-CF3	I	4-CF3<br><br>
-VO 02/070483<br><br>
PCT/DS02/06582<br><br>
73<br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
74<br><br>
R4	(R5)m<br>
	R4	(R5)m<br>
	R4	(R5)m<br><br>
OCF2H	2-SCF3	OCF2H	3-SCF3	OCF2H	4-SCF3<br>
OCF2H	2-SOCF3	OCF2H	3-SOCF3	OCF2H	4-SOCF3<br>
OCF2H	2-S02CF3	OCF2H	3-S02CF3	OCF2H	4-SO?CF3<br>
OCF2H	2-SCF2H	OCF2H	3-SCF2H	OCF2H	4-SCF2H<br>
OCF2H	2-SOCF2H	OCF2H	3-SOCF2H	OCF2H	4-SOCF2H<br>
OCF2H	2-S02CF2H	OCF2H	3-S02CF2H	OCF2H	4-SO3CF2H<br>
Me	2-Me-4-CF3	F	2-Me-4-CF3	a	2-Me-4-CF3<br>
Me	2-Me-4-OCF3	F	2-Me-4-OCF3	Cl	2-Me-4-OCF3<br>
Me	2-Me-4-OCF2H	F	2-Me-4-OCF2H	Cl	2-Me-4-OCF2H<br>
Me	2-Me-4-OCH2CF3	F	2-Me-4-OCH2CF3	C!	2-Me-4-OCH2CF3<br>
Me	2-Me-4-SCF3	F	2-Me-4-SCF3	Cl	2-Me-4-SCF3<br>
Me	2-Me-4-SOCF3	F	2-Me-4-SOCF3	Cl	2-Me-4-SOCF3<br>
.Me	2-Me-4-S02CF3	F	2-Me-4-S02CF3	CI	2-Me-4-S02CF3<br>
Me	2-Me-4-SCF2H	F	2-Me-4-SCF2H	Ci	2-Me-4-SCF2H<br>
Me	2-Me-4-SOCF2H	F	2-Me-4-SOCF2H	Cl	2-Me-4-S0CF2H<br>
Me	2-Me-4-S02CF2H	F	2-Me-4-S02CF2H	Cl	2-Me-4-S02CF2H<br>
Br	2-Me-4-CF3		2-Me-4-CF3	OMe	2-Me-4-CF3<br>
Br	2-Me-4-OCF3		2-Me-4-OCF3	OMe	2-Me-4-0CF3<br>
Br	2-Me-4-OCF2H		2-Me-4-OCF2H	OMe	2-Me-4-0CF2H<br>
Br	2-Me^-OCH2CF3		2-Me-4-OCH2CF3	OMe	2-Me^-OCH2CF3<br>
Br	2-Me-4-SCF3		2-Me^-SCF3	OMe	2-Me^-SCF3<br>
Br	2-Me-4-SOCF3		2-Me^-SOCF3	OMe	2-Me-4-SOCF3<br>
Br	2-Me-4-S02CF3		2-Me-4-S02CF3	OMe	2-Me^-S02CF3<br>
Br	2-Me-4-SCF2H		2-Me-4-SCF2H	OMe	2-Me-4-SCF2H<br>
Br	2-Me-4-SOCF2H		2-Me-4-SOCF2H	OMe	2-Me-4-SOCF2H<br>
Br	2-Me-4-S02CF2H		2-Me-4-S02CF2H	OMe	2-Me-4-SO?CF2H<br>
CF3	2-Me-4-CF3	N02	2-Me^~CF3	SMe	2-Me-4-CF3<br>
CF3	2-Me-4-OCF3   .	N02	2-Me^-OCF3	SMe	2-Me-4-OCF3<br>
CF3	2-Me^-OCF2H	N02	2-Me-4-OCF2H	SMe	2-Me-4-OCF2H<br>
CF3	2-Me-4-OCH2CF3	N02	2-Me-4-OCH2CF3	SMe	2-Me-4-OCH2CF3<br>
CF3	2-Me-4-SCF3	N02	2-Me-4-SCF3	SMe	2-Me-4-SCF3<br>
CF3	2-Me-4-SOCF3	N02	2-Me-4-SOCF3 .	SMe	2-Me-4-SOCF3<br>
CF3	2-Me-4-S02CF3	N02	2-Me-4-S02CF3	SMe	2-Me-4-S02CF3<br>
CF3	2-Me-4-SCF2H	N02	2-Me-4-SCF2H	SMe	2-Me-4-SCF2H<br>
CF3	2-Me^-SOCF2H	â–    -N02	2-Me-4-SOCF2H	SMe	2-Me-4-SOCF2H<br>
CF3	2-Me-4-S02CF2H	N02	2-Me^-.S02CF2H."	SMe	2-Me-4-S02CF2H<br><br>
^    WO 02/070483<br><br>
PCT/US02/06582<br><br><br><br><br><br><br><br><br><br>
g4	<br><br><br><br><br><br>
ffi^im		7:	&gt;	<br><br><br><br><br><br><br>
mhm<br>
Me	2-CF3	Me                   3-CF3.	Me	4-CF3<br>
Me	2-OCF3	Me                 3-OCF3	Me	4-OCF3<br>
Me	2-OCF2H	Me                 3-OCF2H	Me	4-OCF2H<br>
Me	2-OCF2CF2H	Me             3-OCF2CF2H	Me	4-OCF2CF2H<br>
Me	2-OCH2CF3	Me              3-OCH2CF3	Me	4-OCH2CF3<br>
Me	2-SCF3	Me                 3-SCF3	Me	4-SCF3<br>
Me	2-SOCF3	Me                3-SOCF3	Me	4-SOCF3<br>
Me	2-S02CF3	Me               3-S02CF3	Me	4-S02CF3<br>
Me	2-SCF2H	Me                3-SCF2B	Me	4-SCF2H<br>
Me	2-SOCF2H	Me               3-SOCF2H	Me	4-SOCF2H<br>
Me	2-S02CF2H	Me               3-S02CF2H	Me	4-S02CF2H<br>
CI	2-CF3	CI                    3-CF3	CI	4-CF3<br>
CI	2-OCF3	CI                   3-OCF3	CI	4-OCF3<br>
CI	2-OCF2H	CI                 3-OCF2H	CI	4-OCF9H<br>
CI	2-OCF2CF2H	Ci             3-OCF2CF2H	CI	4-OCF2CF2H<br>
CI	2-OCH2CF3	CI               3-OCH2CF3	CI	4-OCH2CF3<br>
CI	2-SCF3	CI                  3-SCF3	CI	4-SCF3<br>
CI	2-SOCF3	CI                 3-SOCF3	CI	4-SOCF3<br>
ci â– 	2-S02CF3	CI                3-SO2CF3	CI	4-S02CF3<br>
CI	2-SCF2H	CI                  3-SCF2H	CI	4-SCF2H<br>
CI	2-SOCF2H	CI                3-SOCF2H -	CI	4-SOCF2H<br>
CI	2-S02CF2H	CI                3-S02CF2H	CI	4-S02CF2H<br>
F	2-CF3	F                     3-CF3	F	4-CF3<br>
F	2-OCF3	F                  3-OCF3	-F	4-OCF3<br>
F	2-OCF2H    "â– 	. .    F                 3-OCF2H	F	4-OCF2H<br>
F	2-OCF2CF2H	F              3-OCF2CF2H	F	4-OCF2CF2H<br>
F	2-OCH2CF3	F		5-OCH2CF3	"F	4-OCH2CF3<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
76<br><br><br>
R4	(R5)m<br><br>
F	2-SCF3<br>
F	2-SOCF3<br>
F	2-S02CF3<br>
F	2-SCF2H<br>
F	2-SOCF2H<br>
F	2-S02CF2H<br>
Br	2-CF3<br>
Br	2-OCF3<br>
Br	2-OCF2H<br>
Br	2-OCF2CF2H<br>
Br	2-OCH2CF3<br>
Br	2-SCF3<br>
Br	2-SOCF3<br>
Br	2-S02CF3<br>
Br	.     2-SCF2H<br>
Br	2-SOCF2H<br>
Br	2-S02CF2H<br>
	2-CF3<br>
	2-OCF3<br>
	2-OCF2H<br>
	2-OCF2CF2H<br>
	2-OCH2CF3<br>
	2-SCF3<br>
	2-SOCF3<br>
	2-S02CF3<br>
	2-SCF2H<br>
	2-SOCF2H<br>
	2-S02CF2H<br>
OMe	2-CF3<br>
OMe	2-OCF3<br>
OMe	2-OCF2H<br>
OMe	2-OCF2CF2H<br>
OMe	2-OCH2CF3<br>
OMe	2^SCF3<br>
OMe	2-SOCF3<br>
OMe	2-S02CF3"<br>
OMe	2-SCF7H<br><br><br>
R4	(R5)m<br><br>
F	" 3-SCF3    â– <br>
F	3-SOCF3<br>
F	3-S02CF3<br>
F	3-SCF2H<br>
F	3-SOCF2H<br>
F	3-S02CF2H<br>
Br	3-CF3<br>
Br	3-OCF3<br>
Br	3-OCF2H<br>
Br	3-OCF2CF2H<br>
Br	3-OCH2CF3<br>
Br	3-SCF3<br>
Br	3-SOCF3<br>
Br	3-SO7CF3<br>
Br	3-SCF2H<br>
Br	3~SOCF2H<br>
Br	3-S02CF2H<br>
	3-CF3<br>
	3-OCF3<br>
	3-OCF2H<br>
	3-OCF2CF2H<br>
	3-OCH2CF3<br>
	3-SCF3<br>
	3-SOCF3<br>
	3-S02CF3<br>
	3-SCF2H<br>
	3-SOCF2H<br>
	3-S02CF2H<br>
OMe	3-CF3<br>
OMe	3-OCF3<br>
OMe	3-OCF2H<br>
OMe	3-OCF2CF2H<br>
OMe	3-OCH2CF3<br>
OMe	3-SCF3<br>
OMe	3-SOCF3<br>
OMe	3-S02CF3<br>
OMe	3-SCF7H<br><br><br>
R4	(R5)m<br><br>
F	4-SCF3<br>
F	4-SOCF3<br>
F	4-S02CF3<br>
F	4-SCF2H<br>
F	4-SOCF2H<br>
F	4-S02CF2H<br>
Br	4-CF3<br>
Br	4-OCF3<br>
Br	4-OCF2H<br>
Br	4-OCF2CF2H<br>
Br	4-OCH2CF3<br>
Br	4-SCF3<br>
Br	4-SOCF3<br>
Br	4-S02GF3<br>
Br	4-SCF2H<br>
Br	4-S0CF2H<br>
Br	4-S02CF2H<br>
	4-CF3<br>
	4-OCF3<br>
	4-0CF2H<br>
	4-0CF2CF2H<br>
	4-0CH2CF3<br>
	4-SCF3<br>
	4-SOCF3<br>
	4-S02CF3<br>
	4-SCF2H<br>
	4-SOCF2H<br>
	4-S02CF2H<br>
OMe	4-GF3<br>
OMe	4-OCF3<br>
OMe	4-OCF2H<br>
OMe	4-OCF2CF2H<br>
OMe	4-OCH7CF3<br>
OMe	4-SCF3<br>
OMe	4-SOCF3<br>
OMe	4-S02CF3<br>
OMe	4-SCF2H<br><br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
78<br><br>
R4<br>
	(R5)m	R4<br>
		(R5)m<br>
	R4<br>
	(R5)m<br><br>
Br	2-Me-4-OCH2CF3		2-Me^-OCH2CF3	OMe	2-Me-4-OCH2CF3<br>
Br	2-Me-4-SCF3		2-Me-4-SCF3	OMe	2-Me-4-SCF3<br>
Br	2-Me-4-SOCF3		2-Me-4-SOCF3	OMe	2-Me-4-SOCF3<br>
Br	2-Me-4-S02CF3		2-Me-4-S02CF3	OMe	2-Me-4-S02CF3<br>
Br	2-Me-4-SCF2H		2-Me-4-SCF2H	OMe	2-Me-4-SCF2H<br>
Br	2-Me-4-SOCF2H		2-Me-4-SOCF2H	OMe	2-Me-4-SOCF2H<br>
Br	2-Me^-S02CF2H		2-Me-4-S02CF2H	OMe	2-Me-4-S02CF2H<br>
CF3	2-Me-4-CF3	N02	2-Me-4-CF3	SMe	2-Me-4-CF3<br>
CF3	2-Me-4-OCF3	N02	2-Me-4-OCF3	SMe	2-Me-4-0CF3<br>
CF3	2-Me-4-OCF2H	N02	2-Me-4-OCF2H	SMe	2-Me-4-OCF2H<br>
CF3	2-Me-4-OCH2CF3	N02	2-Me-4-OCH2CF3	SMe	2-Me-4-OCH2CF3<br>
CF3	2-Me-4-SCF3	NC"2	2-Me-4-SCF3	SMe	2-Me-4-SCF3<br>
CF3	2-Me-4-SOCF3	N02	2-Me-4-SOCF3	SMe	2_Me-4-SOCF3<br>
CF3	2-Me-4-S02CF3	N02	2_Me-4-S02CF3	SMe	2-Me-4-S02CF3<br>
CF3	2-Me-4-SCF2H	N02	2-Me-4-SCF2H	SMe	2-Me-4-SCF2H<br>
CF3	2-Me-4-SOCF2H	N02	2-Me-4-SOCF2H	SMe	2-Me-4-SOCF2H<br>
CF3	2-Me-4-S02CF2H	N02	2-Me-4~S02CF2H	SMe	2-Me-4-S02CF2H<br>
		Tabl	el2<br>
 			-<br>
El	(Shm	El	Â®hm -	El	(E^)rn<br>
Me	2-CF3	Me	3-CF3	Me	4-CF3<br>
Me	2-OCF3	Me	3-OCF3	Me	4-OCF3<br>
Me	2-OCF2H	Me	3-OCF2H	Me	4-OCF2H<br>
Me	2-OCF2CF2H	Me	3-OCF2CF2H	Me	â€¢    4-OCF2CF2H<br>
Me	2-OCH7CF3	Me	3-OCH2CF3	Me	4-OCH7CF3<br>
Me	2-SCF3   .	Me	3-SCF3	Me	4-SCF3<br>
Me	2-SOCF3	Me	3-SOCF3.	Me	4-SOCF3<br>
Me	2-S02CF3	Me		3-S02Cl	*n	Me	4-S02CF3<br><br>
WO 02/070483	PCT/DS02/06582<br>
79<br><br>
R4	(R5)m<br>
	R4<br>
	(R5)m<br>
	R4<br>
	(R5)m<br>
Mc	2^SCF2H	Me	3-SCF2H	Me	4-SCF2H<br>
Me	2-SOCF2H	Me	3-SOCF2H	Me	4-SOCF2H<br>
Me	2-S02CF2H	Me	3-S02CF2H	Me	4-S02CF2H<br>
CI	2-CF3	CI	3-CF3	CI	â–      4-CF3<br>
CI	"   2-OCF3	CI	3-OCF3	CI	4-OCF3<br>
CI	2-OCF2H	CI	3-OCF2H	CI	4-OCF2H<br>
CI	2-OCF2CF2H	CI	3-OCF2CF2H	CI	4-OCF2CF2H<br>
CI	2-OCH2CF3	Ci	3-OCH2CF3	CI	4-OCH2CF3<br>
CI	2-SCF3	CI	3-SCF3	CI	4-SCF3<br>
CI	2-SOCF3	C!	3-SOCF3	CI	4-SOCF3<br>
CI	2-S02CF3	CI	3-S02CF3	CI	4-S02CF3<br>
CI	2-SCF2H	CI	3-SCF2H	CI	4-SCF2H<br>
CI	2-SOCF2H	CI	3-SOCF2H	CI	4-SOCF2H<br>
CI	2-S02CF2H	CI	3-S02CF2H	CI	4-S02CF2H<br>
F	â–        2-CF3	F	3-CF3	F	4-CF3<br>
F	2-OCF3	F	3-OCF3	F	4-OCF3<br>
F	2-OCF2H	F	3-OCF2H	F	40CF2H<br>
F	2-OCF2CF2H	F	3-OCF2CF2H	F	4-OCF2CF2H<br>
F	2~OCH2CF3	F	3-OCH2CF3	F	4-OCH2CF3<br>
F	2-SCF3	F	3-SCF3	F	4-SCF3<br>
-   F	2-SOCF3	F	3-SOCF3	F	4-SOCF3<br>
F	2-S02CF3	F	3-S02CF3	F	4-S02CF3<br>
F	2-SCF2H	F	3-SCF2H	F	4-SCF2H<br>
F	2-SOCF2H	F	3&gt;SOCF2H	F	4-SOCF2H<br>
F	2-S02CF2H	F	3-S02CF2H	F	4-S02CF2H<br>
Br	2-CF3   â– 	Br	3-CF3	Br	4-CF3<br>
Br	2-OCF3	Br	3-OCF3	Br	4-OCF3<br>
Br	2-OCF2H	Br	3-OCF2H	Br	4-OCF2H<br>
Br	2-OCF2CF2H	Br	3-OCF2CF2H	Br	4-OCF2CF2H<br>
Br	2-OCH2CF3	Br	3-OCH2CF3	Br	4-OCH2CF3<br>
Br	2-SCF3	Br	3-SCF3	Br	4-SCF3<br>
Br	2-SOCF3	Br	3-SOCF3	Br	4-SOCF3<br>
Br	2-S02CF3	Br	3-SO0CF3	Br	4-S02CF3<br>
â– Br	2-SCF2H	Br	3-SCF2H	Br	4-SCF7H<br>
Br	2-SOCF2H	Br	3-SOCF2H	Br	4-SOCF2H<br>
.Br	2-S02CF2H	Br	3-S02CF2H	Br	4-S02CF2H<br>
I	2-CF3	I	3-CF3	I	4-CF3<br><br>
WO 02/070483<br><br><br>
WO 02/070483	PCT/US02/06582<br>
i<br><br>
R4<br>
	(R5m)<br>
	R4<br>
	(R5m)<br>
	R4	(R5m)<br><br>
OCF2H	2-SCF3	OCF2H	3-SCF3	OCF2H	4-SCF3<br>
OCF2H	2-SOCF3	OCF2H	3-SOCF3	OCF2H	4-SOCF3<br>
OCF2H	2-S02CF3	OCF2H	3-S02CF3	OCF2H	4-S02CF3<br>
OCF2H	2-SCF7H	OCF2H	3-SCF9H	OCF2H	4-SCF2H<br>
OCF2H	2-SOCF2H	OCF2H	3-SOCF2H	OCF2H	4-SOCF2H<br>
OCF2H	2-S02CF2H	OCF2H	3-S02CF2H	OCF2H	4-S02CF2H<br>
Me	2-Me-4-CF3	F	2-Me-4-CF3	CI	2-Me-4-CF3<br>
Me	2-Me-4-OCF3	F	2-Me-4-OCF3	CI	2-Me^-OCF3<br>
Me	2-Me-4-OCF2H	F	2-Me-4-OCF2H	CI	2-Me-4-OCF2H<br>
Me	2-Me^-OCH2CF3	F	2-Me-4-OCH2CF3	CI	2-Me-4^0CH2CF3<br>
Me	2-Me-4-SCF3	F	2-Me-4-SCF3	CI	2-Me-4-SCF3<br>
Me	2-M&amp;4-SOCF3	F	2-Me-4-SOCF3	CI	2-Me-4-SOCF3<br>
Me	2-Me-4-S02CF3	F	2-Me-4-S02CF3	CI	2-Me-4-S02CF3<br>
Me	2-Me-4-SCF2H	F	2-M,e-4-SCF2H	CI	2-Me-4-SCF2H<br>
Me	2-Me-4-SOCF2H	F	2-Me-4-SOCF2H	CI	2-Me-4-SOCF2H<br>
Me	2-Me-4-S02CF2H	F	2-Me-4-S02CF2H	CI	2-Me-4-S02CF2H<br>
Br	2-Me-4-CF3	I	2-Me-4-CF3	OMe	2-Me-4-CF3<br>
Br	2-Me-4-OCF3	I	2-Me-4-OCF3	OMe	2-Me-4-OCF3<br>
Br	2-Me-4-OCF2H		2-Me-4-OCF2H	OMe	2-Me^-OCF2H<br>
Br	2-Me^t-OCH2CF3		2-Me-4-OCH2CF3	OMe	2-Me-4-OCH2CF3<br>
Br	2-Me-4-SCF3		2-Me-4-SCF3	OMe	2-Me-4-SCF3<br>
Br	2-Me-4-SOCF3		2-Me^-SOCF3	OMe	2-Me^-SOCF3<br>
Br	2-Me-4-S02CF3		2-Me-4&gt;S02CF3	OMe	2-Me-4-S02CF3<br>
Br	2-Me-4-SCF2H		2-Me-4-SCF2H	OMe	2-Me-4-SCF2H<br>
Br	2-Me-4-SOCF2H		2-Me-4-SOCP2H	OMe	2-Me^-SOCF2H<br>
Br	2-Me-4-S02CF2H		2-Me-4-S02CF2H	OMe	2-Me-4-S02CF2H<br>
CF3	2-Me-4-CF3	N02	2-Me-4-CF3	SMe	2-Me-4-CF3<br>
CF3	2-Me^-OCF3	N02	2-Me-4-OCF3	SMe	,2-Me-4-OCF3<br>
CF3	2-Me-4-OCF2H	N02	2-Me-4-OCF2H	SMe	2-Me-4-OCF2H<br>
CF3	2-Me-4-OCH2CF3	N02	2-Me-4-OCH2CF3	SMe	2-Me-4-OCH2CF3<br>
CF3	2-Me-4-SCF3	NO?	2-Me-4-SCF3-	SMe	2-Me-4-SCF3<br>
CF3	2-Me-4-SOCF3	N02	2-Me-4-SOCF3	SMe	2-Me-4-SOCF3<br>
CF3	2-Me-4-S02CF3	N02	2-Me^-S02CF3	SMe	2-Me-4-S02CF3<br>
CF3	2-Me-4-SCF2H    .	â– ., JMO2	2-Me-4-SCF2H	SMe	2-Me-4-SCF2H<br>
CF3	2-Me-4-SOCF2H	N02	2-Me-4-SOCF2H	SMe	2-Me-4-SOCF2H"<br>
CF3	2-Me-4-S02CF2H "	N02.	2-Me-4-S02CF2Hj	SMe	2-Me-4-S02CF2H<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br><br>
82<br>
Table 13<br><br><br><br>
	â€¢<br><br>
	N^ &gt;<br>
M<br>
I	\           H<br>
y<br>
-T    ^(/-Pr)	<br><br><br><br><br>
R4	(R5m)	R4	(R5m)<br>
	R4	(R5m)<br><br>
Me	2-CF3	Me	3-CF3	Me	4-CF3<br>
Me	2-OCF3	Me	3-OCF3	Me	4-OCF3<br>
Me	2-OCF2H	Me	3-OCF2H    .	Me	4-OCF2H<br>
Me	2-OCF2CF2H	Me	3-OCF2CF2H	Me	4-OCF2CF2H<br>
Me	2-OCH2CF3	Me	3-OCH7CF3	Me	4-OCH2CF3<br>
Me	2-SCF3	Me	3-SCF3	Me	4-SCF3<br>
Me	2-SOCF3	Me	3-SOCF3	Me	4-SOCF3<br>
Me	2-S02CF3	Me	3-S02CF3	Me	4-S02CF3<br>
Me	2-SCF2H	Me	3-SCF2H	Me	4-SCF7H<br>
Me	2~SOCF2H	Me	3-SOCF2H	Me	4-SOCF2H<br>
Me	2-S02CF2H	Me	3-S02CF2H	Me	4-S02CF2H<br>
CI	2-CF3	CI	3-CF3	CI	4-CF3<br>
CI	2-OCF3	CI	3-OCF3	C!	4-OCF3<br>
â– CI	2-OCF2H	CI	3-OCF2H	â– CI	4-OCF2H<br>
CI	2-OCF2CF2H	CI	3-OCF2CF2H	CI	4-OCF2CF2H<br>
CI	2-OCH2CF3	CI	3-OCH7CF3	CI	4-OCH2CF3<br>
CI	2-SCF3	CI	3-SCF3	CI	4-SCF3<br>
CI	2-SOCF3	CI	3-SOCF3	CI	4-SOCF3<br>
CI	2-S02CF3	CI	3-SQ2CF3	CI	4-S02CF3<br>
CI	2-SCF2H	CI	3^SCF2H	CI .	4,SCF2H<br>
CI	2-SOCF2H	CI	3-SOCF2H	CI	4-SOCF2H<br>
CI	2-S02CF,H	CI	3-S02CF2H	CI	4-S02CF2H<br>
F	2-CF3	F	3-CF3	F	4-CF3<br>
.F	2-OCF3	F	3-OCF3	F	4-OCF3<br>
F	2-OCF2H	F. .	3-OCF2H  _	F	4-OCF2H<br>
F    .	2-OCF2CF2H	F	3-OCF2CF2H	F	4-OCF2CF2H<br>
F	2-OCH2CF3	F	3-OCH2CF3	F	4-OCH2CF3<br><br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
84<br><br>
R4	(R5)n<br>
	R4	(R5)n<br>
	R4	(R5)n<br><br>
OMe	2-SOCF2H	OMe	3-SOCF2H	OMe	4-SOCF2H<br>
OMe	2~S02CF2H	OMe	3-S02CF2H	OMe	4-SO,CF2H<br>
CF3	2-CF3	CF3	3-CF3	CF3	4-CF3<br>
CF3	2-OCF3	CF3	3-OCF3	CF3	4-OCF3<br>
CF3	2-OCF2H	CF3	3-OCF2H	CF3	4-OCF7H<br>
CF3	2-OCF2CF2H	CF3	3-OCF2CF2H	CF3	4-OCF2CF2H<br>
CF3	2-OCH2CF3	CF3	3-OCH2CF3	CF3	4-OCH2CF3<br>
CF3	2-SCF3	CF3	3-SCF3	CF3	4-SCF3<br>
CF3	2-SOCF3	CF3	3-SOCF3	â–   CF3	4-SOCF3<br>
CF3	2-S02CF3	CF3	3-SO2CF3	CF3	4-S02CF3<br>
CF3	2-SCF2H	CF3	3-SCF2H	CF3	4-SCF2H<br>
CF3	2-SOCF2H	CF3	3-SOCF2H	CF3	4-SOCF2H<br>
CF3	2-S02CF2H	CF3	3-S02CF2H	CF3	4-S02CF2H<br>
OCF2H	2-CF3	OCF2H	3-CF3	OCF2H	4-CF3<br>
OCF2H	2-OCF3	OCF2H	3-OCF3	OCF2H	4-OCF3<br>
OCF2H	2-OCF2H	OOF2H	3-OCF2H	OCF2H	4-OCF2H<br>
OCF2H	2-OCF2CF2H	OCF2H	3-OCF2CF2Kf	OCF2H	4-OCF2CF2H<br>
OCF2H	2-OCH2CF3	OCF2H	3-OCH2CF3	OCF2H	4-OCH2CF3<br>
OCF2H	2-SCF3	OCF2H	3-SCF3	OCF2H	4-SCF3<br>
OCF2H	2-SOCF3	OCF2H	3-SOCF3	OCF2H	4-SOCF3<br>
OCF2H	2~S02CF3	OCF2H	3-S02CF3	OCF2H	4-S02CF3<br>
OCF2H	2-SCF2H	OCF2H	3-SCF2R	OCF2H	4-SCF2H<br>
OCF2H	2-SOCF2H	OCF2H	3-SOCF2H	OCF2H	4-SOCF2H<br>
OCF2H	2-S02GF2H	OCF2H	3-S02CF2H	OCF2H	4-S02CF2H<br>
Me	2-Me-4-CF3	F	2-Me-4-CF3	CJ	2-Me^-CF3<br>
Me	2-Me-4-OCF3	F	2-Me-4-OCF3	CI	2-Me-4-OCF3<br>
Me	2-Me-4-OCF2H	F	2-Me-4-OCF2H	CI	2-Me-4-OCF2H<br>
Me	2-Me-4-OCH2CF3	F	2-Me-4-OCH2CF3	CI	2-Me-4-OCH2CF3<br>
Me	2-Me-4-SCF3	â– F	2-Me-4-SCF3	CI	. 2-Me-4-SCF3<br>
Me	2-Me-4-SOCF3	F	2-Me^-SOCF3	CI	2-Me-4-  Ot:;F3<br>
Me	2-Me-4-S02CF3	F	2-Me-4-S02CF3	CI	2-Me-4-S02CF3<br>
Me	2-Me-4-SCF2H	F	2-Me-4-SCF2H	CI	2-Mc-4-SCF2E<br>
Me	2-Me-4-SOCF2H	F	2-Me^-SOCF2H	CI	2-Me-4-SOCF2H<br>
Me	2-Me^-SO,CF2H	F	2-Me-4-S02CF2H	CI	2-Me-4TS02CF2H<br>
Br	2-Me-4-CF3"	I	2-Me-4-CF3	OMe	2-Me-4-CF3<br>
Br	2-Me-4-OCF3	I	2-Me-4-OCF3	OMe	2-Me-4-OCF3<br>
Br	2-Me-4-OCF2H	I	2-Me-4-OCF2H	OMe	2-Me-4-OCF2H<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
85<br><br>
R4	(R5)n	R4<br>
		(R5)n		R4<br>
	(R5)n<br>
Br	2-Me-4-OCH2CF3		2-Me-4-OCH2CF3	OMe	2-Me-4-OCH2CF3<br>
Br	2-Me-4-SCF3		2-Me-4-SCF3	OMe	2-Me-4-SCF3<br>
Br	2-Me-4-SOCF3		2-Me^-SOCF3	OMe	2-Me-4-SOCF3<br>
Br	2-Me-4-S02CF3		2-Me^-S02CF3	OMe	2-Me-4-S02CF3<br>
Br	2-Me-4-SCF2H		2-Me-4-SCF2H	OMe	2-Me-4-SCF2H<br>
Br	2-Me-4-SOCF2H		2_Me-4-SOCF2H	OMe	2-Me-4-SOCF2H<br>
Br	2-Me-4-S02CF2H		2-Me-4-S02CF2H	OMe	2-Me-4-S02CF2H<br>
CF3	2-Me-4-CF3	N02	2-Me-4-CF3	SMe	2-Me-4-CF3<br>
CF3	2-Me-4-OCF3	N02	2-Me-4-OCF3	SMe	2-Me-4-OCF3<br>
CF3	2-Me-4-OCF2H	N02	2-Me-4-OCF2H	SMe	2-Me^-OCF2H<br>
CF3	2-Me-4-OCH2CF3	N02	2-Me-4-OCH2CF3	SMe	2-Me^-OCH2CF3<br>
CF3	2-Me-4-SCF3	.N02	2-Me-4-SCF3 .	SMe	2-Me^-SCF3<br>
CF3~	2-Me-4-SOCF3	N02	2-Me-4-SOCF3	SMe	2-Me-4-SOCF3<br>
CF3	2-Me-4-S02CF3	N02	2-Me-4-S02CF3	SMe	2-Me-4-S02CF3<br>
CF3	2-Me^-SCF2H	N02	2-Me-4-SCF2H	SMe	2-Me-4-SCF2H<br>
CF3	2-Me-4-SOCF2H	N02	2-Me-4-SOCF2H	SMe	2-Me-4-SOCF2H<br>
CF3<br>
	2-Me-4-S02CF2H<br>
	N02<br>
L J	2-Me^-S02CF2H Table 14	â–  SMe<br>
n	2-Me-4-S02CF2H<br><br><br><br>
R4<br>
	(R5)n<br>
	R4<br>
	(R5)n<br>
	R4<br>
	(R5)n<br><br>
Me	2-CF3	Me	3-CF3	Me	4-CF3<br>
Me	2-OCF3	Me	3-OCF3	Me	4-OCF3<br>
Me	2-OCF9H	Me	3-OCF2H	Me	4-OCF2H<br>
Me	2-OCF2CF2H	Me	3-OCF2CF2H	Me	4-OCF2CF2H<br>
Me	2-OCH2CF3	Me	3-OCH9CF3	Me	4-OCH2CF3<br>
Me	2-SCF3	Me	. 3-SCF3      .	Me	4-SCF3<br>
Me	2-SOCF3	Me	3-SOCF3	Me	4-SOCF3<br>
Me	2-S02CF3	Me	3-S02CF3	Me	4-S02CF3<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
.86<br><br>
R4	(R5)n	R4	(R5)n	R4	(R5)n<br>
Me	2-SCF2H	Me	3-SCF2H	Me	4-SCF9H<br>
Me	2-SOCF2H	Me	3-SOCF2H	Me	4-SOCF2H<br>
Me	â€¢ 2-S02CF2H	Me	3-S02CF2H .	Me	4-S02CF2H<br>
CI	2-CF3	CI	3-CF3	CI	4-CF3<br>
CI	2-OCF3	CI	3-OCF3	CI	4-OCF3<br>
CI	2-OCF2H	CI	3-OCF2H	CI	4-OCF2H<br>
CI	2-OCF2CF2H	CI	3-OCF2CF2H	CI	4-OCF2CF2H<br>
CI	2-OCH?CF3	CI	3-OCH2CF3	CI	4-OCH2CF3<br>
CI	2-SCF3	CI	3-SCF3	CI	4-SCF3<br>
CI	2-SOCF3	CI	3-SOCF3	CI	4-SOCF3  â– <br>
CI	2-S02CF3	CI	3-S02CF3 "	CI	4-S02CF3<br>
CI	2-SCF2H	CI	3-SCF2H	CI	4-SCF2H<br>
CI	2-SOCF2H	CI	3-SOCF2H	CI	4-SOCF2H<br>
CI	2-S02CF2H	CI	3-S02CF2H	CI	4-S02CF2H<br>
F	2-CF3	F	3-CF3	F	4-CF3<br>
"F	2-OCF3	F	3-OCF3	F	4-OCF3<br>
F	2-OCF2H	F	3-OCF2H	F	4-OCF2H<br>
F	2-OCF2CF2H	F	3-OCF2CF2H	F	4-OCF2CF2H<br>
F	2-OCH2CF3	F	3-OCH2CF3	F	4-OCH2CF3<br>
F	2-SCF3	F	3-SCF3	F	4-SCF3<br>
F	2-SOCF3	F	3-SOCF3	F	4-SOCF3<br>
F	2-S02CF3	F	3-S02CF3	F	4-SO7CF3<br>
F	2-SCF2H	F	3-SCF2H	F	4-SCF2H<br>
F	2-SOCF2H	F	3-SOCF2H	F	4-SOCF7H<br>
F	2~S02CF2H	F	3-S02CF2H	F	4-S02CF2H<br>
Br	2-CF3	Br	3-CF3	Br	4-CF3<br>
Br	2-OCF3	Br	3-OCF3	Br	4-OCF3<br>
Br	2-OCF2H	Br	3-OCF2H	Br	4-OCF2H<br>
Br	2-OCF2CF2H	Br	3-OCF2CF2H	Br	4-OCF2CF2H<br>
Br	2-OCH2CF3	Br	3-OCH2CF3	Br	4-OCH2CF3<br>
Br	2-SCF3	Br	3-SCF3	Br	4-SCF3<br>
Br	2-SOCF3	Br	3^SOCF3	Br	4-SOCF3<br>
Br	2-S02CF3	Br	3-S02CF3	Br	4-S02CF3<br>
Br	2-SCF2H	Br	3-SCF2H	Br	4-SCF2H<br>
Br	2-SOCF2H	â– Br	3-SOCF2H	Br	4-SOCF2H<br>
Br	2-S02CF2H	Br	3-S02CF2H	Br	4-S02CF2H<br>
I	2-CF3	I	3-CF3	I	4-CF3<br><br><br><br><br><br><br><br>
WO 02/070483<br>
90<br><br>
PCT/US02/06582<br><br><br><br>
K	R3	(R4)n	R5.<br>
K-l	/-Pr	4-C1	CF3<br>
K-18	/-Pr	4-Me	CF3<br>
K-18	/-Pr	4-C1	CF3<br>
K-14	/-Pr	1-Me	CF3<br>
K-28	/-Pr	4-Me	CF3<br>
K-28	/-Pr	4-C1	CF3<br>
K-30	/-Pr	5-Me	CF3<br>
K-30	/-Pr	5-C1	CF3<br>
K-31	/-Pr	2-Me	CF3<br>
K-31	/-Pr	2-Cl	CF3<br>
K-33	/-Pr	6-Mc	CF3<br>
K-33	/-Pr	6-C1 ,	CF3<br>
K-l	/-Bu	4-Me	CF3<br>
K-l	/-Bu	4-C1	CF3<br>
K-18	/-Bu	4-Me	CF3<br>
K-18	/-Bu	4-CI	CF3<br>
K-14	/-Bu	1-Me	CF3<br>
K-28	/-Bu	4-Me	CF3<br>
K-28	/-Bu	4-CI	CF3<br>
K-30	/-Bu	5-Me	CF3<br>
K-30	/-Bu	5-C1	CF3<br>
K-31	/-Bu	2-Me	CF3<br>
K-31	/-Bu	2-Cl	CF3<br>
K-33	/-Bu	6-Me	CF3<br>
K-33	f-Bu	6-C1	CF3<br>
K-l	/-Bu	4-Me	CF3<br>
K-l	/-Bu	4-CI	CF3<br>
K-18	/-Bu	4-Me	CF3<br>
K-18	/-Bu	4-CI	CF3<br>
K-14	/-Bu	1-Me	CF3<br>
K-28	/-Bu	4-Me	CF3<br>
K-28	/-Bu	4-CI	CF3<br>
K-30	/-Bu	5-Me	CF3<br>
K-30	/-Bu	5-C1	CF3<br>
K-31	/-Bu	2-Me	â–   CF3<br>
â– K-31	/-Bu	2-Cl	CF3<br>
K-33	/-Bu	6-Me	CF3<br><br><br>
w	X	Y	Z<br>
CMe	CH	N	CH<br>
CMe	CH	N	CH<br>
CMe	CH	N	CH<br>
CMe	CH	N	CH<br>
CMe	CH	CH	N<br>
CMe	CH	CH	N<br>
CMe	CH	CH	N<br>
CMe	CH	CH	N<br>
CMe .	CH	CH	N<br>
CMe	CH	CH	N<br>
CMe	CH	CH	N<br>
CMe	CH	CH	N<br>
CMe	N	â–       CH	CH<br>
CMe	N	CH	CH<br>
CMe	N	CH	CH<br>
CMe	N	CH	CH<br>
CMe	N	CH	CH<br>
CMe	N   â– â– 	CH	CH<br>
CMe	N	CH	CH<br>
CMe	N	CH	CH<br>
CMe	N	CH	CH<br>
CMe	â–  N	CH	CH<br>
CMe	N	CH	CH<br>
CMe	N	CH	CH<br>
CMe	N	CH	CH<br>
CMe	CH	N	CH<br>
CMe	CH	N	CH<br>
â– CMe	CH	N	CH<br>
CMe	CH	N	CH<br>
CMe	CH	N	CH<br>
CMe	CH	N	, CH<br>
CMe	CH	N	CH<br>
CMe	CH	N	CH<br>
CMe	CH	N	CH<br>
CMe	CH	N	CH<br>
CMe	CH	N	CH<br>
CMe	CH	N	CH<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
91<br><br>
K	R3	(R4)n	R5    â€¢	w	X	1  "	2<br>
K-33	/-Bu	6-C1	CF3	CMe	CH	N	CH<br>
K-1	/-Bu	4-Me	CF3	CMe	CH	N	CH<br>
K-1	/-Bu	4C1	CF3	CMe	CH	N	CH<br>
K-18	/-Bu	4-Me	CF3	CMe	CH	N	CH<br>
K-18	r-Bu	4-C1	CF3	CMe	CH	N	CH<br>
K-14	/-Bu	1-Me	CF3	CMe	CH	N	CH<br>
K-28	/-Bu	4-Me	CF3	CMe	CH	CH	N<br>
K-28	/-Bu	4-CI	CF3	CMe	CH	CH	N<br>
K-30	/-Bu	5-Me	CF3	CMe	CH	CH	N<br>
K-30	/-Bu	5-C1	CF3	CMe	CH	CH	N<br>
K-31	/-Bu	2-Me	CF3	CMe	CH	CH	N<br>
K-31	/-Bu	2-Cl .	CF3	CMe	CH	CH	N<br>
K-33	/-Bu	â€¢    6-Me	CF3	CMe	CH	CH	N<br>
K-33	/-Bu	6-C1	CP3	CMe	CH	CH	M<br>
K-1	/-Pr	4-Me	OCF3	CMe	N	CH	CH<br>
K-1	/-Pr	4-CI	OCF3	CMe	N	CH	CH<br>
K-18	/-Pr	4-Me	OCF3	CMe	N	CH	CH<br>
K-18	/-Pr	4-CI	OCF3	CMe	N	CH	CH<br>
K-14	/-Pr	1-Me	OCF3	CMe	N	CH	CH<br>
K-28	i-Pr	4-Me	OCF3	CMe	N	CH	CH<br>
K-28	i-Pr	4-CI	OCF3	CMe	N	CH	CH<br>
K-30	/-Pr	5-Me	OCF3	CMe	N	CH	CH<br>
K-30	/-Pr	5-C1	OCF3	CMe	N	CH	CH<br>
K-31	/-Pr	2-Me	OCF3	CMe	N	CH	CH<br>
K-31	/-Pr	2-Cl	OCF3	CMe	N	CH	CH<br>
K-33	/-Pr	6-Me	OCF3	CMe	N	CH	CH<br>
K-33	/-Pr	6-Ci	OCF3	CMe	N	CH	CH<br>
K-1	/-Pr	4-Me	OCF3	CH	N	CH	CH<br>
K-1	/-Pr	4-CI	OCF3	CH	N	CH	CH<br>
K-18	/-Pr	4-Me	OCF3	CH	N	CH	CH<br>
K-18	/-Pr	4-CI	OCF3	CH	N	CH	CH<br>
K-14	/-Pr	1-Me	OCF3	CH	N	CH	CH<br>
K-28	/-Pr	4-Me	OCF3	CH	N	CH	CH<br>
K-28	/-Pr	4-CI	OCF3	CH ,	N	CH	CH<br>
K-30	/-Pr	5-Me   -"	â–  OCF3	CH  â€¢	N	CH	â–    CH<br>
K-30	/-Pr	5-CI	OCF3	CH	N	CH	CH<br>
K-31	/-Pr	2-Me	OCF3	CH	N	CH	CH<br><br>
WO 02/070483<br><br>
PCT/TJS02/06582<br><br>
92<br><br>
K	(R4)n	Q	R5	w	X	Y	Z<br>
K-31	/-Pr	2-C1	OCF3	CH	N	CH	CH<br>
K-33	/-Pr	6-Me	OCF3	CH	N	CH	CH<br>
K-33	/-Pr	6-CI	OCF3	CH	N	CH	CH<br>
K-1	/-Pr	4-Me	CI	CMe	CH	CH	N<br>
K-1	/-Pr	4-Cl	CI	CMe	CH	CH	N<br>
K-18	/-Pr	4-Me	CI	CMe	CH	CH	N<br>
K-18	/-Pr	4-Cl	CI	CMe	CH	CH	N<br>
K-14	/-Pr	1-Me	CI	CMe	CH	CH	N<br>
K-28	/-Pr	4-Me	CI	CMe	CH	CH	N<br>
K-28	/-Pr	4-Cl	CI	CMe	CH	CH	N<br>
K-30	/-Pr	5-Me	CI	CMe	CH	CH	N<br>
K-30	/-Pr	5-C1 .	â– â– ;i	CMe	CH	CH	N<br>
K-31	/-Pr	2-Me	CI	CMe	CH	CH	N<br>
K-31	/-Pr	2-CI	Cl	CMe	CH	CH	N<br>
K-33	/-Pr	6-Me	Cl	CMe	CH	CH	N<br>
K-33	i-Pr	6-CI	Cl	CMe	CH	CH	N<br>
			Table 16			<br>
x=X<br><br>
R3 is /-Pr<br><br>
K	(R4)n	Q	X	Y	Z<br>
K-1	4-Me	NCHF2	CMe	N	CH<br>
K-1	4-Cl	NCHF2	CMe	N	CH<br>
K-18	4-Me	NCHF2	CMe	N	CH<br>
K-18	4-Cl	NCHF2	CMe	K	CH<br>
K-14	1-Me	NCHF2	CMe	N	CH<br>
K-28	4-Me	NCHF2	CMe	N	CH<br>
K-28	4-Cl	NCHF2	CMe	N	CH<br>
K-30	5-Me	NCHF2	CMe	N	CH<br>
K-30	5-C1	NCHF2	CMe	N	CH<br><br><br><br>
WO 02/070483	PCT/US02/06582<br>
94 R3 is /-Pr<br><br>
K	(R4)	Q	X	Y	Z<br>
K-28	4-C1	NCH2CF3	CMe	N	CH<br>
K-30	5-Me	NCH2CF3	CMe	N	CH<br>
K-30	5-C1	NCH2CF3	CMe	N	CH<br>
K-3]	2-Me	NCH2CF3	CMe	N	CH<br>
K-31	2-C1	NCH2CF3	CMe	N	CH<br>
K-33	6-Me	NCH2CF3	CMe	N	CH<br>
K-33	6-C1	NCH2CF3	CMe	N	CH<br>
K-l	4-Me	NCH2CF3	CH	N	CMe<br>
K-l	4-C1	NCH2CF3	CH	. N	CMe<br>
K-18	4-Me	NCH2CF3	CH	N	CMe<br>
K-18	4-C1	NCH2CF3	CH	N	CMe<br>
K-14	1-Me	NCH2CF3	CH	N	CMe<br>
K-28	4-Me	NCH2CF3	CH	N	CMe<br>
K-28 .	4-C1	NCH2CF3	CH	N	CMe<br>
K-30	5-Me	NCH2CF3	CH	N	CMe<br>
K-30	5-C1	NCH2CF3	CH	N	CMe<br>
K-31	2-Me	NCH2CF3	CH	N	CMe<br>
K-31	2-CI	NCH2CF3	CH	N	CMe<br>
K-33	6-Me	NCH2CF3	CH	N	CMe<br>
K-33	6-CI	NCH2CF3	CH	N	CMe<br>
K-l	4-Me	NCF2CHF2	N	CH"	CMe<br>
K-l	4-C1	NCF2CHF2	N	CH	CMe<br>
K-18	4-Me	NCF2CHF2	N	CH	CMe<br>
K-18	4-C1	NCF2CHF2	N	CH	CMe<br>
K-14	1-Me	NCF2CHF2	N	CH	CMe<br>
K-28	4-Me	NCF2CHF?	N	CH	CMe<br>
K-28	4-C1	NCF2CHF2	N	CH	CMe<br>
K-30	5-Me	NCF2CHF2	N	CH	CMe<br>
K-30	5-C1	NCF2CHF2	N	CH	CMe<br>
K-31	2-Me	NCF2CHF2	N	CH	CMe<br>
K-31	2-CI	NCF2CHF2	N	CH	CMe<br>
K-33	6-Me	NCF2CHF2	N	CH	CMe<br>
K-33	6-CI	NCF2CHF2	N	CH	CMe<br><br>
WO 02/070483<br><br>
PCT/TJS02/06582<br><br>
95<br>
R3 is f-Bu<br><br>
K	(R4)n	0_	X	Y	z<br>
K-l	4-Me	NCHF?	CMe	N	CH<br>
K~l	4-C1	NCHF2	CMe	N	CH<br>
K-18	4-Me	NCHF2	CMe	N	CH<br>
K-18	4-C1	NCHF2	CMe	N	CH<br>
K-14	1-Me	NCHF2	CMe	N	CH<br>
K-28	4-Me	NCHF2	CMe	N	CH<br>
K-28	4-C1	NCHF2	CMe	N	CH<br>
K-30	5-Me	NCHF2	CMe	N	CH<br>
K-30	5-C1	NCHF2	CMe	N	CH<br>
K-31	2-Me	NCHF2	CMe	N	CH<br>
K-31	2-C1	NCHF2	CMe	N	CH<br>
K-33	6-Me	NCHF2	â– CMe	N	CH<br>
K-33	6-C1	NCEF2	CMe	N	CH<br>
K-l .	4-Me	NCHF2	CH	N	CMe<br>
K-l	4-C1	NCHF2	CH	N	CMe<br>
K-18	4-Me	NCHF2	CH	N	CMe<br>
K-18	4-C1	NCHF2	CH	N	CMe<br>
K-14	1-Me	NCHF2	CH	N	CMe<br>
K-28	4-Me	NCHF2	CH	N	CMe<br>
K-28	4-C1	NCHF2	CH	N	CMe<br>
K-30	5-Me	NCHF2	CH	N	CMe<br>
K-30	5-Cl	NCHF2	CH	N	CMe<br>
K-31	2-Me	NCHF2	CH	N	CMe<br>
K-31	2-C1	NCHF2	CH	N	CMe<br>
K-33	6-Me	NCHF2	CH	N	CMe<br>
K-33	6-C1	NCHF2	CH	N	CMe<br>
K-l	4-Me	NCF2CHF2	CMe	N	CH<br>
K-l	4-C1	NCF2CHF2	CMe	N	CH<br>
K-18	4-Me	NCF2CHF2	CMe	N	CH<br>
K^18	4-C1	NCF2CHF2	CMe	N	CH<br>
K-14	1-Me	Â»CF2CHF2	CMe	.N	CH<br>
K-28	4-Me	NCF2CHF2	CMe	N	CH<br>
K-28	4-C1	NCF2CHF2	CMe	N	CH<br>
K-30	5-Me	NCF2CHF2	CMe	N	CH<br>
K-30	5-Cl	NCF2CHF2	CMe	N	CH<br>
K-31	2-Me	NCF9CHF2	CMe	N	CH<br><br>
WO 02/070483<br>
96<br><br>
PCT/US02/06582<br><br><br><br>
R3 is 
 <br>
u<br><br><br><br>
K	(R4)	Q<br>
K-31	2-CI	NCF2CHF2<br>
K-3 3	6-Me	NCF2CHF2<br>
K-3 3	6-C1	NCF2CHF2<br>
K-l	4-Me	NCH2CF3<br>
K-l	4-C1	NCH2CF3<br>
K-18	4-Me	NCH2CF3<br>
K-18	4-C1	NCH2CF3<br>
K-l 4	1-Me	NCH2CF3<br>
K-28	4-Me	NCH2CF3<br>
K-28	4-C1	NCH2CF3<br>
K-30	5-Me	NCH2CF3<br>
K-30	5-C1	NCH2CF3<br>
K-31	2-Me	NCH2CF3<br>
K-31 .	2-CI	NCH2CF3<br>
K-33	6-Me	NCH2CF3<br>
K-33	6-CI	NCH2CF3<br>
K-l	4-Me	NCH2CF3<br>
K-l	4-C1	NCH2CF3<br>
K-18	4-Me	NCH2CF3<br>
K-18	4-C1	NCH2CF3<br>
K-14	]-Me	NCH2CF3<br>
K-28	4-Me	NCH2CF3<br>
K-28	4-C1	NCH2CF3<br>
K-30	5-Me	NCH7CF3<br>
K-30	5-C1	NCH7CF3<br>
K-31	2-Me	NCH2CF3<br>
K-31	2-CI	NCH2CF3<br>
K-33	6-Me	NCH2CF3<br>
K-33 "	6-CI	NCH2CF3<br>
K-l	4-Me	NCF2CHF2<br>
K-l	4-C1	NCF2CHF2<br>
K-18	4-Me	NCF2CHF2<br>
K-18	4-CI	NCF2CHF2<br>
K-14	1-Me	- - TsiCF2GHF2<br>
K-28	4-Me	NCF2CHF2<br>
K-28	4-CI	MCF2CHF2<br><br><br>
X	Y	z<br>
CMe	N	CH<br>
CMe	N	CH<br>
CMe	N	CH<br>
CMe	N	CH<br>
CMe	N	CH<br>
CMe	N	CH<br>
CMe	N	CH<br>
CMe	N	CH<br>
CMe	N	CH<br>
CMe	N	CH<br>
CMe	N	CH<br>
CMe	N	CH<br>
CMe	N	CH<br>
CMe	N	CH<br>
CMe	N	CH<br>
CMe	N	CH<br>
CH	N	CMe<br>
CH	N	CMe<br>
CH	N	CMe<br>
CH	N	CMe<br>
CH	N	CMe<br>
CH	N	CMe<br>
CH	N	CMe<br>
CH	N	CMe<br>
CH	N .	CMe<br>
CH	N	CMe<br>
CH	N	CMe<br>
CH	N	CMe<br>
CH.	N	CMe<br>
N	CH	CMe<br>
N	CH	CMe<br>
N	CH	CMe<br>
N	" CH	CMe<br>
N	CH	CMe<br>
N	CH	CMe<br>
K	CH	CMe<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
91<br><br>
		R.J is /-Bu			<br>
K	(R4)	Q.		X	Y	Z<br>
K-30	5-Me	NCF2CHF2		N	CH	CMe<br>
K-30	5-C1	NCF2CHF2		N	CH	CMe<br>
K-31	2-Me	â–  NCF2CHF2		N	CH	CMe<br>
K-31	2-C1	NCF2CHF2		N	CH	CMe<br>
K-33	6-Me	NCF2CHF2		N	CH	CMe<br>
K-33<br>
	6-C1<br>
	NCF2CHF2 Tabl
\          1	s 17	N	CH<br>
â– &gt;*&gt;	CMe<br><br><br><br><br><br><br><br><br><br>
	" li		
TÂ°<br>
\ A	<br><br><br><br><br><br><br>
K	w	X	Y	Z	R!	ffi^n	E!	R^<br>
K-1	CH	CH	CH	CH	/-Pr	4-Me	CF3	Me<br>
K-1	CH	CH	CH	CH	/-Bu	4-Me	CF3	Me<br>
K-1	CH	CH	CH	CH	/-Pr	4-C1	CF3	Me<br>
K-1	CH	CH	CH	CH	/-Bu	4-C1	ch	Me<br>
K-1	CH	CH	CH	CH	/-Pr	4-Me	CF3	F<br>
K-1	CH	CH	CH	CH	/-Bu	4-Me	CF3	F<br>
K-1	CH	CH	CH	CH	/-Pr	4-C1	CF3	F<br>
K-1	CH	CH	CH	CH	/-Bu	4-CI	CF3	F<br>
K-1	CH	CH	CH	CH	i-Pr	4-Me	CF3	CI<br>
K-1	CH	CH	CH	CH	/-Bu	4-Me	CF3	CI<br>
K-1	CH	CH	CH	CH	/-Pr	4-CI	CF3	CI<br>
K-I	CH	CH	CH	CH	/-Bu	4-C1	CF3	CI<br>
K-1	CH	-     CH	CH	CH	/-Pr	4-Me	CF3	Br<br>
K-1	CH	CH	CH	CH	/-Bu	4-Me	CF3	Br<br>
K-1	CH	â–    CH	CH.	CH	i-Vr	4-Cl	CF3	Br<br>
K-1	CH	CH	CH	" CH	/-Bu	4-CI	CF3	Br<br>
K-1	CH	CH	-   CH	CH	/-Pr	4-Me	CF3	CN<br><br><br><br><br><br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
101<br><br>
K-28	CH	CH	CH	N	/-Bu	4-Cl	CF3	CI<br>
K-28	CH	CH	CH	N	/-Pr	4-Me	CF3	Br<br>
K-28	CH	CH	CH	N	/-Bu	4-Me	CF3	Br<br>
K-28	CH	CH	CH	N	/-Pr	4-Cl	CF3	Br<br>
K-28	CH	CH	CH	N	/-Bu	4-Cl	CF3	Br<br>
K-28	CH	CH	CH	N	/-Pr	4-Me	CF3	CN<br>
K-28	CH	CH	CH	N	/-Bu	4-Me	CF3	CN<br>
K-28	CH	CH	CH	N	/-Pr	4-Cl	CF3	CN<br>
K-28	CH	CH	CH	N	/-Bu	4-Cl	CF3	CN<br>
K-30	CH	CH	CH	CH	/-Pr	Me	CF3	Me<br>
K-30	CH	CH	CH	CH	/-Bu	Me	CF3	Me<br>
K-30	CH	CH	CH	CH	/-Pr	5-CI	CF3	Me<br>
K-30	CH	CH	CH	CH	/-Bu	5-CI	CF3	Me<br>
K-30	CH	CH	CH	CH	/-Pr	Me	CF3	F<br>
K-30	CH	CH	CH	CH	/-Bu	Me	CF3	F<br>
K-30	CH	CH	CH	CH	/-Pr	5-CI	CF3	F<br>
K-30	CH	CH	CH	CH	/-Bu	5-CI	CF3	F<br>
K-30	CH	CH	CH	CH	/-Pr	Me	CF3	CI<br>
K-30	CH	CH	CH	CH	/-Bu	Me	CF3	CI<br>
K-30	CH	CH	CH	CH	/-Pr	5-CI	CF3	CI<br>
K-30	CH	CH	CH	CH	/-Bu	5-CI	CF3	CI<br>
K-30	CH	CH	CH	CH	/-Pr	Me	CF3	Br<br>
K-30	CH	CH	CH	CH	/-Bu	Me	CF3	Br<br>
K-30	CH	CH	CH	CH	/-Pr	5-CI	CF3	Br<br>
K-30	CH	CH	CH	CH	/-Bu	5-CI	CF3	Br<br>
K-30	CH	CH	CH	CH	/-Pr	Me	CF3	CN<br>
K-30	CH	CH	CH	CH	/-Bu	Me	CF3	CN<br>
K-30	CH	CH	CH	CH	/-Pr	5-CI	CF3	CN<br>
K-30	CH	CH	CH	CH	/-Bu	5-CI	CF3	CN<br>
K-30	CH	CH	CH	N	/-Pr	Me	CF3	Me<br>
K-30	CH	CH	CH	N	/-Bu	Me	CF3	Me<br>
K-30	CH	CH	CH	N	/-Pr	5-CI	CF3	Me<br>
K-30	CH	CH	CH	N	/-Bu	5-CI	CF3	Me<br>
K-30	CH	CH	CH	N	/-Pr	Me	CF3	F<br>
K-30	CH	CH	CH	"N	/-Bu	Me	CF3	F<br>
K-30	CH	CH	"   CH	N  "	" /-Pr	5-CI	CF3	F<br>
K-30	CH	CH	CH	N	/-Bu	5-CI	CF3	F<br>
K-30	" CH	CH	CH	"N	/-Pr	Me	CF3	CI<br><br><br><br>
WO 02/070483<br><br>
PCT/US02/065S2<br><br>
103<br><br>
K-30	CH	CH	CH	N	/-Bu	5-C1	CF3	F<br>
K-30	CH	CH	CH	N	/-Pr	Me	CF3	CI<br>
K-30	CH	CH	CH	N	/-Bu	Me	CF3	CI<br>
K-30	CH	CH	CH	N	/-Pr	5-C1	CF3	CI<br>
K-30	CH	CH	CH	N	/-Bu	5-C1	CF3	CI<br>
K-30	CH	CH	CH	N	/-Pr	Me	CF3	Br<br>
K-30	CH	CH	CH	N	/-Bu	Me	CF3	Br<br>
K-30	CH	CH	CH	"N	/-Pr	5-C1	CF3	Br<br>
K-30	CH	CH	CH	N	/-Bu	5-C1	CF3	Br<br>
K-30	CH	CH	CH	"N	/-Pr	Me	CF3	CN<br>
K-30	CH	CH	CH	N	/-Bu	Me	CF3	CN<br>
K-30	CH	CH	CH	N	/-Pr	5-C1	CF3	CN<br>
K-30	CH	CH	CH	"N	/-Bu	5-C1	CF3	CN<br>
K-31	CH	CH	CH	CH	/-Pr	2-Me	CF3	Me<br>
K-31	CH	CH	CH	CH	/-Bu	2-Me	CF3	Me<br>
K-31	CH	CH	CH	CH	/-Pr	2-C1	CF3	Me<br>
K-31	CH	CH	CH	CH	/-Bu	2-C1	CF3	Me<br>
K-31	CH	CH	CH	CH	/-Pr	2-Me	CF3	F<br>
K-31	CH	CH	CH	CH	/-Bu	2-Me	CF3	F<br>
K-31	CH	CH	CE	CH	/-Pr	2-C1	CF3	F<br>
K-31	CH	CH	CH	CH	/-Bu	2-C1	CF3	F<br>
K-31	CH	CH	CH	CH	/-Pr	2-Me	CF3	CI<br>
K-31	CH	CH	CH	CH	/-Bu	2-Me	CF,	CI<br>
K-31	CH	CH	CH	CH	/-Pr	2-C1	CF3	CI<br>
K-31	CH	CH	CH	CH	/-Bu	2-C1	CF3	CI<br>
K-31	CH	CH	CH	CH	/-Pr	2-Me	CF3	Br<br>
â– K-31	CH	CH	CH	CH	/-Bu	2-Me	CF3	Br<br>
K-31	CH	CH	CH	CH	/-Pr	2-C1	CF3	Br<br>
K-31	CH	CH	CH	CH	/-Bu	2-C1	CF3	Br<br>
K-31	CH	CH	CH	CH	/-Pr	2-Me	CF3	CN<br>
K-31	CH	CH	CH	CH	/-Bu	2-Me	CF3	CN<br>
K-31	CH	CH	CH	CH	/-Pr	2-C1	â–  CF3	CN<br>
K-31	CH	CH	CH	CH	/-Bu	2-C1	CF3	CN<br>
K-31	CH	CH	CH	.N	/-Pr	2-Me	CF3	Me<br>
K-31	CH	CH	CH	N	/-Bu	2-Me	CF3	Me<br>
K-31	CH	CH	CH " "	N	/-Pr	2-C1	CF3	Me<br>
K-31	CH	CH	CH	N	/-Bu	2-C1	CF3	Me<br>
K-31	CH	CH	CH	N	/-Pr	2-Me	CF3	F<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
104<br><br>
K-31	CH	CH	CH	N	/-Bu	2-Me	CF3	F<br>
K-31	CH	CH	CH	N	/-Pr	2-Cl	CF3	F<br>
K-31	CH	CH	CH	N	/-Bu	2-Cl	CF3	F<br>
K-31	CH	CH	CH	N	/-Pr	2-Me	CF3	CI<br>
K-31	CH	CH	CH "	N	/-Bu	2-Me	CF3	CI<br>
K-31	CH	CH	CH	N	i-Pr	2-Cl	CF3	CI<br>
K-31	CH	CH	CH	N	/-Bu	2-Cl	CF3	CI<br>
K-31	CH	CH	CH	N"	/-Pr	2-Me	CF3	Br<br>
K-31	CH	CH	CH	N	/-Bu	2-Me	CF3	Br<br>
K-31	CH	CH	CH	N	/-Pr	2-Cl	CF3	Br<br>
K-31	CH	CH	CH	N	/-Bu	2-CI	CF3	Br<br>
K-31	CH	CH	CH	N	/-Pr	2-Me	CF3	CN<br>
K-31	CH	CH	CH	N	/-Bu	2-Me	CF3	CN<br>
K-31	CH	CH	CH	N	/-Pr	2-Cl	CF3	CN<br>
K-31	CH	CH	CH	N	/-Bu	2-Cl	CF3	CN<br>
K-31	CH	CH	CH	CH	/-Pr	2-Me	CF3	Me<br>
K-31	CH	CH	CH	CH	/-Bu	2-Me	CF3	Me<br>
K-31	CH	CH	CH	CH	/-Pr	2-Cl	CF3	Me<br>
K-31	CH	CH	CH	CH	/-Bu	2-Cl	CF3	Me<br>
K-31	CH	CH	CH	CH	/-Pr	2-Me	CF3	F<br>
K-31	CH	CH	CH	CH	/-Bu	2-Me	CF3	F<br>
K-31	CH	CH	CH	CH	/-Pr	2-Cl	CF3	F<br>
K-31	CH	CH	CH	CH	/-Bu	2-Cl	CF3	F<br>
K-31	CH	CH	CH	CH	/-Pr	2-Me	CF3	CI<br>
K-31	CH	CH	CH	CH	/-Bu	2-Me	CF3	CI<br>
K-33	CH	CH	CH	CH	/-Pr	2-Cl	CF3	C)<br>
K-31	CH	CH	CH	CH	/-Bu	2-Cl	CF3	CI<br>
K-31	CH	CH	CH	CH	/-Pr	2-Me	CF3	Br<br>
K-31	CH	CH	CH	CH	/-Bu	2-Me	CF3	Br<br>
K-31	CH	CH	CH	CH	/-Pr	2-Cl	CF3	Br<br>
K-31	CH	CH	CH	CH	/-Bu	2-Cl	CF3	Br<br>
K-31	CH	CH	CH	CH	/-Pr	2-Me	CF3	CN<br>
K-31	CH	CH	CH	CH	/-Bu	2-Me	CF3	CN<br>
K-31	CH	CH	CH	CH	/-Pr	2-Cl	CF3	CN<br>
K-31	CH	CH	CH	CH	/-Bu	2-CI	CF3	CN<br>
K-31	CH	CH	CH	N	/-Pr	2-Me	CF3	Me<br>
K-31	CH	CH	CH	N	/-Bu	2-Me	CF3	Me<br>
K-31	CH   .	CH.	CH	N	/-Pr	2-CI	CF3	Me<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
105<br><br>
K-31	CH	CH	CH	N .	/-Bu	2-C1	CF3	Me<br>
K-31	CH	CH	CH	N	/-Pr	2-MB	CF5	F<br>
K-31	CH	CH	CH	N	/-Bu	2-Me	CF3	F<br>
K-31	CH	CH	CH	N	/-Pr	2-C1	CF3	F<br>
K-31	CH	CH	CH	N	/-Bu	2-C1	CF3	F<br>
K-31	CH	CH	CH	N	/-Pr	2-Me	CF3	CI<br>
K-31	CH	CH	CH	N	/-Bu	2-Me	CF3	CI<br>
K-31	CH	CH	CH	N	/-Pr	2-C1	CF3-	CI<br>
K-31	CH	CH	CH	N	/-Bu	2-C1	CF3	CI<br>
K-31	CH	CH	CH	N	/-Pr	2-Me	CF3	Br<br>
K-31	CH	CH	CH	N	/-Bu	. .2-Me	CF3	Br<br>
K-31	CH	CH	CH	N	j-Pr	2-C1	CF3	Br<br>
K-31	CH	CH	CH	N	/-Bu	2-C1	CF3	Br<br>
K-31	CH	CH	CH	N	i-Pr	2-Me	CF3	CN<br>
K-31	CH	CH	CH	N	/-Bu	2-Me	CF3	CN<br>
K-31.	CH	CH	CH	N	/-Pr	2-C1	CF3	CN<br>
K-31	CH	CH	CH	N	/-Bu	2-Ci	CF3	CN<br>
K-33	CH	CH	CH	CH	/-Pr	6-Me	CF3	Me<br>
K-33	CH	CH	CH	CH	/-Bu	6-Me	CF3	Me<br>
K-33	CH	CH	CH	CH	/-Pr	6-CI	CF3	Me<br>
K-33	CH	CH	CH	CH	/-Bu	6-C1	CF3	Me<br>
K-33	CH	CH	CH	CH	i-Pr	6-Me	CF3	F<br>
K-33	CH	CH	CH	CH	/-Bu	6-Me	CF3	F<br>
K-33	CH	CH	CH	CH	/-Pr	6-CI	CF3	F<br>
K-33	CH	CH	CH	CH	/-Bu	6-CI	CF3	F<br>
K-33	CH	CH	CH	CH	/-Pr	6-Me	CF3	CI<br>
K-33	CH	CH	CH	CH	t-Bu	6-Me	CF3	CI<br>
K-33	CH	CH	.CH	CH	/-Pr	6-CI	CF3	Cl<br>
K-33	CH	CH	CH	CH	. /-Bu	6-CJ	CF3	CI<br>
K-33	CH	CH	CH	CH	/-Pr	6-Me	CF3	Br<br>
K-33	CH	CH	CH	CH	/-Bu	6-Me	CF3	Br<br>
K-33	CH	CH	CH	CH	/-Pr	6-CI	CF3	Br<br>
K-33	CH	CH	CH	CH	/-Bu	6-CI	CF3	Br<br>
K-33	CH	CH	CH	CH	/-Pr	6-Me	CF3	CN<br>
K-33	CH "	CH	CH	CH	/-Bu	6-Me	CF3	CN<br>
K-33	CH	CH	CH	CH	/-Pr	6-CI	CF3	" CN<br>
K-33	CH	CH	CH	CH	/-Bu	6-CI	CF3	CN<br>
K-33	CH	CH	CH	N	/-Pr	6-Me	CF3	Me<br><br><br><br>
WO 02/070483<br><br>
PCTYUS02/06582<br><br>
107<br><br>
K-33	CH		CH	CH		CH	t	-Bu		6-a	CF3		CN<br>
K-33	CH		CH	CH		N	i	-Pr	(	S-Me	CF3		Me<br>
K-33	CH		CH	CH		N	t	-Bu	6-Me	CF3		Me<br>
K-33	CH		CH	CH		N	i	-Pr		6-Cl	CF3		Me<br>
K-33	CH		CH	CH		N	t	-Bu		6-Cl	CF3		Me<br>
K-33	CH		CH	CH		N	i	-Pr	6-Me	CF3		F<br>
K-33	CH		CH	CH		N	t-	Bu	6-Me	CF3		F<br>
K-33	CH		CH	CH		N	i-	â€¢Pr		6-Cl	CF3		F<br>
K-33	CH		CH	CH		N	t-	Bu		5-C1	CF3		F<br>
K-33	CH		CH	CH		N	i-	Pr	6-Me	CF3		CI<br>
K-33	CH		CH	CH		N	t-	Bu	6-Me	CF3		a<br>
K-33	CH		CH	CH		N	i-	Pr	6-cr â– 	CF3		CI<br>
K-33	CH		CH	CH		N	t-	Bu	6-Cl	CF3		CI<br>
K-33	CH		CH	CH		N	i-	Pr	6-Me	CF3		Br<br>
K-33	CH		CH	CH		N	t-	Bu	6-Me	CF3		Br<br>
K-33	CH		CH	CH		N	i-	Pr	6-Cl	CF3		Br<br>
K-33	CH		CH	CH		N	t-Bv	6-Cl	CF3		Br<br>
K-33	CH		CH	CH		N	i-	Pr	6-Me	CF3		CN<br>
K-33	CH		CH	CH		N	H3u	6-Me	CF3		CN<br>
K-33	CH		CH	CH		N	/-)	ar	6-Cl	CF3		CN<br>
K-33	CH		CH	CH		"N	/-Bu	6-Cl	CF3		CN<br><br><br><br><br><br><br>
	R2is	H, R3 is Me	R2 is H. R3	isEt	R2is	H. R3	is /-Pr	R2is	Me. R3	is Me<br>
	R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R6	<br>
	CH3	H	CI	CH3	H	CI	CH3	H	CI	CH3	H	CI	<br>
	CH3	H	Br	CH3	H	Br	CH3	H	Br	CH3	H	Br	<br>
	CH3	I	CI	CH3 "	V "	C\	CH3	1	CI	CH3	i"	CI	<br>
	CH3	I	Br	CH3		I	*,	CH3	I	Br	CH3	1	Br	<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
108<br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
109<br><br><br>
WO 02/070483<br><br>
PCT/tTS02/06582<br><br><br>
110 R5 is Br<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
111<br><br><br>
WO 02/070483<br><br>
PCT/DS02/06582<br><br>
112<br><br><br>
WO 02/070483<br><br>
PCT/OS02/06582<br><br>
113<br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
114<br><br><br>
R5 is CH3CF3<br><br>
WO 02/070483	,	PCT/US02/06582<br>
115<br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br><br><br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
117<br>
R5 is CI<br>
R2	sH. R3	is Me	R2	is H. R3 is Et	R2 is H. R3	is /-FT	R2 is	Me. R3 is Me<br>
R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R6<br>
Br	I	Cl	Br	I	Cl	Br	I	Cl	Br	I	Cl<br>
Br	I	Br	Br	I	Br	Br	I	Br	Br	I	Br<br>
Br	F	Cl	Br	F	Cl	Br	F	Cl	Br	F	Cl<br>
Br	F	Br	Br	F	Br	Br	F	Br	Br	F	Br<br>
Br	CF3	Cl	Br	CF3	Cl	Br	CF3	Cl	Br	CF3	Ci<br>
Br	CF3	Br	Br	CF3	Br	Br	CF3	Br	Br	CF3	Br<br>
Br	Br	CI	Br	Br	Cl	Br	Br	CI	Br	Br	Cl<br>
Br	Br	Br	Br	Br	Br	Br	Br	Br	Br	Br	Br<br>
Br	Cl	Cl	Br	Cl	Cl	Br	Cl	Cl	Br	Cl	Cl<br>
Br	Cl	Br	Br	Cl	Br	Br	Cl	Br	Br	Cl	Br<br>
				R5 is Br				<br>
R2is	H.R3	is Me	R2 is H, R3	isEt	R2is	H,R3	is /-Pr	R2is	Me.R3	is Me<br>
R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R6<br>
CH3	H	Cl	CH3	H	Cl	CH3	H	Cl	CH3	H	Cl<br>
CH3	H	Br	CH3	H	Br	CH3	H	Br	CH3	H	Br<br>
CH3	I	Cl	CH3	r	Cl	CH3	1	Cl	CH3	I	Cl<br>
CH3	I	Br .	CH3	i	Br	CH3	I "	Br	CH3	I	Br<br>
CH3	.F	Cl	CH3	F	Cl	CH3	F	CI	CH3	F	CI<br>
CH3	F	Br	CH3	F	Br	CH3	F	Br	CH3	F	Br<br>
CH3	CF3	Cl	CH3	-CF3	Cl	CH3	CF3	Cl	CH3	CF3	Cl<br>
CH3	CF3	Br	CH3	CF3	Br	CH3	CF3	Br	CH3	CF3	Br<br>
CH3	Br	Cl	CH3	Br	Cl	CH3	Br	Cl	CH3	Br	Cl<br>
CH3	Br	Br	CH3	Br	Br	CH3	Br	Br	CH3	Br	Br<br>
CH3	Cl	Cl	CH3	Cl	Cl	CH3	Cl	Cl	CH3	Cl	Cl<br>
CH3	Cl	Br	CH3	CI	Br	CH3	Cl	Br	CH3	CI	Br<br>
CI	H	CI	Cl	H	Cl	Cl	H	Cl	Cl	H	CI<br>
CI	H	Br	Cl	H	Br	CI	H	Br	Cl	H	Br<br>
CI	I	Cl	Cl	I	CI	Cl	I	Cl	Cl	I	Cl<br>
CI	I	Br	Cl	I	Br	Cl	1	Br	Cl	J	Br<br>
CI	F	Cl	Cl	F	Cl	Cl	F	CI	CI	F	Cl<br>
CI	â– F	Br	Cl	F	Br	Cl	F	Br	Cl	F	Br<br>
Cl	CF3	CI	CI	CF3	Cl    "	Cl	CF3	Cl	Cl	CF3	Cl<br>
CI	CF3	Br	CI	CF3	Br	Cl	CF3	Br	CI	CF3	Br<br>
Cl	Br	Cl	CI	Br	Cl	Cl	Br	Cl	Cl	Br	Cl<br><br>
"WO 02/070483<br><br>
PCT/TJS02/06582<br><br>
118<br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
119<br><br><br>
WO 02/070483<br><br>
PCTYUS02/06582<br><br>
120<br><br><br>
WO 02/070483<br><br>
PCT<rusg2></rusg2><br><br><br>
121 Table 21<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
122<br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
123<br>
R5 is CH2CF3<br>
R2	sH.R:	" is Me	R2	is H. R3 is Et	R2i	sH. R3	is /-Pr	R2i
R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R6<br>
CI	CI	CI	CI	CI	CI	CI	Cl	Cl	Cl	Cl	Cl<br>
CI	CI	Br	CI	CI	Br	CI	Cl	Br	CI	CI	Br<br>
Br	H	CI	Br	H	CI	Br	H	Cl	Br	H	Cl<br>
Br	H	Br	Br	H	Br	Br	H	Br	Br	H	Br<br>
Br	I	CI	Br	I	CI	Br	I	CI	Br	r	Cl<br>
Br	I	Br	Br	I	Br	Br	I	Br	Br	i	Br<br>
Br	F	CI	Br	F	CI	Br	F	Cl	Br	F	Cl<br>
Br	F	Br	Br	F	Br	Br	F	Br	Br	F	Br<br>
Br	CF3	CI	Br	CF3	CI	Br	CF3	Cl	Br	CF3	Cl<br>
Br	CF3	Br	Br	CF3	Br	Br	CF3	Br	Br	CF3	Br<br>
Br	Br	CI	Br	Br	CI	Br	Br	Cl	Br	Br	CI<br>
Br	Br	Br	Br	Br	Br	Br	Br	Br	Br	Br .	Br<br>
Br	CI	CI	Br	CI	CI	Br	Cl	CI	Br	Cl	Cl<br>
Br	CI	Br	Br	CI	Br	Br	Cl	Br	Br	Cl	Br<br>
			R5 is CFoCHFi			<br>
R2is	H,R3	is Me	R2i5	H. R3	isEt	R2is	H,R3i	s ;"-Pr	R2is	Me. R3	is Me<br>
R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R^<br>
CH3	H	CI	CH3	H	CI	CH3	H	Cl	CH3	H	Cl<br>
CR3	H	Br.	CH3	H	Br	CH3	H	Br	CH3	H	Br<br>
CH3	I	CI	CH3	I.	CI	CH3	I	Cl	CH3	I	Cl<br>
CH3	I	Br	CH3	3	Br	CH3	1	Br	CH3	I	Br<br>
CH3	F	CI	CH3	F	CI	CH3	F	Cl	CH3	F	Cl<br>
CH3	F	Br	CH3	F	Br	CH3	F	Br	CH3	F	Br<br>
CH3	CF3	CI	CH3	CF3	CI	CH3	CF3	Cl	CH3	CF3	Cl<br>
CH3	CF3	Br	CH3	CF3	Br	CH3	CF3	Br	CH3	CF3	Br<br>
CH3	Br	CI	CH3	Br	CI	CH3	Br	Cl	CH3	Br	Cl<br>
CH3	Br	Br	CH3	Br	Br	CH3	Br	Br	CH3	Br	Br<br>
CH3	CI	CI	CH3	C)	CI	CH3	Cl	Cl	CH3	Cl	Cl<br>
CH3	CI	Br	CH3	CI	Br	CH3	Cl	Br	CH3	Cl	Br"<br>
CI	H	CI	CI	H	CI	CI	H	CI	CI	H	CI<br>
Ci	H	Br	CI	H    .	Br	CI	H	Br	Cl	H	Br<br>
CI	l"	CI	CI	I	CI	CI	I	Cl	Cl	I	Cl "<br>
C3	I	Br	Cl	I	Br	CI	I	Br	CI	r	Br<br>
CI	F	CI	CI	F	CI	Cl	F	Cl	Cl	F	Cl<br><br>
WO 02/070483<br><br>
PCTYUS02/06582<br><br>
124"<br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
125<br>
R5 is CI<br>
R2 is H. R-	is Me	R2	s H. R3 is Et	R2 is H. R3	is /-Pr	R2is	Me.R	J is Me<br>
R4a	R4b	R6	R4a	R4b	R6	R4a    R4b	R6	R4a	R4b	R6<br>
CH3	I	Br	CH3	I	Br	CH3       I	Br	CH3	I	Br<br>
CH3	F	Cl	CH3	F	CI	CH3      F	CI	CH3	F	Cl<br>
CH3	F	Br	CH3	F	Br	CH3      F	Br	CH3	F	Br<br>
CH3	CF3	Cl	CH3	CF3	Cl	CH3    CF3	C!	CH3	CF3	Cl<br>
CH3	CF3	Br	CH3	CF3	Br	CH3    CF3	Br	CH3	CF3	Br<br>
CH3	Br	Cl	CH3	Br	Cl	CH3     Br	Cl	CH3	Br	Cl<br>
CH3	Br	Br	CH3	Br	Br	CH3     Br	Br	CH3	Br	Br<br>
CH3	CI	Cl	CH3	CI	CI	CH3*   Cl	CI	CH3	CI	Cl<br>
CH3	Cl	Br	CH3	CI	Br	CH3     CI	Br	CH3	Cl	Br<br>
CI	H	Cl	ci	H	Cl	Cl       H	Cl	Cl	H	CI<br>
CI	H	Br	CI	H	Br	CI       H	Br	CI	H	Br<br>
CI	I	Cl	Cl	I	Cl	Cl        I	CI	Cl	I	Cl<br>
ci	I	Br	Cl	I	Br	Cl        I	Br	Cl	T	Br<br>
CI	F	Cl	Cl	F	C)	Cl       F	Cl	Cl	F	Cl<br>
â– CI	F	Br	Cl	F	Br	Cl       F	Br	Cl	F	Br<br>
CI	CF3	Cl	Cl	CF3	CI	CI      CF3	Cl	Cl	CF3	Cl<br>
Cl	CF3	Br	Cl	CF3	Br	CI     CF3	Br	CI	CF3	Br<br>
CI	Br	Cl	Cl	Br	Cl	C!       Br	Cl	Cl	Br	Cl<br>
Cl	Br	Br	. Cl	Br	Br	Cl       Br	Br	Cl	Br	Br<br>
Cl	C)	Cl	Cl	Cl	Cl	Cl       Cl	Cl	CI	Cl	Cl<br>
CI	Cl	Br	Cl	Cl	Br	Cl       Cl	Br	Cl	Cl	Br<br>
Br	H	Cl	Br	H	Cl	Br       H	Cl	Br	H	Cl<br>
Br	H	Br	Br	H	Br	Br       H	Br	Br	H	Br<br>
Br	I	Cl	Br	I	Cl	Br        I	Cl	Br	I	CI<br>
Br	I	Br	Br	I	Br	Br       I	Br	Br	I	Br<br>
Br	F	CI	Br	F	Cl	Br       F	Cl	Br	F	CI<br>
Br	F	Br	Br	F	Br	Br        F	Br	Br	F	Br<br>
Br	CF3	Cl	Br	CF3	Cl	Br      CF3	Cl	Br	CF3	Cl<br>
Br	CF3	Br	Br	CF3	Br	Br     CF3	Br	Br	CF3	Br<br>
Br	Br	Cl	Br	Br	CI	Br       Br	Cl	Br	Br	Cl<br>
Br	Br	Br	Br	Br	Br	Br       Br	Br	Br	Br	Br<br>
Br	Cl	Cl	Br	Cl	Cl	Br       Cl	Cl	Br	Cl	Cl<br>
Br	Cl	Br	Br	Cl	Br	BT       Cl	Br	Br	CI	Br<br><br>
WO 02/070483<br><br>
PCT/TJS02/O6582<br><br>
126<br><br><br>
WO 02/070483<br><br>
PCT7US02/06582<br><br>
127<br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
128<br><br><br>
WO 02/070483<br><br>
PCT/OS02/06582<br><br>
129<br><br><br>
_   WO 02/070483<br><br>
PCT/US02/06582<br><br>
130<br><br><br>
WO 02/070483<br><br>
PCTYUS02/06582<br><br>
131<br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
132<br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
133<br>
Table 24<br>
RP<br><br><br>
WO 02/070483<br><br>
PCT/US02/06S82<br><br>
134<br><br><br>
^WO 02/070483<br><br>
PCT/US02/O6582<br><br>
135<br><br><br>
WO 02/070483<br><br>
PCT7tJS02/0<j582></j582><br>
136<br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
137"<br><br><br>
WO 02/070483<br><br>
PCT7US02/06582<br><br><br><br><br><br>
,W0 02/070483<br><br>
PCT/US02/06582<br><br>
139<br><br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
140<br>
VisN<br>
R2 is H, R3 is Me	â– 	R2 is H. R3 is Et	B	2 is H. R3 is i-Pr	R-	- is Me. R3 is Me<br>
R4	R5          R6	R4	R5	R6	R4	R5	R6	R4	R5	R6<br>
CI	OCH2CF3     CI	CI	OCH2CF3	CI	CI	"OCH2CF3	CI	CI	OCH2CF3	C!<br>
CI	OCH7CF3     Br	CI	OCH2CF3	Br	CI	OCH2CF3	Br	CI	OCH2CF3	Br<br>
CI	OCH2CF3    CN	CI	OCH2CF3	CN	CI	OCH2CF3	CN	CI	OCH2CF3	CN<br>
Br	Br           CI	Br	Br	CI	Br	Br	CI	Br	Br	CI<br>
Br	Br          Br	Br	Br	Br	Br	Br	Br	Br	Br	Br<br>
Br	Br          CN	Br	Br	CN	Br	Br	CN	Br	Br	CN<br>
Br	CI           CI	Br	CI	CI	Br	CI	CI	Br	CI	CI<br>
Br	CI           Br	Br	CI	Br	Br	CI	Br	Br	CI	Br<br>
Br	CI          CN	Br	CI	CN	Br	CI	CN	Br	CI	CN<br>
Br	CF3          CI	Br	CF3	CI	Br	CF3	CI	Br	CF3	CI<br>
Br	CF3          Br	Br	CF3	Br	Br	CF3	Br	Br	CF3	Br<br>
Br	CF3         CN	Br	CF3	CN	Br	CF3	CN	Br	CF3	CN<br>
Br	OCH2CF3.    CI	Br	OCH7CF3	CI	Br	OCH2CF3	CI	Br	OCH2CF3	CI<br>
Br	OCH2CF3     Br	Br	OCH2CF3	Br	Br	OCH2CF3	Br	Br	OCH2CF3	Br<br>
Br	OCH9CF3    CN	Br	OCH2CF3	CN	Br	OCH9CF3	CN	Br	OCH7CF3	CN<br>
CH3	Br           CI	CH3	Br	CI	CH3	Br	CI	CH3	Br	CI<br>
CH3	Br           Br	CH3	Br	. Br	CH3	Br	Br	CH3	Br	Br<br>
CH3	Br          CN	CH3	Br	CN	CH3	Br	CN	CH3	Br	CN<br>
CH3	CI            CI	CH3	CI	CI	CH3	CI	CI	CH3	CI	CI<br>
CH3	CI           Br	CH3	CI	Br	CH3	CI	Br	CH3	CI	Br<br>
CH3	CI           CN	CH3	CI	CN	CH3	CI	CN	CH3	CI	CN<br>
CH3	CF3          CI	CH3	CF3	CI	CH3	CF3	CI	CH3	CF3"	CI<br>
CH3	CF3          Br	CH3	CF3	Br	CH3	CF3	Br	CH3	CF3	Br<br>
CH3	CF3         CN	CH3	CF3	CN	CH3	CF3	CN	CH3	CF3	CN<br>
CH3	OCH2CF3     CI	CH3	OCH2CF3	CI	CH3	OCH2CF3	CI	CH3	OCH2CF3	CI<br>
CH3	OCB2CF3    Br	CB3	OCB2CF3	Br	CKi3	OCH2CF3	BT	CH3	ocn2c^3	Br<br>
CH3	OCH2CF3    CN	CH3	OCH2CF3	CN	CH3	OCH2CF3	CN	CH3	OCH2CF3	CN<br>
CF3	Br           CI	CF3	Br	CI	CF3	Br	CI	CF3	Br	CI<br>
CF3	Br           Br	CF3	Br	Br	CF3	Br	Br	CF3	Br	Br<br>
CF3	Br          CN	CF3	Br	CN	CF3	Br	CN	CF3	Br	CN<br>
CF3	CI           CI	CF3	CI	CI	CF3	CI	CI	CF3	CI	CI<br>
CF3	CI           Br	CF3	CI	Br	CF3	CI	Br	CF3	CI	Br<br>
CF3	CI          CN	CF3	.  -CI	CN	CF3	C)	CN	CF3 â€¢	CI	CN<br>
CF3	CF3          CI     -,	CF3	CF3	CI	CF3	CF3	CI	CF3	CF3	CI<br>
CF3	CF3         Br  ."	:F3	CF3	Br	CF3	CF3	Br	CF3	CF3	Br<br><br>
â–º WO 02/070483<br><br>
PCT/US02/06582<br><br>
141-<br><br><br>
WO 02/070483<br><br>
PCTYUS02/06582<br><br>
142<br><br><br>
VisCH<br>
Br<br>
CN<br>
CI<br>
Br<br>
CN<br>
CI<br>
Br<br>
CF3	CN<br>
CF3 OCH2CF3 CI CF3 OCH?CF3 Br CF3    OCH2CF3    CN<br>
R2 is H. R3 is Me<br>
R4        R5 "  R6<br>
Br	CF3	CI<br>
Br	CF3	Br<br>
Br	CF3	CN<br>
Br	OCH2CF3	CI<br>
Br	OCH2CF3	Br<br>
CI<br>
Br<br>
CN<br>
CI<br>
Br<br>
CN<br>
CI<br>
Br<br>
CN<br>
Br<br>
Br<br>
Br<br>
CI<br>
CI<br>
CI<br>
CF3<br>
CF3<br>
CF\?<br>
Br	OCH2CF3	CN<br>
CH3 CH3 CH3 CH3 CH3 CH3 CH3 CH3 CH3<br>
CH3	OCH2CF3	CI<br>
CH3	OCH2CF3	Br<br>
CH3	OCH2CF3	CN<br>
CF3          Br	CI<br>
CF3          Br	Br<br>
CF3          Br	CN<br>
CF3          CI	CI<br>
CF3          CI	Br<br>
CF3          CI	CN<br>
CF3         CF3	CI<br>
CF3         CF3	Br<br>
CF3         CF3	CN<br>
CF3	OCH2CF3	CI<br>
CF3	OCH2CF3	Br<br>
CF3	OCH2CF3	CN<br><br><br>
R4 Br Br Br<br>
R2 is H. R3 is Et<br>
CI<br>
Br CN<br>
CF3 CF3 CF3<br>
Br    OCH2CF3	CI<br>
Br    OCH2CF3	Br<br>
Br    OCH2CF3	CN<br>
CH3 CH3 CH3 CH3 CH3 CH3<br>
CHq<br>
CH3	Br	CI<br>
Br	Br<br>
Br	CN<br>
.CI	CI<br>
CI	Br<br>
CI	CN<br>
CF3	CI<br>
CF3	Br<br>
CH3        CF3	CN<br>
CH3   OCH2CF3	CI<br>
CH3   OCH2CF3	Br<br>
CH3   OCH2CF3	CN<br>
CF3	Br	CI<br>
3 CF3<br>
CF,<br>
CF<br>
CF:<br>
CF<br>
3<br>
CF3<br>
CF3 CF3<br>
Br Br CI CI CI CF3 CF3<br><br><br>
R^	is Me. RJ is Me<br>
RR4	R5             R6<br>
Br	CF3           CI<br>
Br	CF3          Br<br>
Br	CF3         CN<br>
R2 is H, R3 is ,-Pr<br>
Rf	R^	  R6<br>
Br	CF3	CI<br>
Br	CF3	Br<br>
Br	CF3	CN<br><br>
Br	OCH2CF3	CI	Br	OCH2CF3	CI<br>
Br	OCH2CF3	Br	Br	OCH2CF3	Br<br>
Br	OCH2CF3	CN	Br	OCH2CF3	CN<br>
CH3	Br	CI	CH3	Br	CI<br>
CH3	Br	Br	CH3	Br	Br<br>
CH3	Br	CN	CH3	Br	CN<br>
CH3	CI	CI	CH3	CI	CI<br>
CH3	CI	Br	CH3	CI	Br<br>
CH3	CI	CN	CH3	CI	CN<br>
CH3	CF3	CI	CH3	CF3	CI<br>
CH3	CF3	Br	CH3	CF3	Br<br>
CH3	CF3	CN	CH3	CF3	CN<br>
CH3	OCH2CF3	CI	CH3	OCH2CF3	CI<br>
CH3	OCH2CF3	Br	CH3	OCH2CF3	Br<br>
CH3	OCH9CF3	CN	CH3	OCH2CF3	CN<br>
CF3	Br	CI	CF3	Br	CI<br>
CF3	Br	Br	CF3	Br	Br<br>
CF3	Br	CN	CF3	Br	CN<br>
CF3	CI	CI	CF3	CI	CI<br>
CF3	CI	Br	CF3	CI	Br<br>
CF3	CI	CN	CF3	CI	CN<br>
CF3	CF3	CI	CF3	CF3	CI<br>
CF3	CF3	Br	CF3	CF3	Br<br>
CF3	CF3	CN	CF3	CF3	CN<br>
CF3	OCH2CF3	CI	CF3	OCH7CF3	CI<br>
CF3	OCH2CF3	Br	CF3	OCH2CF3	Br<br>
CF3	OCH9CF3	CN	CF3	OCH2CF3	CN<br><br>
VisN<br><br>
R2 is H. R3 is Me	R2 is H. R3 is Et R4          R5          R6	~R2 is H. R3 is	j-Pr	R2 is Me. R3 is Me<br>
R4          R5          R6	<br>
	R4          R^	R^	R4          R5          R^<br>
CI           Br          CI	CI           Br           CI	CI           Br	CI	CI           Br           CI<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
143<br>
VisN<br><br>
R2 is H. R3 is	Me		R2 is H. RJ is Et	R2 is H. RJ is ;-Pr	R	- is Me. RJ is Me<br>
R4	R5	  R6	R4	R5	  R6	R4	R5	  R6	R4	R5          R6<br>
CI	Br	Br	CI	Br	Br	CI	Br	Br	CI	Br          Br<br>
CI	Br	CN	CI	Br	CN	CI	Br	CN	CI	Br          CN<br>
CI	CI	CI	CI	CI	CI	CI	CI	CI	CI	CI            CI<br>
CI	CI	Br	CI	CI	Br	CI	CI	Br	CI	CI           Br<br>
CI	CI	CN	Ci	CI	CN	CI	CI	CN	CI	CI          CN<br>
CI	CF3	CI	CI	CF3	CI	CI	CF3	CI	CI	CF3          CI<br>
CI	CF3	Br	CI	CF3	Br	CI	CF3	Br	CI	CF3         Br<br>
CI	CF3	CN	CI	CF3	CN	CI	CF3	CN	CI	CF3         CH<br>
CI	OCH2CF3	CI	CI	OCH2CF3	CI	CI	OCH2CF3	CI	CI	OCH2CF3     CI<br>
CI	OCH2CF3	Br	CI	OCH2CF3	Br	CI	OCH2CF3	Br	CI	OCH2CF3     Br<br>
CI	OCH2CF3	CN	Ci	OCH2CF3	CN	CI	OCH2CF3	CN	CI	OCH2CF3    CN<br>
Br	Br	CI	Br	Br	CI	Br	Br	CI	Br	Br           CI<br>
Br	Br	Br	Br	Br	Br	Br	Br	Br	Br	Br           Br<br>
Br	Br	CN	Br	Br	CN  |   Br	Br	CN	Br	Br          CN<br>
Br	CI	" CI	Br	CI	CI	Br	CI	CI	Br	CI           CI<br>
Br	CI	Br	Br	CI	Br	Br	CI	Br	Br	CI           Br<br>
Br	CI	CN	Br	CI	CN	Br	CI	CN	Br	CI          CN<br>
Br	CF3	CI	Br	CF3	CI	Br	CF3	CI	Br	CF3    .     CI<br>
Br	CF3	Br	Br	CF3	Br	Br	.    CF3	Br	Br	CF3          Br<br>
Br	CT2	CN	Br	CF3	CN â– 	Br	CF3	CN	Br	CF3         CN<br>
Br	OCH0CF3	CI	Br	OCH2CF3	CI	Br	OCH2CF3	a	Br	OCH2CF3     CI<br>
Br	OCH2CF3	Br	Br	OCH2CF3	Br	Br	OCH2CF3	Br	Br	OCH7CF3     Br<br>
Br	OCH2CF3	CN	Br	OCH2CF3	CN	Br	OCH9CF3	CN "	Br	OCH2CF3    CN<br>
CH3	Br	a	CH3	Br	CI	CH3	Br	a	CH3	Br           CI<br>
CH3	Br	Br	CH3	Br	Br	CH3	Br	Br	CH3	Br          Br<br>
CH3	Br	CN    CH3	Br	CN	CH3	Br	CN	CH3	Br          CN<br>
CH3	CI	CI	CH3	CI	CI	CH3	CI	CI	CH3	CI           CI<br>
CH3	CI	Br	CH3	CI	Br	CH3	CI	Br	CH3	CI           Br<br>
CH3	CI	CN	CH3	CI	CN	CH3	CI	CN	CH3	CI          CN<br>
CH3	CF3	CI	CH3	CF3	CI	CH3	CF3	CI     CH3	CF3          CI<br>
CH3	CF3	Br	CH3	CF3	Br	CH3	CF3	Br     CH3	CF3          Br<br>
CH3	CF3	CN	CH3	CF3 .	CN	CH3	CF3	CN	CH3	CF3         CN<br>
CH3	OCH2CF3	CI	CH3	OCH2CF3	ci   â– 	CH3	OCH2CF3	CI	CH3	OCH2CF3     CI<br>
CH3	OCH2CF3	Br     (	2H3	OCH2CF3	Br	CH3	OCH2CF3	Br	CH3	OCH2CF3     Br<br>
CH3	DCH2CF3	CN     (	:H3	OCH2CF3	CN    
^rt3	OCH2CF3    CN<br><br>
WO 02/070483<br><br>
PCT/TTS02/06582<br><br>
144<br>
VisN<br>
R2 is H. R3 is Me	R2 is H. R3 is Et             R2 is H. R3 is J"-FT	B2	is Me. R3 is Me<br>
R4          R5          R6	R4          R5          R6      R4          R5	R6	R4	R5	R6<br>
CF3         Br           CI	CF3         Br           CI     CF3          Br	CI	CF3	Br	CI<br>
CF3         Br           Br	CF3          Br           Br     CF3          Br	Br	CF3	Br	Br<br>
CF3          Br          CN	CF3         Br          CN     CF3          Br	CN	CF3	Br	CN<br>
CF3         CI           CI	CF3          CI           CI     CF3          CI	CI	CF3	CI	CI<br>
CF3          CI           Br	CF3          CI           Br     CF3          CI	Br	CF3	CI	Br<br>
CF3         CI-          CN	CF3         CI          CN     CF3          CI	CN	CF3	CI	CN<br>
CF3        CF3          CI	CF3        CF?          CI      CF3        CF3	CI	CF3	CF3	CI<br>
CF3        CF3         Br	CF3         CF2          Br      CF3         CF3	Br	CF3	CF3	Br<br>
CF3        CF3         CN	CF3        CF3         CN     CF3        CF3	CN	CF3	CF3	CN<br>
CF3   OCH2CF3     CI	CF3   OCH2CF3     CI      CF3    OCH2CF3	CI	CF3	OCH2CF3	CI<br>
CF3   OCH2CF3     Br	CF3   OCH7CF3     Br     CF3    OCH7CF3	Br	CF3	OCH2CF3	Br<br>
CF3   OCH2CF3    CN	CF3   OCH2CF3    CN     CF3    OCH2CF3	CN	CF3	OCH2CF3	CN<br><br>
VisCH			<br>
R2 is H, R3 is Me	R2 is H, R3 is Et             R2 is H, R3 is i-	FT	R2 is Me, R3 is	Me<br>
R4          R5          R6	R4          R5           R6      R4           R5	R6	R4	R5	R6<br>
CI           Br           CI	CI           Br           CI        CI           Br	CI	CI	Br	CI<br>
CI           Br           Br	CI           Br           Br       CI           Br	Br	CI	Br	Br<br>
CI           Br          CN	CI          Br          CN      CI           Br	CN	CI	Br	CN<br>
CI           CI           CI	CI       ,   CI           CI       CI           CI	CI	CI	.   CI	CI<br>
CI           CI           Br	0       a       Br     a       a	Br	a	CI	Br<br>
CI           CI          CN .	CI           CI          CN      CI           CI	CN	a	CI	CN<br>
CI          CF3          CI	CI          CF3          CI        CI          CF3	CI	c\	CF3	CI<br>
CI          CF3          Br	CI         CF3          Br       CI     .    CF3	Br	a	CF3	Br<br>
CI          CF3         CN	CI        "CF3         CN      CI          CF3	CN     "CI	CF3	CN<br>
CI    .OCH2CF3  â–  CI  :	CI     OCH2CF3     CI   1   CI     OCH2CF3	CI   J	a   OCH2CF3	CI<br><br><br><br>
WO 02/070483<br><br>
PCT/DS02/06582<br><br>
146<br>
VisCH<br><br>
R2 is H. R3 is Me	R2 is H. R3 is Et	R2 is H. R3 is /-Pr	R2 is Me. R3 is Me<br>
R4          R5          R6	R4          R5          R6	R4          R5          R6	R4          R5          R6<br>
CF3   OCH2CF3     CI	CF3    OCH2CF3     CI	CF3    OCH2CF3     CI	CF3   OCH2CF3     CI<br>
CF3   OCH2CF3     Br	CF3    OCH2CF3     Br	CF3    OCH9CF3     Br	CF3    OCH2CF3     Br<br>
CF3   OCH2CF3    CN	CF3    OCH2CF3    CN"	CF3    OCH2CF3    CN	CF3   OCH2CF3    CN<br>
VisN<br>
R2 is H. R3 is	Me		R2 is H. R3 is Et	.   R2 is H. R3 is /-Pr	R	2 is Me. R3 L	&gt; Me<br>
R4	R5	R6	K4	R5	R6	R4	R5	R6	R4	R5	R6<br>
CI	Br	CI	CI	Br	CI	CI	Br	CI	CI	Br	CI<br>
C"l	Br	Br	CI	Br	Br	CI	Br	Br	CI	Br	Br<br>
CI	Br	CN	CI	Br	CN	CI	Br	CN	Ci	Br	CN<br>
CI	CI	CI	CI	CI	CI	CI	CI	CI	CI	CI	CI<br>
CI	â–  CI	Br	CI	CI	Br	C!	CI	Br	CI	CI	Br<br>
CI	CI	CN	CI	CI	CN	CI	C)	CN	CI	CI	CN<br>
CI	CF3	CI	CI	CF3	C!	CI	CF3	CI	CI	CF3	CI<br>
CI	CF3	Br	CI	CF3	Br	CI	CF3	Br	CI	CF3	Br<br>
CI	CF3	CN	CI	CF3	CN	CI	CF3	CN	CI	CF3	CN<br>
CI	OCH2CF3	CI	CI	OCH2CF3	CI	CI	OCH2CF3	CI	CI	OCH2CF3	C)<br>
CI	OCH2CF3	Br	ci	OCH2CF3	Br	CI	OCH2CF3	Br	CI	OCH2CF3	Br<br>
CI	OCH2CF3	CN	CI	OCH2CF3	CN	CI	OCH2CF3	C^	CI	OCH2CF3	CN<br>
Br	Br	CI	Br	Br	O	Br	Br	CI	Br	Br	C)<br>
Br	Br	Br	Br	Br	Br	Br	Br	Br	Br	Br	Br<br>
Br	Br	CN	Br	Br	CN	Br	Br	CN	Br	Br	CN<br>
Br	CI	CI	Br	CI	CI	Br	CI	CI	Br	CI	CI<br>
Br	CI	Br	Br	CI	Br	Br	CI	Br	Br	CI	Br<br>
Br	CI	CN	Br	CI	CN	Br	CI	CN	Br	CI	CN<br>
Br	CF3	â– ci	Br	CF3	CI	Br	CF3	CI	Br	CF3	CI<br>
Br	CF3	Br	Br	CF3	Br	Br	CF3	Br	Br	CF3	Br<br>
Br	CF3	CN	Br	CF3	CN	Br	CF3	CN	Br	CF3	CN<br>
Br	OCH9CF3	CI	Br	OCH2CF3	CI	Br	OCH2CF3	CI	Br	OCH2CF3	CI<br>
Br	OCH2CF3	Br	Br	OCH2CF3	Br	Br	OCH2CF3	Br      Br	OCH2CF3	Br<br>
Br	OCH2CF3	CN	Br	OCH2CF3	CN	Br	OCH2CF3	CN	Br	OCH2CF3	CN<br>
CH3-	Br	CI	CH3	Br	CI	CH3	Br	CI	CH3	Br	CI<br>
CH3	Br	Br	CH3 â– 	Br	Br	CH3	Br	Br	CH3	Br	Br<br>
CH3	Br	CN	CH3	Br	CN	CH3	Br	CN	CH3	Br	CN<br>
CH3	CI	CI	CH3	CI	CI	CH3	CI	CI	CH3	CI	CI<br><br>
PCT/US02/06582<br>
147<br>
VisN<br>
R	2 is H. R3 is	Me	R2 is H. R3 is	Et	R2 is H. R3 is	-Pr	R2 is Me. R3 is	Me<br>
R4	R5	R6	R4	R5	R6	R4	R5	R6	R4           R5	R6<br>
CH3	CI	Br	CH3	CI	Br	CH3	CI	Br	CH3          CI	Br<br>
CH3	CI	CN	CH3	CI	CN	CH3	CI	CN	CH3         CI	CN<br>
CH3	CF3	CI	CH3	CF3     .	CI	CH3	CF3	CI	CH3        CF3	CI<br>
CH3	CF3	Br	CH3	CF3	Br	CH3	CF3	Br	CH3        CF3	Br<br>
CH3	CF3	CN	CH3	CF3	CN	CH3	CF3	CN	CH3        CF3	CN<br>
CH3	OCH2CF3	CI	CH3	OCH2CF3	CI	CH3	OCH2CF3	CI	CH3   OCH2CF3	CI<br>
CH3	OCH2CF3	Br	CH3	OCH2CF3	Br	CH3	OCH2CF3	Br	CH3   OCH2CF3	Br<br>
CH3	OCH2CF3	CN	CH3	OCH2CF3	CN	CH3	OCH2CF3	CN	CH3   OCH2CF3	CN<br>
CF3	Br	CI	CF3	Br	CI	CF3	Br	CI	CF3          Br	CI<br>
CF3	Br	Br	CF3	Br	Br	CF3	Br	Br	CF3          Br	Br<br>
CF3	Br	CN	CF3	Br	CN	CF3	Br	CN	CF3          Br	CN<br>
CF3	CI	CI	CF3	CI	CI	CF3	CI	CI	CF3          CI	CI<br>
CF3	CI	Br	CF3	CI	Br     CF3	CI	Br	CF3          CI	Br<br>
CF3	CI	CN	CF3	CI	CN	CF3	CI	CN	CF3      a	CN<br>
CF3	CF3	CI	CF3	CF3	CI	CF3	CF3	CI	CF3        CF3	CI<br>
CF3	CF3	Br	CF3	CF3	Br	CF3	CF3	Br	CF3         CF3	Br<br>
CF3	CF3	CN	CF3	CF3	CN	CF3	CF3	CN	CF3        CF3	CN<br>
CF3	OCH2CF3	CI	CF3	OCH2CF3	CI	CF3	OCH2CF3	CI	CF3    OCH2CF3	CI<br>
CF3	OCH2CF3	Br	CF3	OCH2CF3	Br	CF3	OCH2CF3	Br	CF3    OCH2CF3	Br<br>
CF3	OCH2CF3	CN	CF3	OCH2CF3	CN  J CF3	OCH2CF3	CN	CF3    OCH2CF3	CN<br>
					Tat	&gt;le28				<br><br><br><br>
R- is H, RJ is i-Vr<br>
Rl	RÂ£	R6<br>
CI	Br	CI<br>
CI	Br	Br<br>
R2 is H. R3 is Me<br>
R4	R5	R6<br>
CI	Br	CI<br>
CI    .      Br	Br<br><br>
R2 is Me. R3 is Me<br>
Rl	R5	R6<br>
CI	Br	CI<br>
CI	Br	Br<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
148<br>
VisCH<br>
R2 is H. R3 is Me	R2 is H. R3 is	Et	B	? is H. R3 is 2-Pr	R2 is Me. R3 is	Me<br>
R4	R5          K6	R4          R5	R6	R4	R5	R6	R4	R5	R6<br>
CI	Br          CN	CI           Br	CN	CI	Br	CN	CI	Br	CN<br>
C?	CI           CI	CI           CI	CI	CI	CI	CI	CI	CI	CI<br>
CI	CI           Br	CI           CI	Br	CI	CI	Br	CI	C)	Br<br>
C)	CI          CN	CI           CI	CN	CI	CI	CN	Ci	CI	CN<br>
CI	CF3         CI	CI          CF3	CI	CI	CF3	CI	CI	CF3	CI<br>
CI	CF3         Br	CI          CF3	Br	CI	CF3	Br	Ci	CF3	Br<br>
CI	CF3         CN	CI          CF3	CN	CI	CF3	CN	CI	
CI	OCH2CF3     CI	CI    "OCH2CF3	CI	CI	OCH2CF3	CI	CI	OCH2CF3	CI<br>
CI	OCH2CF3     Br	CI     OCH2CF3	Br	CI	OCH2CF3	Br	CI	OCH2CF3	Br<br>
CI	OCH2CF3    CN	CI     OCH2CF3	CN	CI	OCH2CF3	CN	CI	OCH2CF3	CN<br>
Br	Br          CI	Br           Br	CI	Br	Br	CI	Br	Br	CI<br>
Br	Br          Br	Br           Br	Br	Br	Br	Br	Br	Br	Br<br>
Br	Br      .   CN	Br           Br	CN	Br	Br	CN	Br	Br	CN<br>
Br	CI           C!	Br           CI	CI	Br	a	CI	Br	CI	CI<br>
Br	CI          Br	Br           C!	Br	Br	CI	BT	Br	CS	Br<br>
Br	CI          CN	Br           C!	CN	Br	CI	CN	Br	CI	CN<br>
Br	CF3          Ci	Br         CF3	CI       Br	CF3	Ci	Br	CF3	Ci<br>
Br	CF3          Br	Br          CF3	Br	Br	CF3	Br	Br	CF3	Br<br>
Br	CF3         CN	Br          CF3	CN	Br	CF3	CN	Br	CF3	CN<br>
Br	OCH2CF3     CI	Br    OCH2CF3	CI	Br	OCH2CF3	CI	Br	OCH2CF3	CI<br>
Br	OCH2CF3     Br	Br    OCH2CF3	Br	Br	OCH2CF3	Br	Br	OCH2CF3	Br<br>
Br	OCH2CF3    CN	Br    OCH2CF3	CN	Br	OCH2CF3	CN	Br	OCH2CF3	CN<br>
CH3	Br          CI	CH3          Br	CI	CH3	Br	CI	CH3	Br	CI<br>
CH3	Br           Br	CH3          Br	Br	CH3	Br	Br	CH3	Br	Br<br>
CH3	Br          CN	CH3          Br	CN	CH3	Br	CN	CH3	Br	CN<br>
CH3	CI           CI	CH3          CI	CI	CH3	CI	C)	CH3	CI	CI<br>
CH3	CI           Br	CH3          CI	Br	CH3	CI	Br	CH3	CI	Br<br>
CH3	CI          CN	CH3          CI	CN	CH3	CI	CN	CH3	CI	CN<br>
CH3	CF3          CI	CH3        CF3	CI	CH3	CF3	C!	CH3	CF3	CI<br>
CH3	CF3         Br	CH3        CF3    .	Br	CH3	CF3	Br	CH3	CF3	Br<br>
CH3	CF3         CN	CH3        CF3	CN	CH3	CF3	CN	CH3	CF3	CN<br>
CH3	OCH7CF3     CI	CH3   OCH2CF3	CI	CH3	OCH7CF3	CI	CH3	OCH2CF3	CI<br>
CH3	OCH2CF3     Br	CH3   GCH2CF3	Br	CH3	OCH2CF3	Br	CH3	OCH2CF3	Br<br>
CH3 .	OCH2CF3    CN	CH3   OCH2CF3	CN	CH3	OCH2CF3	CN	CH3	OCH7CF3	CN<br>
CF3	Br           CI	CF3          Br	CI	CF3	Br	Ci	CF3	Br	CI<br><br>
WO 02/070483<br><br>
PCT7TJS02/06582<br><br>
149<br>
VjsCH<br>
R2 is H. R3 is	Me	P	2 is H. R3 is	Et	R:	- is H. R3 is	/-Pr	R2 is Me. R3 is Me<br>
R4      R5	R6<br>
	R4   	R5	R6<br>
	R4   	R5	R6<br>
	R4      R5      R6<br>
CF3          Br	Br	CF3	Br	Br	CF3	Br	Br	CF3          Br           Br<br>
CF3          Br	CN	CF3	Br	CN	CF3	Br	CN	CF3          Br          CN<br>
CF3          CI	CI	CF3	Cl	Cl	CF3	Cl	Cl	CF3          Cl            Cl<br>
CF3          CI	Br	CF3	Cl	Br	" CF3	Cl	Br	CF3          C.           Br<br>
CF3          CI	CN	CF3	Cl	CN	CF3	Cl	CN	CF3          Cl           CN<br>
CF3        CF3	CI	CF3	CF3	Cl	CF3	CF3	Cl	CF3        CF3          CI<br>
CF3        CF3	Br	CF3	CF3	Br	CF3	CF3	Br	CF3        CF3          Br<br>
CF3        CF3	CN	CF3	CF3	CN	CF3	CF3	CN	CF3        CF3         CN<br>
CF3    OCH2CF3	CI	CF3	OCH2CF3	Cl	CF3	OCH2CF3	Cl	CF3    OCH2CF3     Cl<br>
CF3    OCH2CF3	Br	CF3	OCH2CF3	Br	CF3	OCH2CF3	Br	CF3    OCH2CF3     Br<br>
CF3   OCH2CF3	CN	CF3	OCH2CF3	CN	CF3	OCH2CF3	CN	CF3   OCH2CF3    CN<br>
			YJ	lN			<br>
R2 is H. R3 is	Me	R2 is H. R3 is	Et	R2	is H, R3 is i	-Pr	R2 is Me. R3 is Me<br>
R4          R5	R6	R4	R5	R6	R4	R5	R6	R4          R5           R6<br>
CI           Br	C!	CI	Br	Cl	Cl	Br	Cl	Cl           Br           C!<br>
CI           Br	Br	CI	Br	Br	CJ	Br	Br	Cl           Br           Br<br>
CI           Br	CN	CI	Br	CN	Cl	Br	CN	Cl           Br          CN<br>
CI           CI	CI	CI	Cl	Cl	Cl	Cl	Cl "	Cl           Cl            Cl<br>
CI           CI	Br	CI	Cl	Br	Cl	Cl	Br	Cl           Cl           Br<br>
CI           Ci	CN	a	Cl	CN	Cl	Cl	CN	CI           CI           CN<br>
CI          CF3	CI	a	CF3	Cl	CI	CF3	Cl	Cl          CF3          Cl<br>
CI          CF3	Br	a	CF3	Br	a	CF3	Br	Cl          CF3          Br<br>
CI          CF3	CN	Cl	CF3	CN	Cl	CF3	CN	Cl          CF3          CN<br>
CI     OCH2CF3	CI	Cl	OCH2CF3	Cl	Cl	OCH2CF3	Cl	Cl  . OCH2CF3     Cl<br>
CI     OCH7CF3	Br	Cl	OCH2CF3	Br	Cl	OCH2CF3	Br	Cl     OCH2CF3     Br<br>
CI     OCH2CF3	CN	CI	OCH2CF3	CN	CI	OCH2CF3	CN	Cl     OCH2CF3    CN<br>
Br           Br	CI	.Br	Br	Cl	Br	Br	CI	Br           Br            Cl<br>
Br          Br	Br	Br	Br	Br	Br	Br	Br	Br           Br           Br<br>
Br            Br	CN	Br	Br	CN	Br	Br	CN	Br           Br           CN<br>
Br           CI	CI	Br	Cl	Cl	Br	Cl	Cl	Br           Cl            Cl<br>
Br           CI	Br	Br	Cl	Br	Br	Cl	Br	Br           Cl           Br<br>
Br           CI	CN	Br	CI "	CN	Br	Cl	CN	Br           Cl          CN<br>
Br         CF3	CI	Br	CF3	CI	Br	CF3	CI	Br         CF3          CI<br>
Br         CF3	Br	Br	CF3	Br	Br	CF3	Br	Br         CF3          Br<br><br>
WO 02/070483<br><br>
PCT/O502/06582<br><br>
150<br><br>
R2 is H. RJ is Me<br>
R4	R5	R6<br>
Br	CF3	CN<br>
Br	OCH2CF3	CI<br>
Br	OCH2CF3	Br<br>
Br	OCH2CF3	CN<br>
CH3	Br	CI<br>
CH3	Br	Br<br>
CH3	BT	CN<br>
CH3	CI	CI<br>
CH3	CI	Br<br>
CH3	C)	CN<br>
CH3	CF3	CI<br>
CH3	CF3	Br<br>
CH3	CF3	CN<br>
CH3	OCH2CF3	CI<br>
CH3	OCH2CF3	Br<br>
CH3	OCH2CF3	CN<br>
CF3	Br	CI<br>
CF3	Br	Br<br>
CF3	Br	CN<br>
CF3	CI	CI<br>
CF3	CI	Br<br>
CF3	CI	CN<br>
CF3	CF3	C!<br>
CF3	CF3	Br<br>
CF3	CF3	CN<br>
CF3	OCH2CF3	CI<br>
CF3   OCH2CF3	Br<br>
CF3    OCH?CF3	CN<br><br>
v<br>
R2 is H. R3 is Et<br>
R4<br>
R5	R6<br>
Br	CF3	CN<br>
Br	OCH2CF3	CI<br>
Br	OCH2CF3	Br<br>
Br	OCH2CF3	CN<br><br>
CH3	Br	CI<br>
CH3	Br	Br<br>
CH3	Br	CN<br>
CH3	CI	CI<br>
CH3	CI	Br<br>
CH3	CI	CN<br>
CH3	CF3	CI<br>
CH3	CF3	Br<br>
CH3	CF3	CN<br>
CH3	OCH2CF3	CI<br>
CH3	OCH2CF3	Br<br>
CH3	OCH2CF3	"CN<br>
CF3	Br	CI<br>
CF3	Br	Br<br>
CF3	Br	CN<br>
CF,<br>
CI	CI<br>
CF3<br>
CI	Br<br>
CI	CN<br>
CF3        CF3<br>
CI<br>
CF3        CF3	Br<br>
CF3        CF3	CN<br>
CF3    OCH2CF3	CI<br>
CF3   OCH2CF3	Br<br>
CF3   OCH2CF3	CN<br><br>
isN<br>
R2 is H. R3 is j-Pr R4	R5	R6<br><br>
Br	CF3	CN<br>
Br	OCH2CF3	CI<br>
Br	OCH2CF3	Br<br>
Br	OCH9CF3	CN<br>
CH3	Br	CI<br>
CH3	Br	Br<br>
CH3	Br	CN<br>
CH3	CI	CI<br>
CH3	CI	Br<br>
CH3	CI	CN<br>
CF3 CF3<br>
CH3	CF3	CI<br>
Br<br>
CN<br>
CH3 CH,<br>
CH3	OCH2CF3	CI<br>
CH3	OCH2CF3	Br<br>
CH3	OCH2CF3	CN<br>
CF3	Br	CI<br>
CF3<br>
CF3 CF3 CF3 CF3<br>
CF3 CF3 CF<br>
Br	Br<br>
Br	CN<br>
Br<br>
CN<br>
CI<br>
Br<br>
CN<br>
CI	CI<br>
CI<br>
CI CF3 CF3 CF,<br>
i        "3<br>
CF3	OCH2CF3	CI<br>
CF3	OCH2CF3	Br<br>
CF3	OCH7CF3	CN<br><br>
R2 is Me. R3 is Me<br>
R4<br>
R6<br>
R3<br>
CN<br>
Br<br>
CF,<br>
Br	OCH2CF3	CI<br>
Br	OCH2CF3	Br<br>
Br	OCH2CF3	CN<br>
CH3	Br	CI<br>
CH3	Br	Br<br>
CH3	Br	CN<br>
CH3	CI	CI<br>
CH3	CI	Br<br>
CH3	CI	CN<br>
CH3	CF3	CI<br>
CH3	CF3	Br<br>
CH3	CF3	CN<br>
CH3	OCH2CF3	CI<br>
CH3	OCH2CF3	Br<br>
CH3	OCH2CF3	CN<br>
CF3	Br	CI<br>
CF3	Br	Br<br>
CF3	Br	CN<br>
CF3	CI	CI<br>
CF3	CI	Br<br>
CF3	CI	CN<br>
CF3	CF3	CI<br>
CF3	CF3	Br<br>
CF3	CF3	CN<br>
CF3	OCH2CF3	CI<br>
CF3	OCH2CF3	Br<br>
CF3	OCH2CF3	CN<br><br>
WO 02/070483<br><br>
PCTYUS02/06582<br><br><br><br><br><br><br><br><br><br>
R2 is H. R3	<br><br><br><br><br>
is Me	<br><br>
R4<br>
\ /      ll	151		<br><br><br><br><br>
is /-Pr	<br><br><br><br><br>
R2 is Me. R3	<br><br>
R6<br><br><br><br>
is Me<br>
R5	R6<br>
	R5	R6<br>
	R5	R6	R5	<br><br>
Br	c\	Br	CI	Br	CI	Br	Cl<br>
Br	Br	Br	Br	Br	Br	Br	Br<br>
Br	CN	Br	CN	Br	CN	Br	CN<br>
CI	CI	CI	CI	CI	CI	CI	Cl<br>
CI	Br	CI	Br	CI	Br	CI	Br<br>
CI	CM	CI	CN	CI	CN	CI	CN<br>
CF3	CI	CF3	CI	CF3	CI	CF3	CI<br>
CF3	Br	CF3	Br	CF3	Br	CF3	Br<br>
CF3	CN	CF3	CN	CF3	CN	CF3	CN<br>
OCH2CF3	CI	OCH2CF3         CI	OCH2CF3	CI	OCH7CF3	Cl<br>
OCH2CF3	Br	OCH2CF3        Br	OCH2CF3 *	Br	OCH2CF3	Br<br>
OCH2CF3	CN	OCH2CF3        CN	OCH2CF3	CN	OCH2CF3	CN<br>
Br	CI	Br	CI	Br	CI	Br	Cl<br>
Br	Br	Br	Br	Br	Br	Br	Br<br>
Br	CN	Br	CN	Br	CN	Br	CN<br>
CI	Cl-	a	CI	CI	CI	CI	Cl<br>
CI	Br	a	Br	CI	Br	CI	Br<br>
CI	CN	ci	CN	CI	CN	CI	CN<br>
CF3	CI	CF3	CI	CF3	CI	CF3	Cl<br>
CF3	Br	CF3	Br	CF3	Br	CF3	Br<br>
CF3	CN	CF3-	CN	CF3	CN	CF3	CN<br>
OCH2CF3	C!	OCH9CF3         CI	OCH2CF3	CI	OCH2CF3	Cl<br>
OCH2CF3	Br	OCH2CF3        Br	OCH2CF3	Br	OCH2CF3	Br<br>
OCH2CF3	CN	OCH2CF3 .     CN	OCH2CF3	CN	OCH2CF3	CN<br>
Br	CI	Br	CI	Br	CI	Br	Cl<br>
Br	Br	Br	Br	Br	Br	Br	Br<br><br>
WO 02/070483<br><br>
PCT/US02/O6582<br><br>
152<br>
R4 is CHFo<br>
R2 is H. I	lJ is Ms     R6	R2 is H.	R3 is Et	R2 is H. R3 is i-Pr R5,            R6	R2 is Me. R3 is Me<br>
R5	<br>
	R5	    R6	<br>
	R5	    R6<br>
Br	CN	Br	CN	Br	CN	Br	CN<br>
CI	CI	CI	CI	CI	CI	Cl	Cl<br>
CI	Br	CI	Br	C!	Br	CI	Br<br>
C!	CN	CJ	CN	CJ	CN	C)	CN<br>
CF3	CI	CF3	CI	CF3	CI	CF3	Cl<br>
CF3	Br	CF3	Br	CF3	Br	CF3	Br<br>
CF3	CN	CF3	CN	CF3	CN	CF3	CN<br>
OCH2CF3	CI	OCH2CF3	CI	OCH2CF3	CI	OCH2CF3	CI<br>
OCH2CF3	Br	OCH2CF3	Br	OCH2CF3	Br	OCH2CF3	Br<br>
OCH2CF3	CN	OCH2CF3	CN	OCH2CF3	CN	OCH2CF3	CN<br>
Br	CI	Br	CI	Br	CI	Br	Cl<br>
Br	Br	Br	Br	Br	Br	Br	Br<br>
Br	CN	Br	CN	Br	CN	Br	CN<br>
CI	CI	CI	CI	CI	CI	Cl	Cl<br>
CI-	Br	CI	Br	CI	Br	Cl	Br<br>
CI	CN	CI	CN	CI	CN	Cl	CN<br>
CF3	CI	CF3	CI	CF3	CI	CF3	Cl<br>
CF3     	Br	CF3	Br	CF3	Br	CF3	Br<br>
CF3	CN	CF3	CN	CF3	CN	CF3	CN<br>
OCH2CF3	CI	OCH2CF3	CI	OCH2CF3	CI	OCH2CF3	Cl<br>
OCH2CF3	Br	OCH2CF3	Br	OCH2CF3	Br	OCH2CF3	Br<br>
OCH?CF3	CN      1  OCH2CF3	CN	OCH2CF3	CN	OCH2CF3	CN<br>
		R4 is CH3			<br>
R2isH. R3	is Me 6	R2 is H. R:<br>
R5	= is Et 6	R2 is H. R3<br>
R5	is /-Pr<br>
6	R2 is Me. R3	is Me<br>
R5	<br><br><br><br><br>
	R5	R6<br>
Br	CI	Br	CI	Br	Cl	Br	Cl<br>
Br	Br	Br	Br	Br	Br	Br	Br<br>
Br	CN	Br	CN	Br	CN	Br	CN<br>
CI	CI	Cl	CI            CI	CI	Cl	CI<br>
CI	Br	CI	Br	CI	Br	Cl	Br<br>
CI	CN	CI	CN	CI	CN	"     Cl	CN<br>
CF3	CI	"    CF3	CI	CF3	CI	CF3	Cl<br>
CF3	Br	CF3	Br	CF3	Br	CF3      â– 	Br<br>
CF3	CN	CF3	CN	CF3	CN	CF3	CN<br><br>
0 02/070483<br><br>
PCTYUS02/06582<br><br>
153<br>
R4 is CHu<br><br>
T?2 is H. R3<br>
R5	is Me<br>
R6	R2 is H. R3<br>
R5	isEt<br><br>
R6	R2 is H. R3	1S y.pr        T?2 k Ms. R3 is Me<br><br><br><br><br>
	R5	R6	R5	R6<br>
OCH2CF3<br>
OCH2CF3<br>
OCH2CF3<br>
Br	Cl	OCH2CF3	Cl	OCH2CF3	Cl	OCH2CF3	Cl<br><br>
	Br	OCH2CF3	Br	OCH9CF3	Br	OCH2CF3	Br<br><br>
	CN Cl	OCH2CF3 Br	CN Cl	OCH2CF3 Br	CN Cl	OCH2CF3 Br	CN Cl<br>
Br	Br	Br	Br	Br	Br	Br	Br<br>
Br	CN	Br	CN	Br	CN	Br	CN<br>
CI	Cl	Cl	Cl	Cl	â€¢    Cl	Cl	Cl<br>
CI	Br	Cl	Br	Cl	Br	CI	Br<br>
CI	CN	Cl	CN	Cl	CN	Cl	CN<br>
CF3<br>
CF3<br>
CF3<br>
OCH2CF3.	Cl Br CN	CF3 CF3 CF3	Cl Br<br>
CN	CF3<br>
CF3<br>
CF3	Cl Br CN	CF3 CF3 CF3	Cl Br CN<br><br>
	Cl	OCH2CF3	Cl	OCH2CF3	Cl	OCH2CF3	Cl<br>
OCH2CF3<br>
OCH2CF3<br>
Br	Br<br>
CN Cl	OCH2CF3<br>
OCH2CF3<br>
Br	Br CN Cl	OCH7CF3 OCH9CF3<br>
Br	Br CN Cl	OCH2CF3<br>
OCH2CF3<br>
Br	Br CN Cl<br>
Br	Br	Br	Br	Br	Br	Br	Br<br>
Br	CN	Br	CN	Br	CN	Br	CN<br>
CI	C!	Cl	Cl	Cl	Cl	Cl	Cl<br>
CI	Br	Cl	Br	Cl	Br	Cl	Br<br>
CI	CN	Cl	CN	Cl	CN	Cl	CN<br>
CF3<br>
CF3<br>
CF3<br>
OCH2CF3	Cl Br CN	CF3 CF3 CF3	Cl Br CN	CF3 CF3 CF3	Cl Br CN	CF3 CF3 CF3	Cl Br<br>
CN<br><br>
	Cl	OCH2CF3	Cl	OCH2CF3	Cl	OCH2CF3	Cl<br>
4~            ~J<br>
OCH2CF3<br>
OCH2CF3 Br	Br	OCH2CF3	Br	OCH2CF3	Br	OCH2CF3	Br<br><br>
	CN<br>
"    Cl	OCH2CF3 Br	CN Cl	OCH2CF3 Br	CN Cl	OCH2CF3 Br	CN Cl<br>
Br	Br	Br	Br	Br	Br	Br	Br<br>
Br	CN	Br	CN	Br	CN	Br	CN<br>
CI	Cl	Cl	Cl	Cl	Cl	Cl	Cl<br>
CI	Br	Cl	Br	Cl	Br	Cl	Br<br>
CI	CN	Cl	CN	Cl	CN	.Cl	â€¢   CN<br>
CF3	Cl	CF3	Cl	CF3	Cl	CF3	Cl<br>
CF3	Br	CF3	Br	CF3	Br	CF3	Br<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
154<br>
R4 is CHi<br>
R2 IS n_ R3	is M&amp;	R2 is H. R3	isEt	R2 is H. R3	is z"-Pr	R2 is Me. R3	is Me<br>
R5	R6	R5	R6	R5	R6	R5	R6<br>
CF3	CN	CF3	CN	CF3	CN	CF3	CN<br>
OCH2CF3	CI	OCH2CF3	Cl	OCH2CF3	Cl	OCH2CF3	Cl<br>
OCH2CF3	Br	OCH2CF3	Br	OCH9CF3	Br	OCH2CF3	Br<br>
OCH2CF3	CN	OCH2CF3	CN	OCH2CF3	CN	OCH2CF3	CN<br>
			R4 is CF3			<br>
R2 is H. R3	is K4c	R2 is H, R3	isEt	R2 is H. R3	is /-Pr	R2 is Me, R3	is Me<br><br>
	R6	R5	R6	R5	R6	R5	R6<br>
Br	Cl	Br	Cl	Br	ci.	Br	Cl<br>
Br	Br	Br	Br	Br	Br	Br	Br<br>
Br	CN	Br	CN	Br	CN	Br	CN<br>
C!	C!	Cl	Cl	CI	Cl	Cl	Cl<br>
ci	Br	Cl	Br	Cl	Br	Cl	Br<br>
Cl	CN	Cl	CN	Cl	CN	CI	CN<br>
CF3	Cl	CF3	Cl	CF3	Cl	CF3	CI<br>
CF3	Br	CF3	Br	CF3	Br	CF3	Br<br>
CF3	CN	CF3	CN	CF3	CN	CF3	CN<br>
OCH2CF3	Cl	OCH2CF3	Cl	OCH2CF3	Cl	OCH2CF3	Cl<br>
OCH9CF3	Br	OCH9CF3	Br	OCH2CF3	Br	OCH2CF3	Br<br>
OCH2CF3	CN	OCH2CF3	CN	OCH2CF3	CN	OCH2CF3	CN<br>
Br	Cl	Br	Cl	Br	Cl	Br	Cl<br>
Br	Br	Br	Br	Br	Br	Br	Br<br>
Br	CN	Br	CN	Br	CN	Br	CN<br>
CI	Cl	Cl	Cl	Cl	Cl	Cl	Cl<br>
ci	Br	Cl	Br	Cl	Br	Cl	Br<br>
CI	CN	Cl	CN	Cl	CN	CI	CN<br>
CF3	Cl	CF3	CI	CF3	Cl	CF3	Cl<br>
CF3	Br	CF3	Br	CF3	Br	CF3	Br<br>
CF3	CN	CF3	CN	CF3	CN	CF3	CN<br>
OCH2CF3	CI	OCH2CF3	Cl	OCH2CF3	Cl	OCH2CF3	CI<br>
OCH2CF3	Br	OCH7CF3	Br	OCH2CF3	Br	OCH2CF3	Br<br>
OCH2CF3	CN	OCH7CF3	CN	OCH2CF3	CN	OCH2CF3	CN<br>
Br	Cl	Br	Cl	Br	Cl	Br	Cl<br>
Br	Br	Br	Br	Br	Br	Br	Br<br>
Br	CN	Br	CN	Br	CN	Br	CN<br><br>
"WO 02/070483<br><br>
PCTYUS02/06582<br><br>
155<br><br><br>
CI Br CN CI Br CN CI Br CN CI Br CN CI Br CN CI Br CN CI Br CN<br>
R2 is H-. R3 is Me<br>
R5 CI Cl<br>
Cl CF3 CF3 CF3 OCH2CF3 OCH2CF3 OCH2CF3 Br Br Br CI CI CI CF3 CF3 CF3 OCH2CF3 OCH2CF3 OCH2CF3<br><br>
RiisiLRi<br><br>
CI<br>
CI<br>
CI<br>
CF3<br>
CF3<br>
CF3<br>
OCH2CF3<br>
OCH2CF3<br>
OCH2CF3<br>
Br<br>
Br<br>
Br<br>
CI<br>
CI<br>
CI<br>
CF3<br>
CF3<br>
CF3 OCH2CF3 OCH2CF3 OCH2CF3<br><br>
R4 is CF?<br>
is Et<br>
R6<br>
Cl Br CN Cl Br CN Cl Br CN Cl Br CN Cl Br CN Cl Br CN Cl Br CN<br><br><br>
R2isH,R3	is i-Pr	R^jsJvjOli	sMe<br>
R5	R6	R5	R6<br>
Cl	Cl	Cl	Cl<br>
ci	Br	Cl	Br<br>
Cl	CN	Cl	CN<br>
CF3	Cl	CF3	Cl<br>
CF3	Br	CF3	Br<br>
CF3	CN	.   CF3	CN<br>
OCH2CF3	Cl	OCH2CF3	Cl<br>
OCH2CF3	Br	OCH2CF3	Br<br>
OCH2CF3	CN	OCH2CF3	CN<br>
Br	Cl	Br	Cl<br>
Br	Br	Br	Br<br>
Br	CN	Br	CN<br>
Cl	Cl	Cl	Cl<br>
Cl	Br	Cl	Br<br>
Cl	CN	Cl	CN<br>
CF3	Cl	CF3	Cl<br>
CF3	Br	CF3	Br<br>
CF3"	CN	CF3	CN<br>
OCH2CF3	Cl	OCH2CF3	Cl<br>
OCH2CF3	Br	OCH2CF3	Br<br>
OCH2CF3	CN	OCH2CF3	CN<br><br><br><br><br>
CI<br>
Br<br>
CN<br>
CI<br>
Br<br>
CN<br>
CI<br>
Br<br>
CN<br>
CI<br>
T?2 is H. R3 is Me<br>
Br<br>
Br<br>
Br<br>
CI<br>
CI<br>
CI CF3 CF3<br>
CF3 OCH2CF3<br><br>
RiiiCH?CF3<br>
R2 is H. R3 is /-Pr<br>
R6<br>
Cl Br CN Cl Br CN Cl Br CN Cl<br>
RiisJlRdisEt<br>
El<br>
Br<br>
Br<br>
Br<br>
Cl<br>
Cl<br>
Cl<br>
CF3<br>
CF3<br>
CF3<br>
OCH2CF3<br>
El<br>
Cl Br CN Cl Br CN Cl Br CN Cl<br>
R!<br>
Br Br Br Cl Cl Cl CF3 CF<br>
1 j CF3<br>
OCH2CF3<br><br><br>
Cl Br CN Cl Br CN Cl Br CN Cl<br>
P^kMe.R3 is Me<br>
R5	R6<br>
Br<br>
Br<br>
Br<br>
Cl<br>
Cl<br>
Cl<br>
CF3<br>
CF3<br>
CF3<br>
OCH2CF3<br><br>
 WO 02/070483<br><br>
PCT/US02/06582<br><br>
156<br>
R4is<br><br><br>
R2 is H. R3	is Me<br>
R5	R6<br>
OCH2CF3	Br<br>
OCH2CF3	CN<br>
Br	CI<br>
Br	Br<br>
Br	CN<br>
CI	CI<br>
CI	Br<br>
CI	CN<br>
CF3	CI<br>
CF3	Br<br>
CF3	CN<br>
OCH7CF3	CI<br>
OCH2CF3	Br<br>
OCH2CF3	CN<br>
Br	CI<br>
Br	Br<br>
Br	CN<br>
CI	CI<br>
CI	Br<br>
CI	CN<br>
CF3	CI<br>
CF3	Br<br>
CF3	CN<br>
OCH2CF3	CI<br>
OCH2CF3	Br<br>
OCH2CF3	CN<br>
Br	CI<br>
Br	Br<br>
Br	CN<br>
CI	CI<br>
CI	Br<br>
CI	CN<br>
CF3	CI<br>
CF3	Br<br>
CF3	CN<br><br><br>
R2 is H. R3	isEt<br>
R5	R6<br>
OCH2CF3	Br<br>
OCH2CF3	CN<br>
Br	CI<br>
Br	Br<br>
Br	CN<br>
CI	CI<br>
CI	Br<br>
CI	CN<br>
CF3	CI<br>
CF3	Br<br>
CF3	CN<br>
OCH2CF3	CI<br>
OCH2CF3	Br<br>
OCH2CF3	CN<br>
Br	CI<br>
Br	Br<br>
Br	CN<br>
CI	CI<br>
CI	Br<br>
CI	CN<br>
CF3	CI<br>
CF3	Br<br>
CF3	CN<br>
OCH2CF3	CI<br>
OCH2CF3	Br<br>
OCH2CF3	CN<br>
Br	CI<br>
Br	Br<br>
Br	CN<br>
CI	CI<br>
CI	Br<br>
CI	CN<br>
CF3	CI<br>
CF3	Br<br>
CF3	CN<br><br><br>
R2 is H. R3	isf-Pr<br>
R5	R6<br>
OCH2CF3	Br<br>
OCH2CF3	CN<br>
Br	CI<br>
Br	Br<br>
Br	CN<br>
cl-	CI<br>
CI	Br<br>
CI	CN<br>
CF3	CI<br>
CF3	Br<br>
CF3	CN<br>
OCH2CF3	CI<br>
OCH2CF3	Br<br>
OCH2CF3	CN<br>
Br	CI<br>
Br	Br<br>
Br	CN<br>
CI	CI<br>
CI	Br<br>
CI	CN<br>
CF3	CI<br>
CF3	Br<br>
CF3	CN<br>
OCH2CF3	CI<br>
OCH2CF3	Br<br>
OCH2CF3	CN<br>
Br	CI<br>
Br	Br<br>
â€¢    Br	CN<br>
CI	CI<br>
CI	Br<br>
CI	CN<br>
CF3	CI<br>
CF3	Br<br>
CF3	CN<br><br>
R2 is Me. R3 is Me<br><br>
R5	R6<br>
OCH2CF3	Br<br>
OCH2CF3	CN<br>
Br.	CI<br>
Br	Br<br>
Br	CN<br>
CI	CI<br>
CI	Br<br>
CI	CN<br>
CF3	CI<br>
CF3	Br<br>
CF3	CN<br>
OCH2CF3	CI<br>
OCH2CF3	Br<br>
OCH2CF3	CN<br>
Br	CI<br>
Br	Br<br>
Br	CN<br>
CI	CI<br>
CI	Br<br>
CI	CN<br>
CF3	CI<br>
CF3	Br<br>
CF3	CN<br>
OCH2CF3	C!<br>
OCH2CF3	Br<br>
OCH2CF3	CN<br><br>
Br	CI<br>
Br	Br<br>
Br	CN<br>
CI	CI<br>
CI	Br<br>
CI	CN<br>
CF3	CI<br>
CF3	Br<br>
CF3	CN<br><br>
  WO 02/070483<br><br>
PCT/DS02/06582<br><br>
157<br>
R4 is CHnCF;<br><br>
R2 is H.	R3 is Me	R2 is H. R<br>
R!	3isEt		R2 is H. R3 is /-Pr<br>
R!        R^		R2 is Me. R3 is Me<br>
R!	<br><br>
	R6	<br><br>
	ll          R^<br>
OCH2CF3	Cl.	OCH2CF3	Cl	OCH2CF3         Cl		OCH2CF3     Cl<br>
OCH2CF3	Br	OCH2CF3	Br .	OCH2CF3         Br		OCH2CF3   .Br<br>
OCH2CF3	CN	OCH2CF3	CN	OCH2CF3         CN		OCH2CF3    CN<br><br><br><br>
R2is	H, R3 is Me	R2 is H. R3	isEt	R2isRR3is/-Pr	R2is	Me, R3 is Me<br>
R4a	R4b     R6	R4a    R4b	R6	R4a     R4b     R6	R4a	R4b     R6<br>
CH3	H       Cl	CH3      H	Cl	CH3      H        Cl	CH3	H       Cl<br>
CH3	H       Br	CH3      H	Br	CH3      H       Br	CH3	H       Br<br>
CH3	I        Cl	CH3      I	Cl	CH3       I        Cl	CH3	I        Cl<br>
CH3	1        Br	CH3      I	Br	CH3      I        Br	CH3	1        Br<br>
CH3	F        Cl	CH3      F	Cl	CH3      F       Cl	CH3	F        Cl<br>
CH3	F        Br	CH3      F	Br	CH3      F       Br	CH3	F        Br<br>
CH3	CF3      Cl	CH3    CF3	Cl	CH3    CF3      Cl	CH3	CF3      Cl<br>
CH3	CF3      Br	CH3    CF3	Br	CH3    CF3     Br	CH3	CF3      Br<br>
CH3	Br       Cl	CH3     Br	Cl	CH3     Br       Cl	CH3	Br       Cl<br>
CH3	Br      Br"	CH3     Br	Br	CH3     Br      Br	CH3	Br       Br<br>
CH3	Cl       Cl	CH3     Cl	Cl	CH3     Cl       Cl	CH3	Cl       Cl<br>
CH3	CI       Br	CH3     Cl	Br	CH3      Ci       Br	CH3	Cl       Br<br>
CI	H       Cl	Cl       H	CI	Cl        H        Cl	Cl	H        Cl<br>
CI	H       Br	Cl       H	Br       Cl        H       Br<br>
1	Cl	H        Br<br>
CI	1        Cl	Cl        I	ci j  ci      r      ci	Cl	I        Cl<br>
CI	I        Br	Cl        I	Br	Cl        J        Br	Cl	I        Br<br>
CI	F        Cl  â– 	-XI       F	Cl	Cl        F        Cl	Cl	F        Cl<br>
CI	F      .Br	Cl       F	Br	Cl        F        Br	Cl	F        Br<br>
CI	CF3      Cl	Cl     CF	3	Cl	Cl	CF	3      C1	Cl	CF3      Cl<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
158<br><br>
					R5b is CI					<br>
R2	s H.R3	is Me	R2	isH.R	3 isEt	R2 is H. R3	is ;"-Pr	R2 is	Me. R3 is Me<br>
R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R^<br>
CI	CF3	Br	CI	CF3	Br	CI	CF3	Br	CI	CF3	Br<br>
CI	Br	CI	CI	Br	CI	CI	Br	CI	CI	Br	CI<br>
CI	Br	Br	CI	Br	Br	CI	â–     Br	Br	CI	Br	Br<br>
CI	CI.	CI	CI	CI	CI	CI	CI	CI	CI	CI	CI<br>
CI	CI	Br	CI	CI	Br	CI	CI	Br	CI	CI	Br<br>
Br	H	CI	Br	H	CI	Br	H	CI	Br	H	CI<br>
Br	H	Br	Br	H	Br	Br	H	Br	Br	H	Br<br>
Br	I	CI	Br	I	CI	Br	I	CI	Br	I	CI<br>
Br	I	Br	Br	I	Br	Br	I	Br	Br	I	Br<br>
Br	F	CI	Br	F	CI	Br	F	CI	Br	F	CI<br>
Br	F	Br	Br	F	Br	Br	F	Br	Br	F	Br<br>
Br	CF3	CI	Br	CF3	CI	Br	CF3	CI	Br	CF3	CI<br>
Br.	CF3	Br	Br	CF3	Br	Br	CF3	Br	Br	CF3	Br<br>
Br	Br	CI	Br	Br	Ci	Br	Br	CI	Br	Br	CI<br>
Br	Br	Br	Br	Br	Br	Br	Br	Br	Br	Br	Br<br>
Br	CI	CI	Br	CI	CI	Br	CI	CI	Br	CI	CI<br>
Br	CI	Br	Br	CI	Br	Br	CI	Br	Br	CI	Br<br>
				R5 is OCF3				<br>
R2is	H. R3i	s Me	R2is	H. R3	isEt	R2is	H, R3 is /-Pr	R2is]	Vie. R3	is Me<br>
R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R6<br>
CH3	H	CI	CH3	H	CI	CH3	H	CI	CH3	H	CI<br>
CH3	H	Br	C%	H	Br	CH3	H	Br	CH3	H	Br<br>
CH3	I	CI	CH3	I	CI	CH3	I	C!	CH3	I	CI<br>
CH3	I	Br	CH3	I	Br	CH3	I	Br	CH3	I	Br<br>
CH3	F	CI	CH3	F	CI	CH3	F	CI	CH3	F	CI<br>
CH3	F	Br	CH3	F	Br	CH3	F	Br	CH3	F	Br<br>
CH3	CF3	CI	CH3	CF3	CI	CH3	CF3	CI	CH3	CF3	CI<br>
CH3	CF3	Br	CH3	CF3	Br	CH3	CF3	Br	CH3	CF3	Br<br>
CH3	Br	CI	CH3	Br	CI	CH3	Br	CI	CH3	Br	CI<br>
CH3	Br	Br	CH3	Br	Br	CH3	Br	Br	CH3	Br	Br<br>
CH3	CI	CI	CH3	CI	CI	CH3	CI	ci.	CH3	CI	CI<br>
CH3	CI	Br	CH3	CI	Br	CH3	CI	Br	CH3	CI	Br<br>
CI	H .	CI	CI	H	CI	CI	H	CI	CI	H	CI<br>
CI	H	Br	CI	H	Br	CI	H	Br	CI	H	Br<br><br>
02/070483<br><br>
PCT/US02/O6582<br><br>
159<br>
R5 is OCF-<br>
R2iH.R3	is Me	R2	sH.R3	isEt	â€”â–    "Â»	^<br>
R2is	H.R3	is i-Pr	R2 is	Me. R3	is Me<br>
R4S	R4b	R6	R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R6<br>
CI	I	CI	CI	I	CI	CI	I	CI	ci	I	CI<br>
CI	I	Br	CI	I	Br	CI	I	Br	CI	I	Br<br>
CI	F	CI	CI	F	CI	CI	F	CI	CI	F	CI<br>
CI	F	Br	CI	?	BT	a	F	BT	C\	F	Br<br>
CI	CF3	CI	CI	CF3	CI	CI	CF3	CI	Cl	CF3	CI<br>
CI	CF3	Br	CI	CF3	Br	CI	CF3	Br	CI	CF3	Br<br>
CI	Br	CI	CI	Br	CI	Ci	Br	CI	CI	Br	CI<br>
CI	Br	Br	CI	Br	Br	CI	Br	Br	CI	Br	Br<br>
CI	CI	CI	CI	CI	CI	CI	CI	CI	CI	CI	CI<br>
CI	CI	Br	ci	CI	Br	CI	a	Br	CI	CI	Br<br>
Br	H	CI	Br	H	CI	Br	H	CI	Br	H	CI<br>
Br	H	Br	Br	H	Br	Br	n	Br	Br	H	Br<br>
Br.	I	CI	Br	I	CI	Br	I	CI	Br	I	CI<br>
Br	I	Br	Br	I	Br	Br	I	Br	Br	I	Br<br>
Br	F	CI	Br	F	â– CI	Br	F	CI	Br	F	CI<br>
Br	F	Br	Br	F	Br	Br	F	Br	Br	F	Br<br>
Br	CF3	CI	Br	CF3	CI	Br	CF3	CI	Br	CF3	CI<br>
Br	CF3	Br	Br	CF3	Br	Br	CF3	Br	Br	CF3	Br<br>
Br	Br	CI	Br	Br	CI	Br	Br	CI   .	Br	Br	CI<br>
Br	Br	Br	Br	Br	Br	Br	Br	Br	Br	Br	Br<br>
Br	CI	CJ	Br	CI	CI	Br	CI	CI	Br	CI	CI<br>
Br	CI	Br	Br	CI	Br	Br	CI	Br	Br	CI	Br<br>
R5 is CF3<br><br>
R2 is Ft. R3	is Me	R2i	sH.R3	is Et	R2is	H,R3	is ?-Pr	R2is	Me, R3 is Me<br>
R4a    R4b	R6	R4a	R4b	R6	R4a	R4b	R6	R4a	R4b     R6<br>
CH3      H	CI	CH3	H	Cl	CH3	H	Cl	CH3	H        Cl<br>
CH3      H	Br	CH3	H	Br	CH3	H	Br	CH3	H       Br<br>
CH3      I	CI	CH3	I	Cl	CH3	I	CI	CH3	I        Cl<br>
CH3      I	Br	CH3	1	Br	CH3	1	Br	CH3	I        Br<br>
CH3      F	CI	CH3	F	Cl	CH3	F	Cl	CH3	F        Cl<br>
CH3     .F	Br	CH3	F	Br	CH3	F	Br	CH3	F        Br<br>
CH3    CF3	a	CH3	CF3	CI	CH3	CF3	Cl	CH3	CF3      Cl<br>
CH3    CF3	Br	CH3	CF3	Br	CH3	CF3	Br	CH3	CF3     Br<br>
CH3      Br	CI	CH3	Br	Cl	CH3	Br.	Cl	CH3	Br      Cl<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
160<br>
R5 is CF3<br>
R2 is H. R3 is Me	R2	is H. R3 is Et	-&gt;<br>
R2is	H. R3	is /-Pr	R2is	Me. R3 is Me<br>
R4a	R4b     R6	R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R6<br>
CH3	Br       Br	CH3	Br	Br	CH3	Br	Br	CH3	Br	Br<br>
 CH3	CI       CI	CH3	CI	CI	CH3	CI	CI	CH3	CI	CI<br>
CH3	CI       Br	CH3	CI	Br	CH3	CI	Br	CH3	CI	Br<br>
CI	H        CI	CI	H	CI	CI	H	CI	CI	H	CI<br>
CI	H       Br	CI	H	Br	CI	H	Br	CI	H	Br<br>
CI	I        CI	CI	I	CI	CI	I	CI	CI	I	CI<br>
CI	I         Br	CI	I	Br	CI	I	Br.	CI	I	Br<br>
CI	F        CI	CI	F	CI	CI	F	CI	CI	F	CI<br>
CI	F        Br	CI	F	Br	CI	F	Br	CI	F	Br<br>
CI	CF3      CI	CI	CF3	CI	CI	CF3	CI	CI	CF3	CI<br>
CI	CF3      Br	CI	CF3	Br	CI	CF3	Br	CI	CF3	Br<br>
CI	Br       CI	CI	Br	CI	CI	Br	CI	CI	Br	Cl<br>
CI .	Br       Br	C!	Br	Br	CI	Br	Br	CI	Br	Br<br>
CI	CI       CI	CI	CI	CI	CI	cI	CI	CI	CI	CI<br>
CI	CI       Br	CI	CI	Br	CI	CI	Br	CI	CI	Br<br>
Br	H        CI	Br	H	CI	Br	H	CI	Br	H	CI<br>
Br	H        Br	Br	H	Br	Br	H	Br	Br	H	Br<br>
Br	1         CI	Br	I	CI	Br	I	CI	Br	I	CI<br>
Br	I        Br	Br	I	Br	Br	I	Br	Br	1	Br<br>
Br	F        CI	Br	F	CI	Br	F	CI	Br	F	CI<br>
Br	F        Br	Br	F	Br	Br	F	Br	Br	F	Br<br>
Br	CF3      CI	Br	CF3	CI	Br	CF3	CI	Br	CF3	CI<br>
Br	CF3      Br	Br	CF3	Br	Br	CF3	Br	Br	CF3	Br<br>
Br	Br       CI	Br	Br	CI	Br	Br	CI	Br	Br	CI<br>
Br	Br       Br	Br	Br	Br	Br	Br	Br	Br	Br	Br<br>
Br	Cl     Cl	Br	CI	CI	Br	CI	CI	Br	CI	Cl<br>
Br	CI       Br	Br	Ci	Br	Br	CI	Br	Br	CI	Br<br>
		R5b is CFfCFi"h				<br>
R2 is H. R3 is Me	R2is	HL R3 is Et	R2isF	I. R3 is /-Pr	R2 is Me. R3 i	s Me<br>
R4a	R4b     R6	R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R6<br>
CH3	H        CI	CH3	H	CI	CH3	H	CI	CH3	H	CI<br>
CH3	H        Br	CH3	H	Br	CH3    .	H	Br	CH3"	H	Br<br>
CH3	r     ci	CH3	I	CI	CH3	I	CI	CH3	I	CI<br>
CH3	I        Br"	^Â£13	I	Br	CH3	I	Br	CH3	]	Br<br><br>
WO .02/070483<br><br>
PCT/DS02/06582<br><br>
161<br><br>
				I	l5b is (	:Ffc?3	&gt;2				<br>
R2 is H. R3	is Me	R2i	sH. R3	is Et	R2is	H.R3	is i-Pr	R2is	Me. R:	is Me<br>
R4a	R4b	R6	R4a	R4b	R6	R4a	R4b.	R6	R4a	R4b	R6<br>
CH3	F	CI	CH3	F	ci	CH3	F	ci	CH3	F	Cl<br>
CH3	F	Br	CH3	F	Br	CH3	F	Br	CH3	F	Br<br>
CH3	CF3	CI	CH3	CF3	CI	CH3	CF3	CI	CH3	CF3	Cl<br>
CH3	CF3	Br	CH3	CF3	Br	CH3	CF3	Br	CH3	CF3	Br<br>
CH3	Br	CI	CH3	Br	CI	CH3	Br	CI	CH3	Br	CI<br>
CH3	Br	Br	CH3	-Br	Br	CH3	Br	Br	CH3	Br	Br<br>
CH3	CI	CI	CH3	CI	CI	CH3	CI	CI	CH3	C!	CI<br>
CH3	CI	Br	CH3	CI	Br	CH3	CI	Br	CH3	CI	Br<br>
CI	H	CI	CI	H	CI	CI	H	CI	CI	H	Cl<br>
CI	H	Br	Ci	H	Br	CI	H	Br	CI	H	Br<br>
CI	I	CI	CI	I	CI	CI	I	CI	CI	I	Cl<br>
CI	I	Br	CI	I	Br	CI	1	Br	CI	I	Br<br>
cI.	F	C!	CI	F	CI	CI	F	CI	CI	F	Cl<br>
CI	F	Br	CI	F	Br	CI	F	Br	CI	F	Br<br>
CI	CF3	C!	CI	CF3	CI	CI	CF3	CI	CI	CF3	Cl<br>
CI	CF3	Br	CI	CF3	Br	CI	CF3	Br	CI	CF3	Br<br>
CI	Br	Ci	Ci	Br	Ci	Cl	Br	CI	CI	Br	Cl<br>
CI	Br	Br	CI	Br	Br	CI	Br	Br	CI	Br	Br<br>
CI	CI	CI	CI	CI	CI	CI	CI	CI	CI	CI	Cl<br>
CI	C1	Br	C)	CI	Br	CI	CI	Br	CI	CI	Br<br>
Br	H	CI	Br	H	CI	Br	H	CI	Br	H	Cl<br>
Br	H	Br	Br	H	Br	Br	H	Br	Br	H	Br<br>
Br	I	cI	Br	I	CI	Br	I	CI	Br	I	CI<br>
Br	I	Br	Br	I	Br	Br	I	Br	Br	r	Br<br>
Br	F	CI  "	Br	F	CI	BT	F	CI	Br	F	Cl<br>
Br	F	Br	Br	F	Br	Br	F	Br	Br	F	.Br<br>
Br	CF3	CI	Br	CF3	CI	Br	CF3	CI	Br	CF3	CI<br>
Br	CF3	Br	Br	CF3	Br	Br	CF3	Br	Br	CF3	Br<br>
Br	Br	CI	Br	Br	CI	Br	Br	CI	Br	Br	Cl<br>
Br	Br	Br	Br	Br	Br	Br	Br	Br	Br	Br	Br<br>
Br	CI	cI	Br	CI	CI	Br	CI	CI	Br	CI	Cl<br>
Br	CI	Br	..Br	CI	Br	Br	CI	Br	Br	CI	Br<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br>
R4b<br><br>
				[62			<br>
CH3<br>
N R5b<br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br>
R2i	&gt;H.R3	is Me	R2 is H. R2	is Et	R2is	H.R3	is /-Pr	R2is	Me.R:	" is Me<br>
R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R*<br>
CH3	H	CI	CH3	â€¢H	CI	CH3	H	ci"	CH3	H	CI<br>
CH3	H	Br	CH3	H	Br	CH3	H	Br	CH3	H	Br<br>
CH3	I	CI	CH3	I	CI	CH3	I	C!	CH3	I	CI<br>
CH3	I	Br	CH3	I	Br	CH3	r	Br	CH3	I	Br<br>
CH3	F	CI	CH3	F	CI	CH3	F	CI	CH3	F	CI<br>
CH3	F	Br	CH3	F	Br	CH3	F	Br	CH3	F	Br<br>
CH3	CF3	CI	CH3	CF3	CI	CH3	CF3	CI	CH3	CF3	CI<br>
CH3	CF3	Br	CH3	CF3	Br	CH3	&amp;3	Br	CH3	CF3	Br<br>
CH3	Br	CI	CH3	Br	CI	CH3	Br	CI	CH3	Br	CI<br>
CH3	Br	Br	CH3	Br	Br	CH3	Br	Br	CH3	Br	Br<br>
CH3	CI	CI	CH3	CI	CI	CH3	CI	CI	CH3	CI	CI<br>
CH3	CI	Br	CH3	CI	Br	CH3	CI	Br	CH3	CI	Br<br>
CI	H	CI	CI	H	CI	CI	H	CI	CI	H	CI<br>
CI	H	Br	CI	H	Br	CI	H	Br	CI	H	Br<br>
CI	I	CI	CI	I	CI	CI	I	CI	CI	I	CI<br>
CI	I	Br	CI	I	Br	CI	I	Br	CI	I	Br<br>
CI	F	CI	CI	F	CI	CI	F	CI	CI	F	CI<br>
CI	F	Br	CI	F	Br	CI	F	Br	CI	F	Br<br>
cI  	CF3	CI	CI	CF3	CI	CI	CF3	CI	CI	CF5	CI<br>
CI	CF3	Br	CI	CF3	Br	CI	CF3	Br	CI	CF3	Br<br>
CI	Br	CI	CI	Br	CI	CI	Br	CI	CI	Br	CI<br>
CI	Br	Br	CI	Br	Br	CI	Br	Br	CI	â– Br	Br<br>
CI	CI	CI	CI	CI	CI	CI	CI	CI	CI	CI	CI<br>
CI	-CI	Br	CI	CI	Br	CI	CI	Br	CI	CI	Br<br>
Br	H	CI	Br	H	CI	Br	H	CI	Br	H	CI<br>
Br	H	Br	Br	H		Br	Br	H		Br	Br	H	Br<br><br>
WO 02/070483<br><br>
PCT/DS02/06582<br><br>
163<br>
R5b is CHF2<br>
R2	is H, R:	is Me	R2 is H. R3 is Et R4a    R4b     R6	R2 is H. R3 R4a    R4b	is /-Pr R6	R2iE R4a	Me. R R4b	3 is Me<br>
R4a	R4b	RÂ«	<br><br><br><br><br>
	R*<br>
Br	I	Cl	Br        1	Cl	Br	r	Cl	Br	I	CI<br>
Br	I	Br	Br        I	Br	Br	i	Br	Br	I	Br<br>
Br	F	Cl	Br       F	Cl	Br	F	Cl	Br	F	Cl<br>
Br	F	Br	Br       F	Br	Br	F	Br	Br	F	Br<br>
Br	CF3	Cl	Br     CF3	Cl	Br	CF3	Cl	Br,	CF3	Cl<br>
Br	CF3	Br	Br     CF3	Br	Br	CF3	Br	Br	CF3	Br<br>
Br	Br	Cl	Br      Br	Cl	Br	Br	Cl	Br	Br	Cl<br>
Br	Br	Br	Br       Br	Br	Br	Br	Br	Br	Br	Br<br>
Br	Cl	Cl	Br       Cl	Cl	Br	Cl	CI	Br	Cl	Cl<br>
Br	Cl	Br	Br     CI	Br	Br	CI	Br	Br	Cl	Br<br>
			]	\5b is CH2CF	3			<br>
R2is	H. R3 R4b	is Me R6	R2 is H. R3	is Et	R2is R4a	H. R3 R4b	s /-Pr R6	R2is R4a	Me. R3<br>
R4b	is Me<br>
R4a	<br><br>
	R|a    R4b	R6	<br><br><br><br><br>
	R6<br>
CH3	H	Cl	Cffi3 _    H	Cl	CH3	H	Cl	CH3	H	Cl<br>
CH3	H	Br	CH3      H	Br	CH3	H	Br	CH3	H	Br<br>
CH3	I	Cl	CH3      I	CI	CH3	I	CI	CH3	I	Cl<br>
CH3	I	Br	CH3      I	Br	CH3	J	Br	CH3	I	Br<br>
CH3	F	Cl	CH3        F	CI	CH3	F	Cl	CH3	F	Cl<br>
CH3	F	Br	CH3     F	Br	CH3	F	Br	CH3	F	Br<br>
CH3	CF3	Cl	CH3     CF3	Cl	CH3	CF3	Cl	CH3	CF3	Cl<br>
CH3	CF3	Br	  CF3	Br	CH3	CF3	Br	CH3	CF3	Br<br>
CH3	Br	Cl	CH3     Br	Cl	CH3	Br	Cl	CH3	Br	Cl<br>
CH3	Br	Br	CH3     Br	Br	CH3	Br	Br	CH3	Br	Br<br>
CH3	Cl	CI     
CH3	Cl	Br     (	CH3   	Br	CH3	C)	Br	CH3	Cl	Br<br>
CI	H	Cl	Cl       H	ci	Cl	H	Cl	Cl	H	Cl<br>
CI	H	Br	CI       H	Br	Cl	H	Br	Cl	H	Br<br>
CI	I	Cl	Cl        I	a	Cl	J	a	CI	J	Cl<br>
CI	I	Br	Cl        I	Br	Cl	I	Br	Cl	I	Br  â€¢<br>
CI	F	CI	CI       F	Cl	Cl	F	CI	CI	F	Cl<br>
CI	F	Br     â– 	Cl       F	Br	Cl	F	Br	Cl	F	Br<br>
CI	CF3	Cl	Cl     CF3	Cl	Cl "	CF3	Cl	Cl	CF3	Cl<br>
CI	CF3	Br	Cl     CF3	Br	Cl	CF3	Br	Cl	CF3	Br<br>
Cl	Br	Cl	CI      Br	Cl	Cl	Br	Cl	Cl	Br	Cl<br><br>
WO 02/070483<br><br>
PCT/US02/065S2<br><br>
164<br><br>
R5b is CHoCFs<br>
R2 is H. R3 is Et   1 R2 is H. R3 is i-Pr R4a    R4b     R6     R4a    R4b     R6<br>
R2 is H. R3 is Me<br>
R4a	R4b	R6	R4a	R4b	R6<br>
Cl	Br	Br	Cl	Br	Br<br>
Ci	Cl	Cl	Cl	Cl	CI<br>
Cl	Cl	Br	Cl	Cl	Br<br>
Br	H	Cl	Br	H	Cl<br>
Br	H	Br	Br	H	Br<br>
Br	1	Cl	Br	I	Cl<br>
Br	I	Br	Br	I	Br<br>
Br	F	Cl	Br	F	Cl<br>
Br	F	Br	Br	F"	Br<br>
Br	CF3	Cl .	Br	CF3	Cl<br>
Br	CF3	Br	Br	CF3	Br<br>
Br	Br	Cl	Br	Br	Cl<br>
Br.	Br	Br	Br	Br	Br<br>
Br	Cl	Cl	Br	CI	CI<br>
Br	Cl	Br	Br	Cl	Br<br><br>
Cl<br>
Cl<br>
Cl<br>
Br<br>
Br<br>
Br<br>
Br<br>
Br<br>
Br<br>
Br<br>
Br<br>
Br<br>
Br<br>
Br<br>
Br<br><br><br>
6<br>
R4a<br>
Bfb<br>
E*<br>
IT<br>
CI<br>
Br<br>
Br<br>
:I<br>
Cl<br>
Cl<br>
Cl<br>
\T<br>
Cl<br>
Cl<br>
Br<br>
:I<br>
Br<br>
H<br>
Cl<br>
r<br>
Br<br>
H<br>
Br<br>
:i<br>
Br<br>
I.<br>
Cl<br>
r<br>
Br<br>
I<br>
Br<br>
1<br>
Br<br>
F<br>
Cl<br>
r<br>
Br<br>
F<br>
Br<br>
1<br>
Br<br>
CF3<br>
Cl<br>
r<br>
Br<br>
CF3<br>
Br<br>
I<br>
Br<br>
Br<br>
Cl<br>
r<br>
Br<br>
Br<br>
Br<br><br>
Br<br>
Cl<br>
CI<br><br>
Br<br>
Cl<br>
Br<br>
R2 is Me. R3 is Me<br><br>
R4b	R6	R4a	R4b	R6<br>
Br	Br	CI	Br	Br<br>
Cl	Cl	Cl	Cl	Cl<br>
Cl	Br	Cl	Cl	Br<br>
H	Cl	Br	H	Cl<br>
H	Br	Br	H	Br<br>
I	Cl	Br	I.	Cl<br>
I	Br	Br	I	Br<br>
F	Cl	Br	F	Cl<br>
F	Br	Br	F	Br<br>
^3	Cl	Br	CF3	Cl<br>
^3	Br	Br	CF3	Br<br>
Br	CI	Br	Br	Cl<br>
Br	Br	Br	Br	Br<br>
CI	Cl	Br	Cl	CI<br>
Cl	Br	Br	Cl	Br<br><br>
R5b is CF3<br><br><br>
R2 is Me. R3 is Me R4a     R4b     R6<br>
R2 is H. R3 is Me      R2 is E. R3 is Et<br>
R4a    R4b     R6<br><br>
CH3	H	Cl<br>
CH3	H	Br<br>
CH3	i	Cl<br>
CH3	I	Br<br>
CH3	F	Cl<br>
CH3	F	Br<br>
CH3	CF3	Cl<br>
CH3	CF3	Br<br>
CH3	Br	Cl<br>
CH3	Br	Br<br>
CH3	Cl	CI<br>
CH3	Cl	Br<br>
Cl	H	Cl<br>
Cl	H	Br<br>
Cl	I	Cl<br>
Cl	I	Br<br><br><br>
R4a    R4b     R6<br><br>
CH3	H	Cl<br>
CH3	H	Br<br>
CH3	I	CI<br>
CH3	I	Br<br>
CH3	F	Cl<br>
CH3	F	Br<br>
CH3	CF3	CI<br>
CH3	CF3	Br<br>
CH3	Br	Cl<br>
CH3	Br"	Br<br>
CH3	CI	CI<br>
CH3	Cl	Br<br>
Cl	H	Cl<br>
Cl	H	Br<br>
Cl	I	Cl<br>
Cl	I	Br<br><br><br>
r<br>
R2 is H. R3_is /-Pr R4a     R4b     R6<br><br>
CH3	H	Cl<br>
CH3	H	Br<br>
CH3	I	Cl<br>
CH3	I	Br<br>
CH3	F	Cl<br>
CH3	F	Br<br>
CH3	CF3	Cl<br>
CH3	CF3	Br<br>
CH3	Br	Cl<br>
CH3	Br	Br<br>
CH3	Cl	CI<br>
CH3	CI	Br<br>
Cl	H	Cl<br>
Cl	â– H	Br<br>
CI	I	CI<br>
Cl	I	\Br<br><br><br>
R2is	Me. R3	is Me<br>
R4a	R4b	R6<br>
CH3	H	Cl<br>
CH3	H	Br<br>
CH3	I	Cl<br>
CH3	I	Br<br>
CH3	F	Cl<br>
CH3	F	Br<br>
CH3	CF3	.CI<br>
CH3	CF3	Br<br>
CH3	Br	Cl<br>
CH3	Br	Br<br>
CH3	Cl	Cl<br>
CH3	Cl	Br<br>
Cl	H	CI<br>
CI	H	Br<br>
Cl	I	Cl<br>
CI	I	Br<br><br>
WO 02/070483<br><br>
PCTYUS02/O6582<br><br>
165<br><br>
					R5b	isCF3					<br>
R2	is H. R;	is Me	R2	is H. R3 is Et	R2 is H. R3	is /-Pr	R2i	&gt;Me. R	3 is Me<br>
R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R6<br>
a	F	Cl	Cl	F	Cl	Cl	F	Cl	Cl	F	Cl<br>
Cl	F	Br	Cl	F	Br	Cl	F	Br	CI	F "	Br<br>
Ci	CF3	Cl	Ci	CF3	Cl	Cl	CF3	Cl	Cl	CF3	Cl<br>
CI	CF3	Br	CI	CF3	Br	Cl	CF3	Br	Cl	CF3	Br<br>
Cl	Br	Cl	Cl	Br	CI	Cl	Br	Cl	Cl	Br	Cl<br>
Cl	Br	Br	Cl	Br	Br	Cl	Br	Br	Cl	Br	Br<br>
Cl	Cl	CI	Cl	Cl	Cl	Cl	Cl	Cl	Cl	Cl	Cl<br>
Cl	Cl	Br	Cl	Cl	Br	Cl	Cl	Br	Cl	Cl	Br<br>
Br	Ft	Cl	Br	H	c1	Br	H	Cl	Br	H	Cl<br>
Br	H	Br	Br	H	Br	Br	H	Br	Br	H	Br<br>
Br	I	Cl	Br	1	Cl	Br	I	Cl	Br	I	Cl<br>
Br	I	Br	Br	I	Br	Br	I	Br	Br	I	Br<br>
Br.	F	Cl	Br	F	Cl	Br	F	Cl	Br	F	Cl<br>
Br	F	Br	Br	F	Br	Br	F	Br	Br	F	Br<br>
Br	CF3	Cl	Br	CF3	Cl	Br	CF3	Cl	Br	CF3	Cl<br>
Br	CF3	Br	Br	CF3	Br	Br	CF3	Br	Br	CF3	Br<br>
Br	Br	Cl	Br	Br	Cl	Br	Br	CI	Br	Br	Cl<br>
Br	Br	Br	Br	Br	Br	Br	Br	Br	Br	Br	Br<br>
Br	Cl	Cl â– 	Br	Cl	Cl	Br	CI	Cl	Br	Cl	Cl<br>
Br	Cl	Br   J   Br	Cl	Br   |   Br	Cl	Br	Br	Cl	Br<br>
			R-	5b is CFoCHFo			<br>
R2is	H. R3 is"Me	R2is	H,R3	sEt	R2is	H. R3 is /-Pr   R2 is 3	Vie. R3	is Me<br>
R4a	R4b	R
CH3	H	Cl	CH3	H	Cl	CH3	H	Cl	CH3	H	Cl<br>
CH3	H	Br	CH3	H	Br	CH3	H	Br-	CH3	H	Br<br>
CH3	I.	Cl	CH3	I	â– CI	CH3	I	Cl	CH3	I	Cl<br>
CH3	I	Br	CH3	I	Br	CH3	I	Br	CH3	T	Br<br>
CH3	F	Cl	CH3	F	Cl	CH3	F	Cl	CH3	F	Cl<br>
CH3	F	Br	CH3	F	Br	CH3	F	Br	CH3	F	Br<br>
CH3	CF3	Cl	CH3	CF3	CI	CH3	CF3	Cl	CH3	CF3	CI<br>
CH3	CF3	Br	CH3	CF3	Br	CH3	CF3	Br	CH3	CF3	Br<br>
CH3	Br	Cl	CH3	Br	Cl	CH3	Br	Cl	CH3	Br	CI<br>
CH3	Br	Br	CH3	Br	Br	CH3	Br	Br	CH3	Br	Br<br>
CH3	Cl	Cl	CH3	Cl	Cl	CH3	Cl	Cl	CH3	Cl	Cl<br><br>
WO 02/070483<br><br>
PCTATS02/06582<br><br>
166<br><br>
				R5b is CFoCHF-,				<br>
R2i	sH,R3 R4b	is Me R6	R2 R4a	sH.R3 R4b	is Et R6	R2is R4a	H. R3 R4b	is ;"-Pr R6	R2 is	Me.R3	is Me<br>
R4a	<br><br><br><br><br><br><br><br>
	R4a	R4b	R6<br>
CH3	Cl	Br	CH3	Cl	Br	CH3	Cl	Br	CH3	Cl	Br<br>
CI	H	CI	Cl	H	Cl	CI	-H	CI	CI	H	Cl<br>
CI	H	Br	Cl	H	Br	Cl	H	Br	Cl	H	Br<br>
Cl	I	Cl	Cl	I	Cl	Cl	I	Cl	Cl	1	Cl<br>
Cl	1	Br	Cl	I	Br	Cl	I	Br	Cl	I	Br<br>
CI	F	Cl	Cl	F	Cl	Cl	F	Cl	Cl	F	Cl<br>
Cl	F	Br	Cl	F	Br	Cl	F	Br	Cl	F	Br<br>
CI	CF3	Cl	Cl	CF3	Cl	CI	CF3	Cl	Cl	CF3	Cl<br>
Cl	CF3	Br	Cl	CF3	Br	Cl	CF3	Br	"Cl	CF3	Br<br>
CI	Br	Cl	Cl	Br	CI	Cl	Br	Cl	Cl	Br	Cl<br>
Cl	Br	Br	Cl	Br	Br	CI	Br	Br	Cl	Br	Br<br>
Cl	Cl	Cl	Cl	Cl	Cl	Cl	CI	Cl	Cl	Cl	Cl<br>
CI	Cl	Br	Cl	Cl	Br	CI	Cl	Br	Cl	Cl	Br<br>
Br	H	Cl	Br	H	CI	Br	H	CI	Br	H	Cl<br>
Br	H	Br	Br	H	Br	Br	H	Br	Br	H	Br<br>
Br	I	Cl	Br	I	Cl	Br	I	Cl	Br	I	Cl<br>
Br	I	Br	Br	I	Br	Br	I	Br	Br	I	Br<br>
Br	F	Cl	Br	F	Cl	Br	F	Cl	Br	F	Cl<br>
Br	F	Br	Br	F	Br	Br	F	Br	Br	F	Br<br>
Br	CF3	Cl	Br	CF3	a	Br	CF3	Cl	Br	CF3	Cl<br>
Br	CF3	Br	Br	CF3	Br	Br	CF3	.Br	Br	CF3	Br<br>
Br	Br	Cl	Br	Br	CI	Br	Br	Cl	Br	Br	Cl<br>
Br	Br	Br	Br-	Br	Br	Br	Br	Br	Br	Br	Br<br>
Br	CI	Cl	Br	Cl	Cl	Br	Cl	Cl	Br	ci	Cl<br>
Br	Cl	Br	Br	Cl	Br	Br	Cl	Br	Br	Cl	Br<br><br>
WO/ 02/070482<br><br>
PCT/US02/06582<br><br><br>
167 Table 32<br><br><br><br><br><br>
sH, R	R2""   ^R3<br>
R5b is CHF-7<br>
3 is Et     R2 is	<br><br>
H.R3			<br><br><br>
R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	E^<br>
CH3	H	C1	CH3	H	CI	CH3	H	CI	CH3	H	CI<br>
CH3	H	Br	CH3	H	Br	CH3	H	Br	CH3	H	Br<br>
CH3	I	CI	CH3	I	CI	CH3	I	CI	CH3	I	CI<br>
CH3	I	Br	CH3	I	Br	CH3	I	Br	CH3	r	Br<br>
CH3	F	CI	CH3	F	CI	CH3	F	CI	CH3	F	CI<br>
CH3	F	Br	CH3	F	Br	CH3	F	Br	CH3	F	Br<br>
CH3	CF3	CI	CH3	CF3	CI	CH3	CF3	CI	CH3	CF3	CI<br>
CH3	CF3	Br	CH3	CF3	Br	CH3	CF3	Br	CH3	CF3	Br<br>
CH3	Br	CI	CH3	Br	CI	CH3	Br.	Ci	CH3	Br	CI<br>
CH3	Br	Br	CH3	Br	Br	CH3	Br	Br	CR3	Br	Br<br>
CH3	C!	CI	CH3	CI	CI	CH3	CI	CI	CH3	Ci	CI<br>
CH3	CI	Br	CH3	CI	Br	CH3	CI	Br	CH3	CI	Br<br>
CI	H	CI	CI	H	CI	CI	H	CI	CI	H	CI<br>
CI	H	Br	CI	H	Br	CI	H	Br	ci	H	Br<br>
CI	1	CI	CI	I	CI	CI	I	CI	CI	I	CI<br>
CI	J	Br	CI	I	Br	CI	I	Br	CI	I	Br<br>
CI	F	CI	CI	F	CI	CI	F	CI	CI	F	CI<br>
CI	F	Br	CI	F	Br	CI	F	Br	CI	F	Br<br>
CI	CF3	CI	CI	CF3	CI	CI	CF3	CI	CI	CF3	CI<br>
CI	CF3	Br	CI	CF3	Br	CI	CF3	Br	CI	CF3	Br<br>
CI	Br	CI	CI	Br	CI       CI	Br	CI	CI	Br	CI<br>
CI	Br	Br	CI	Br	Br	CI	Br	Br	CI	Br	Br<br>
CI	CI	CI	CI	CI	CI	CI	CI	CI	CI	CI	CI<br>
CI	CI	Br	CI	CI	Br	CI.	CI	Br	CI	CI	Br<br>
Br	H	CI	Br	H	CI	Br	H	CI     .	Br	H	CI<br>
Br	H	Br	Br	H	Br	Br	H	Br"	Br	H	Br<br><br>
(WO 02/070483<br><br>
PCT/US02/06582<br><br>
168<br>
R5b is CHFo<br>
R2	sH.R-	is Me	R2	is H. R3 is Et	R2 is H, R3	is /-Pr	R2i
R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R^<br>
Br	I	CI	Br	I	CI	Br	I	CI	Br	I	CI<br>
Br	I	Br	Br	I	Br	Br	I	Br	Br	I	Br<br>
Br	F	CI	Br	F	CI	Br	F	CI	Br	F	CI<br>
Br	F	Br	Br	F	Br	Br	F	Br	Br	F	Br<br>
Br	CF3	CI	Br	CF3	CI	Br	CF3	CI	Br	CF3	CI<br>
Br	CF3	Br	Br	CF3	Br	Br	CF3	Br	Br	CF3	Br<br>
Br	Br	CI	Br	Br	CI	Br	Br	CI	Br	Br	CI<br>
Br	Br	Br	Br	Br	Br	Br	Br	Br	Br	Br	Br<br>
Br	CI	CI	Br	.CI	CI	Br	CI .	CI	Br	CI	CI<br>
Br	CI	Br	Br	CI	Br	"Br	CI	Br	Br	CI	Br<br>
			R5b is CH2CF	3 â– 			<br>
R2is	^R3	is Me	R2 is H. R3	isEt	R2is	H. R3	is i-Pr	R2 is	Me. R3	is Me<br>
R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R^<br>
CH3	H	CI	CH3	H	CI	CH3	H	CI	CH3	H	CI<br>
CH3	H	Br	CH3	H	Br	CH3	H	Br	CH3	H	Br<br>
CH3	I	CI	CH3	I	CI	CH3	I	CI	CH3	I	CI<br>
CH3	I	Br	CH3	I	Br	CH3	I	Br	CH3	I	Br<br>
CH3	F	CI	CH3	F	CI	CH3	F	CI	CH3	F	CI<br>
CH3	F	Br	CH3	F	Br	CH3	F	Br  ,	CH3	F	Br<br>
CH3	CF3	CI	CH3	CF3	CI	CH3	CF3	CI	CH3	CF3	CI<br>
CH3	CF3	Br	CH3	CF3	Br	CH3	CF3	Br	CH3	CF3	Br<br>
CH3	Br	CI	CH3	Br	CI	CH3	Br	CI	â– CH3	Br	CI<br>
CH3	Br	Br	CH3	Br	Br	CH3	Br	Br	CH3	Br	Br<br>
CH3	C!	CI	CH3	CI	CI	CH3	C!	CI	CH3	CI	CI<br>
CH3	CI	Br	CH3	CI	Br	CH3	CI	Br	CH3	CI	Br<br>
CI	H	CI	CI	H	CI	CI	H	CI	CI	H	CI<br>
CI	H	Br	CI	H	Br	CI	H	Br	CI	H	Br<br>
CI	I	CI"	CI	I	CI	CI	I	CI	C)	I	CI<br>
CI	I	Br	CI	I	Br	CI	I	Br	CI	I	Br<br>
CI	F	CI	CI	F	CI	CI	F	CI	CI	F	CI<br>
CI	F	Br	CI	F	Br	CI	F	Br	CI	F	Br<br>
CI	CF3	CI	CI	CF3	CI	CI	CF3	CI	CI	CF3	CI<br>
CI	CF3	Br	CI	CF3	Br	CI	CF3	Br	CI	CF3	Br<br>
CI	Br	CI	CI	â€¢Br	CI	CI	Br	CI	CI	Br	CI<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
169<br>
R5b is CH2CF3<br>
			,			=	3-				<br>
R2	is H. R:	" is Me	R^	is H, R3 is Bt	R2,	sH.R3	is /-Pr	R2 IE	Me. R^ is Me<br>
R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R^<br>
CI	Br	Br	CI	Br	Br	CI	Br	Br	CI	Br	Br<br>
CI	CI	CI	CI	CI	CI	CI	CI	CI	CI	CI	CI<br>
CI	CI	Br	CI	CI	Br	CI	CI	Br	CI	CI	Br<br>
Br	H	CI	Br	H	CI	Br	H	CI	Br	H	CI<br>
Br	H	Br	Br	H	Br	Br	H	Br	Br	H	Br<br>
Br	I	CI	Br	I	CI	Br	I	CI	Br	I	CI<br>
Br	f	Br	Br	I	Br	Br	I	Br	Br	I	Br<br>
Br	F	CI	Br	F	CI	Br	F	CI	Br	F	CI<br>
Br	F	Br	Br	F	Br	Br	F	Br	Br	F	Br<br>
Br	CF3	CI	Br	CF3	C!	Br	CF3	CI	Br	CF3	CI<br>
Br	CF3	Br	Br	CF3	Br	Br	CF3	Br	Br	CF3	Br<br>
Br	Br	CI	Br	Br	CI	Br	Br	CI	Br	Br	CI<br>
Br ,	Br	Br	Br	Br	Br	Br	Br	Br	Br	Br	Br<br>
Br	CI	CI	Br	CI	CI	Br	CI	CI	Br	CI	C!<br>
Br	CI	Br	Br	CI	Br	Br	CI	Br	Br	CI	Br<br>
				R5b	is CF3				<br>
R2is	H.R3	is Me	R2is	H.R3	isEt	R2 is	H. R3 is /-Pr	R2 is!	Me. R3	is Me<br>
R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R6	R4a	R4t&gt;	R6<br>
CH3	H	C!	CH3	H	CI	CH3	H	CI	CH3	H	CI<br>
CH3	H	Br	CH3	H	Br	CH3	H	Br	CH3	H	Br<br>
CH3	I	CI	CH3	I	CI	CH3	I	CI	CH3	I	CI<br>
CH3	I	Br	CH3	I	Br	CH3	I	Br	CH3	I	Br<br>
CH3	F	CI	CH3	F	CI	CH3	F	CI	CH3	F	CI<br>
CH3	F	Br	CH3	F	Br	CH3	F	Br	CH3	F	Br<br>
CH3	CF3	CI     CH3	CF3	CI	CH3	CF3	CI	CH3	CF3	CI<br>
CH3	CF3	Br	CH3	CF3	Br	CH3	CF3	Br	CH3	CF3	Br<br>
CH3	Br	C!	CH3	Br	CI	CH3	Br	CI	CH3	Br	CI<br>
CH3	Br	Br	CH3	Br	Br	CH3	Br	Br	CH3	Br	Br<br>
CH3	CI	CI	CH3	CI	CI	CH3	CI	CI	CH3	CI	CI<br>
CH3	CI	Br	CH3	CI	Br	CH3	CI	Br	CH3	CI	Br<br>
CI	H	CI	CI	H	CI	CI	H	CI	CI	H	CI<br>
CI	H	Br	CI	H	Br	CI	H	Br	Cf	H	Br<br>
CI	I	CI	CI	I	CI	CI	I	CI	CI	I-	C!<br>
CI	I	Br	CI	I	Br	CI	I	Br	CI	I	Br<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
170<br><br>
					R5b	isCF3					<br>
R2	is H. R:	* is Me	R2	is H. R3 is Et	R2~,	s H. R3	is /-FT	R2 is Me. R	3 is Me<br>
R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R
CI	F	CI	CI	F	CI	CI	F	CI	CI	F	CI<br>
CI	F	Br	CI	F	Br	CI	F	Br	CI	F	Br<br>
CI	CF3	CI	CI	CF3	CI	CI	CF3	CI	CI	CF3	CI<br>
CI	CF3	Br	CI	CF3	Br	CI	CF3	Br	C!	CF3	Br<br>
CI	Br	CI	CI	Br	CI	CI	Br	CI	CI	Br	CI<br>
CI	Br	Br	CI	Br	Br	CI	Br	Br	CI	Br	Br<br>
CI	CI	C!	CI	CI	CI	CI	CI	CI	CI	CI	CI<br>
CI	CI	Br	CI	CI	Br	CI	CI	Br	CI	CI	Br<br>
Br	H	CI	Br	H	CI	Br	â– H	CI	Br	H	CI<br>
Br	H	Br	Br	H	Br	Br	H	Br	Br	H	Br<br>
Br	I	CI	Br	I	CI	Br	I	CI	Br	I	CI<br>
Br	I	Br	Br	I	Br	Br	I	Br	Br	I	Br<br>
Br.	F	CI	Br	F	CI	Br	F	CI	Br	F	CI<br>
Br	F	Br	Br	F	Br	Br	F	Br	Br	F	Br<br>
Br	CF3	CI	Br	CF3	CI	Br	CF3	C!	Br	CF3	CI<br>
Br	CF3	Br	Br	CF3	Br	Br	CF3	Br	Br	CF3	Br<br>
Br	Br	CI	Br	Br	CI	Br	Br	CI	Br	Br	CI<br>
Br	Br	Br	Br	Br	Br	Br	Br	Br	Br	Br	Br<br>
Br	CI	CI	Br	CI	CI	Br	CI	CI	Br	CI	CI<br>
Br	CI	Br	Br	CI	Br	Br	C!	Br	Br	CI	Br<br>
			R5b is CF2CHF	2			<br>
R2is	H. R3 is Me	R2is	H.R3	is Et	R2is	H, R3is/-Pr ]R2isMe..R3	is Me<br>
R4a	R4b	R6	R4a	R4b	R6	R4a	RÂ«b	R6	R4a	R4b	R6<br>
CH3	H	CI	CH3	H	CI	CH3	H	CI	CH3	H	CI<br>
CH3	H	Br	CH3	H	Br	CU3	H	Br	CH3	H	Br<br>
CH3	I	CI	CH3	I	CI	CH3	I	CI	CH3	I	CI<br>
CH3	I	Br	CH3	I	Br	CH3	I	Br	CH3	I	Br<br>
CH3	F	CI	CH3	F	CI	CH3	F	CI	CH3	F	CI<br>
CH3	F	Br	CH3	F	Br	CH3	F	Br	CH3	F	Br<br>
CH3	CF3	CI	CH3	CF3	CI	CH3	CF3	CI	CH3	CF3	CI<br>
CH3	CF3	Br	CH3	CF3	Br	CH3	CF3	Br	CH3	CF3	Br<br>
CH3	Br	CI     (	CH3	Br	CI	CH3	Br	CI	CH3	Br	CI<br>
CH3	Br	Br     (	=H3"	Br	Br     (	:H3	Br	Br	CH3	Br	Br<br>
CH3	CI	CI     (	"H3	CI	CI     (	3H3	CI	CI	2E3	CI   â– 	CI<br><br>
|W0 02/070483<br><br>
PCTAJS02/0U582<br><br>
171<br><br>
				I	R3is CFoCHF-)				<br>
R2 is H. R3	is Me	R2	sH.R3	is Et	R2iH.R3	is f"-Pr	R2is	Me. R3	is Me<br>
R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R6	R4a	R4b	R6<br>
CH3	CI	Br	CH3	C)	Br	CH3	Cl	Br	CH3	Cl	Br<br>
CI	H	CI	CI	H	Cl	Cl	H	Cl	Cl	H	Cl<br>
CI	H	Br	C!	H	Br	Cl	H	Br	CI	H	Br<br>
CI	I	CI	C!	I	Cl	Cl	I	Cl	Cl	I	Cl<br>
CI	I	Br	CI	I	Br	Cl	1	Br	Cl	I	Br<br>
CI	F	CI	CI	F	Cl	Cl	F	Cl	CI	F	Cl<br>
CI	F	Br	CI	F	Br	Cl	F	Br	CI	F	Br<br>
CI	CF3	CI	CI	CF3	CI	Cl	CF3	Cl	Cl	CF3	CI<br>
CI	CF3	Br	CI	CF3	Br	CI	CF3	Br	Cl	CF3	Br<br>
CI	Br	CI	Q	Br	Cl	CI	Br	CI	Cl	Br	Cl<br>
CI	Br	Br	CI	Br	Br	CI	Br	Br	Cl	Br	Br<br>
CI	CI	CI	a	CI	CI	Cl	CI	CI	Cl	Cl	CI<br>
ci.	CI	Br	Cl	CI	Br	CI	CI	Br	CI	Cl	Br<br>
Br	H	CI	Br	fi	CI	Br	H	Cl	Br	H	CI<br>
Br	H	Br	Br	H	Br	Br	H	Br	Br	H	Br<br>
Br	I	CI	Br	I	Cl	Br	I	Cl	Br	I	Cl<br>
Br	I	Br	Br	I	Br	Br	I	Br	Br	I	Br<br>
Br	F   .	CI	Br	F	"Cl	Br	F	Cl	Br	F	Cl<br>
Br	F	Br	Br	F	Br	Br	F	Br	Br	F	Br<br>
Br	CF3	CI	Br	CF3	Cl	Br	CF3	Cl	Br	CF3	Cl<br>
Br	CF3	Br	Br	CF3	BT	Br	CF3	Br	Br	CF3	Br<br>
Br	Br	CI	Br	Br	Cl	Br	Br	Cl	.Br	Br	Cl<br>
Br	Br	Br	Br	Br	Br	Br	Br	Br	Br	Br	Br<br>
Br	CI	CI	Br	Cl	Cl	Br	Cl	Cl	Br	Cl	Cl<br>
Br	CI	Br	Br	Cl	Br	Br	Cl	Br	Br	C!	Br<br>
Formulation/Utility<br>
Compounds of this invention will generally be used as a formulation or composition with an agriculturally suitable carrier comprising at least one of a liquid diluent, a solid diluent or a surfactant. The formulation or composition ingredients are selected to be consistent with the physical properties of the active ingredient, mode of application and environmental factors such as soil type, moisture and temperature. Useful formulations include liquids such as solutions-(including emulsifiable concentrates), suspensions, emulsions (including microemulsions and/or suspoemulsions) and the like which optionally can be thickened into gels. Useful formulations further include solids such as dusts,<br><br>
WO 02/070483	PCT/TJS02/06582<br>
172<br>
powders, granules, pellets, tablets, films, and the like which can be water-dispersible<br>
("wettable") or water-soluble. Active ingredient can be (micro)encapsulated and further<br>
formed into a suspension or solid formulation; alternatively the entire formulation of active<br>
ingredient can be encapsulated (or "overcoated"). Encapsulation can control or delay release<br>
of the active ingredient. Sprayable formulations can be extended in suitable media and used<br>
at spray volumes from about one to several hundred liters per hectare. High-strength<br>
compositions are primarily used as intermediates for further formulation.<br>
The formulations will typically contain effective amounts of active ingredient, diluent<br>
and surfactant within the following approximate ranges that add up to 100 percent by weight.<br>
Weight Percent<br>
Active<br>
Ingredient	Diluent	Surfactant<br>
Water-Dispersible and Water-soluble	5-90	0-94	1-15<br>
Granules, Tablets and Powders.<br>
Suspensions, Emulsions, Solutions	5-50	40-95	0-15<br>
(including Emulsifiable Concentrates)<br>
Dusts	1-25	70-99	0-5<br>
Granules and Pellets	0.01-99	5-99.99	0â€”15<br>
High Strength Compositions	90-99	0-10	"0-2<br>
Typical solid diluents are described in Watkins, et al., Handbook of Insecticide Dust Diluents and Carriers, 2nd Ed., Dorland Books, Caldwell, New Jersey. Typical liquid diluents are described in Marsden, Solvents Guide, 2nd Ed., Interscience, New York, 1950. McCutcheon "s Detergents and Emulsifiers Annual, Allured Publ. Corp., Ridgewood, New Jersey, as well as Sisely and Wood, Encyclopedia of Surface Active Agents, Chemical Publ. Co., Inc., New York, 1964, list surfactants and recommended uses. All formulations can contain minor amounts of additives to reduce foam, caking, corrosion, microbiological growth and the like, or thickeners to increase viscosity.<br>
Surfactants include, for example, polyethoxylated alcohols, polyethoxylated alkylphenols, polyethoxylated sorbitan fatty acid esters, dialkyl sulfosuccinates, alkyl sulfates, alkylbenzene sulfonates, organosilicones, N,N-dialkyltaurates, lignin sulfonates, naphthalene sulfonate formaldehyde condensates, polycarboxylates, and polyoxyethylene/polyoxypropylene block copolymers. Solid diluents include, for example, clays such as bentonite, montmorillonite, attapulgite and kaolin, starch, sugar, silica, talc, diatomaceous earth, urea, calcium carbonate, sodium carbonate and bicarbonate, and sodium sulfate. Liquid diluents include, for example, water, N,N-dimethylformamide, dimethyl sulfoxide,N-alkylpyrrolidone, ethylene glycol, polypropylene glycol, paraffins, alkylbenzenes, alkylnaphthalenes, oils of olive, castor, linseed, rung, sesame, corn, peanut, cotton-seed, soybean, rape-seed and coconut, fatty acid esters, ketones such as<br><br>
W0 02/070483	PCT/US02/06582<br>
173<br>
cyclohexanone, 2-heptanone, isophorone and 4-hydroxy-4-methyl-2-pentanone: and alcohols such as methanol, cyclohexanol. decanol and tetrahydroforfuryl alcohol.<br>
Solutions, including emulsifiable concentrates, can be prepared by simply mixing the<br>
ingredients. Dusts and powders can be prepared by blending and, usually, grinding as in a<br>
5      hammer mill or fluid-energy mill. Suspensions are usually prepared by wet-milling; see, for<br>
example, U.S. 3,060,084. Granules and pellets can be prepared by spraying the active<br>
material upon preformed granular carriers or by agglomeration techniques. See Browning,<br>
"Agglomeration""", Chemical Engineering, December 4, 1967, pp 147^8, Perry"s Chemical<br>
Engineer"s Handbook, 4th Ed., McGraw-Hill, New York, 1963, pages 8-57 and following,<br>
10      and PCT Publication WO 91/13546. Pellets can be prepared as described in U.S. 4,172,714.<br>
Water-dispersible and water-soluble granules can be prepared as taught in U.S. 4,144,050,<br>
U.S. 3,920,442 and DE 3,246,493. Tablets can be prepared as taught in U.S. 5,180,587, U.S.<br>
5,232,701 and U.S. 5,208,030. Films can be prepared as taught in GB 2,095,558 and U.S.<br>
3,299,566.<br>
15	For further information regarding the art of formulation, see T. S. Woods, "The<br>
Formulator"s Toolbox - Product Forms for Modern Agriculture" in Pesticide Chemistry and<br>
Bioscience, The Food-Environment Challenge, T. Brooks and T. R. Roberts, Eds.,<br>
Proceedings of the 9th International Congress on Pesticide Chemistry, The Royal Society of<br>
Chemistry, Cambridge, 1999, pp. 120-133. See also U.S. 3,235,361, Col. 6, line 16 through<br>
20      Col. 7, line 19 and Examples 10-41; U.S. 3,309,192, Col. 5, line 43 through Col. 7, line 62<br>
and Examples 8, 12, 15, 39,41, 52, 53, 58, 132, 138-140, 162-164, 166, 167 and 169-182;<br>
U.S. 2,891,855, Col. 3, line 66 through Col. 5, line 17 and Examples 1-4; Klingman, Weed<br>
Control as a Science, John Wiley and Sons, Inc., New York, 1961, pp 81-96; and Hance<br>
et al., Weed Control Handbook, 8th Ed., Blackwell Scientific Publications, Oxford, 1989.<br>
25	In the following Examples, all percentages are by weight and all formulations are<br>
prepared in conventional ways. Compound numbers refer to compounds in Index Table A.<br>
Example A Wettable Powder<br>
Compound 1	65.0%<br>
30                dodecylphenol polyethylene glycol ether	2.0%<br>
sodium, ligninsulfonate	4.0%<br>
sodium silicoaluminate	6.0%<br>
. montmorillonite (calcined)	23.0%.<br><br>
WO 02/070483	PCT/US02/06582<br>
L<br>
174<br>
Example B Granule<br>
Compound 1	10.0%<br>
attapulgite granules (low volatile matter,<br>
5	0.71/0.30 mm; U.S.S. No. 25-50 sieves)	90.0%.<br>
Example C Extruded Pellet<br>
Compound 1	25.0%<br>
anhydrous sodium sulfate	10.0%<br>
10               crude calcium ligninsulfonate	5.0%<br>
sodium alkylnaphthalenesulfonate	1.0%<br>
calcium/magnesium bentonite	59.0%.<br>
Example D<br>
Emulsifiable Concentrate<br>
15	Compound 1	20.0%<br>
blend of oil soluble sulfonates<br>
and polyoxyethylene ethers	10.0%<br>
isophorone	70.0%.<br>
Example E 20      Granule<br>
Compound!	0.5%<br>
cellulose	2.5%<br>
lactose	4.0%<br>
commeal	93.0%o.<br>
25	Compounds of this invention are characterized by favorable metabolic and/or soil<br>
residual patterns and exhibit activity controlling a spectrum of agronomic and non-agronomic invertebrate pests. (In the context of this disclosure "invertebrate pest control" means inhibition of invertebrate pest development (including mortality) that causes significant reduction in feeding or other injury or damage caused by the pest; related<br>
30      expressions are defined analogously.) As referred "to in this disclosure, the term<br>
"invertebrate pesi" includes arthropods, gastropods and nematodes of economic importance as pests. The term "arthropod" includes insects, mites, spiders, scorpions, centipedes, millipedes, pill bugs and symphylans. The term "gastropod" includes snails, slugs and other Stylommatophora. The term "nematode" includes all of the helminths, such as: 35      roundworms, heartworms, and phytophagous nematodes (Nematoda), flukes (Tematoda), Acanthocephala, and tapeworms (Cestoda). Those skilled in the art will recognize that not all compounds are equally effective against all pests. Compounds of this invention display<br><br>
WO/ 02/070483<br><br>
PCT/US02/06582<br><br>
175<br>
activity against economically important agronomic and nonagronomic pests. The term "agronomic" refers to the production of field crops such as for food and fiber and includes the growth of cereal crops (e.g., wheat, oats, barley, rye, rice, maize), soybeans, vegetable crops (e.g., lettuce, cabbage, tomatoes, beans), potatoes, sweet potatoes, grapes, cotton, and 5     tree fruits (e.g., pome fruits, stone fruits and citrus fruits). The term "nonagronomic1" refers to other horticultural (e.g., forest, greenhouse, nursery or ornamental plants not grown in a field), public (human) and animal health, domestic and commercial structure, household, and stored product applications or pests. For reason of invertebrate pest control spectrum and economic importance, protection (from damage or injury caused by invertebrate pests) of 10     agronomic crops of cotton, maize, soybeans, rice, vegetable crops, potato, sweet potato, grapes and tree fruit by controlling invertebrate pests are preferred embodiments of the invention. Agronomic or nonagronomic pests include larvae of the order Lepidoptera, such as armyworms, cutworms, loopers, and heliothines in the family Noctuidae (e.g., fall armyworm (Spodoptera fugiperda J. E. Smith), beet armyworm (Spodoptera exigua 15      Hiibner), black cutworm (Agrotis ipsilon Hufnagel), cabbage looper (Trichoplusia ni<br>
Hubner), tobacco budworm (Heliothis virescens Fabricius)); borers, casebearers, webworms, coneworms, cabbageworms and skeletonizers from the family Pyralidae (e.g., European com borer (Ostrinia nubilalis Hubner), navel orangeworm (Amyelois transitella Walker), com root webworm (Crambus caliginosellus Clemens), sod webworm (Herpetogramma 20     licarsisalis Walker)); leafrollers, budworms, seed worms, and fruit worms in the family Tortricidae (e.g., codling moth (Cydiapomonella Linnaeus), grape berry moth (Endopiza viteano Clemens), oriental fruit moth {Grapholita molesta Busck)); and many other economically important lepidoptera (e.g., diamondback moth (Plutella xylostella Linnaeus), pink bollworm (Pectinophora gossypiella Saunders), gypsy moth (Lymantria dispar 25     Linnaeus)); nymphs and adults of the order Blattodea including cockroaches from the families Blattellidae and Blattidae (e.g., oriental cockroach (Blatta orientalis Linnaeus), Asian cockroach (Blatella asahinai Mizukubo), German cockroach (Blattella germanica Linnaeus), brownbanded cockroach (Supella longipalpa Fabricius), American cockroach (Periplaneta americana Linnaeus), brown cockroach {Periplaneta brunnea Burmeister), 30      Madeira cockroach (Leucophaea maderae Fabricius)); foliar feeding larvae and adults of the order Coleoptera including weevils from the families Anthribidae, Bruchidae, and Curculionidae (e.g., boll weevil (Anthonomus grandis Boheman), rice water weevil (Lissorhoptrus oryzophilus Kuschel), granary weevil (Sitophilus granarius Linnaeus), rice weevil (Sitophilus oryzae Linnaeus)); flea beetles, cucumber beetles, rootworms, leaf 35     beetles, potato beetles, and leafminers in the family Chrysomeiidae (e.g., Colorado potato beetle (Leptinotarsa decemllneata Say), western com roorworm (Diabrotica virgifera virgifera LeConte)); chafers andother beetles from the family Scaribaeidae (e.g., Japanese beetle (Popilliajaponica Newman) and European chafer (Rhizotrogus majalis<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
176<br>
Razoumowsky)); carpet beetles from the family Dermestidae; wireworms from the family Elateridae; bark beetles from the family Scolytidae and flour beetles from the family Tenebrionidae. In addition agronomic and nonagronomic pests include: adults and larvae of the order Dermaptera including earwigs from the family Forficulidae (e.g., European earwig 5      (Forficula auricularia Linnaeus), black earwig (Chelisoches morio Fabricius)): adults and nymphs of the orders Hemiptera and Homoptera such as, plant bugs from the family Miridae, cicadas from the family Cicadidae, leafhoppers (e.g. Empoasca spp.) from the family Cicadellidae, planthoppers from the families Fulgoroidae and Delphacidae, treehoppers from the family Membracidae, psyllids from the family Psyllidae, whiteflies 10     from the family Aleyrodidae, aphids from the family Aphididae, phylloxera from the family Phylloxeridae, mealybugs from the family Pseudococcidae, scales from the families Coccidae, Diaspididae and Margarodidae, lace bugs from the family Tingidae, stink bugs from the family Pentatomidae, cinch bugs (e.g., Blissus spp.) and other seed bugs from the family Lygaeidae, spittlebugs from the family Cercopidae squash bugs from the family 15     Coreidae, and red bugs and cotton stainers from the family Pyrrhocoridae. Also included are adults and larvae of the order Acari (mites) such as spider mites and red mites in the family Tetranychidae (e.g., European red mite (Panonychus ulmi Koch), two spotted spider mite (Tetranychus urticae Koch), McDaniel mite (Tetranychus mcdanieli McGregor)), flat mites in the family Tenuipalpidae (e.g., citrus flat mite (Brevipalpus lewisi McGregor)), rust and 20     bud mites in the family Eriophyidae and other foliar feeding mites and mites important in human and animal health, i.e. dust mites in the family Epidermoptidae, follicle mites in the family Demodicidae, grain mites in the family Glycyphagidae, ticks in the order Ixodidae (e.g., deer tick {Ixodes scapularis Say), Australian paralysis tick (Ixodes holocyclus Neumann), American dog tick (Dermacentor variabilis Say), lone star tick (Amblyomma 25      americanum Linnaeus) and scab and itch mites in the families Psoroptidae, Pyemotidae, and Sarcoptidae; adults and immatures of the order Orthoptera including grasshoppers, locusts and crickets (e.g., migratory grasshoppers (e.g., Melanoplus sanguinipes Fabricius, M. differentialis Thomas), American grasshoppers (e.g., Schistocerca americana Drury), desert locust (Schistocerca gregaria Forskal), migratory locust (Locusta migratoria Linnaeus), 30     house cricket (Acheta domesticus Linnaeus), mole crickets (Gryllotalpa spp.)); adults and immatures of the order Diptera including leafminers, midges, fruit flies (Tephritidae), frit flies (e.g., Oscinellafrit Linnaeus), soil maggots, house flies (e.g., Musca domestica Linnaeus), lesser house flies (e.g., Fannia canicularis Linnaeus, F. femoralis"Stein), stable flies (e.g., Stomoxys calcitrans Linnaeus), face flies, horn flies, blow flies (e.g., Chrysomya 35      spp., Phormia spp.), and other muscoid fly pests, horse flies (e.g., Tabanus spp.), bat flies (e.g., Gastrophilus spp., Oestrus spp.), cattle grubs (e.g.. Hypoderma spp.), deer flies (e.g., Chrysops spp.), keds (e.g., Melophagus ovinus Linnaeus) and other Brachycera, mosquitoes (e.g., Aedes spp., Anopheles spp., Culex spp.), black flies (e.g., Prosimulium spp., Simulium<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
177<br>
spp.), biting midges, sand flies, sciarids, and other Nematocera; adults and immatures of the order Thysanoptera including onion thxips {Thrips tabaci Lindeman) and other foliar feeding thrips; insect pests of the order Hymenoptera including ants (e.g., red carpenter ant {Camponotus ferrugineus Fabricius), black carpenter ant {Camponotus pennsylvanicus De 5      Geer), Pharaoh ant (Monomorium pharaonis Linnaeus), little fire ant (Wasmannia auropunctata Roger), fire ant (Solenopsis geminata Fabricius), red imported fire ant {Solenopsis invicta Buren), Argentine ant (Iridomyrmex kumilis Mayr), crazy ant {Paratrechina longicornis Latreille), pavement ant {Tetramorium caespitum Linnaeus), cornfield ant {Lasius alienus Forster), odorous house ant {Tapinoma sessile Say)), bees 10     (including carpenter bees), hornets, yellow jackets and wasps; insect pests of the order<br>
Isoptera including the eastern subterranean termite {Reticulitermes flavipes Kollar), western subterranean termite {Reticulitermes hesperus Banks), Formosan subterranean termite (Coptotermes formosanus Shiraki), West Indian drywood termite {Incisitermes immigrans Snyder) and other termites of economic importance; insect pests of the order Thysanura such 15      as silverfish (Lepisma saccharina Linnaeus) and firebrat {Thermobia domestica Packard); insect pests of the order Mallophaga and including the head louse (Pediculus humanus capitis De Geer), body louse {Pediculus humanus humanus Linnaeus), chicken body louse {Menacanthus stramineus Nitszch), dog biting louse {Trichodectes canis De Geer), fluff louse {Goniocotes gallinae De Geer), sheep body louse {Bovicola ovis Schrank), short-nosed 20     cattle louse {Haematopinus eurysternus Nitzsch), long-nosed cattle louse {Linognathus vituli Linnaeus) and other sucking and chewing parasitic lice that attack man and animals; insect pests of the order Siphonoptera including the oriental rat flea {Xenopsylla cheopis Rothschild), cat flea {Ctenocephalides felisBouche), dog flea {Ctenocephalides canis Curtis), hen flea {Ceratophyllus gallinae Schrank), sticktight flea {Echidnophaga gallinacea 25      Westwood), human flea {Pulex irritans Linnaeus) and other fleas afflicting mammals and birds. Additional arthropod pests covered include: spiders in the order Araneae such as the brown recluse spider {Loxosceles reclusa Gertsch &amp; Mulaik) and the black widow spider {Latrodectus mactans Fabricius), and centipedes in the order Scutigeromorpha such as the house centipede {Scutigera coleoptrata Linnaeus). Compounds of the present invention also 30     have activity on members of the Classes Nematoda, Cestoda, Trematoda, and<br>
Acanthocephala including economically important members of the orders Strongylida, Ascaridida, Oxyurida, Rhabditida, Spirurida, and Enoplida such as but not limited to economically important agricultural pests (i.e. root knot nematodes in the genus Meloidogyne, lesion nematodes in the genus Pratylenchus, stubby root nematodes in the 35     genus Trickodorus, etc.) and animal and human health pests (i.e. all economically important flukes, tapeworms, and roundworms, such as Strongylus vulgaris in horses, -Toxocara canis in dogs, Haemonchus contortus in sheep, Dirofilaria immitis Leidy in dogs, Anoplocephala perfoliata in horses, Fasciola hepatica Linnaeus in ruminants, etc.).<br><br>
&gt;W0 02/070483<br><br>
PCTYUS02/06-582<br><br>
178<br>
Compounds of the invention show particularly high activity against pests in the order Lepidoptera (e.g.. Alabama argillacea Hiibner (cotton leaf worm), Archips argyrospila Walker (fruit tree leaf roller), A. rosana Linnaeus (European leaf roller) and other Ar chips species, Chilo suppressalis Walker (rice stem borer), Cnaphalocrosis medinalis Guenee (rice 5      leaf roller), Crambus caliginosellus Clemens (corn root webworm), Crambus teterrellus Zincken (bluegrass webworm), Cydia pomonella Linnaeus (codling moth), Earias insulana Boisduval (spiny"bollworm), Earias vittella Fabricius (spotted bollworm), Helicoverpa armigera Hiibner (American bollworm), Helicoverpa zea Boddie (corn earworm), Heliothis virescens Fabricius (tobacco budworm), Herpetogramma licarsisalis Walker (sod 10     webworm), Lobesia botrana Denis &amp; Schiffermuller (grape berry moth), Pectinophora gossypiellaSaunders (pink bollworm), Phyllocnistis citrella Stainton (citrus leafininer), Pieris brassicae Linnaeus (large white butterfly), Pier is rapae Linnaeus (small white butterfly), Plutella xylostella Linnaeus (diamondback moth), Spodoptera exigua Hiibner (beet armyworm), Spodoptera litura Fabricius (tobacco cutworm, cluster caterpillar), 15      Spodoptera frugiperda J. E. Smith (fall armyworm), Trichoplusia ni Hiibner (cabbage<br>
looper) and Tuta absoluta Meyrick (tomato leafininer)). Compounds of the invention also have commercially significant activity on members from the order Homoptera including: Acyrthisiphon pisum Harris (pea aphid), Aphis craccivora Koch (cowpea aphid), Aphis fabae Scopoli (black bean aphid), Aphis gossypii Glover (cotton aphid, melon aphid), Aphis pomi 20     De Geer (apple aphid), Aphis spiraecola Patch (spirea aphid), Aulacorthum solani Kaltenbach (foxglove aphid), Chaeto siphon fragaefolii Cockerell (strawberry aphid), Diuraphis noxia Kurdjumov/Mordvilko (Russian wheat aphid), Dysaphis plantaginea Paaserini (rosy apple aphid), Eriosoma lanigerum Hausmann (woolly apple aphid), Hyalopteruspruni Geoffroy (mealy plum aphid), Lipaphis erysimi Kaltenbach (turnip 25      aphid), Metopolophium dirrhodum Walker (cereal aphid), Macrosipum euphorbiae Thomas (potato aphid), Myzus persicae Sulzer (peach-potato aphid, green peach aphid), Nasonovia ribism"gri Mosley (lettuce aphid), Pemphigus spp. (root aphids and gall aphids), Rhopalosiphum maidis Fitch (com leaf aphid), Rhopalosiphum padi Linnaeus (bird cherry-oat aphid), Schizaphis graminum Rondani (greenbug), Sitobion avenae Fabricius (English 30     grain aphid), Therioaphis maculata Buckton (spotted alfalfa aphid), Toxoptera aurantii<br>
Boyer de Fonscolombe (black citrus aphid), and Toxoptera citricida Kirkaldy (brown citrus aphid); Adelges spp. (adelgids); Phylloxera devastatrix Pergande (pecan phylloxera); Bemisia tabaci Gennadius (tobacco whitefly, sweetpotato whitefly), Bemisia argentifolii Bellows &amp; Perring (silverleaf whitefly), Dialeurodes citri Ashmead (citrus whitefly) and 35      Trialeurodes vaporariorum Westwood (greenhouse whitefly); Empoasca fabae Harris<br>
(potato leafhopper), Laodelphax striatellus Fallen (smaller brown planthopper), Macrolestes quadrilineatus Forbes (aster leafhopper), Nephotettix cinticeps Uhler (green leafhopper), Nephotettix nigropictus Stal (rice leafhopper),Nilaparvata lugens Stal (brownplanthopper),<br><br>
""0 02/070483<br><br>
PCT/US02/06582<br><br>
179<br>
Peregrinus maidis Ashmead (corn planthopper), Sogatella furcifera Horvath (white-backed planthopper). Sogatodes orizicola Muir (rice delphacid), Typhlocyba pomaria McAtee white apple leafhopper, Erythrone.ov.ra spp. (grape leafhoppers); Magicidada septendecim Linnaeus (periodical cicada); Iceryapurchasi Maskell (cottony cushion scale), Ouadraspidiotus perniciosus Comstock (San Jose scale); Planococcus citri Risso (citrus mealybug); Pseudococcus spp. (other mealybug complex); Cacopsylla pyricola Foerster   â–  (pear psylla), Trioza diospyri Ashmead (persimmon psylla). These compounds also have activity on members from the order Hemiptera including: Acrosternum hilare Say (green stink bug), Anasa tristis De Geer (squash bug), Blissus leucopterus leucopterus Say (chinch bug), Corythuca gossypii Fabricius (cotton lace bug), Cyrtopeltis modesta Distant (tomato bug), Dysdercus suturellus Herrich-Schaffer (cotton stainer), Euchistus servus Say (brown stink bug), Euchistus variolarius Palisot de Beauvois (one-spotted stink bug), Graptosthetus spp. (complex of seed bugs), Leptoglossus corculus Say (leaf-footed pine seed bug), Lygus lineolaris Palisot de Beauvois (tarnished plant bug), Nezara viridula Linnaeus (southern green stink bug), Oebalus pugnax Fabricius (rice stink bug), Oncopeltus fasciatus Dallas (large milkweed bug), Pseudatomoscelis seriatus Reuter (cotton fleahopper). Other insect orders controlled by compounds of the invention include Thysanoptera (e.g., Frankliniella occidentalis Pergande (western flower thrip), Scirthothrips citri Moulton (citrus thrip), Sericothrips variabilis Beach (soybean thrip), and Thrips tabaci Lindeman (onion thrip); and the order Coleoptera (e.g., Leptinotarsa decemlimata Say (Colorado potato beetle), Epilachna varivestis Mulsant (Mexican bean beetle) and wireworms of the genera Agriotes, Athous or Limonius).<br>
Compounds of this invention can also be mixed with one or more other biologically active compounds or agents including insecticides, fungicides, nematocides, bactericides, acaricides, growth regulators such as rooting stimulants, chemosterilants, semiochemicals, repellents, attractants, pheromones, feeding stimulants, other biologically active compounds or entomopathogenic bacteria, virus or fungi to form a multi-component pesticide giving an even broader spectrum of agricultural utility. Thus compositions of the present invention can further comprise a biologically effective amount of at least one additional biologically active compound or agent. Examples of such biologically active compounds or agents with which compounds of this invention can be formulated are: insecticides such as abamectin, acephate, acetamiprid, avermectin, azadirachtin, azinphos-methyl, bifenthrin, binfenazate, buprofezin, carbofuran, chlorfenapyr, chlorfluazuron, chlorpyrifos, chJorpyrifos-methyl, chromafenozide, clothianidin, cyfluthrin, beta-cyfiuthrin, cyhalothrin, lambda-cyhalothrin, cypermethrin, cyromazine, deltamethrin, diafenthiuron, diazinon, diflubenzuron, dimethoate, diofenolan, emamectin, endosulfan, esfenvalerate, ethiprole, fenotbicarb, fenoxycarb, fenpropathrin, fenprbximate, fenvalerate, fipronil, flonicamid, flucythrinate, tau-fluvalinate, flufenoxuron, fonophos, halofenozide, hexaflumuron, imidacloprid, indoxacarb, isofenphos,<br><br>
.WO 02/070483	PCT/US02/06582<br>
180<br>
lufenuron, malathion, metaldehyde, methamidophos, methidathion, methomyl, methoprene, mefhoxychlor. monocrotophos, methoxyfenozide, nithiazin, novaluron, oxamyl parathion. parathion-methyL permethrin, phorate, phosalone, phosmet, phosphamidon. pirimicarb. profenofos, pymetrozine, pyridalyl, pyriproxyfen, rotenone, spinosad, sulprofos, 5     tebufenozide, teflubenzuron. tefluthrin, terbufos, tetrachlorvinphos, thiacloprid,<br>
thiamethoxam, thiodicarb, thiosultap-sodium, tralomethrin, trichlorfon and triflumuron; fungicides such as acibenzolar, azoxystrobin, benomyl, blasticidin-S, Bordeaux mixture (tribasic copper sulfate), bromuconazole, carpropamid, captafoL captan, carbendazim, chloroneb, chlorothalonil, copper oxychloride, copper salts, cyflufenamid, cymoxanii, 10     cyproconazole, cyprodinil, (5)-3,5-dichloro-A/-(3-chloro-l-ethyl-1 -methyl-2-oxopropyl)-4-methylbenzamide (RH 7281), diclocymet (S-2900), diclomezine, dicloran, difenoconazole, (iS)-3,5-dihydro-5-memyl-2-(memyltMo)-5-phenyl-3-(phenylainino)-4H"-imidazol-4-one (RP 407213), dimethomorph, dimoxystrobin, diniconazole, diniconazole-M, dodine, edifenphos, epoxiconazole, famoxadone, fenamidone, fenarimol, fenbuconazole, fencaramid 15      (SZX0722), fenpiclonil, fenpropidin, fenpropimorph, fentin acetate, fentin hydroxide,<br>
fiuazinam, fludioxonil, flumetover (RPA 403397), fluquinconazole, flusilazole, flutolanil, flutriafol, folpet, fosetyl-aluminum, furalaxyl, furametapyr (S-82658), hexaconazole, ipconazole, iprobenfos, iprodione, isoprothiolane, kasugamycin, kresoxim-methyl, mancozeb, maneb, mefenoxam, mepronil, metalaxyl, metconazole, metomino-20     strobin/fenominostrobin (SSF-126), myclobutanil, neo-asozin (ferric methanearsonate),<br>
oxadixyl, penconazole, pencycuron, probenazole, prochloraz, propamocarb, propiconazole,<br>
pyrifenox, pyraclostrobin, pyrimethanil, pyroquilon, quinoxyfen. spiroxamine, sulfur,<br>
tebuconazole, tetraconazole, thiabendazole, thifluzamide, thiophanate-methyl, thiram,<br>
tiadinil, triadimefon, triadimenol, tricyclazole, trifloxystrobin, triticonazole, validamycin and<br>
25      vinclozolin; nematocides such as aldicarb, oxamyl and fenamiphos; bactericides such as<br>
streptomycin; acaricides such as amitraz, chinomethionat, chlorobenzilate, cyhexatin,<br>
dicofol, dienochlor, etoxazole, fenazaquin, fenbutatin oxide, fenpropathrin, fenpyroximate,<br>
hexythiazox, propargite, pyridaben and tebufenpyrad; and biological agents such as Bacillus<br>
thuringiensis including ssp. aizawai and kurstaki, Bacillus thuringiensis delta endotoxin,<br>
30     baculovirus, and entomopathogenic bacteria, virus and fungi. Compounds of this invention<br>
and compositions thereof may be applied to plants genetically transformed to express<br>
proteins toxic to invertebrate pests (such as Bacillus thuringiensis toxin). The effect of the<br>
exogenous invertebrate pest control compounds and compositions may be synergistic with<br>
the expressed toxin proteins.<br>
35	A general reference for these agricultural protectants is The Pesticide Manual, 12th<br>
Edition, C. D. S. Tomlin. Ed., British Crop Protection Council, Famham, Surrey, U.K., 2000.<br><br>
 W0 02/070483<br><br>
PCTYUS02/06582<br><br>
181<br>
Preferred insecticides and acaricides for mixing with compounds of this invention include pyrethroids such as cypermethrin, cyhalothrin, cyfluthrin, beta-cyfiuthrin, esfenvalerate, fenvalerate and tralomethrin; carbamates such as fenothicarb, methomyl, oxamyl and thiodicarb; neonicotinoids such as clothianidin, imidacloprid and thiacloprid; 5      neuronal sodium channel blockers such as indoxacarb; insecticidal macrocyclic lactones such as spinosad, abamectin, avermectin and emamectin; y-aminobutyric acid (GABA) antagonists such as endosulfan, ethiprole and fipronil; insecticidal ureas such as fhifenoxuron and triflumuron; juvenile hormone mimics such as diofenolan and pyriproxyfen; pymetrozine; and amitraz. Preferred biological agents for mixing with 10      compounds of this invention include Bacillus thuringiensis and Bacillus thuringiensis delta endotoxin as well as naturally occurring and genetically modified viral insecticides including members of the family Baculoviridae as well as entomophagous fungi.<br>
Most preferred mixtures include a mixture of a compound of this invention with cyhalothrin; a mixture of a compound of this invention with beta-cyfluthrin; a mixture of a 15      compound of this invention with esfenvalerate; a mixture of a compound of this invention with methomyl; a mixture of a compound of this invention with imidacloprid; a mixture of a compound of this invention with thiacloprid; a mixture of a compound of this invention with indoxacarb; a mixture of a compound of this invention with abamectin; a mixture of a compound of this invention with endosulfan; a mixture of a compound of this invention with 20      ethiprole; a mixture of a compound of this invention with fipronil; a mixture of a compound of this invention with flufenoxuron; a mixture of a compound of this invention with pyriproxyfen; a mixture of a compound of this invention with pymetrozine; a mixture of a compound of this invention with amitraz; a mixture of a compound of this invention with Bacillus thuringiensis and a mixture of a compound of this invention with Bacillus 25      thuringiensis delta endotoxin.<br>
In certain instances, combinations with other invertebrate pest control compounds or<br>
agents having a similar spectrum of control but a different mode of action will be<br>
particularly advantageous for resistance management. Thus, compositions of the present<br>
invention can further comprise a biologically effective amount of at least one additional<br>
30     invertebrate pest control compound or agent having a similar spectrum of control but a<br>
different mode of action. Contacting a plant genetically modified to express a plant<br>
protection compound (e.g., protein) or the locus of the plant with a biologically effective<br>
amount of a compound of invention can also provide a broader spectrum of plant protection<br>
and be advantageous for resistance management.<br>
35	Invertebrate pests are controlled in agronomic and nonagronomic applications by<br>
applying one-or more of the compounds of this invention in an effective amount to the environment of the pests including the agronomic and/or nonagronomic locus of infestation to the area to be protected, or directly on the pests to be controlled. Thus, the present<br><br>
,W0 02/070483<br><br>
PCT/US02/06582<br><br>
182<br>
invention further comprises a method for the control of invertebrates in agronomic and/or nonagronomic applications, comprising contacting the invertebrates or their environment with a biologically effective amount of one or more of the compounds of the invention, or with a composition comprising at least one such compound or a composition comprising at least one such compound and an effective amount of at least one additional biologically active compound or agent. Examples of suitable compositions comprising a compound of the invention and an effective amount of at least one additional biologically active compound or agent include granular compositions wherein the additional biologically active compound is present on the same granule as the compound of the invention or on granules separate from those of the compound of this invention.<br>
A preferred method of contact is by spraying. Alternatively, a granular composition comprising a compound of the invention can be applied to the plant foliage or the soil. Compounds of this invention are also effectively delivered through plant uptake by contacting the plant with a composition comprising a compound of this invention applied as a soil drench of a liquid formulation, a granular formulation to the soil, a nursery box treatment or a dip of transplants. Compounds are also effective by topical application of a composition comprising a compound of this invention to the locus of infestation. Other methods of contact include application of a compound or a composition of the invention by direct and residual sprays, aerial sprays, gels, seed coatings, microencapsulations, systemic uptake, baits, eartags, boluses, foggers, fumigants, aerosols, dusts and many others. The compounds of this invention may also be impregnated into materials for fabricating invertebrate control devices (e.g. insect netting).<br>
The compounds of this invention can be incorporated into baits that are consumed by the invertebrates or within devices such as traps and the like. Granules or baits comprising between 0.01-5% active ingredient, 0.05-10% moisture retaining agent(s) and 40-99% vegetable flour are effective in controlling soil insects at very low application rates, particularly at doses of active ingredient that are lethal by ingestion rather than by direct contact.<br>
The compounds of this invention can be applied in their pure state, but most often application will be of a formulation comprising one or more compounds with suitable carriers, diluents, and surfactants and possibly in combination with a food depending on the contemplated end use. A preferred method of application involves spraying a water dispersion or refined oil solution of the compounds. Combinations with spray oils, spray oil concentrations, spreader stickers, adjuvants, other solvents, and synergists such as piperonyl butoxide often enhance compound efficacy.<br>
The rate of application required for effective control (i.e. "biologically effective amount") will depend on such factors as the species of invertebrate to be controlled, the pest"s life cycle, life stage, its size, location, time of year, host crop or animal, feeding<br><br>
W0 02/070483<br><br>
PCT/US02/06582<br><br>
183<br>
behavior, mating behavior, ambient moisture, temperature, and the like. Under normal circumstances, application rates of about 0.01 to 2 kg of active ingredient per hectare are sufficient to control pests in agronomic ecosystems, but as little as 0.0001 kg/hectare may be sufficient or as much as 8 kg/hectare may be required. For nonagronomic applications, 5      effective use rates will range from about 1.0 to 50 mg/square meter but as little as<br>
0.1 mg/square meter may be sufficient or as much as 150 mg/square meter may be required. One skilled in the art can easily determine the biologically effective amount necessary for the desired level of invertebrate pest control.<br>
The following TESTS demonstrates the control efficacy of compounds of this<br>
10     invention on specific pests. "Control efficacy" represents inhibition of invertebrate pest development (including mortality) that causes significantly reduced feeding. The pest control protection afforded by the compounds is not limited, however, to these species. See Index Tables A through K and L for compound descriptions. The following abbreviations are used in the Index Tables which follow: t is tertiary, n is normal, i is iso, c is cyclo, s is<br>
15     secondary, Me is methyl, Et is ethyl, Pr is propyl, i-Pr is isopropyi, c-Pr is cyclopropyl, Bu is butyl, s-Bu is secondary butyl, Pent is pentyl, OMe is methoxy, OEt is ethoxy, SMe is methylthio, SEt is efhylthio, CN is cyano, and N02 is nitro. The abbreviation "Ex." stands for "Example" and is followed by a number indicating in which example the compound is prepared.<br><br>
20<br><br>
INDEX TABLE A<br><br><br><br><br><br><br>
Compound	R2	R3<br>
l(Ex.	3)	H	/-Pr<br>
2		H	/-Bu<br>
		H	/-Pr<br>
4		H	/-Pr<br>
5		H	r-Bu<br>
6		H	/-Bu<br>
1		H	/-Pr<br>
8		H	/-Pr<br><br>
{R4}2<br>
4-Me<br>
4-Me<br>
4-Me<br>
4-Me<br>
4-Me<br>
4-Me<br>
4-Me<br>
4-Me<br><br>
4-CF3-Ph<br>
4-CF3-Ph<br>
4-OCF3~Ph<br>
2-Me,4-SCHF2-Ph<br>
2-Me,4-SCHF2-Pii<br>
4-OCF3-Ph<br>
2-Me;4-S02CHF2-Ph<br>
2-Me,4-SOCF3-Ph<br><br>
m.p. Â°C.<br><br>
184<br><br><br>
Compound	R2	R3	(R4)n<br>
9	H	f-Bu	4-Me<br>
  10	H	f-Bu	4-Me<br>
11	H	i-Pr	4-Me :<br>
12/	H	r-Bii	4-Me<br>
" 13."   .	H	"-&gt;**.â– "	4-Me<br>
   14	H	i-Pr	4-Me.<br>
15	H	&gt;Bu	4-Me<br>
16	H	f-Bu	4-Me<br>
17	H	i-Pr	4-Me<br>
.18	H	f-Bu	4-Me<br>
"..19	H	i-Pr	4-Me<br>
 20	H	r-Bu	4-Me<br>
21	H	i-Pr	4-Me<br>
22	H	r-Bu	4-Me<br>
. 23/	H	i-Pr	4-Me<br>
.    24	H	f-Bu	4-Me<br>
,25			<br>
26			<br>
27			<br>
28			<br>
29	H	H	4-r-Bu-Ph<br>
 30	H	Me	4-Me<br>
31	H	i-Pr	4-Me<br>
32	H	i-Pr	4-Me<br>
33	H	Me	4-Me<br>
34	H	i-Pr	4-Me<br>
35	H	Me	4-Me<br>
36	H	Me	4,5-Cl2<br>
37	H	i-Pr	4,5-Cl2<br>
.:   38	H	i-Pr	4,5-Cl2<br>
39	H	Me	"      4,5-Cl2<br>
:      40	H	i-Pr	4-Me-5-Cl<br>
;            41	H	Me	4-Me-5-Cl<br>
42	H	i-Pr	4-Me-5-Cl<br>
43	H	Me	4-Me-5-Cl<br><br>
2-Me,4-S02CHF2-Ph<br>
2-Me,4-SOCHF2"ph<br>
4-SCHF2-Ph â– .".:â–  4-SCHF^Pt 2-Me,4-GF3-Ph 2-Me,4&gt;OCEyPh<br>
2-Me,4-Cl-Ph<br>
2-Me,4-Cl-Ph<br>
2-Me-6-GF3-3-pyridiQyl<br>
2-MeT6-GF3-3-pyridihyl<br>
l-Ph-3rMe-5-pyrazolyl<br>
l-Ph-3-Me^pyrazdyl<br>
2-Me-6-Cl-3-pyridinyl<br>
2-Me-6-Cl-3-pyridinyi<br>
3,5-Cl2-Ph l-(2-a-3-pyridinyl)-3-Br-5-pyrazolyl l-(2-Cl-3-pyridinyl)-3-Br-r5-pyrazolyl<br>
l-(2-Cl-Ph)-3-CF3-5-pyrazolyl l-(2-Cl-3-pyridinyI)-3-CF3-5-pyrazolyl l-(2-Ci-3-pyridinyl)-3-CF3-5-pyrazolyl l-(2-Cl-Ph)-3-CF3-5-pyrazolyl l-(2-Cl-Ph)-3^CF3-5.pyrazolyl l-(2-Cl-Th)-3-CF3-5-pyrazolyl l-(2-Cl-3-pyridinyl&gt;3-Br-5-pyrazolyl l-(2-Cl-3-pyridiriyl)-3-Br-5-pyrazolyl l-(2-Ci-3-pyridinyi)-3-CF3-5-pyrazolyl l-(2-Cl-3-pyridinyi)-3-Br-5-pyrazolyl l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl l-(2-Cl-3-pyridihyl)-3-CF3-5-pyrazolyl<br><br>
mp:?C.<br>
â– â– .*."-"â– â– <br>
.â– *â– â– ;.. * .â– <br>
*:"<br>
*<br>
*.<br>
222.5-225 214-215<br>
*<br>
* *<br>
. *<br>
*â– â– 
214-215 159-161 198-202 188-190 170-174 201-203 238-240<br>
240 208-210<br>
208 234-236 229-231 222-223 226-228<br><br>
* See Index Table L for !H NMR data.<br><br>
WO 02/070483<br><br>
PCTYUS02/06582<br><br>
185 INDEX TABLE B<br><br><br><br><br><br>
Compound	R3<br>
Bl	/i-Pr<br>
B2	/-Pr<br>
B3	/-Pr<br>
B4	/-Pr<br>
B5	i-?T<br>
B6	/-Pr<br>
B7	r-Bu<br>
B8	r-Bu<br>
B9	/-Pr<br>
BIO	Me<br>
Bll	/-Pr<br>
B12	Me<br>
B13	/-Pr<br>
B14	Me<br>
B15	/-Pr<br>
* See Index Table L for l H NMR data.<br><br>
J	m.p. "C.<br>
2-Me,4-SCHF2-Ph	178.5-180.5<br>
2-Me,4-S02CHF2-Ph	207-210<br>
2-Me,4-SOCF3-Ph	175-180<br>
2-Me,4-CF3-Ph .	201-203<br>
2-Me-6-CF3-3-pyridinyl	221-5-222.5<br>
l-Ph-3-Me-5-pyrazolyl	*<br>
l-Pb-3-Me-5-pyrazo!y)	*<br>
2-Me-6-CF3-3-pyridinyl	*<br>
2-Me-5-Cl-3-thienyl	*<br>
1 -C2-Cl-Ph)-3-CF3-5-pyTazolyl	266-270<br>
1 -(2-Cl-Ph)-3-CF3-5-pyrazo)yl	232-236<br>
1 -C2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl	233-236<br>
l-(2-Cl-3-pyridinyI)-3-CF3-5-pyrazolyl	220-222<br>
1 -(2-Cl~3-pyridinyl)-3-Br-5-pyrazolyl	235-238<br>
l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl	198-200<br>
INDEX TABLE C<br><br><br><br><br><br><br><br>
Compound	<br>
E2	<br>
R!	R4	<br><br>
	R3<br><br>
J<br>
CJ	H	/-Pr	Me				4-F-Ph<br>
C2	H	/-Pr	Me				4-Br-Ph<br><br>
m.p. Â°C.<br>
*<br><br>
186<br><br><br>
(Inmpound	R2.	R3<br>
C3 	H	i-Pr<br>
      C4	H	i-Pr<br>
     .C5	H	i-Pr<br>
     C6	H	i-Pr<br>
   C7	H	i-Pr<br>
C8	H	i-Pr<br>
C9 Ex.2)	H	i-Pr<br>
C10	H	I-PR<br>
C12<br>
C14 C15<br>
-(CH2)5-<br>
H H<br>
i-Pr c-hexyl<br><br>
R4 Me Me Me Me Me : Me Me Me<br>
Ph<br>
Me Ph<br><br>
"    4-Cl-Ph 2-N02-Ph 3-Cl-Ph 4-CN-Fh i-G%Ph 2-Me-4-SOCF3Ph â–     4-pCT3-Ph 2-Me-4-Br-Ph<br>
2-rthienyl<br>
3-pyridinyI 2-thienyl"<br><br><br>
m	;p;6c;<br>
	â–  *:â– .â– <br>
	, *: â– â– â– <br>
	â– : â– *"â– â– ".-<br>
	â–  .*,â€ž-â–  "â– <br>
	*"â– "â– "!â– "<br>
68-75-<br><br><br><br><br>
C23	H	Et	Me<br>
C24	H	i-Pr	Me<br>
C25 .	H	Me	Me<br>
C26	H	Me	Me<br>
C27	H	i-Pr	Me<br>
C28	H	i-Pr	Me<br>
C30	H	Et	CH2CF3<br>
C31	H	i-Pr	CH2CF3<br>
C32	H	Me	Et<br>
C33	H	Et	Et<br>
C34	H	i-Pr	Et<br>
C35	H	Me	CH2CF3<br>
C36	H	Me	CH2CF3<br>
C37	H	Et	CH2CF3<br>
C38	H	i-Pr	CH2CF3<br>
C39	H	Me	.    -   Et<br><br>
l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl<br>
l-(2-a-3-pyridinyl)-3-CF3-5-pyrazolyl<br>
l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl<br>
l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl<br>
l-(2-Cl-Ph)-3-CF3-5-pyrazolyl<br>
l-(2-Cl-Ph)-3-Br-5-pyrazolyl<br>
l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl<br>
l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl<br>
l-(2-Cl-3-pyridinyl&gt;3-GF3-5-pyrazolyl<br>
l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl<br>
l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl<br>
l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl<br>
l-(2-Gl-3-pyridmyl)-3-Br-5-pyrazolyl<br>
l-(2-Cl3-pyridinyl)-3-Br-5-pyrazolyl<br>
l-(2-CI-3-pyridmyD-3-Br-5-pyrazolyl<br>
l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl<br><br>
253-255 -.-;<br>
214-216<br>
230-232 ::<br>
234-236<br>
218-220<br>
170-173<br>
236-238<br>
216-218<br>
238-240<br>
216-218<br>
198-201<br>
260-262<br>
253-256<br>
220-223<br>
188-190<br>
221-223<br><br>
187<br><br><br>
Compound	R2	R3	R4.<br>
C40	H	Et	Et<br>
C41	H	i-Pr	Et<br><br>
l-(2-Cl-3-pyricliiiyl)-3-Br-5-pyrazolyl l-2-Cl-3-pyridinyi)-3-Br-5-pyrazoIyl<br><br>
m.p. Â°C 182-184 172-175<br><br>
INDEX TABLED<br>
* See Index Table L for JH NMR data.<br><br><br>
Compound	R2	R3	R4	J	m.p. Â°C.<br>
Dl	H	i-Pr	2-Me	4-CF3-Ph	223-225<br>
D2	H	f-Bu	2-Me	4-CF3-PI1	260-261<br>
D3 (Ex. 1)	H	i-Pr	2-Me	4-OCF3-ph	202-204<br>
D4	H	i-Pr	2-Me	2-.Me,4-CF3-Ph	235-236<br>
D5	H	z-Pr	2-Me	2-Me,4-OCF3-Ph	198-200<br>
D6	H	i-Pr	2-Me	2-Me-â‚¬-CF3-3-pyridinyl	240-243<br>
D7	H	i-Pr	2-Me	l-Ph-3-CF3-5-pyrazblyI	215-220 (dec.)<br>
D8	H	i-Pr	2-Me	l-(2-Cl-Ph)-3-CF3-5-pyrazolyl	140-144<br>
D9	H	i-Pr	2-Me	2-Me-3-Cl-Ph	260-261<br>
D10	H	i-Pr	2-Me	l-(2-Cl-3-pyridiijyl)-3-CF3-5-pyrazolyl	207-209*<br>
Dll	Me	Me	2-Me	l-(2-CI-Ph)-3-CF3-5-pyrazoryl	172-175<br>
D12	H	Me	2-Me	l-(2-a-Ph)-3-CF3-5-pyrazolyl	193-195<br>
D13	H	i-Pr	2-C1	l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl	175-179<br>
D14	H	i-Pr	2-Me	l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazoIyl	156-158<br>
D15	H	i-Pr	2-C1	l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl	160-165<br><br>
-WO 02/070483<br><br>
PCT7US02/06582<br><br>
188<br><br><br>
Compound	R2	R3	R4<br>
D16	H	Me	2-C1<br>
D17	H	Me	2-C1<br>
D18	H	Me	2-Me<br>
D19	H	Me	2-Me<br>
D20	H	ally!	Me<br>
D21	H	all.yl	Me<br>
See Index Table L for lE NMR data.<br><br>
J	m.B. Â°C.<br>
l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl	178-180<br>
1 -(2-Cl-3-pyridmy])-3-Br-5-pyrazolyl	118-125<br>
1 -(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl	207-209<br>
1 -(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl	216-218<br>
1 -(2-Cl-3-pyridinyI)-3-CF3-5-pyra2olyl	187<br>
l-f2-C!-3-pyridinyl)-3-Br-5-pyrazolyl	199-201<br>
INDEX TABLE E<br><br><br><br><br><br><br>
Compound	R2	R3	{R4<br>
El	H	/-Pr	H<br>
E2	H	/-Pr	H<br>
E3	H	/-Pr	2-C1<br>
E4	H	/-Pr	H<br>
E5	H	/-Pr	2-Me<br>
E6	H	/-Pr	2-Me<br>
E7	H	/-FT	2-Me<br>
E8	H	/-Pr	2-Me<br>
E9	H	/-Pr	2-Me<br>
E10	H	â–      Et	2,6-Cl2<br>
EH	H	Me	2,6-Ci2<br>
E12	H	/-Pr	2,6-Ch<br>
E13	H	Me	2,6-Ch<br>
EI4	H	Et	2,6-Ch<br>
EI5(Ex. 5)	H	/-Pr	2,6-Ch<br>
E16	Me	Me	2,6-Ch<br>
E17	Me	Me	2:6-C12<br>
E18	Me	Me	. 2,6-Br2<br>
E19	H	Et	2,6-Br2<br><br>
J<br>
4-CF3-Ph 4-OCF3-Ph 4-CFrPh 2-Me,3-Cl-Ph l-(2-CI-3-pyridinyl)-3-CF3-5-pyrazolyl 1 -(2-Cl-Ph)-3-CF3-5-pyra2olyl 1 -(2-C]-Ph)-3-Br-5-pyrazolyl l-(2-Cl-3-pyridinyl)-3-CN-5-pyrazolyl K2-Cl-3-pyridinyI)-3-Br-5-pyrazolyl l-C2-Cl-3-pyridinyl)-3-Br-5-pyra2olyl 1 -(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl ]-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl â–  1 -(2-Cl-3-pyridinyl)-3-CF3-5-pyra2olyl l-(2-CI-3-pyridinyI)-3-CF3-5-pyrazoly[ l-(2-"Cl-3-pyridmy])-3-CF3-5-pyrazolyl l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl I-(2-Cl-3-pyridinyI)-3-Cl-5-pyrazoIyI 2,6-Br2-3-NH2-4-pyridinyl l-(2-Cl-3-pyridmyl)-3-CF3-5-pyrazolyl<br><br>
m.p. Â°C.<br>
*<br>
138-140<br>
170-173<br>
*<br>
112-115<br>
147-150<br>
223-224<br>
142-145<br>
238-240<br>
207-209<br>
240-242<br>
153-155<br>
224-226<br>
208-210<br>
223-225<br><br>
W0 02/070483<br><br>
PCT/US02/06582<br><br>
189<br><br>
Compound      R2<br>
E20<br>
E2I<br>
E22<br>
E23<br>
E24<br>
E25<br>
E26<br>
E27<br>
E28<br>
E29<br>
E30<br>
E31<br>
E32<br>
E33<br>
E34<br>
E35<br>
E36<br>
H Et H H H H Me H H H H H H H H H Et<br>
R3 /-Pr Et /-Pr<br>
NMe2 H<br>
NMe2 Me Me Et Me Et Me /-Pr<br>
NMe2 /-Pr<br>
NMe2 Et<br>
* See Index Table L for *H NMR<br><br>
2,6-Br2 2:6-Cl2 2-Cl-6-Br 2,6-Br2 2,6-C!2 2,6-C\2 2-Cl-6-NMe2 2,6-Br2 2,6-BF2 236-Br2 2,6-Br2 2,6~Br2 2,6-Br2 2,6-Cl2 2,6-Br2 2,6-Cl2 2,6-Cl2 data.<br><br>
J<br>
l-(2-Clo-pyridinyI&gt;3-CF3"5-pyrazolyl<br>
]-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl<br>
l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyi<br>
l-(2-Cl-3-pyridinyI)-3-Cl-5-pyrazolyl<br>
]-(2-Cl-3-pyridinyI)-3-Br-5-pyrazolyl<br>
U(2-C\-3-pyridmyl)-3-BT-5-pyrazolyl<br>
l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl<br>
1 -(2~CI-Ph)-3-CF3-5-pyrazoiyi<br>
1 -(2-Cl-Ph)-3-CF3-5-pyrazolyl<br>
l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl<br>
I-(2-Cl-3-pyridirryI)-3-Cl-5-pyrazoiyl<br>
1 -(2-C1-3 -pyridinyl)-3-Cl-5-pyrazolyl<br>
l-(2-Cl-3-pyridiriyl)-3-Cl-5-pyrazolyl<br>
H2-Cl-3-pyridinyI)-3-CF3-5-pyrazoIyI<br>
1 -(2-Cl-Ph)-3-CF3-5-pyrazoly!<br>
2,6-Cl2-3-NH2-4-pyridiiryI<br>
2,6-ci2-3-NH2-4-pyTidiny1<br><br><br>
m.D. Â°C.<br>
&gt;240<br>
231-233<br>
224-226<br><br>
INDEX TABLE F<br><br><br>
Compound	R3	(R4	J	m.p. Â°C.<br>
Fl	/-Pr	H	4-CF3-Ph	<br>
F2	t-Bu	H	4-CF3-Ph	199-200<br>
F3	/-Pr	6-Me	4-CF3-Ph	218-220<br>
F4	;-Pr	4,6-Me-2	4-CF3-Ph	235-237<br>
F5	/-Pr	6-Me	2-Me-4-Cl-Ph	172-174<br>
F6	t-Bu	H	2-Me-3-CJ-Ph	2IS-220<br>
F7  "	/-Pr	H	2-Me-3-Cl-Ph	<br>
* See Index Table L for lH NMR data				<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br><br>
190 INDEX TABLE G<br>
Compound     R2.	R3                 (R4)n	J	m.p. Â°C.<br>
Gl	H	/-Pr                4-Me	4-CF3~Ph	121-123*<br>
G2	H	/-Pr                4-Me	. l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl      183-184<br>
G3	H	S-CH(Ph)Me             H	3-pyridinyl<br>
G4	H	/-Pr                 4--Me	l-(2-C]-3-pyridinyl)-3-Br-5-pyrazo!yl	172-175<br>
G5	H	/-Pr                4-Me	l-(2-Cl-3-Ph)-3-Br-5-pymzolyl<br>
G6	H	/-Pr	4-Me-6-Cl	l-(2-Cl-3-pyridinyl)-3-Br~5-pyrazoIyi        175-177<br>
G7	H	Me	4-Me-6-Cl	l-(2-C]-3-pyridiayl)-3-Br-5-pyrazolyl        230-235<br>
G8	Me	Me               4,6-Cl?	l-C2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl       225-227<br>
G9	H	NMe2             4,6-Ci2	l-(2-Cl-3-pyridinyl&gt;3-Br-5-pyrazolyl        125-130<br>
G10	H	H                4,6-Cl2	K2-C]-3-pyridiny])-3-Br-5-pyrazoly]	130-135<br>
Gil	H	Me                4,6-Cl2	l-(2-Cl-3-pyridinyI)-3-Br-5-pyrazolyl       214-216<br>
G12	H	-   Et                4,6-Cl2	l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl	210-212<br>
G13	H	/-Pr               4,6-Cl2	l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyI       208-210<br>
G14   .	H	NMe2             4,6-Cl2	4,6-C]2-3-NH2-2-pyridinyl	192-194<br>
G15	Me	Me	4,6-C!2	4,6-Cl2-3-NH2-2-pyridmy]                171-172<br>
G16	H	H	4,6-Br2	l-(2-Cl-3-pyridinyl)-3-Cl-5-pyrazolyl          &gt;240<br>
G17	H	Me	4,6-Cl2	l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl<br>
G18	H	Et	4,6-Cl2	l-(2-Cl-3-pyridinyI)-3-CF3-5-pyrazolyl<br>
G19	H	/-Pr	4,6-Cl2 .	l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl<br>
G20	H	H	4,6-Cl2	l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl<br>
G21	Et	Et	4,6-CI2	l-(2-CI-3-pyridinyl)-3-CF3-5-pyrazolyI<br>
G22	H	Me            .  4,6-Cb	l-(2-CI-3-pyridinyl&gt;3-Cl-5-pyrazolyl<br>
G23	H	Et	4,6-Cl2	l-(2-Cl-3-pyridinyl)-3-Cl-5-pyrazolyl<br>
G24	H	/-Pr	4,6-Cb	l-(2-Cl-3-pyridinyI)-3-Cl-5-pyrazoJyI<br>
G25	H	NMe2	4,6-Cl2	l-(2-CI-3-pyridinyl)-3-CF3-5-pyra2;oly]<br>
G26	Me	Me. .	4,6-Cl2	l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazo]yl<br>
G27	Me	Me	4,6-Cl2	l-(2-Cl-3-pyridinyI)-3-C]-5-pyrazoly]<br>
G28	H	H	4..6-Cl2	l-(2-Cl-3-pyridinyl)-3-a-5-pyrazolyl<br><br>
 02/070483<br><br>
PCT/US02/06582<br><br>
191<br><br>
ComDOund	R2	R3	(R4)n<br>
G29	H	NMe2	4,6-012<br>
G30	Et	Et	4:6-Cl2<br>
G31	H	Me	4,5,6-Cl3<br>
G32	H	-Et	4,5,6-CS3<br>
G33	H	CH2CH2SMe	4,6-Cl2<br><br>
l-(2-Cl-3-pyridinyI)-3-Cl-5-pyrazoryI<br>
l-(2-Cl-3-pyridinyl)-3-Cl-5-pyrazolyl<br>
l-(2-Cl-3-pyridinyI)-3-CF3-5-pyrazolyl<br>
l-(2-CI-3-pyridmyI}-3-CF3"5-pyra2olyl<br>
l-(2-Cl-3-pyridiDyl)-3-CI-5-pyrazolyl<br><br>
m.p. Â°C.<br><br>
* See Index Table L for * H NMR data.<br>
INDEX TABLE H<br><br>
HNi-Pr<br><br>
Compound HI * See Index Table J for l H NMR data.<br><br>
2~Me-4-Br-Ph<br><br>
m.p. Â°C.<br>
*<br><br>
INDEX TABLE I<br><br><br><br><br>
Compound<br>
U 12 13 14 15 16 (Ex. 4) 17 18 .19<br><br>
Ed<br>
Me H H Me H Me H H H<br><br>
R3 Me<br>
/-Pr<br>
Me<br>
Me,<br>
Me<br>
Me<br>
/-Pr<br>
/-Pr<br>
Me<br><br>
(R4)	J	m.p. Â°C.<br>
4,6-Me2	]-(2-CJ-3-pyridinyI)-3-CF3-5-pyrazoIyl	244-245*<br>
4,6-Me2	l-(2-Cl-3-pyridinyl)-3-CF3-5-pyra20lyl<br>
4,6-Me2	l"(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl      195-197<br>
4,6-Me2	l-(2-C]-3-pyridinyJ}-3-Br-5-pyrazolyl	243-244<br>
4;6-Me2	l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl	202-204<br>
4-Me	l-(2-Cl-3~pyridinyI)-3-Cl-5-pyrazolyl	232-236<br>
4-Me	2-(2-a-3-pyridmyI&gt;3-Cl-5-pyrazo]yl	87-90<br>
4,6-Me2	l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl	81-83<br>
4-Me	l-(2-C]-3-pyridinyl)-3-Cl-5-pyrazolyl	205-207<br><br>
* See Index Table L for ] H NMR data.<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
192 INDEX TABLE J<br><br><br><br><br>
Compound	R2	R3<br>
J1	H	i-Pr<br>
J2	H	/-Pr<br>
J3	H	Me<br>
J4	H	Me<br>
J5	H	Me<br>
J8	H	/-Pr<br><br>
El Me<br>
Me Me Me Me Me<br><br>
] -(2-C1-Ph)-3-CF3-5-pyrazoIyI 1 -(2-C1-3 -pyridinyI)-3 -CF3 -5 -pyrazolyl<br>
1 -(2-Cl-Ph)-3-CF3-5-pyrazolyl<br>
1-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazoly]<br>
l-(2-CI-3-pyridinyl)-3-Br-5-pyrazolyl<br>
1 -(2-C1-3 -pyridinyI)-3-Br-5-pyrazo)yl<br><br>
m.p. Â°C.<br>
174-176*<br>
206-208<br>
166-168<br>
176-178<br>
227-229<br>
172-174<br><br>
See Index Table L for 1HNMR data.<br>
INDEX TABLE K<br><br><br><br><br>
m.p. Â°C. 224-226* 168-172 185-190 160-162 176-179<br><br>
Compound	R2	R3<br>
Kl	H	Me<br>
K2	H	/-Pr<br>
K3	H	Me<br>
K4	H	/-Pr<br>
â– K5	H	Me<br>
K6	H	/-Pr<br><br>
EZ Me Me Me Me Me Me<br><br>
l-(2-Cl-3-pyridinyI)-3-Br-5-pyrazolyl<br>
1 -(2-C1-3 -pyridinyI)-3-Br-5-pyrazo]yl<br>
â– 1 -(2-CI-Ph)-3-CF3-5-pyrazoIyI<br>
1 -(2-C!-Ph)-3-CF3-5-pyrazolyl<br>
l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazo]yl<br>
] -(2-a-3-pyri&amp;myd-3-CF3-5-pyrazo)yl      180-182<br><br>
* See Index Table L for ] H NMR data.<br><br>
 WO 02/070483<br><br>
PCT/US02/06582<br><br>
193<br>
INDEX TABLE L<br>
Compd. No.	1HNMR Partial Spectrum Data (CDCI3 solution unless indicated otherwise)5<br>
1	10.63 (s,lH), 5.58 (d,1lH)"<br>
2	10.55 (s,lH), 5.60 (s.lH)<br>
3	"  10.55 (S.1H), 5.58 (d,lH)<br>
4	9.80 (s,lH), 5.60 (d,lH)<br>
5	9.68 (s,lH), 5.60 (s,lH)<br>
6	10.45 (s/IH), 5.60 (d,lH)<br>
7	9.93 (s,!H), 5.60 (d,lH)<br>
8	9.90 (s,lH), 5.59 (d,lH)<br>
9	9.83 (s,lH), 5.60 (s,lH)<br>
10	9.78 (s,lH), 5.60 (s,lH)<br>
11	10.57 (s,lH), 5.58 (d,lH)<br>
12	10.46 (s1H), 5.60 (s1H)<br>
13	9.85 (s,lH), 5.60 (d,lH)<br>
14	9.82 (s,lH), 5.58 (d,lH)<br>
15	9.76{s,lH), 5.62(s,IH)<br>
16	9.68 (s,lH), 5.60 (s,lH)<br>
. CI	10.19 (s,lH), 5.72 (d;IH)<br>
C2	10.23 (s, IH), 5.71 (d,IH)<br>
C3	10.23 (s,!H), 5.66 (s,lH)<br>
C4	9.50 (s,lH), 5.62 (d,IH)<br>
C5	10.18 (s,lH), 5.67 (s,lH)<br>
C6	10.41 (s,lH), 5.62 (s,IH)<br>
C7	10.36 (s,lH), 5.66 (sslH)<br>
C8	9.56 (s.lH).. 5.54 (d,lH)<br>
C10	9.56 (s,lH), 5.53 (d,lH)<br>
D10	12.2 (brs,lH), 6.0 (s,IH)<br>
El	10:10 (s,lH), 6.24 (s,lH)<br>
E2	10.08 (s,lH),6.30 (s,lH)<br>
E3	8.36 (mJH), 7.94 (d,lH), 7.79 (d,2H), 4.36 (m,lH), 1.32 (d,6H)<br>
E4	10.05;IH),6.16(d,IH)<br>
E7	7.75 (d,lH), 7.67 (sTlH)<br>
ES	8.23 (s,lH),7.77 (d,IHy<br>
E23	(DMSO-d6) 10.8 Cm, 1H), 9.5 (s, 1H)<br>
E24	(DMSO-d6))10.5(s,lH)<br>
E25	(DMSOd6)) 10.9 (s,lH)<br>
E26	(DUSO-d6) 13.4(brS;lH)<br><br>
tW0 02/070483	PCT/OS02/065S2<br>
194<br>
E27	9.0(s,lED,6.2(m,lH)<br>
E28	9.25 (s5lH), 6.18 (rn5lH)<br>
E29	(DMSO-d6) 10.9 (s,]H), 8.55 (m,lH)<br>
E30	9.3(s,lH), 625(t,lH)<br>
E31	(DMSO-d6) 10.75 (s,lH), 8.55 (m,lH)<br>
E32	(DMSOd6)13.5(brs,lH)<br>
E33	(DMSO-d6) 10.9 (m,lH), 9.6 (s,lH)<br>
E34	9.5 (brs,lH), 6.05 (d,lH)<br>
E35	(DMSO-d6) 10.9 (s,lH), 6.66 (m,lH)<br>
E36	10.3 (s,lH)<br>
Fl	11.56 felH), 8.4] (d,lH)<br>
Gl	11.97 (s,lH)<br>
HI	5.56 (d,lH)<br>
a 1H NMR data are in ppm downfield from tetramethylsilane. Couplings are designated by (s)-singiet, (d)-doublet, (t)-triplet, (q)-quartet, (m)-rrraltiplet, (dd)-doublet of doublets, (dt)-doublet of triplets, (br s)-broad singlet.<br>
. BIOLOGICAL EXAMPLES OF THE INVENTION<br>
.TESTA For evaluating control of diamondback moth (Plutella xylostella) the test unit consisted of a small open container with a 12-14-day-old radish plant inside. This was pre-infested with 10-15 neonate larvae on a piece of insect diet by use of a core sampler to remove a plug from a sheet of hardened insect diet having many larvae growing on it and transfer the plug containing larvae and diet to the test unit. The larvae moved onto the test plant as the diet plug dried out.<br>
Test compounds were formulated using a solution containing 10% acetone, 90% water and 300 ppm X-77Â® Spreader Lo-Foam Formula non-ionic surfactant containing alkylarylpolyoxyethylene, free fatty acids, glycols and isopropanol (Loveland Industries, Inc.), unless otherwise indicated. The formulated compounds were applied in 1 mL of liquid through a SUJ2 atomizer nozzle with 1/8 JJ custom body (Spraying Systems Co.) positioned 1.27 cm (0.5 inches) above the top of each test unit. AH experimental compounds in these tests were sprayed at 250 ppm and replicated three times. After spraying of the formulated test compound, each test unit was allowed to dry for 1 hour and then a black, screened cap was placed on top. The test units were held for 6 days in a growth chamber at 25 Â°C and 70% relative humidity. Plant feeding damage was then visually assessed based on foliage consumed.<br>
Of the compounds tested the following provided very good to excellent levels of plant protection (ratings of 0-1,10% or less feeding damage): 1, 2, 3, 4, 5, 6, 7, 8,9, 12, 13,15,<br><br>
 02/070483<br><br>
PCT/rTS02/06582<br><br>
195<br>
16,19, 20, 21, 22, 23, 24, 30, 31, 32, 33, 34, 36, 37, 38, Bl, B3, B5, Bl 1, B12, B15, CI, C2, C3, C7, C9, C24, Dl, D3, D4, D5, D6, D7, D8, D10, Dl 1, D12, D13, D14, D18, D19, D20, D21, E5, E6, E7, E8, E9, E10, El 1, E12, E13, E14, E15, E16, E17, E19, E20, E21, E22, Gl, G2, G4, G5, G6, G7, G8 G9: G10, G1l, G12, G13, J6, Kl and K2.<br>
5	TEST B<br>
For evaluating control of fall armyworm (Spodoptera frugiperda) the test unit consisted of a small open container with a 4â€”5-day-old com (maize) plant inside. This was pre-infested (using a core sampler) with 10-15 1-day-old larvae on a piece of insect diet. Test compounds were formulated and sprayed at 250 ppm as described for Test A. 10      The applications were replicated three times. After spraying, the test units were maintained in a growth chamber and then visually rated as described for Test A.<br>
Of the compounds tested, the following provided excellent levels of plant protection (10% or less feeding damage): 30, 31, 32, 33, 34, 35, 36, B10, Bll, B12, B13, B14, Dl, D3, D7,D8, D10,D11, D14, D15, E5, E6, E7, E9, ElO, El 1, E12, E13, E22, G2, G4, G5, G6, G7, 15      G9, G10, Gll,G12,G13,J6 and K2.<br>
TEST C<br>
For evaluating control of tobacco budworm (Heliothis virescens) the test unit<br>
consisted of a small open container with a 6-7 day old cotton plant inside. This was pre-<br>
infested (using a core sampler) with 8 2-day-old larvae on a piece of insect diet.<br>
20	Test compounds were formulated and sprayed at 250 ppm as described for Test A.<br>
The applications were replicated three times. After spraying, the test units were maintained in a growth chamber and then visually rated as described for Test A.<br>
Of the compounds tested, the following provided very good to excellent levels of plant protection (20% or less feeding damage): 31,32,33,34,35,36,37,312313,614,    ; 25      B15, Dl, D4, D5, D6, D8, D10, Dl 1, D12, D13, D14, D15, D18, D19, D20, D21, E5, E6, E7,E9, E10,E12, E15,E20,E21, E22, G2, G5t G6, G7, G8, G9, G10, Gil, G12, and G13.<br>
TEST D For evaluating control of beet armyworm (Spodoptera exigua) the test unit consisted of a small open container with a 4â€”5-day-old corn plant inside. This was pre-infested (using 30      a core sampler) with 10-15 1-day-old larvae on a piece of insect diet.<br>
Test compounds were formulated and sprayed at 250 ppm as described for Test A. The applications were replicated three times. After spraying, the test units were maintained in a growth chamber and then visually rated as described for Test A.<br>
Of the compounds tested, the following provided very good to excellent levels of 35     plant protection (20% or less feeding damage): 31, 32, 34, B13, B15, Dl, D3, D4, D7, D8, D10, Dll, D14, D19, E5, E6, E7, E9, ElO, E15, E22, Gl, G2, G4, G5, G6, G7, G9, G10, Gl 1, G12, G13, D20, J6 and K2.<br><br>
WO 02/070483<br><br>
PCT/US02/06582<br><br>
196<br>
TEST E For evaluating control of green peach aphid {Myzus persicae) through contact and/or systemic means, the test unit consisted of a small open container with a 12-15-day-old radish plant inside. This was pre-infested (using the cut leaf method) with 30-40 insects on 5      each piece of leaf, and the soil was covered with a layer of sand.<br>
Test compounds were formulated and sprayed at 250 ppm as described for Test A. The applications were repUcated three times. After spraying, the test units were maintained in a growth chamber and then visually assessed for insect mortality.<br>
Of the compounds tested, the following resulted in at least 80% mortality: C48, El 3, 10     E14,E16, G4, G9,G1Q,G11 and G13.<br>
TEST F For evaluating control of cotton melon aphid (Aphis gossypii) through contact and/or systemic means, the test unit consisted of a small open container with a 6-7-day-old cotton plant inside. This was pre-infested (using the cut leaf method) with 30-40 insects on each 15      piece of leaf, and the soil was covered with a layer of sand.<br>
Test compounds were formulated and sprayed at 250 ppm as described for Test A. The applications were replicated three times. After spraying, the test units were maintained in a growth chamber and then visually rated as described for Test E.<br>
Of the compounds tested, the following resulted in at least 80% mortality: E9.<br><br>
We Claim<br>
1. A compound of Formula I, an //-oxide thereof or suitable salt thereof<br><br><br>
"     .N.   â– "."â– . <br>
I<br>
wherein<br>
A and B are independently O or S;<br>
each J is independently a phenyl ring, a naphthyl ring system, a 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system wherein each ring or ring system is optionally substituted with 1 to 4 R5;<br>
K is, together with the two contiguous linking carbon atoms, a 5- or 6-membered heteroaromatic ring optionally substituted with 1 to 3 R4;<br>
nis 1 to 3;<br>
R1 is H; or C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl or C3-C6 cycloalkyl, each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, N02, hydroxy, C1-C4 alkoxyC1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C2-C4 alkoxycarbonyl, C1-C4 alkylammo, C2-C6 dialkylammo and C3-C6 cycloalkylamino; or<br>
R1 is C2-C6 alkylcarbonyl, C2-C6 alkoxycarbonyl,C2-C6 alkylaminocarbonyl, C3-C8 dialkylaminocarbonyl or C(=A)J;<br>
R2 is H, CrC6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C1-C4 alkoxy, C1-C4 alkylammo, C2-C6 dialkylammo, C3-C6 cycloalkylamino, C2-C6 alkoxycarbonyl or C2-Cg alkylcarbonyl;<br>
R3 is H; G; or CrC6 alkylC2-C6  alkenyl,C2-C6  alkynyl, C3-C6 cycloalkyl, each optionally substituted with one or more substituents selected from the group consisting of G, halogen, CN, N02, hydroxy,C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthioC1-C4alkylsulfinyl, C1-C4 alkylsulfonyl, C2-C6 alkoxycarbonyl, C2-C6 alkylcarbonyl, C3-C6 trialkylsilyl and a phenyl,<br><br>
phenoxy or 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6; or<br>
R2 and R3 can be taken together with the nitrogen to which they are attached to form a ring containing 2 to 6 atoms of carbon and optionally one additional atom of nitrogen, sulfur or oxygen, and said ring may be optionally substituted with one to four substituents selected from R12; and G is a 5- or 6-membered nonaromatic carbocyclic or heterocyclic ring, optionally including one or two ring members selected from the group consisting of C(=0), SO and S(0)2, and optionally substituted with one to four substituents selected from R12;<br>
each R4 is independently H,C1C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C1C6 haloalkyl, C2-C6 haloalkenyl, C2-C6g haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, hydroxy,  C1-C4 alkoxy,  C1-C4 haloalkoxy,  C1-C4 alkylthio,  C1-C4 alkylsulfinyl, Cj-C4 alkylsulfonyl,  C1-C4 haloalkylthio, C1-C4 haloalkylsulfinyl,  C1-C4 haloalkylsulfonyl,  C1-C4 alkylammo, C2-C6 dialkylamuio, C3-C6 cycloalkylamino, C1-C4 alkoxyalkyl, C1-C4hydroxyalkyl, C(O)RW, C02R10, C(O)NRlOR11, NR10Rn, N(R11)C02R10; or each R4 is independently a phenyl, benzyl, phenoxy or 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6;<br>
each R5 is independently H, C^-Cg alkyl, C2-Cg alkenyl, C2-Cg alkynyl, C3-Cg cycloalkyl, Cj-Cg haloalkyl, C2-Cg haloalkenyl, C2-Cg haloalkynyl, C3-Cg halocycloalkyl, halogen, CN, C02H, CONH2, N02, hydroxy, CrC4 alkoxy, C1-C4 haloalkoxy, C!-C4 alkylthio, CJ-C4 alkylsulfinyl, CJ-C4 alkylsulfonyl, C1-C4 haloalkylthio, C \ -C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylamino, C2-C8 dialkylamino, C3-C6 cycloalkylamino, C2-Cg alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3-C8 dialkylaminocarbonyl, C3-Cg trialkylsilyl; or<br>
each R5 is independently a phenyl, benzyl, benzoyl, phenoxy, 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system, each ring or ring system optionally substituted with one to three substituents independently selected from R6; or<br>
(R5)2 when attached to adjacent Carbon atoms can be taken together as -OCF2Q-," -CF2CF20-, or-OCF2CF20-; and<br><br>
each R6 is independently C1-C4 alkyl, C2-C4 alkenyl,  C2-C4 alkynyl, C3-C6<br>
cycloalkylC1-C4  haloalkyl/C2-C4 haloalkenyl,  C2-C4 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, C1-C4 alkoxy, C1-C4   haloalkoxy, C2-C4 alkylthio, C1-C4  alkylsulfinylC1-C4  alkylsulfonyl, C1-C4  alkylamino,  C2-C4 dialkylamino, C3-C6 cycloalkylamino, C4-C6 (alkyl)cydoalkylamino, C2-C4 alkylcarbonyl, C2-C6 alkoxycarbonyl,  C2-C6  alkylaminocarbonyl, C3-C8 dialkylaminocarbonyl or, C3-C6trialkylsilyl;<br>
each R10 is independently H, C1-C4 alkyl or C4-C6  haloalkyl;<br>
each R11 is independently H or C1-C4 alkyl; and<br>
each R12 is independently C1-C2 alkyl, halogen, CN, N02 or C1-C2  alkoxy; provided that<br>
(1)	when J is a phenyl ring optionally substituted with 1 to 4 R5, then<br>
A and B are both O;<br>
R1sH;<br>
R2 is H or CH3;<br>
R3  is C1-C4 4 alkyl optionally substituted with one or more substituents independently selected from halogen, CN, OCH3 or S(0)pCH3;<br>
each R4 is independently CH3, CF3, CN or halogen, and one R4 group is attached to the K ring at the atom adjacent to the NR^C(=A)J moiety;<br>
each R5 is independently H, halogen, methyl, CF3, OCF3, OCHF2, S(0)pCF3,<br>
S(0)pCHF2, OCH2CF3, OCF2CHF2, S(0)pCH2CF3 or S(0)pCF2CHF2; or a phenyl, pyrazole, imidazole, triazole, pyridine or pyrimidine ring, each ring optionally substituted with one to three substituents independently selected from C1-C4  alkyl, C1-C4  haloalkyl, halogen or CN;<br>
p is 0,1 or 2;<br>
(2)	the compound of Formula I is other than 5-(benzoylamino)-iV-methyl- \H-<br>
imidazole-4-carboxamide; and<br>
(3)	the compound of Formula I is other than l-(4-fluorobenzyl)-4-(3-<br>
pyridylcarbonylamino)-5-irnidazolecarboxamide, l-(3-chlorobenzyl)-4-(3-pyridylcarbonylammo)-5-imidazolecarboxarnide, l-(4-t-butylbenzyi)-4-(3-pyridylcarbonylamino)-5-imidazolecarboxamide, l-(3-methoxybenzyl)-4-(3-pyridylcarbonylamino)-5-imidazolecarboxamide, l-(4-methylbenzyl)-4-(3-pyridylcarbonylamino)-5-imidazolecarboxamide, l-(2-fiuorobenzyl)-4-(3-pyridylcarbonylamino)-5-imidazolecarboxamide, l-benzyl-4-(2-pyridylcarbonylamino)-5-imidazolecarboxamide, 1 -benzyl-4-(4-pyridylcarbonylammo)-5-imidazolecarboxamide, l-(4-t-butylbenzyl)-4-(4-<br><br>
pyridylcarbonylanimo)-5-imidazolecarboxarmde/l-(4-fluorobenzyl)-4-(4-pyridylcarbonylamino)-5-imidazolecarboxamide, and l-benzyl-4-(2-mienylcarbonylammo)-5-imidazolecarboxamide.<br>
2.	The compound as claimed in claim 1 wherein J is a phenyl ring optionally substituted with 1 to 4 R5.<br>
3.	The compound as claimed in claim 2 wherein R3 is C1-C4 alkyl.<br>
4.	The compound as claimed in claim 1 wherein<br>
A and B are both O;<br>
J is a 5- or 6-membered heteroaromatic ring selected from the group consisting of J-1.J-2.J-3, J-4 and J-5,<br><br><br><br><br><br>
Q is O, S or NR5; and<br>
W, X, Y and Z are independently N or CR5, provided that in J-4 and J-5 at least one ofW,X,Y or Z is N.<br>
5.	The compound of Claim 4 wherein<br>
each R4 is independently C1C4 alkyl C1C4haloalkyl, halogen, CN, N02 or<br>
 C1C4 alkoxy, and one R4 group is attached to the K ring at the atom adjacent to either the NR1C(=A)J moiety or the C(=B)NR2R3 moiety; and<br>
each R5 is independently H,  C1C4alkyl,  C1C4 haloalkyl, halogen, CN, N02, C1-C4 haloalkoxy C1C4alkylthio,  C1C4alkylsulfinyl,  C1C4 alkylsulfonyl,  C1C4 haloalkylthio, C1C4haloalkylsulfinyl,  C1C4 haloalkylsulfonyl or C2-C4 alkoxycarbonyl; or a phenyl or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with R6.<br>
6.	The compound as claimed in claim 5 wherein<br>
J is selected from the group consisting of J-6, J-7, J-8, J-9, J-10, J-11, J-12 and J-13<br><br><br><br><br><br><br><br><br><br>
and<br><br>
R5 is H, C1C4 alkyl, C1-C4 haloalkyl, or<br>
V is N, CH, CF, CC1, CBr or CI;<br>
each R6 and R7 is independently H,  C1-C6 alkyl, C3-C6 cycloalkyl, C1-C6<br>
haloalkyl, halogen, CN,  C1-C4 alkoxy,  C1-C4 haloalkoxy or C1-C4<br>
haloalkylthio; and R9 is H, CrC6 alkyl, CrC6 haloalkyl, C3-C6 alkenyl, C3-C6 haloalkenyl, C3-C6<br>
alkynyl or C1-C6 haloalkynyl; provided R7 and R9 are not both H.<br>
7.	The compound of Claim 6 wherein V is N.<br>
8.	The compound of Claim 6 wherein V is CH, CF, CC1 or CBr.<br>
9.	The compound of Claim 7 or Claim 8 wherein R1is H;<br>
R2is H or CH3;<br>
R3 is  C1-C4 alkyl optionally substituted with one Or more substituents<br>
independently selected from halogen, CN, OCH3 or S(0)pCH3; each R4 is independently CH3, CF3, CN or halogen, and one R4 group is attached<br>
to the K ring at the atom adjacent to the NR1C(=A)J moiety;<br><br>
R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R7 is H, CH3, CF3, OCH2CF3, OCHF2 or halogen; and p is 0,1 or 2.<br>
10.	The compound as claimed in claim 9 wherein R3 is C1-C4 alkyl; one R4 group is independently CH3, C1, Br or I and is attached to the K ring at the atom adjacent to the NR!C(=A)J moiety; and a second optional R4 is H, F, CI, Br, I or CF3.<br>
11.	The compound as claimed in claim 10 wherein J is J-6; R6 is Cl or Br; and R7 is halogen, OCH2CF3 or CF3.<br>
12.	The compound as claimed in claim 11 wherein V is N; R3 is methyl, ethyl, isopropyl or tertiary butyl; and R7 is Br, Cl, OCH2CF3, or CF3.<br>
13.	The compound as claimed in claim 10 wherein J is J-7; R6 is Cl or Br; and R9 is CF3, CHF2, CH2CF3 or CF2CHF2.<br>
14.	The compound as claimed in claim 10 wherein J is J-8; R6 is Cl or Br; and R7 is halogen, OCH2CF3 or CF3.<br>
15.	The compound as claimed in claim 10 wherein J is J-9; R6 is Cl or Br; and R7 is OCH2CF3 or CF3.<br>
16.	The compound as claimed in claim 10 wherein J is J-10;R6 is Cl or Br; and R9 is CF3, CHF2, CH2CF3 or CF2CHF2.<br>
17.	The compound as claimed in claim 10 wherein J is J-ll; R6 is Cl or Br; and R7 is halogen, OCH2CF3 or CF3.<br>
18.	The compound as claimed in claim 10 wherein J is J-12; R6 is Cl or Br; R7 is H, halogen or CF3, and R9 is H, CF3, CHF2, CH2CF3, or CF2CHF2.<br>
19.	The compound as claimed in claim 10 wherein J is J-13; R6 is Cl or Br; R7 is H, halogen or CF3, and R9 is H, CF3, CHF2, CH2CF3 or CF2CHF2-<br>
20.	The compound as claimed in claim 1 selected from the group consisting of:<br>
4- [[[ 1 -(2-Chlorophenyl)-3 -(trifluoromethyl)- l#-pyrazol-5-yl] carbonyl] amino] -<br>
5-memyl-iV-l-memylethyl)-3-pyridincarboxamide,<br>
4-Memyl-N(l-methylethmyl)-3-[[2-memyl-4-(trifluoromemyl)benzoyl]amino]-2-thiophencarboxamide,<br>
1 -Methyl-N-( 1 -methylethyl)-5- [ [4-(trifluoromethyl)benzoyl] amino] - \H-<br>
pyrazole-4-carboxamide;<br>
4-[[[3-Bromo-l-(3-chloro-2-pyridmyl)-l/f-pyrazol-5-yl]carbonyl]amino]-5-<br>
chloro-iV-methyl-3-pyridinecarboxamide;<br>
3-[[[3-Bromo-l-(3-chloro-2-pyridmyl)-l//-pyrazol-5-yl]carbonyl]amino]-2,6-<br>
dichloro-iV-methyl-4-pyridinecarboxamide;<br><br>
2,6-dichlord-3-f[[l-(3-chloro-2-pyridinyl)-3-(truf1uoromethyl)-li/-pyrazol-5-<br>
yl] carbonyl] amino] -N-( 1 -methylethyl)- 4-pyridinecarboxamide;<br>
3-[[[3-Bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]carbonyl]amino]-6-<br>
chloro-A^,4-dimethyl-2-pyridinecarboxamide;<br>
3-[[[3-Bromo-l-(3-chloro--2-pyridmyl)-l//-pyrazol-5-yl]carbonyl]amino]-4,6-<br>
dichloro-A^methyl-2-pyridinecarboxamide;<br>
5- [[ [3 -Chloro-1 -(3 -ehloro-2-pyridjnyl)- l#-pyrazol-5-yl] carbonyl] amino] -N,6-<br>
dimethyl-4-pyrimidinecarboxami(|e; and<br>
5- [[ [3-Bromo-l -(3 -chloro-2-pyridinyl)- l/7-pyrazol-5-yl] carbonyl] amino] -<br>
Af,A^2,6tetramemyl-4-pyridmecarboxamide.<br>
21.	A method for controlling an invertebrate pest comprising contacting the<br>
invertebrate pest or its environment with a biologically effective amount of a compound<br>
of Claim 1 or a compound selected from the group consisting of 5-(benzoylamino)-iV-<br>
methyl- l/H-midazole-4-carboxamide, 1 -(4-fluorobenzyl)-4-(3 -pyridylcarbonylamino)-5-<br>
imidazolecarboxamide, l-(3-cmorobenzyl)-4-(3-pyridylearbonylamino)-5-<br>
imidazolecarboxamide, l-(4-t-butylbenzyl)-4-(3-pyridylcarbonylamino)-5-<br>
imidazolecarboxamide, l-(3-memoxybenzyl)-4-(3-pyridylcarbonylamino)-5-<br>
imidazolecarboxamide, l-(4-memylberizyl)-4-(3-pyridylcarbonylamino)-5-<br>
imidazolecarboxamide, l-(2-fluoroberizyl)-4K3-pyridylcarbonylamino)-5-<br>
imidazolecarboxamide, 1 -benzyl-4-(2-pyridylcarbonylamino)-5-imidazolecarboxamide,<br>
1 -benzyl-4-(4-pyridylcarbonylamino)-5-imidazolecarboxamide, 1 -(4-t-butylbenzyl)-4-(4-pyridylcarbonylamino)-5-imidazolecarboxamide) l-(4-fluorobenzyI)-4-(4-pyridylcarbonylamino)-5-imidazolecarboxamide, and 1-benzyl-4-(2-thienylcarbonylamino)-5-imidazolecarboxamide, or an agriculturally suitable salt thereof.<br>
22.	The method as claimed in claim 21 comprising a biologically effective amount of at least one additional compound or agent for controlling invertebrate pests.<br>
23.	A composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Claim 1, or a compound Selected from the group consisting of 5-(benzoylamino)-iV-methyl-l//-imidazole-4-carboxamide, l-(4-fluorobenzyl)-4-(3-pyridylcarbonylammo)-5-imidazolecarboxamide, l-(3-chlorobenzyl)-4-(3-pyridylcarbonylamino)-5-imidazolecarboxamide, l-(4-t-butylbenzyl)-4-(3-pyridylcarbonylanTino)-5-imidazolecarboxamide, l-(3-methoxybenzyl)-4-(3-pyridylcarbonylamino)-5-imidazolecarboxamide, l-(4-methylbenzyl)-4-(3-pyridylcarbonylammo)-5-imidazolecarboxamide, l-(2-fluorobenzyl)-4-(3-pyridylcarbonylamino)-5-imidazolecarboxamide, l-benzyl-4-(2-pyridylcarbonylamino)-5-imidazolecarboxamide, l-benzyl-4-(4-pyridylcarbonylamino)-5-<br><br>
imidazolecarboxamide, l-(4-t-butylbenzyl)-4-(4-pyridylcarbonylamino)-5-imidazolecarboxamide, 1 -(4-fluorobenzyl)-4-(4-pyridylcarbonylamino)~5-imidazolecarboxamide, and l-benzyl-4-(2-thienylcarbonylamino)-5-irnidazolecarboxamide, or an agriculturally suitable salt thereof, and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents.<br>
24.     The composition as claimed in claim 23 further comprising a biologically effective amount of at least one additional compound or agent for controlling invertebrate pests.<br>
Dated this 22nd day of July 2003<br>
Archana Shanker<br>
Anand and Anand Advocates<br>
Attorneys for the applications<br>
Anand and Anand, Advocates Attorneys for the applicants</td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLW11bW5wLTIwMDMtYWJzdHJhY3QoMDgtMDItMjAwOCkuZG9j" target="_blank" style="word-wrap:break-word;">720-mumnp-2003-abstract(08-02-2008).doc</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLW11bW5wLTIwMDMtYWJzdHJhY3QoMDgtMDItMjAwOCkucGRm" target="_blank" style="word-wrap:break-word;">720-mumnp-2003-abstract(08-02-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLW11bW5wLTIwMDMtY2FuY2VsbGVkIHBhZ2VzKDA4LTAyLTIwMDgpLnBkZg==" target="_blank" style="word-wrap:break-word;">720-mumnp-2003-cancelled pages(08-02-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLW11bW5wLTIwMDMtY2xhaW1zKGdyYW50ZWQpLSgwOC0wMi0yMDA4KS5kb2M=" target="_blank" style="word-wrap:break-word;">720-mumnp-2003-claims(granted)-(08-02-2008).doc</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLW11bW5wLTIwMDMtY2xhaW1zKGdyYW50ZWQpLSgwOC0wMi0yMDA4KS5wZGY=" target="_blank" style="word-wrap:break-word;">720-mumnp-2003-claims(granted)-(08-02-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLW11bW5wLTIwMDMtY29ycmVzcG9uZGVuY2UgMSgwOC0wOC0yMDAzKS5wZGY=" target="_blank" style="word-wrap:break-word;">720-mumnp-2003-correspondence 1(08-08-2003).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLW11bW5wLTIwMDMtY29ycmVzcG9uZGVuY2UgMigwOC0wMi0yMDA4KS5wZGY=" target="_blank" style="word-wrap:break-word;">720-mumnp-2003-correspondence 2(08-02-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLU1VTU5QLTIwMDMtQ09SUkVTUE9OREVOQ0UoMTgtNC0yMDExKS5wZGY=" target="_blank" style="word-wrap:break-word;">720-MUMNP-2003-CORRESPONDENCE(18-4-2011).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLW11bW5wLTIwMDMtY29ycmVzcG9uZGVuY2UoaXBvKS0oMTktMDItMjAwNykucGRm" target="_blank" style="word-wrap:break-word;">720-mumnp-2003-correspondence(ipo)-(19-02-2007).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLW11bW5wLTIwMDMtZm9ybSAxKDA4LTAyLTIwMDgpLnBkZg==" target="_blank" style="word-wrap:break-word;">720-mumnp-2003-form 1(08-02-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLU1VTU5QLTIwMDMtRk9STSAxKDE4LTQtMjAxMSkucGRm" target="_blank" style="word-wrap:break-word;">720-MUMNP-2003-FORM 1(18-4-2011).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLW11bW5wLTIwMDMtZm9ybSAxMygwOC0wMi0yMDA4KS5wZGY=" target="_blank" style="word-wrap:break-word;">720-mumnp-2003-form 13(08-02-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLW11bW5wLTIwMDMtZm9ybSAxMygxOC00LTIwMTEpLnBkZg==" target="_blank" style="word-wrap:break-word;">720-mumnp-2003-form 13(18-4-2011).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLW11bW5wLTIwMDMtZm9ybSAxMygyMi0wNy0yMDAzKS5wZGY=" target="_blank" style="word-wrap:break-word;">720-mumnp-2003-form 13(22-07-2003).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLW11bW5wLTIwMDMtZm9ybSAxMygyMi0xMS0yMDA1KS5wZGY=" target="_blank" style="word-wrap:break-word;">720-mumnp-2003-form 13(22-11-2005).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLW11bW5wLTIwMDMtZm9ybSAxOCgyNy0wMi0yMDA2KS5wZGY=" target="_blank" style="word-wrap:break-word;">720-mumnp-2003-form 18(27-02-2006).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLW11bW5wLTIwMDMtZm9ybSAxYSgyMi0wNy0yMDAzKS5wZGY=" target="_blank" style="word-wrap:break-word;">720-mumnp-2003-form 1a(22-07-2003).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLW11bW5wLTIwMDMtZm9ybSAyKGdyYW50ZWQpLSgwOC0wMi0yMDA4KS5kb2M=" target="_blank" style="word-wrap:break-word;">720-mumnp-2003-form 2(granted)-(08-02-2008).doc</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLW11bW5wLTIwMDMtZm9ybSAyKGdyYW50ZWQpLSgwOC0wMi0yMDA4KS5wZGY=" target="_blank" style="word-wrap:break-word;">720-mumnp-2003-form 2(granted)-(08-02-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLU1VTU5QLTIwMDMtRk9STSAyKFRJVExFIFBBR0UpLSgxOC00LTIwMTEpLnBkZg==" target="_blank" style="word-wrap:break-word;">720-MUMNP-2003-FORM 2(TITLE PAGE)-(18-4-2011).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLW11bW5wLTIwMDMtZm9ybSA1KDA4LTAyLTIwMDgpLnBkZg==" target="_blank" style="word-wrap:break-word;">720-mumnp-2003-form 5(08-02-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLW11bW5wLTIwMDMtZm9ybSA1KDIyLTA3LTIwMDMpLnBkZg==" target="_blank" style="word-wrap:break-word;">720-mumnp-2003-form 5(22-07-2003).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLW11bW5wLTIwMDMtZm9ybS1wY3QtaXBlYS00MDkoMjItMDctMjAwMykucGRm" target="_blank" style="word-wrap:break-word;">720-mumnp-2003-form-pct-ipea-409(22-07-2003).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLW11bW5wLTIwMDMtZm9ybS1wY3QtaXNhLTIxMCgyMi0wNy0yMDAzKS5wZGY=" target="_blank" style="word-wrap:break-word;">720-mumnp-2003-form-pct-isa-210(22-07-2003).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLW11bW5wLTIwMDMtcG93ZXIgb2YgYXR0b3JuZXkoMDgtMDItMjAwOCkucGRm" target="_blank" style="word-wrap:break-word;">720-mumnp-2003-power of attorney(08-02-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzIwLW11bW5wLTIwMDMtcG93ZXIgb2YgYXR0b3JuZXkoMjItMDctMjAwMykucGRm" target="_blank" style="word-wrap:break-word;">720-mumnp-2003-power of attorney(22-07-2003).pdf</a></p>
		<br>
		<div class="pull-left">
			<a href="216028-composition-for-the-effective-treatment-of-mycoses.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="216030-profiled-rail-system-for-bridging-floorcovering-transitions.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>216029</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>720/MUMNP/2003</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>13/2008</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>28-Mar-2008</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>05-Mar-2008</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>22-Jul-2003</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>E.I. DU PONT DE NEMOURS AND COMPANY</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>1007 MARKET STREET, WILMINGTON, DELAWARE 19898</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>GARY DAVID ANNIS</td>
											<td>13 FRANKLIN ROAD,LANDENBERG, PA 19350, USA</td>
										</tr>
										<tr>
											<td>2</td>
											<td>BRUCE LAWRENCE FINKELSTEIN</td>
											<td>204 VALLEY STREAM DRIVE, NEWARK, DE 19702</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>C07D213/82</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/US02/06582</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>2002-02-28</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>09/273,474</td>
									<td>2001-03-05</td>
								    <td>U.S.A.</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/216029-a-zirconium-complex by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 10:12:03 GMT -->
</html>
